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ABSTRACT 
 Direct C–H bond functionalization provides an efficient route by allowing the 
construction of C – C bonds directly from C–H bonds. In this dissertation, methods using 
first-row transition metals as catalysts for C–H bond functionalization have been 
developed. Furthermore, protocols for direct arylation via benzyne intermediates have 
been demonstrated. 
 A number of first-row transition metal salts such as nickel, cobalt, and manganese 
chlorides have been shown to catalyze deprotonative dimerization of acidic arenes. Five- 
or six-membered ring heterocycles as well as electron-poor arenes can be dimerized 
under oxygen atmosphere when tetramethylpiperidine or dicyclohexylamide bases are 
employed.  
 An auxiliary-assisted, copper-catalyzed fluorination of benzoic derivative β-C-H 
bonds has been developed. The method employs silver(I) fluoride as fluorinating reagent, 
copper(I) iodide catalyst, and N-methylmorpholine oxidant. By optimizing conditions, 
mono- or di-fluorination can be achieved selectively. The method provides an efficient 
alternative for preparation of aryl fluorides.  
 An efficient method for base-promoted direct C-arylation of arenes such as 
heterocycles, alkynes, phenols, and anilines has been demonstrated. Under basic 
conditions, a variety of arenes can be arylated by aryl halides and aryl triflates. A variety 
of functional groups, such as alkene, ether, dimethylamino, trifluoromethyl, ester, cyano, 
halide, hydroxyl, ketone, and silyl are tolerated. The reactions are carried out at mild 
temperatures and proceed via aryne intermediates. In addition, a general method for 
 vi 
trapping aryl lithium intermediates with various electrophiles has been described. 
Furthermore, new reaction between phenols and aryl halides forming helicenes has been 
discovered. 
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Chapter 1 
Biaryl Formation Via Oxidative Homocoupling Reactions 
 
 
 
 
 
 
 
 
 
 
 2 
1.1. Transition-metal Catalysis 
1.1.1. Introduction 
 The potential applications of symmetrical bi- or polyaryls in optical materials, 
molecular devices, or organic conductors are well-recognized.
1
 Traditional routes to 
access these molecules often suffer from disadvantages such as harsh conditions, low 
yields, and limited reaction scope.
2
 Ullmann coupling is an example in which a 
stoichiometric reductant and high temperature are needed to obtain reasonable yields. 
Therefore, it is interesting to develop more convenient methods for polyaryl synthesis. 
Within this chapter, recent developments to construct symmetrical arenes using transition 
metal catalysts will be reviewed. 
1.1.2. Homocoupling of Arenes 
1.1.2.1. Homocoupling of Aryl Metals 
Oxidative homocoupling of aryl–metal reagents has been extensively 
investigated.
3
 A wide variety of transition metals such as palladium, copper, and iron 
have been used as catalysts in combination with various oxidants. Additionally, several 
other methods have also been disclosed for the formation of symmetrical biaryls from 
corresponding aryl Grignards.
3,4 
Ellis and co-workers reported the formation of biphenyl by irradiation of aryl 
lithium.
4
 Under a high-pressure mercury arc lamp, 0.04 M solutions of phenyllithium in 
diethyl ether gave over 80% yield of biphenyl and metallic lithium. This coupling is 
regiospecific. 2-Naphthyllithium afforded exclusively 2,2’-binaphthyl. Only small 
amounts of products resulting from radical attack on solvent were detected. 
 3 
Scheme 1.1. Biphenyl formation by irradiation of aryl lithium 
 
 
 Homocoupling of organogold species was also observed by Vaughan.
5
 2-
Quinolylgold(I) was subjected to the pyrolysis conditions at high temperatures. Clean 
formation of 2,2’-biquinolyl was obtained. Similar transformations were reported with 
other quinolylgold(I) derivatives.  
Scheme 1.2. Biaryl formation via organogold species 
 
 
In 1996, Manas reported a method for symmetric biaryl formation from 
arylboronic acids under palladium catalysis. Reactions were conducted at room 
temperature and good yields were obtained with various arylboronic acids when oxygen 
was used as oxidant.
6
 A palladium-catalyzed transformation using arylstannates as 
starting materials was also described.
7
 The method employed a palladium-
 4 
iminophosphine complex as catalyst, air as oxidant and reactions were run at elevated 
temperatures. 
Scheme 1.3. Homocoupling of aryl boronic acids under palladium catalysis 
 
 
Procedures using non-noble transition metals have been reported. Copper-
catalyzed homocoupling of arylsilanes has been disclosed by the Kang group.
8
 In the 
presence of tetrabutylamonium fluoride, a variety of aryl silanes can be efficiently 
dimerized at room temperature in 5-10 minutes.  
Scheme 1.4. Copper-catalyzed homocoupling of organosilicon compounds 
 
 
The first catalytic system using iron as a catalyst for homocoupling of aryl 
grignard reagents was reported by Hayashi.
9
 In the presence of 1-5 % FeCl3 and 
stoichiometric amount of 1,2-dichloroethane oxidant, a variety of arylmagnesium 
 5 
bromides were efficiently converted into the corresponding symmetrical biaryls in good 
yields.  
Scheme 1.5. Iron-catalyzed dimerization of aryl Grignards 
 
 With minor modification in reaction conditions, Cahiez reported a more effient 
method applicable to wider scope of substates.
10
 Aryl Grignards were synthesized in situ 
by treating corresponding aryl iodides with isopropylmagnesium bromide at low 
temperatures. However, these methods require a stoichiometric amount of organic 
oxidant. 
Scheme 1.6. Iron-catalyzed homocoupling of aryl Grignard  
 
 The efficient iron- and manganese-catalyzed procedures to couple aryl Grignard 
at mild conditions were reported by Cahiez in 2007.
11
 For the first time, the method used 
atmospheric oxygen, an ideal oxidant for practical synthetic applications due to its 
availability and environmental friendliness. 
 6 
Scheme 1.7. Homocoupling using atmospheric oxygen as oxidant 
 
 
The reaction mechanism under manganese catalysis was proposed. The key step 
of this catalytic cycle is the conversion of the stable diorganomanganese (II) to a 
manganese (IV) peroxo complex. Rapid reductive elimination would give the 
homocoupling product and a manganese (II) peroxo complex which would react with the 
Grignard reagent to regenerate the diorganomanganese (II) species. 
 
 
 
 
 
 
 
 
 7 
Scheme 1.8. Tentative mechanism for Mn-catalyzed dimerization under oxygen 
 
Grignard dimerization under cobalt catalysis is known.
12
 In 2009, Yu reported an 
efficient procedure for cobalt-catalyzed homocoupling of aryl bromides in the presence 
of metallic magnesium. The method employed CoCl2 as catalyst and oxygen as terminal 
oxidant. 
Scheme 1.9. Homocoupling under cobalt catalysis 
 
Transition-metal-free homocoupling reactions of various organomagnesium 
compounds in the presence of commercially available TEMPO as an organic oxidant 
have been developed.
13
 The reactions could be conducted with 15 mol% of TEMPO by 
using dioxygen as the terminal oxidant. 
 
 
 8 
Scheme 1.10. Dimerization of aryl Grignard with TEMPO catalyst under oxygen 
 
 
1.1.2.2. Oxidative Homocoupling of Phenol and Aniline Derivatives 
 From economic and environmental perspectives, the direct oxidative coupling of 
two aromatic rings should be an ideal method for the synthesis of biaryls.
3
 The number of 
synthetic steps in the processes can be significantly reduced, further lowering production 
cost, and minimizing the amount of hazardous waste. Consequently, an increasing 
attention has been recently paid to direct oxidative homocoupling methodology.  
 The oxidative coupling of phenols or anilines to dimeric products is a useful 
procedure which has found extensive applications in chemical synthesis. Nakaya and co-
workers reported the first example of manganese-mediated directed dimerization of 
phenols in late 60s. 
14 
 
 
 
 
 
 
 9 
Scheme 1.11. Mn-mediated phenol dimerization 
 
 
Methods employing other first-row transition metals such as copper have been 
described.
15
 Specifically, Smrcina and co-workers have developed a facile synthesis of 
BINAPH by oxidation of 2-naphthylamine with (BnNH2)4CuCl2 promoter. Reasonable 
enantioselectivity was obtained when chiral diamine ligands such as (-)-sparteine was 
used.
16
 However, stoichiometric amount of metal was required. 
Scheme 1.12. Copper-mediated dimerization of phenols and anilines 
 
 
 10 
The first catalytic phenol homocoupling procedure was reported by Hovorka and 
co-workers. By using 10 % CuCl catalysts and stoichiometric AgCl oxidant, a variety of 
BINOLs were obtained in reasonable yields. 
17 
Scheme 1.13. Dimerization of 2-naphtholate under copper catalysis 
 
 Further modifications of reaction conditions were investigated to avoid the use of 
silver oxidant. As a result, the first efficient catalytic process for oxidative homocoupling 
of naphthol derivatives using air as the terminal oxidant under ambient conditions was 
developed.
18 
Scheme 1.14. Copper-catalyzed dimerization of phenols under oxygen 
 
Moverever, Wang and co-workers disclosed the procedure for iron-catalyzed 
biaryl coupling of 2-naphthols using meta-chloroperbenzoic acid (m-CPBA) as sole 
oxidant.
19
 Using simple workup procedues and mild conditions, reactions showed the 
potential for large-scale preparation. 
 
 11 
Scheme 1.15. Iron-catalyzed homocoupling of naphthols using m-CPBA oxidant 
 
Methods employing heterogeneous catalytic systems were also reported. High-
yielding conditions for homocoupling of 2-naphthols using alumina-supported copper(II) 
sulfate under air were described. Interestingly, the catalysts can be recycled without 
significant degradation in catalytic activity by appropriate reactivation treatment after 
oxidation reactions.
20 
Scheme 1.16. Alumina-supported copper-catalyzed dimerization of phenols 
 
I.2.3 Oxidative Homocoupling of Arenes 
In contrast with the dimerization of phenols and anilines, transition-metal-
mediated oxidative homocoupling of common arenes is more challenging. Palladium-
catalyzed dimerization of benzene has been described by employing high oxygen 
pressures and temperatures.
3
 In particular, protocols for homocoupling of arenes under 
aerobic oxidation have also been described in the presence of PdCl2 catalyst, 
Zr(OAc)4/Co(OAc)2/ Mn(OAc)2/acetylacetone cocatalyst, and AcOH/AcONa.
21
 The 
 12 
authors suggested that a peroxocobalt(III) species, Co(III)-OO-Co(III), could be 
generated in this system, although the exact role of each metallic salt was unclear. 
Reaction of Pd(0) with this species could give a Pd(II)-peroxo complex. In this way, it is 
possible to regenerate the active palladium catalyst with a faster rate than the rate of 
aggregation of Pd(0) to form inactive palladium black.  
Scheme 1.17. Palladium-catalyzed homocoupling of arenes under aerobic oxidation 
 
 
Gold could also be an efficient catalyst for the direct oxidative homocoupling of 
unactivated arenes in the presence of PhI(OAc)2 oxidant.
22
 In general, the reaction 
showed a typical electrophilic aromatic substitution pattern. It is worth mentioning that 
 13 
electron-rich heterocycles, such as thiophene, also gave the corresponding products in 
moderate yields. Remarkable functional group tolerance was observed. 
Scheme 1.18. Dimerization of arenes under gold catalysis 
 
 
The unsymmetric homocouplings of indoles were performed affording dimers at 
C2- and C3-positions.
23
 Pd(OAc)2 (5 mol %) and 1.5 equiv of monohydrated Cu(OAc)2 
were the optimum catalyst and oxidant in DMSO, respectively. Indoles bearing electron-
rich to weakly electron-poor substituents were converted to 2,3-biindolyls in moderate to 
high yields at room temperature.  
Scheme 1.19. Unsymmetric homocouplings of indoles using palladium catalyst 
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Recently, a method for copper-promoted homocoupling of 2-phenylpyridine was 
reported by the Yu group.
24
 In the presence of iodine, various 2-phenylpyridine 
derivatives could couple to afford the dimeric products in reasonable yields. The 
iodinated intermediate is formed either by single electron transfer (route A) or 
electrophilic metalation/iodination process (route B). This intermediate was suggested to 
undergo Ullmann coupling to give the desired products. 
Scheme 1.20. Proposed mechanisms for oxidative dimerization of 2-phenylpyridine 
 
 The same transformations were accomplished by employing ruthenium as the 
catalyst and FeCl3 as the oxidant.
25
 Homocouplings of arenes containing triazole- or 
pyrazole-directing groups have also been described.
26  
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Scheme 1.21. Ruthemium-catalyzed, directing group assisted dimerization of arenes 
 
 
1.2. Nickel, Cobalt, and Manganese-catalyzed Deprotonative Arene Homocoupling 
1.2.1. Introduction  
Most of the existing biaryl synthesis including Ullmann reaction requires 
functionalized starting materials. Direct dimerization of non-functionalized aromatic 
compounds should be beneficial in term of synthetic efficiency. The presence of a 
stoichiometric oxidant is essential for successful arene dimerization due to unfavorable 
energetics of dehydrogenative coupling processes. Oxygen is an ideal oxidant for 
practical synthetic applications due to its availability and environmental friendliness.
27
 
Palladium-catalyzed arene dimerization by employing oxygen as the terminal oxidant is 
known.
3
 Recently, our group described a method for copper-catalyzed, deprotonative 
arene dimerization by employing oxygen as the terminal oxidant.
28
 By analogy with 
Glaser-Hay reaction, dimerization products were obtained under oxygen from an 
organocopper species formed by combination of in situ deprotonation and 
transmetallation. 
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Scheme 1.22. Copper-catalyzed dimerization of acidic arenes 
 
 
It is known that dimerization of organometallic species can be catalyzed or 
promoted by non-noble transition metals such as Mn, Co, or Ni.
11,12,29
 As a consequence, 
one should be able to perform the deprotonation/oxidative dimerization sequences by 
employing first-row transition metals other than copper, some of which may have 
advantages.  
1.2.2. Results and Discussion 
1.2.2.1. Nickel Catalysis 
Our initial optimization focuses on developing procedure for nickel-catalyzed 
deprotonative dimerization.
 
Major amounts of phenol byproduct were obtained upon 
reacting tetrafluoroanisole with lithium or potassium alkoxide bases and catalytic NiCl2 
under O2 atmosphere. As observed in copper catalysis chemistry,
 
phenol byproducts can 
be formed either by the direct reaction of arylalkali metal intermediate with oxygen or by 
reaction of a high-valent arylnickel with hydroxide derived from water.
30
 Removing 
hydroxide from the reaction mixture, therefore, should prevent phenol formation. In 
addition, cations in less polarized carbon-metal bonds can tightly bind to hydroxide as 
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well as stabilize aryl carbanion resulting in slower reactions of arylmetal towards oxygen 
and water. As observed for copper-catalyzed dimerization, the best product yields were 
obtained by employing magnesium or zinc amide bases.  
Scheme 1.23. Formation of phenol byproducts in dimerization 
 
Magnesium tetramethylpiperidides were introducted by Eaton.
31
 Numerous 
tetramethylpiperidide bases have been extensively investigated by Knochel for a variety 
of deprotonation/functionalization procedures.
32
 The rationale for the use of base 
mixtures is as follows. Even though the basicity of zinc bases is weaker than that of 
magnesium bases, zinc amide bases afford more stable organometal intermediates 
avoiding phenol formation. Therefore, for functionalization of highly acidic or sensitive 
substrates, zinc bases are employed. For less acidic compounds, magnesium amide bases 
allow for a relatively rapid deprotonation. In most cases, a mixture of magnesium and 
zinc bases was employed. The optimal composition of the base depends on substrate. 
Four different bases were synthesized and employed in arene dimerization.  
Scheme 1.24. Base sythesis 
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Table 1.1. Dimerization under nickel catalysis 
 
Entry Arene, base Product Yield (%) 
1 
Thiazole 
base 1+base 3 (0.54/1)  
83 
71
b 
2 Benzofuran, base 1 
 
45 
3 3-Chloropyridine, base 1 
 
53 
4 
1,3-Difluorobenzene, 
base 1+base 3 (2/1) 
 
75 
70
b 
5 
2,4-Difluoronitro-
benzene, base 3 
 
73 
a
Substrate (1 equiv), base (1.2-1.4 equiv). Yields are isolated yields. 
b
Dicyclohexylamide base. 
 
The results of dimerization reactions under nickel catalysis are shown in Table 
1.1. The optimal procedure employs 5 mol % of NiCl2 catalyst at 0-60 °C in THF solvent 
under 1 atm of oxygen. Electron-rich heterocycles such as thiazole (entry 1) and 
benzofuran (entry 2) can be dimerized in good yields. Six-membered ring heterocycles 
such as 3-chloropyridine are reactive affording the dimer in 33% yield (entry 3). 
Reactions are not limited to electron-deficient arenes. 1,3-Difluorobenzene and 
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difluoronitrobenzene (entries 4 and 5) are functionalized at the most acidic C-H bonds. In 
entries 1 and 4, cheaper dicyclohexylamide bases afford yields comparable to those using 
tetramethylpiperidides. 
1.2.2.2. Cobalt Catalysis 
Table 1.2. Dimerization under cobalt catalysis 
 
Entry Arene, base Product Yield (%) 
1 
Thiazole 
base 1+base 3 (0.8/1)  
86 
70
b 
2 Benzothiophene, base 1 
 
85 
78
b
 
3 n-Butylimidazole, base 1 
 
80 
4 
Tetrafluoroanisole, base 
1+base 3 (7.3/1) 
 
90 
87
b 
5 
3,5-difluorobenzonitrile, 
base 1+base 3(1/2) 
 
80 
a
Substrate (1 equiv), base (1.2-1.7 equiv). Yields are isolated yields. 
b
Dicyclohexylamide base. 
Cobalt salts are known to selectively catalyze dimerization of aryl Grignards.
12
  
As shown in Table 1.2, under conditions similar to the ones described for nickel, cobalt 
(II) chloride catalyzes arene deprotonative dimerization. The thiazole dimerization is 
possible affording the dimer in 86% yield (entry 1). Homocoupling of electron-rich 
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heterocycles such as benzothiophene (entry 2) and N-butylimidazole (entry 3) affords 
products in 85 % and 80 %, respectively. Electron-poor tetrafluoroanisole (entry 4) and 
difluorobenzonitrile (entry 5) can be dimerized in excellent yields. Entries 1, 2, and 4 
were also run with dicyclohexylamide bases. 
1.2.2.3. Manganese Catalysis 
 Dimerization of organomagnesium species can be catalyzed by employing 
manganese salts.
11
 The use of manganese complexes for organic transformations is 
preferred because of its low toxicity. We show that manganese dichloride catalyzes 
deprotonative arene dimerization under an atmosphere of oxygen (Table 1.3). Thiazole 
and 2-chlorothiophene are reactive (entries 1 and 2). Six-membered-ring heterocycle 
methoxypyrazine is dimerized in an acceptable yield (entry 3). Homocoupling of 
electron-deficient arenes such as 1,2,4-trifluorobenzene and ethyl 3,4-difluorobenzoate 
afford products in good yields (entries 4 and 5). As shown in entries 1, 4, and 5, cheaper 
dicyclohexylamide is almost as efficient as the tetramethylpiperidide base. 
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Table 1.3. Dimerization under manganese catalysis 
 
Entry Arene, base Product Yield (%) 
1 
Thiazole 
base 1+base 3 (0.54/1)  
82 
74
b 
2 
2-Chlorothiophene,  
base 1+ base 3 (5/1)  
75 
70
b
 
3 
Methoxypyrazine, 
 base 1 
 
42 
4 
1,2,4-Trifluorobenzene, 
base 1+base 3 (2/1) 
 
81 
71
b 
5 
Ethyl-3,4-difluorobenzoate 
base 1 
 
65 
a
Substrate (1 equiv), base (1.2-1.4 equiv). Yields are isolated yields. 
b
Dicyclohexylamide base. 
 
Control experiments were conducted to confirm the essential role of metal 
catalysts as well as to determine if trace of other transition metal impurities catalyze the 
dimerization.
33
 Reactions run with either reagent grade or ultra-pure metal salts afford 
similar results indicating that reactivity by contaminants is unlikely. If metal salts were 
omitted, less than 10 % of desired products were obtained. 
 
 22 
Scheme 1.25. Control experiments 
 
 
1.2.3. Conclusions 
We have developed methods for first-row transition-metal-catalyzed, 
deprotonative dimerization of arenes by employing oxygen as the terminal oxidant. 
Under nickel, cobalt, and manganese catalysis, 5-membered and 6-membered ring 
heterocycles as well as electron-deficient arenes react to afford biaryls in good yields. 
Various functionalities such as nitro, cyano, and ester groups are tolerated. 
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1.2.4. Experimental Section 
General considerations: Reactions were performed in 1-dram vials using screw caps 
with 13 mm hole and white silicone septum with white teflon face (from SUPELCO). 
Column chromatography was performed on 60Å silica gel (Sorbent Technologies). 
Purification by preparative HPLC was performed on a Shimadzu Prominence LC (LC-
20AB) equipped with a SPD-20A UV-Vis detector and a Varian Dynamax (250 mm x 
21.4 mm) column. GC-MS analyses were performed on a Shimadzu GCMS-QP5000 
chromatograph equipped with a Restek column (Rtx-XLB, 30 m x 0.25 mm I.D.). The 
1
H, 
19
F and 
13
C NMR were recorded on a GE QE-300, JEOL EC-400 or JEOL EC-500 
spectrometers using residual solvent peak as a reference. -Trifluorotoluene (neat, δ 
= -62.3ppm) was employed as an external standard in 
19
F NMR spectra. IR spectra were 
obtained by ThermoNicolet Avatar 370 FT-IR instrument. Analytical thin layer 
chromatography was performed on silica gel IB-F (Baker-flex) by J. T. Baker. 
II.4.2. Materials. The following starting materials were obtained from commercial 
sources and were used without further purification: nickel(II) chloride (anhydrous), 
cobalt(II) chloride (anhydrous), manganese(II) chloride (anhydrous), iron(III) chloride 
(anhydrous), 2-methoxypyrazine, benzothiophene, zinc chloride (anhydrous), and 1,2,4-
triazole were purchased from Alfa Aesar. Thiazole, 1,3-difluorobenzene, 2,3,5,6-
tetrafluoroanisole, 4,5-dimethylthiazole, 2,3,5,6-tetrafluoropyridine, 2-chlorothiophene, 
2,4-difluoronitrobenzene, 2,2,6,6-tetramethylpiperidine, and 3,5-difluorobenzonitrile 
were bought from Matrix Scientific. Benzofuran was obtained from TCI. 1-
Butylimidazole, 3,5-dichloropyridine, N-methylbenzimidazole, 3-chloropyridine, 1,2,4-
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trifluorobenzene, isopropylmagnesium chloride-lithium chloride complex solution (1.3 M 
in THF), nickel(II) chloride (99.99%), cobalt(II) chloride (99.99%), manganese(II) 
chloride (99.999%) were purchased from Aldrich. 1-Butyl-1,2,4-triazole was made from 
1,2,4-triazole as previously described.
34
  
Preparation of bases 
TMPMgCl*LiCl 1.0 M (base 1), Cy2NMgCl*LiCl 1.0 M (base 2):
 
A reported 
procedure was followed.
35 
Inside the glove box, a dry and argon-flushed 50 mL Schlenk 
flask, equipped with a magnetic stirring bar and a septum was charged with 
iPrMgCl*LiCl (23 mL, 1.3 M in THF, 30 mmol). The flask was taken out of the glove 
box and THF (7 mL) was added via syringe to give 30 mL of 1.0 M solution. After that, 
TMPH (2,2,6,6-tetramethylpiperidine, 4.45 g, 31.5 mmol) or Cy2NH (dicyclohexylamine, 
5.71 g, 31.5 mmol) was added to the Grignard solution. The mixture was stirred at room 
temperature for 24 hours followed by concentration under reduced pressure to 30 mL. All 
procedures were performed under Ar atmosphere. The base was titrated before use at 0 
o
C with solution of benzoic acid in THF (0.2 M). (Phenyl)[4-(phenylazo)-phenyl]amine 
was employed as indicator.
36
 
 (TMP)2Zn*2MgCl2*2LiCl 0.5 M (base 3); (Cy2N)2Zn*2MgCl2*2LiCl 0.5 M (base 
4):
37
 Inside the glove box, a dry and argon-flushed 25 mL Schlenk flask, equipped with a 
magnetic stirring bar and a septum, was charged with anhydrous zinc (II) chloride (680 
mg, 5 mmol). The flask was taken out the glove box. TMPMgCl*LiCl (1.0 M in THF, 10 
mL) or  Cy2NMgCl*LiCl (1.0M, 10 mL) was added dropwise. The mixture was stirred at 
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room temperature for 8 hours. The fresh base was titrated before use as described above. 
Note that 1 equivalent of zinc base is able to deprotonate 2 equivalents of C-H. 
Nickel catalysis 
General procedure: A 1 dram vial equipped with a magnetic stir bar was charged with 
anhydrous nickel (II) chloride (6.5 mg, 0.05 mmol, 5 mol %; use of wet NiCl2 results in 
lower yields) and substrate (1 mmol). The vial was flushed with argon and capped. To 
this mixture was added the appropriate base solution (1.2-1.4 equiv) by injecting through 
the septum via syringe. The vial was flushed with dry oxygen (1 min) and then stirred at 
room temperature under 1 atmosphere of oxygen for indicated time. The reaction mixture 
was diluted with ethyl acetate (30 mL) and washed with brine (1 x 10 mL). The aqueous 
phase was extracted with ethyl acetate (3 x 15 mL). Combined organic phase was dried 
over anhydrous MgSO4 and concentrated under reduced pressure. The residue was 
dissolved in minimum amount of dichloromethane or ethyl acetate and subjected to 
column chromatography on silica gel (hexane followed by appropriate solvent to elute the 
products). After concentrating the fractions containing the product, the residue was dried 
under reduced pressure.  
 
2,2'-Bithiazole (Entry 1, Table 1.1): Nickel(II) chloride (6.5 mg, 0.05 mmol), thiazole 
(85 mg, 1.0 mmol), (TMP)2Zn*2MgCl2*2LiCl (0.5 M, 1.1 mL); or 
(Cy2N)2Zn*2MgCl2*2LiCl (0.5 M, 0.7 mL). Reaction mixture was cooled to 0 
o
C and 
TMPMgCl*LiCl (1.0 M, 0.3 mL; cooled to 0 °C before addition) or Cy2NMgCl*LiCl 
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(1.0 M, 0.7 mL; cooled to 0 °C before addition) was added. Reaction mixture was stirred 
5 minutes at 0 
o
C and then warmed to room temperature, and stirred for additional 2 
hours. After column chromatography (gradient EtOAc/hexane 0/100 – 25/75), 70 mg 
(83% yield; TMP base) or 60 mg (71% yield; Cy2N base) of a white solid was obtained. 
Rf = 0.25   (SiO2, 3/7 ethyl acetate/hexanes). This compound is known.
38
 
1
H NMR (400 
MHz, CDCl3) δ 7.45 (d, J=3.4 Hz, 2H), 7.90 (d, J=3.4 Hz, 2H). 
13
C NMR (100 MHz, 
CDCl3, ppm)  161.7, 144.0, 121.1. 
Note: Reaction needs to be run for 5 hours to afford comparable yield if only 
(TMP)2Zn*2MgCl2*2LiCl base (0.5 M, 1.3 mL) is used. 
 
2,2'-Bibenzofuran (Entry 2, Table 1.1): Nickel(II) chloride (6.5 mg, 0.05 mmol), 
benzofuran (118 mg, 1.0 mmol), TMPMgCl*LiCl (1.0 M, 1.4 mL), 60 
o
C, 5 hours. After 
column chromatography (hexanes, then 5% ethyl acetate in hexanes) and preparative 
HPLC (2% ethyl acetate in hexanes) 53 mg (45%) of a colorless solid was obtained. Rf = 
0.29 (SiO2, 1% EtOAc in hexanes). This compound is known.
39
 
1
H NMR (400 MHz, 
CDCl3) δ 7.18 (d, J=1.0 Hz, 2H), 7.26 (dt, J=7.4 Hz, 1.0 Hz, 2H), 7.35 (dt, J=7.4 Hz, 1.8 
Hz, 2H), 7.55 (d, J=7.4 Hz, 2H), 7.60-7.65 (m, 2H). 
13
C NMR (100 MHz, CDCl3, ppm)  
155.2, 147.8, 128.6, 125.2, 123.5, 121.5, 111.4, 103.8. 
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3,3
’-
Dichloro-2,2
’
-bipyridine (Entry 3, Table 1.1): Nickel(II) chloride (6.5 mg, 0.05 
mmol), 3-chloropyridine (114 mg, 1.0 mmol), TMPMgCl*LiCl (1.0 M, 1.4 mL), room 
temperature, 2 hours. After column chromatography (gradient EtOAc/hexane 0/100 – 
85/15), 37.5 mg (33%) of a white solid was obtained. Rf = 0.38 (SiO2, 1/4 ethyl 
acetate/hexanes). This compound is known.
40
 
1
H NMR (400 MHz, CDCl3) δ 7.36 (dd, J= 
3.4 Hz, 1.8 Hz, 2H), 7.84 (d, J = 3.4 Hz, 2H), 8.6 (d, J= 1.8 Hz, 2H). 
13
C NMR (100 
MHz, CDCl3, ppm)  154.4, 147.7, 137.6, 131.2, 124.7. 
Note: 20% yield was obtained if (TMP)2Zn*2MgCl2*2LiCl base (0.5 M, 1.4 mL) was 
used. 
 
2,2',6,6'-Tetrafluorobiphenyl (Entry 4, Table 1.1): Nickel(II) chloride (6.5 mg, 0.05 
mmol), 1,3-difluorobenzene (114 mg, 1.0 mmol), (TMP)2Zn*2MgCl2*2LiCl (0.5 M, 0.6 
mL) followed by TMPMgCl*LiCl (1.0 M, 0.6 mL); or Cy2NMgCl*LiCl (1.0 M, 1.0 mL) 
followed by (Cy2N)2Zn*2MgCl2*2LiCl (0.5 M, 0.4 mL), room temperature, 1 hour. After 
column chromatography (gradient Et2O/pentane 0/100 – 2/98), 85 mg (75%; TMP bases) 
or 79 mg (70%; Cy2N bases) of a light tan solid was obtained. Rf = 0.45 (SiO2, 1/99 
diethyl ether/hexanes). This compound is known.
39
 
1
H NMR (400 MHz, CDCl3) δ 6.95-
7.10 (m, 4H), 7.35-7.45 (m, 2H). 
19
F (376 MHz, CDCl3) δ -110.5 (s, 4F). 
13
C NMR (100 
MHz, CDCl3, ppm)  160.6 (d, JC-F = 256 Hz), 130.8-131 (m), 111.3-111.7 (m), 106.7 (t, 
JC-F=20.6 Hz). 
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Note: Substantial amounts of phenol byproduct and fluorine nucleophilic substitution 
products were obtained when reaction was carried out using only Mg base. 
 
2,2',6,6'-Tetrafluoro-3,3'-dinitrobiphenyl (Entry 5, Table 1.1): Nickel(II) chloride 
(6.5 mg, 0.05 mmol), 2,4-difluoronitrobenzene (159 mg, 1.0 mmol), cooled 
(TMP)2Zn*2MgCl2*2LiCl (0.5 M, 1.3 mL), 0 
o
C, 1 hour. After column chromatography 
(gradient EtOAc/hexane 0/100 – 30/70), 116 mg (73%) of a light brown solid was 
obtained. Rf = 0.30 (SiO2, 1/4 ethyl acetate/hexanes). This compound is known.
40
 
1
H 
NMR (400 MHz, CDCl3) δ 7.25-7.30 (m, 2H), 8.30-8.40 (m, 2H). 
19
F NMR (376MHz, 
CDCl3) δ -110.8--110.5 (m, 2F), -97.3--97.00 (m, 2F). 
13
C NMR (100 MHz, CDCl3, ppm) 
 163.04 (d, JC-F = 262 Hz), 154.3 (d, JC-F = 268 Hz), 134.5 (d, JC-F = 5.5 Hz), 129.3 (t, 
JC-F =5.5 Hz), 112.4 (d, JC-F =24.5 Hz), 107.6 (t, JC-F =22 Hz). 
Note: Only 51% yield was obtained if Mg base was used. 
Cobalt catalysis 
General procedure: Outside the glove box, a 1 dram vial equipped with a magnetic stir 
bar was charged with anhydrous cobalt (II) chloride (6.5 mg, 0.05 mmol, 5 mol %) and 
substrate (1 mmol). The vial was flushed with argon and capped. To this mixture was 
added THF (0.5 – 1.0 mL) by injecting through the septum via syringe. The mixture was 
stirred until catalyst dissolved. The appropriate base solution (1.1-1.7 equiv) was then 
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added by injecting through the septum. The vial was flushed by dry oxygen (1 min) 
followed by stirring at room temperature under oxygen (1 atm) for indicated time. Work-
up was performed as described for nickel catalysis. 
 
2,2'-Bithiazole (Entry 1, Table 1.3): Cobalt(II) chloride (6.5 mg, 0.05 mmol), THF (0.5 
mL),  thiazole (85 mg, 1.0 mmol), (TMP)2Zn*2MgCl2*2LiCl (0.5 M, 1 mL) followed by 
TMPMgCl*LiCl (1.0 M, 0.4 mL); or Cy2NMgCl*LiCl (1.0 M, 0.7 mL)  followed by 
(Cy2N)2Zn*2MgCl2*2LiCl (0.5 M, 0.7 mL), room temperature, 2 hours. After column 
chromatography (gradient EtOAc/hexane 0/100 – 25/75), 71 mg (86%; TMP bases), or 
59 mg (70%; Cy2N bases) of a white solid was obtained. This compound is known.
38
 
1
H 
NMR (400 MHz, CDCl3) δ 7.45 (d, J=3.4 Hz, 2H), 7.90 (d, J=3.4 Hz, 2H). 
13
C NMR 
(100 MHz, CDCl3, ppm)  161.7 , 144.0, 121.1. 
Note: Lower yield (75%; TMP bases) was obtained if nickel and manganese catalysts 
were used under these conditions. 
 
2,2'-Bibenzo[b]thiophene (Entry 2, Table 1.3): Cobalt(II) chloride (6.5 mg, 0.05 
mmol), benzothiophene (134 mg, 1.0 mmol), THF (1.0 mL), TMPMgCl*LiCl (1.0 M, 1.4 
mL); or Cy2NMgCl*LiCl (1.0 M, 1.7 mL), room temperature, 2 hours. After column 
chromatography (hexane) 112 mg (85%; TMP base) or 104 mg (78%; Cy2N base) of a 
light green solid was obtained. Rf = 0.20 (SiO2, hexanes). This compound is known.
45
 
1
H 
 30 
NMR (400 MHz, CDCl3) δ 7.31-7.37 (m, 4H), 7.52 (s, 2H), 7.75-7.82 (m, 4H). 
13
C NMR 
(125 MHz, DMSO-D6, ppm)  140.5, 139.2, 137.1, 125.9, 125.7, 124.5, 123.1, 122.4. 
 
1,1'-Dibutyl-1H,1'H-2,2'-biimidazole (Entry 3, Table 1.3): Cobalt(II) chloride (6.5 mg, 
0.05 mmol), 1-butylimidazole (124 mg, 1.0 mmol), THF (0.6 mL), TMPMgCl*LiCl (1.0 
M, 1.4 mL), room temperature, 1 hour. After column chromatography (gradient 
EtOAc/hexane 0/1 – 4/1), 98 mg (80%) of a colorless oil was obtained. Rf = 0.25 (SiO2, 
3/2 ethyl acetate/hexanes). This compound is known.
46
 
1
H NMR (400 MHz, CDCl3) δ 
0.85 (t, J=7.1 Hz, 6H), 1.23 (sextet, J=7.1 Hz, 4H), 1.68 (quintet, J=7.1 Hz, 4H), 4.41 (t, 
J=7.1 Hz, 4H), 6.95 (d, J=1.2 Hz, 2H), 7.08 (d, J=1.2 Hz, 2H). 
13
C NMR (100 MHz, 
CDCl3, ppm)  138.1, 128.0, 121.1, 47.1, 33.2, 19.7, 13.6. 
 
2,2',3,3',5,5',6,6'-Octafluoro-4,4'-dimethoxybiphenyl (Entry 4, Table 1.3): Cobalt(II) 
chloride (6.5 mg, 0.05 mmol), 2,3,5,6-tetrafluoroanisole (180 mg, 1.0 mmol), 
TMPMgCl*LiCl (1.0 M, 1.1 mL); or Cy2NMgCl*LiCl (1.0 M, 0.8 mL) followed by 
(Cy2N)2Zn*2MgCl2*2LiCl (0.5 M, 0.3 mL), room temperature, 1 hour. After column 
chromatography (hexanes, then 10% ethyl acetate in hexanes) 161 mg (90%; TMP base) 
or 156 mg (87%; Cy2N bases) of a white solid was obtained. Rf = 0.25 (SiO2, 1/10 ethyl 
acetate/hexanes). This compound is known.
47
 
1
H NMR (400 MHz, CDCl3) δ 4.18 (s, 6H). 
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19
F (376 MHz, CDCl3) δ -157.4--157.1 (m, 4F), -139.6--139.5 (m, 4F). 
13
C NMR (100 
MHz, CDCl3, ppm, list of peaks, 
13
C-
19
F couplings not assigned) 146.1-146.0 (m), 
143.7-143.5 (m), 142.3-142.1 (m), 139.8-139.6 (m), 100.1-99.9 (m), 62.2. Fluorine 
nucleophilic substitution products were obtained when reaction was carried out using 
only Cy2NMgCl*LiCl, presumably due to lower steric bulk compared with TMP base.   
Note: Phenol byproduct was observed if larger excess of magnesium base 1 was used. 
 
2,2',6,6'-Tetrafluorobiphenyl-4,4'-dicarbonitrile (Entry 5, Table 1.3): Cobalt(II) 
chloride (6.5 mg, 0.05 mmol), 3,5-difluorobenzonitrile (139 mg, 1.0 mmol), 
(TMP)2Zn*2MgCl2*2LiCl (0.5 M, 0.7 mL) + TMPMgCl*LiCl (1.0 M, 0.7 mL), room 
temperature, 4 hours. After column chromatography (gradient EtOAc/hexane 0/1 – 1/4), 
110 mg (80%) of a white solid was obtained. Rf = 0.32 (SiO2, 2/9 ethyl acetate/hexanes). 
This compound is known.
28 1
H NMR (400 MHz, CDCl3) δ 7.35-7.45 (m, 4H). 
19
F (376 
MHz, CDCl3) δ-105.1 (s, 4F). 
13
C NMR (100 MHz, CDCl3, ppm)  110.7 (t, JC-F = 3.6 
Hz;), 115.6-116.3 (m, 4C), 160.2 (dt, JC-F = 248 Hz, 3.3 Hz; 4 C). 
Manganese catalysis 
General procedure: Outside the glove box, a 1 dram vial equipped with a magnetic stir 
bar was charged with the substrate (1 mmol). The vial was flushed with argon, capped 
and placed into the glove-box. Anhydrous manganese (II) chloride (8.8 mg, 0.07 mmol, 7 
mol%) was added and the vial was taken out of the glove box. The appropriate base 
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solution (1.2-1.4 eq) was injected through the septum. The vial was flushed with dry 
oxygen (1 min) followed by stirring at room temperature under oxygen (1 atm) for 
indicated time. Work-up was performed as described for nickel catalysis. 
 
2,2'-Bithiazole (Entry 1, Table 1.2): Manganese(II) chloride (8.8 mg, 0.07 mmol),  
thiazole (85 mg, 1.0 mmol), (TMP)2Zn*2MgCl2*2LiCl (0.5 M, 1.1 mL) followed by 
TMPMgCl*LiCl (1.0 M, 0.3 mL); or Cy2NMgCl*LiCl (1.0 M, 0.7 mL) followed by 
(Cy2N)2Zn*2MgCl2*2LiCl (0.5 M, 0.7 mL), room temperature, 2 hours. After column 
chromatography (gradient EtOAc/hexane 0/100 – 25/75), 69 mg (82%; TMP bases) or 62 
mg (74%; Cy2N bases) of a white solid was obtained. This compound is known.
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1
H 
NMR (400 MHz, CDCl3) δ 7.45 (d, J=3.4 Hz, 2H), 7.90 (d, J=3.4 Hz, 2H). 
13
C NMR 
(100 MHz, CDCl3, ppm)  161.7 , 144.0, 121.1. 
 
5,5'-Dichloro-2,2'-bithiophene (Entry 2, Table 1.2): Manganese (II) chloride (8.8 mg, 
0.07 mmol), 2-chlorothiophene (118.5 mg, 1.0 mmol), (TMP)2Zn*2MgCl2*2LiCl (0.5 M, 
0.4 mL) followed by TMPMgCl*LiCl (1.0 M, 1 mL); or Cy2NMgCl*LiCl (1.0 M, 1.3 
mL), room temperature, 2 hours. After column chromatography (hexanes, then 5/95 ethyl 
acetate/hexanes) 87 mg (75%; TMP bases) or 82 mg (70%; Cy2N base) of a yellow solid 
was obtained. Rf = 0.62 (SiO2, 1/99 ethyl acetate/hexanes). This compound is known.
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1
H NMR (400 MHz, CDCl3) δ 6.82 (d, J=4.0 Hz, 2H), 6.85 (d, J=4.0 Hz, 2H). 
13
C NMR 
(100 MHz, CDCl3, ppm)  135.1, 129.3, 127.0, 123.1. 
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3,3'-Dimethoxy-2,2'-bipyrazine (Entry 3, Table 1.2): Manganese(II) chloride (8.8 mg, 
0.07 mmol), 2-methoxypyrazine (110 mg, 1.0 mmol), TMPMgCl*LiCl (1.0 M, 1.3 mL), 
room temperature, 2 hours. After column chromatography (gradient EtOAc/hexane 0/100 
– 60/40), 45 mg (42%) of a light tan solid was obtained. Rf = 0.23 (SiO2, 1/1 ethyl 
acetate/hexanes). This compound is known.
28
 
1
H NMR (400 MHz, CDCl3) δ 3.92 (s, 6H), 
8.18 (d, J=2.6 Hz, 2H), 8.25 (d, J=2.6 Hz, 2H). 
13
C NMR (100 MHz, CDCl3, ppm) , 
158.9, 141.3, 140.5, 136.4, 54.0. 
Note: Only 30% conversion was obtained if base 3 was used. 
 
2,2',5,5
’
,6,6'-Hexafluorobiphenyl (Entry 4, Table 1.2): Manganese(II) chloride (8.8 
mg, 0.07 mmol), 1,3,4-trifluorobenzene (132 mg, 1.0 mmol), (TMP)2Zn*2MgCl2*2LiCl 
(0.5 M, 0.6 mL) + TMPMgCl*LiCl (1.0 M, 0.6 mL); or Cy2NMgCl*LiCl (1.0 M, 1.0 
mL) + (Cy2N)2Zn*2MgCl2*2LiCl (0.5 M, 0.4 mL), room temperature, 1 hour. After 
column chromatography (pentane, then 1% diethyl ether in pentane) 105 mg (81%; TMP 
base) or 93 mg (71%; Cy2N base) of a white solid was obtained. Rf = 0.40 (SiO2, 
hexanes). This compound is known.
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1
H NMR (400 MHz, CDCl3) δ 6.9-7.0 (m, 2H), 
7.2-7.3 (m, 2H) .
19
F (376 MHz, CDCl3) δ -141.6--1.41.5 (m, 2F), -132.6--132.5 (m, 2F), -
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115.5--115.4 (m, 2F). 
13
C NMR (100 MHz, CDCl3, ppm)  155.5 (d, JC-F = 246 Hz), 
149.4-146.8 (m), 148.4-146.0 (m), 118.5-118.2 (m), 111.3-110.9 (m), 108.0-107.5 (m). 
Note: Substantial amounts of phenol byproduct and fluorine nucleophilic substitution 
products were obtained when reaction was carried out using only Mg bases. 
 
Ethyl-2,2',3,3'-tetrafluorobiphenyl-6,6'-dicarboxylate (Entry 5, Table 1.2): 
Manganese(II) chloride (8.8 mg, 0.07 mmol), ethyl-3,4-difluorobenzoate (186 mg, 1.0 
mmol), TMPMgCl*LiCl (1.0 M, 1.4 mL), 0
o
C, 1 hour. After column chromatography 
(gradient EtOAc/hexane 0/100 – 20/80), 120 mg (65%) of a white solid was obtained. Rf 
= 0.29 (SiO2, 1/5 ethyl acetate/hexanes). This compound is known.
28
 
1
H NMR (400 MHz, 
CDCl3) δ 1.07 (t, J= 7.1 Hz, 6H), 4.10 (q, J=7.1 Hz, 4H), 7.30 (dd, J=17.9 Hz, 9.0 Hz, 
2H), 7.95 (ddd, J=9.0 Hz, 4.8 Hz, 1.5 Hz, 2H).
 19
F (376 MHz, CDCl3) δ -136.3--136.1 
(m, 2F), -130.4 (m, 2F). 
13
C NMR (100 MHz, CDCl3, ppm)  13.8, 61.3, 116.9 (d, JC-F 
= 17.0 Hz), 125.6 (d, JC-F = 14.0 Hz), 126.7 (d, JC-F = 2.8Hz), 127.1 (dd, JC-F = 7.6 
Hz, 3.8 Hz), 147.8 (dd, JC-F = 246.0 Hz, 13.3 Hz), 152.9 (dd, JC-F =255.0 Hz, 13.3 Hz), 
164.6. 
Control reactions: 
Reaction conversions were measured by GC using hexadecane as internal standard. 
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Nickel catalysis:  
- Using reagent grade NiCl2 (Alfa Aesar, anhydrous 98%): Nickel (II) chloride (6.5 mg, 
0.05 mmol), 1,3-difluorobenzene (114 mg, 1.0 mmol), (TMP)2Zn*2MgCl2*2LiCl (0.5 M, 
0.6 mL) + TMPMgCl*LiCl (1.0 M, 0.6 mL), room temperature, 1 hour. Conversion: 96%  
- Using ultra pure NiCl2 (Aldrich, 99.99%): Nickel (II) chloride (6.5 mg, 0.05 mmol), 
1,3-difluorobenzene (114 mg, 1.0 mmol), (TMP)2Zn*2MgCl2*2LiCl (0.5 M, 0.6 mL) + 
TMPMgCl*LiCl (1.0 M, 0.6 mL), 1 hour, rt. Conversion: 98%. 
- Without NiCl2 catalyst: 1,3-difluorobenzene (114 mg, 1.0 mmol), 
(TMP)2Zn*2MgCl2*2LiCl (0.5 M, 0.6 mL) + TMPMgCl*LiCl (1.0 M, 0.6 mL), rt, 1 
hour. Conversion: 5%.  
Manganese catalysis:  
- Using reagent grade MnCl2 (Alfa Aesar, anhydrous 98%): Manganese (II) chloride (8.8 
mg, 0.07 mmol), 1,3,4-trifluorobenzene (132 mg, 1.0 mmol), (TMP)2Zn*2MgCl2*2LiCl 
(0.5 M, 0.6 mL) + TMPMgCl*LiCl (1.0 M, 0.6 mL), rt, 1 hour. Conversion: 98%. 
- Using ultra pure MnCl2 (Aldrich, 99.999%): Manganese (II) chloride (8.8 mg, 0.07 
mmol), 1,3,4-trifluorobenzene (132 mg, 1.0 mmol), (TMP)2Zn*2MgCl2*2LiCl (0.5 M, 
0.6 mL) + TMPMgCl*LiCl (1.0 M, 0.6 mL), rt, 1 hour. Conversion: 95%. 
- Without MnCl2 catalyst: 1,3,4-trifluorobenzene (132 mg, 1.0 mmol), 
(TMP)2Zn*2MgCl2*2LiCl (0.5 M, 0.6 mL) + TMPMgCl*LiCl (1.0 M, 0.6 mL), room 
temperature, 1 hour. Conversion: 7%. 
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Cobalt catalysis: 
- Using reagent grade CoCl2 (Alfa Aesar, anhydrous 98%): Cobalt (II) chloride (6.5 mg, 
0.05 mmol), 2,3,5,6-tetrafluoroanisole (180 mg, 1.0 mmol), TMPMgCl*LiCl (1.0 M, 1.1 
mL), rt, 1 hour. Conversion: >99%. 
- Using ultra pure CoCl2 (Aldrich, 99.99%): Cobalt (II) chloride (6.5 mg, 0.05 mmol), 
2,3,5,6-tetrafluoroanisole (180 mg, 1.0 mmol), TMPMgCl*LiCl (1.0 M, 1.1 mL), RT, 1 
hour. Conversion: >99%. 
- Without CoCl2 catalyst: 2,3,5,6-tetrafluoroanisole (180 mg, 1.0 mmol), 
TMPMgCl*LiCl (1.0 M, 1.1 mL), rt, 1 hour. Conversion: 10%. 
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2.1. Sp
2
 C-F Bond Formation  
2.1.1. Introduction 
The presence of fluorine atoms in arenes often affects the reactivity, solubility, 
and the stability of molecules.
1
 A wide range of materials and biologically active 
compounds contain fluorine substituents. In medicinal chemistry, the high strength of C-
F bonds can result in the inhibition of metabolism if fluorine is incorporated at or near a 
reactive site, improving the efficacy of lead compounds. Furthermore, 
18
F-labeled organic 
compounds are widely used as contrast agents for position emission tomography (PET).
2
 
However, traditional methods to introduce fluorine into an aromatic framework often 
require harsh conditions. In particular, the conversion of amines via aryldiazonium salt 
with HBF4 (Balz-Schiemann reaction) and nucleophilic substitution of electron-deficient 
chloro- or nitroarenes (Halex reaction) are not compatible with many functional groups 
(Scheme 2.1).
3
 
Scheme 2.1. Traditional routes to aryl fluorides 
 
 
Additionally, the substrate scope of these reactions is limited and the fluorine 
source is not readily amenable to the preparation of 
18 
F-labeled compounds. Because of 
these limitations, fluorine atoms are usually introduced early in the synthetic sequences 
which greatly increases the difficulty of accessing target molecules. Modern methods 
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based on transition-metal catalysis, therefore, have been sought as an alternative. Within 
this chapter, recent developments in constructing fluoroarenes will be discussed.  
2.1.2. Aryl Fluoride Formation from Aryl Metals 
Because of their remarkable importance in pharmaceuticals, agrochemicals, and 
biological imaging agents, significant recent efforts have focused on the development of 
new synthetic procedures for the generation of sp
2
 C-F bonds. Transition-metal-promoted 
fluoroarene formation is of particular interest. Over the past few years, several different 
methods have been developed to construct sp
2
 C-F bonds via cross-coupling with aryl 
metals. 
Studies used to elucidate features of coordination environment of Pd (II) that 
could enable Ar-F reductive elimination have been reported by Yandulov.
4
 Several 
palladium complexes with bulky ligands were synthesized and characterized (Scheme 
2.2). The results indicated that the stability of the fluoride-bridge dimer is a key 
remaining obstacle to Ar-F reductive elimination (Scheme 2.2). The use of Buchwald’s 
ligand, however, provides the additional steric pressure on the [PdArL(µ-F)]2 core, thus 
enabling formation of Ar-F in quantifiable yield (10 %) via reductive elimination. 
Scheme 2.2. Ar-F reductive elimination from Pd complexes with bulky ligands 
 
The systematic investigation of C-F reductive elimination from Pd(IV) fluoride 
complexes has also been described.
5
 The experimental data suggested that elimination 
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occurs from cationic Pd(IV) fluoride complexes via dissociative mechanism. Specifically, 
the pyridyl-sulfonamide-supported Pd(IV) has the appropriate geometry and electronic 
structure to enable reductive elimination (Scheme 2.3). The authors also found that 
electron-donating ancillary ligand accelerated C-F bond formation. Electron-withdrawing 
substituents  on the carbon ligand accelerate reductive elimination. 
Scheme 2.3. Fluorination of boronic acids via palladium complexes 
 
 
A procedure for silver-mediated fluorination of functionalized aryl stannanes has 
been disclosed.
6
 Method employs 2 equivalents of silver triflate and uses electrophilic 
Selectfluor as fluorinating reagent (Scheme 2.4). The applicability to broad substrate 
scope has been demonstrated. Reactions are regiospecific and wide range of functional 
groups is tolerated. A bimetallic redox mechanism was proposed. 
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Scheme 2.4. Silver-mediated electrophilic fluorination of aryl stannanes 
 
 
Silver-mediated fluorination of aryl boronic acids was also reported by the same 
group.
7
 Electron-rich, electron-poor, and heterocylic boronic acids are active in 
fluorination (Scheme 2.5). It is worth mentioning that arylboron reagents are valuable 
alternative sources of aryl groups for the synthesis of aryl fluorides because they are 
commercially available, non-toxic, and shelf stable. Additionally, conditions are practical 
and multigram scale synthesis was performed. 
Scheme 2.5. Silver-mediated fluorination of aryl boronic acids 
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In mechanistic studies, transmetalation from boron to silver was performed and an 
arylsilver complex was isolated. Subsequent fluorination of this complex with 
electrophilic F-TEDA-BF4 in the presence of AgOTf afforded fluoroarene product in 85 
% yield (Scheme 2.6). 
Scheme 2.6. Transmetalation from boron to silver during reaction 
 
Direct conversion of aryl silanes to aryl fluorides has been achieved.
8
 Ritter group 
reported a functional-group-tolerant, one-step fluorination of aryltriethoxysilanes with F-
TEDA-BF4 mediated by Ag2O (Scheme 2.7). Although the silver is used in 
superstoichiometric amounts for optimal results, it can be recycled by appropriate 
reactivation treatment. 
Scheme 2.7. Silver-mediated fluorination of aryl silanes 
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Nickel complexes were also examined in C-F reductive elimination. A one-step 
oxidative fluorination for C-F bond formation from well-defined nickel complexes with 
oxidant and aqueous fluoride was presented by the Ritter group.
9
 A variety of moisture-
and air-stable nickel complexes have been synthesized (Scheme 2.8a). Upon treating with 
a hypervalent iodine salt oxidant and aqueous fluoride, fluoroarene products were 
obtained in good yields at room temperature in less than one minute (Scheme 2.8b). The 
transformation represents the first example of mild fluorination with a first-row transition 
metal and the first example of a reaction that affords aryl fluoride by 
18 
F-C bond 
formation via reductive elimination. 
Scheme 2.8. Synthesis of Ni(II) aryl complexes and their reactivity toward fluorination 
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A protocol for copper-mediated fluorination of aryl stannanes and aryl 
trifluoroborates has been demonstrated.
10
 The method employed one equivalent of copper 
(I) complex and N-fluoro-2,4,6-trimethylpyridinium triflate (N-FTPT) fluorinating source 
at room temperature (Scheme 2.9). The sequential one-pot procedure initially started with 
oxidation of Cu(I) complex with N-FTPT to form putative Cu(III)-F intermediates 
followed by addition of stannanes or trifluoroborates. The reaction proceeds at mild 
temperatures and exhibits a broad substrate scope and functional group tolerance.  
Scheme 2.9. Copper-mediated fluorination of aryl stannanes and aryl trifluoborates 
 
 
A method for the direct conversion of aryl boronate esters to aryl fluorides using 
copper salt promoter has also been described by Hartwig.
11
 Reaction conditions include 
stoichiometric amount of Cu(I) complex, electrophilic fluorinating source, and silver (I) 
fluoride. Electron-rich, electron-deficient, ortho-substituted, and diversely functionalized 
aryl boronate esters undergo fluorination in good yields (Scheme 2.10). 
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Scheme 2.10. Copper-mediated fluorination of arylboronate esters 
 
 
Reaction mechanism was also investigated. The authors provided evidence that 
the fluorination occurs by facile formation of a cationic copper(III) fluoride complex, 
which reacts with AgF and ArBpin to form neutral fluoroarylboronate complex. Rate-
determining transmetalation forms an arylcopper(III) fluoride, which undergoes reductive 
elimination to form aryl fluoride product (Scheme 2.11). Copper(III) intermediates have 
been generated independently and identified by NMR and ESI-MS. 
Scheme 2.11. Proposed mechanism for the fluorination of ArBPin with (tBuCN)2CuOTf 
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2.1.3 Aryl Fluoride Formation from Aryl Halides and Aryl Triflates  
Methods for the conversion of aryl metals such as aryl stannanes, aryl boronic 
acids, and silanes to aryl fluorides with silver, palladium or copper and an electrophilic 
fluoride source have been shown. However, aryl nucleophiles in these reactions are often 
prepared from aryl halides. Therefore, a transition-metal-catalyzed or –mediated 
formation of fluoroarenes from corresponding aryl halides is a highly desirable 
transformation.  
 The preparation of a well-characterized Pd(II) complex that undergoes reductive 
elimination forming an aryl fluoride was reported by Buchwald in 2009.
12
 Based on this 
result, a palladium-catalyzed formation of aryl fluorides from aryl triflates or aryl 
bromides was developed. The method employs 2-3 % [(cinnamyl)PdCl2]2 catalyst, 5-7 % 
tBuBrettPhos ligand, and CsF or AgF fluoride sources (Scheme 2.12). Method uses the 
sterically demanding, electron-rich biaryl monophosphine tBuBrettPhos ligand. The 
authors suggested that this ligand not only facilitates reductive elimination of the Ar-F 
bond but also prevents the formation of dimeric [LPdAr(F)]2 due to its large size. The 
transformation exhibits a wide substrate scope and tolerates a number of functional 
groups. However, in several cases, formation of regioisomeric byproducts was observed. 
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Scheme 2.12. Pd-catalyzed fluorination of aryl triflates 
 
 
 
 A transition-metal-free approach to aryl fluorides from aryl bromides was also 
reported.
13
 Upon treatment with [Me4N]F in DMSO at elevated temperatures, 
bromoarenes are converted to aryl fluorides. Isomeric mixture of products were obtained 
when unsymmetrical aryl bromides were used indicating aryne intermediacy (Scheme 
2.13). 
Scheme 2.13. Fluorination of an aryl bromide via benzyne intermediate 
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 Ritter and co-workers reported a method for fluoroarene formation from 
phenols.
14
 Specifically, a practical deoxyfluorination of phenols was developed using a 
fluorinating reagent that delivers aryl fluorides from phenols by a one-step ipso 
substitution. From mechanistic viewpoint, hydrogen bonding is crucial for the reaction to 
proceed. A wide range of common functional groups are tolerated and the method allows 
the access to complex molecules (Scheme 2.14). 
Scheme 2.14. Deoxyfluorination of phenols 
 
 
 Reductive elimination of Ar-F from well-defined Ar-Cu(III)-F complexes has also 
been described.
15
 Based on these precedents, a method for copper-catalyzed aryl halide 
fluorination in a macrocyclic polyamine system has been reported (Scheme 2.15). 
Reactions were proposed to proceed through the intermediacy of Ar-Cu(III)-F species. 
Furthermore, experimental and computational data support a redox Cu(I)/Cu(III) catalytic 
cycle involving Ar-X oxidative addition, followed by halide exchange and reductive 
elimination steps. For the first time, Ar-F reductive elimination from copper centers was 
shown. Although the work relies on an elaborate model system, these results provide 
mechanistic understanding for further developments of Cu-based fluorination. 
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Scheme 2.15. Catalytic fluorination of macrocyclic Ar-X (X = Cl, Br) 
 
 A method for copper-mediated direct conversion of aryl iodides to corresponding 
aryl fluorides has been disclosed.
16
 The reactions occur with stoichiometric amounts of 
(tBuCN)CuOTf  and silver fluoride in DMF solvent at 140
 o
C. Electron-rich, electron-
poor, as well as sterically hindered aryl iodides are reactive affording products in good to 
excellent yields (Scheme 2.16). In addition, various functional groups are tolerated. 
Preliminary mechanistic results suggest facile reductive elimination from cationic 
arylcopper(III) fluoride. 
Scheme 2.16. Copper-mediated fluorination of aryl iodides 
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2.1.4. Direct Aryl Fluoride Formation from Arenes 
As shown before, several procedures for transition-metal-catalyzed C-F bond 
formation have been developed and constitute powerful synthetic tools to complement 
conventional methods. However, the requirement of pre-functionalized starting materials 
limits their applications in late stage introduction of fluorine into biologically active 
molecules. Therefore, a method that can directly convert Ar-H bonds into Ar-F bonds 
would be highly desirable. 
The ortho-lithiation/fluorination protocol with F
+
 reported by Snieckus and Davis 
represented an important approach for regioselective fluorination of arenes in early 
1990s.
17
 In particular, ortho-metalated aromatic substrates generated in situ by treating 
arenes with nBuLi at low temperatures undergo reactions with N-
fluorobenzenesulfonimide (NFSi) to provide regiospecifically fluorinated products 
(Scheme 2.17). However, reaction scope is limited and is not applicable to preparative 
scale synthesis. 
Scheme 2.17. ortho-Lithiation/fluorination of arenes 
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The process for the preparation of fluorobenzene from benzene has been 
described.
18
 The method involves HF, oxygen, and Cu2O. Acceptable yields were 
obtained only when high reaction temperature, 500 
o
C, was applied. The process 
produces H2O as the only by-product and the reaction cycle is shown in Scheme 2.18. 
Scheme 2.18. Fluorobenzene formation via copper (II) fluoride 
 
 
In a pioneering study, Sanford and co-workers reported the first example of 
Pd(II)-catalyzed ortho-fluorination of C-H bonds in 2-phenylpyridine derivatives.
19
 
These reactions were achieved under oxidizing conditions using N-fluoro-2,4,6-
trimethylpyridinium tetrafluorborate as electrophilic fluorinating reagent (Scheme 2.19). 
In most cases, microware irradiation is required to obtain reasonable yields. 
Difluoronation is also possible and reactions tolerate ketone, ester, and halide groups. 
Further mechanistic investigations into the reductive elimination of fluoride from Pd(IV) 
center provided evidence for the involvement of a Pd(II)/Pd(IV) catalytic cycle.
20 
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Scheme 2.19. Pd-catalyzed fluorination of 2-phenylpyridine derivatives 
 
 
 
A method for palladium-catalyzed ortho sp
2
 C-H bond fluorination with a 
removable directing group has also been developed.
21
 Yu has demonstrated a protocol for 
efficient benzylamine triflamide ortho-fluorination using Pd(OTf)2*2H2O catalyst, N-
fluoro-2,4,6-trimethylpyridinium triflate F
+ 
source, and N-methylpyrrolidone (NMP) as a 
crucial promoter (Scheme 2.20). Notably, the aryl fluoride reductive elimination occurs at 
a satisfactory rate without microware irradiation. In addition, the facile displacement of 
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triflamide directing group with a wide range of heteroatom and carbon nucleophiles has 
been shown. 
Scheme 2.20. Pd-catalyzed ortho-fluorination of benzylamine derivatives 
 
 
The palladium-catalyzed C-H fluorination of 8-methylquinoline derivatives with 
nucleophilic fluoride was reported.
22
 The transformation involves the use of silver(I) 
fluoride in combination with a hypervalent iodine oxidant (Scheme 2.21). Mechanistic 
studies indicated a key Pd(IV) complex intermediate and two possible pathways for 
formation of this complex were proposed. 
Scheme 2.21. Pd-catalyzed fluorination of 8-methylquinoline derivatives 
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2.2. Copper-catalyzed Direct Fluorination of Sp
2
 C-H Bonds 
2.2.1. Introduction 
 Over the last few years, transition-metal catalysis has been exploited in creating 
aryl-fluorine bonds. Palladium-, silver-, and copper-based protocols have been developed 
to construct aryl-fluoride bonds via cross-coupling with arylmetals or aryl 
(pseudo)halides. Despite significant advances, the reaction generally remains limited by 
requirement of pre-functionalized starting materials. Thus, late stage fluorination in 
complex molecules is difficult to achieve. Efficient transformations for direct formation 
of aryl fluorides from arenes have also been described.  However, in most cases, 
expensive palladium catalysts and electrophilic fluorinating reagents are required. A 
general procedure for non-noble transition-metal-catalyzed direct fluorination of sp
2
 C-H 
bonds has not yet been disclosed. 
 Recently, our group described methods for copper-catalyzed sulfenylation and 
amination C-H bonds in 8-aminoquinoline benzamides and benzylamine picolinamides 
(Scheme 2.22).
23
 In addition, C-H activation in macrocylic model substrates using copper 
salts has been shown.
15
 Furthermore, reductive elimination from Ar-Cu(III)-F complexes 
has been observed.
11,15
 Since it is likely that 8-aminoquinoline benzamide could stabilize 
high-valent copper intermediates, we reasoned that copper-catalyzed aminoquinoline and 
picolinamide-directed benzoic acid and benzylamine derivative ortho-fluorination is 
possible. 
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Scheme 2.22. Copper-catalyzed sulfenylation and amination of sp
2
 C-H bonds 
 
 
2.2.2. Results and Discussion 
2.2.2.1. Monofluorination 
 Reaction optimization was conducted for monofluorination of p-trifluoromethyl-
benzamide. Copper catalyst, fluorine source, oxidant, and solvent were investigated 
(Table 2.1). Oxygen and Ph(OPiv)2 oxidants gave full conversion to product but low 
yields were obtained due to decomposition (entries 2 and 4). Similar phenomenon was 
observed when DMSO was used as a solvent (entries 1 and 2). In pyridine, acceptable 
yields were achieved although longer reaction time was required (entry 9). The optimal 
conditions for monofluorination involve CuI catalyst, AgF fluorine source, NMO 
oxidant, and DMF solvent.  
Table 2.1. Optimization of Reaction Conditions
a 
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Entry Catalyst (mol %) T, °C 1, % 2, % 3, % 
1
b 
Cu(OAc)2 (25%) 100 4 17 5 
2
b,c 
Cu(OAc)2 (25%) 100 <2 13 4 
3 Cu(OAc)2 (25%) 100 20 42 8 
4
d
 CuI (25%) 100 4 36 6 
5 CuI (25%) 100 11 54 6 
6 CuI (25%) 80 20 60 5 
7 CuI (15%) 80 18 70 3 
8
e 
CuI (15%) 80 4 79 7 
9
e,f 
CuI (15%) 80 16 80 3 
10
g 
CuI (20%) 80 <2 17 38 
11
f,g 
CuI (20%) 80 10 52 33 
12
g,h 
CuI (20%) 80 <2 5 78 
a 
Amide 0.25 mmol, AgF 3 equiv, NMO 4 equiv, DMF 1 mL. 
b
 DMSO solvent. 
c
 Ph(OPiv)2 
oxidant instead of NMO. 
d
 O2 was used. 
e
 AgF 4 equiv, NMO 5 equiv. 
f
 Pyridine solvent. 
g 
AgF 6 
equiv, 8 equiv NMO, 1.5 h. 
h
 Pyridine additive 2 equiv.  
 Reaction scope with respect to monofluorination of 8-aminoquinoline benzamides 
is presented in Table 2.2. Electron-rich (entries 2 and 6) as well as electron-poor (entries 
1, 3-5, 7, 8) benzamides are fluorinated in good yields. Reaction of meta-substituted 
benzamide gives monofluorinated product predominantly (entry 8). Heterocyclic 3-
indolyl (entry 9) and 4-pyridinyl (entry 10) carboxamides are active. Nitrile, ester, and 
nitro groups are tolerated under reaction conditions. Pyridine solvent is required to 
prevent decomposition of strongly electron-deficient substrates such as 4-nitrobenzoyl 
and pyridyl derivatives (entries 7 and 10). However, longer reaction times are needed to 
obtain reasonable yields. 
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Table 2.2. Monofluorination reaction scope 
 
a
 Amide 0.25 mmol, DMF 1 mL. Yields are isolated yields. 
b 
Reaction scale: 5 mmol. 
c 
Pyridine solvent. 
 
 
 
Entry Ar Product 
Yield, 
% 
Entry Ar Product 
Yield, 
% 
1 4-CF3C6H4 
 
71 6 
2-
MeC6H4 
 
63 
2 4-MeC6H4 
 
75 7c 
4-
NO2C6H4 
 
60 
3 
4-
MeO2CC6H4 
 
56 
 
8 
3-
CF3C6H4 
 
71 
4 4-NCC6H4 
 
62 
60b 
 
9 
3-(N-Me-
indolyl) 
 
54 
5 2-CF3C6H4 
 
80 10c 4-Pyridyl 
 
62 
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2.2.2.2. Difluorination 
 Optimization results in Table 2.1 show that fast decomposition and low yields 
were obtained when CuI and AgF loading, temperature, and reaction time were increased. 
As observed for monofluorination, the use of pyridine prevents decomposition of 
aminoquinoline amides. Difluorinated product was formed in good yield when two 
equivalents of pyridine were added in combination with six equivalents of AgF. 
Reaction scope with respect to difluorination is presented in Table 2.3. Similar to 
monofluorination, difluorination of electron-rich (entries 4, 5, 7), electron-poor (entries 1-
3, 6), and heterocyclic (entry 8) amides is possible. Interestingly, difluorination of m-
substituted amides affords products in good yields (entries 4, 7). Palladium-catalyzed 
dual C-H functionalization of substrates that possess 3-substituents is not efficient and 
thus products such as the one generated in entries 4 and 7 typically cannot be accessed 
under palladium catalysis. 
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Table 2.3. Difluorination of Carboxylic Acid Derivatives
a
 
 
a
 Amide 0.25 mmol, DMF 1 mL. Yields are isolated yields. 
b
 Pyridine solvent. 
 
The 8-aminoquinoline group can be efficiently removed by base hydrolysis. Thus, high 
yield of trifluorobenzoic acid was obtained when amide 1 was treated with NaOH in 
ethanol (Scheme 2.23). 
 
Entry Ar Product 
Yield, 
% 
Entry Ar Product 
Yield, 
% 
1 4-CF3C6H4 
 
67 5 
4-
MeOC6H4 
 
75 
2 4-MeO2CC6H4 
 
62 6 4-FC6H4 
 
61 
3 NCC6H4 
 
70 
 
7 3-MeC6H4 
 
77 
4 2-Naphthyl 
 
70 8b 4-Pyridyl 
 
61 
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Scheme 2.23. Removal of directing group 
 
2.2.3. Conclusions 
A method for direct, auxiliary-assisted fluorination of β-sp2 C−H bonds of benzoic 
acid derivatives has been developed. The reaction employs catalytic CuI (10-30 %), AgF 
as nucleophilic fluoride source, and DMF or pyridine solvent at moderately elevated 
temperatures. High generality, excellent selectivity toward ortho C−H bonds, as well as 
good functional group tolerance are observed. 
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2.2.4. Experimental Section 
General Considerations:  
Reactions were run in 1-dram vials using screw caps with PTFE/Liner (from SUPELCO). 
Column chromatography was performed on 60Å silica gel (Dynamic Adsorbents Inc.). 
Purification by preparative HPLC was performed on a Shimadzu Prominence LC (LC-
20AB) equipped with a SPD-20A UV-Vis detector and a Varian Dynamax (250 mm x 
21.4 mm) column. GC-MS analyses were performed on a Shimadzu GCMS-QP5000 
chromatograph equipped with a Restek column (Rtx-XLB, 30 m x 0.25 mm I.D.). The 
1
H 
NMR, 
13
C NMR, and 
19
F NMR were recorded on JEOL EC-400 or JEOL EC-500 
spectrometers using residual solvent peak as a reference. Compounds for HRMS were 
analyzed by positive mode electrospray ionization (ESI) using Agilent QTOF mass 
spectrometer in the Mass Spectrometry Facility (MSF) of the Department of Chemistry 
and Biochemistry of University of Texas-Austin. IR-spectra were obtained using a Perkin 
Elmer Spectrum 100 FT-IR spectrometer. Analytical thin layer chromatography was 
performed on silica gel IB-F (Baker-flex) by J. T. Baker. All procedures were performed 
under nitrogen atmosphere unless otherwise noted. 
Materials. The following starting materials were obtained from commercial sources and 
were used without further purification: 8-aminoquinoline, 4-trifluoromethylbenzoyl 
chloride, 4-methylbenzoyl chloride, 4-cyanobenzoyl chloride, 4-nitrobenzoyl chloride, 3-
trifluoromethylbenzoyl chloride, 2-trifluoromethylbenzoyl chloride, 2-naphthoyl 
chloride, isonicotinic acid, 4-(methoxycarbonyl)benzoic acid, 2-methylbenzoyl chloride, 
1-methyl-1H-indole-3-carboxylic acid, 4-fluorobenzoyl chloride, 3-methylbenzoyl 
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chloride, 4-methoxybenzoyl chloride, silver(I) fluoride, N-methylmorphorine oxide 
(NMO), dimethylformamide, pyridine, thionyl chloride, triethylamine, picolinic acid, 
tert-butyl benzonitrile, 2-phenylpropan-2-amine, dimethylformamide (DMF) 
Synthesis of Amides 
These amides were synthesized according to literature procedures: N-(quinolin-8-yl)-4-
(trifluoromethyl)benzamide, N-(quinolin-8-yl)-4-methylbenzamide, methyl 4-(quinolin-
8-ylcarbamoyl)benzoate, N-(quinolin-8-yl)-2-(trifluoromethyl)benzamide, N-(quinolin-8-
yl)-2-methylbenzamide, N-(quinolin-8-yl)-5-(trifluoromethyl)benzamide, N-(quinolin-8-
yl)-2-naphthamide, N-(1-methyl-1-phenylethyl)picolinamide.
23,24,25
 
N
HN O
CN  
4-Cyano-N-(quinolin-8-yl)benzamide: 8-Aminoquinoline (1.44 g, 10 mmol) and 
triethylamine (1.8 mL, 13 mmol) were dissolved in anhydrous CH2Cl2 (20 mL) in a 100 
mL round-bottom flask followed by dropwise addition of suspension of 4-cyanobenzoyl 
chloride  (2.15 g, 13 mmol) in 50 mL of CH2Cl2 though syringe. The reaction mixture 
was stirred overnight. After completion, the reaction was diluted with CH2Cl2 (50 mL), 
washed by aqueous HCl (15 mL, 1N), NaHCO3 (saturated aqueous solution, 15 mL), 
brine (25 mL), and dried over MgSO4. The organic solvent was removed by evaporation. 
Purification by column chromatography in hexanes/EtOAc (70/30) afforded 2.54 g of 
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amide (94 %) as an off white solid. Rf = 0.52 (hexane/EtOAc 70/30), mp  150 – 152 
o
C 
(from diethyl ether). 
1
H NMR (400 MHz, CDCl3) δ 10.77 (s, 1H), 8.88 (dd, J = 6.7 Hz, 
2.4 Hz, 1H), 8.84 (dd, J = 4.6 Hz, 1.7 Hz, 1H), 8.20 (dd, J = 8.0 Hz, 1.7 Hz, 1H), 8.17 – 
8.14 (m, 2H), 7.84 – 7.81 (m, 2H), 7.60 – 7.56 (m, 2H), 7.50 (dd, J = 8.0 Hz, 4.5 Hz, 1H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 163.5, 148.6, 139.0, 138.7, 136.6, 134.0, 132.7, 
128.1, 128.0, 127.5, 122.5, 122.0, 118.2, 116.9, 115.4. HRMS (EIS+): Calculated for 
C17H11N3O [M+H]
+ 
 274.09749, Found 274.09748. 
N
HN O
NO
2  
4-Nitro-N-(quinolin-8-yl)benzamide: 8-Aminoquinoline (1.44 g, 10 mmol) and 
triethylamine (1.8 mL, 13 mmol) were dissolved in anhydrous CH2Cl2 (20 mL) in a 100 
mL round-bottom flask followed by dropwise addition of suspension of 4-nitrobenzoyl 
chloride  (2.4 g, 13 mmol) in 50 mL of CH2Cl2 though syringe. The reaction mixture was 
stirred overnight. After completion, the reaction was diluted with CH2Cl2 (50 mL), 
washed by aqueous HCl (2 x 15 mL, 1N), NaHCO3 (saturated aqueous solution, 15 mL x 
2), brine (25 mL), and dried over MgSO4. The organic solvent was removed to afford 
2.78 g of amide (96 %) as a yellow solid. Rf = 0.49 (hexane/EtOAc 70/30), mp 158 – 159 
o
C (from diethyl ether). 
1
H NMR (400 MHz, CDCl3) δ 10.81 (s, 1H), 8.89 (dd, J = 5.9 
Hz, 3.2 Hz, 1H), 8.86 (dd, J = 4.5 Hz, 1.7 Hz, 1H), 8.40 – 8.36 (m, 2H), 8.24 – 8.20 (m, 
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3H), 7.63 – 7.56 (m, 2H), 7.51 (dd, J = 8.2 Hz, 4.5 Hz, 1H). 13C NMR (100 MHz, CDCl3, 
ppm) δ 163.3, 149.8, 148.6, 140.7, 138.7, 136.7, 133.9, 128.6, 128.1, 127.5, 124.1, 122.6, 
122.1, 116.9. HRMS (EIS+): Calculated for C16H11N3O3 [M+H]
+ 
 294.08732, Found 
294.08705. 
N
HN O
N
 
1-Methyl-N-(quinolin-8-yl)-1H-indole-3-carboxamide: 8-Aminoquinoline (1.44 g, 10 
mmol) and triethylamine (3.6 mL, 26 mmol) were dissolved in anhydrous CH2Cl2 (20 
mL) in a 100 mL round-bottom flask followed by dropwise addition of suspension of 1-
methyl-1H-indole-3-carbonyl chloride in 30 mL of CH2Cl2 though syringe. The acid 
chloride was prepared from 1-methyl-1H-indole-3-carboxylic acid (2.3 g, 13 mmol).
23
 
The reaction mixture was stirred overnight. After completion, the reaction was diluted 
with CH2Cl2 (50 mL), washed by aqueous HCl (15 mL, 1N), NaHCO3 (saturated aqueous 
solution, 15 mL), brine (25 mL), and dried over MgSO4. The organic solvent was 
removed by evaporation. Purification by column chromatography in hexane/EtOAc 
(50/50) afforded 2.31 g of amide (77 %) as a light yellow solid. Rf = 0.38 (hexane/EtOAc 
50/50), mp 184 – 186 oC (from acetonitrile). 1H NMR (400 MHz, CDCl3) δ 10.55 (s, 1H), 
8.94 (dd, J = 7.3 Hz, 1..4 Hz, 1H), 8.88 (dd, J = 4.5 Hz, 1.7 Hz, 1H), 8.47 – 8.44 (m, 1H), 
8.17 (dd, J = 8.0 Hz, 1.4 Hz, 1H), 7.91 (s, 1H), 7.58 (t, J = 8.0 Hz, 1H), 7.50 – 7.48 (m, 
1H), 7.46 (t, J = 4.5 Hz, 1H), 7.40 – 7.32 (m, 3H), 3.87 (s, 3H). 13C NMR (100 MHz, 
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CDCl3, ppm) δ 163.5, 148.2, 138.7, 137.5, 136.5, 135.3, 133.2, 128.1, 127.7, 125.5, 
122.8, 122.0, 121.7, 121.0, 120.8, 116.4, 111.8, 110.2, 33.6. HRMS (EIS+): Calculated 
for C19H15N3O [M+H]
+ 
 302.12879, Found 302.12871. 
N
HN O
N  
N-(Quinolin-8-yl)isonicotinamide: 8-Aminoquinoline (1.44 g, 10 mmol) and triethyl 
amine (3.6 mL, 26 mmol) were dissolved in anhydrous CH2Cl2 (20 mL) in a 100 mL 
round-bottom flask followed by dropwise addition of suspension of isonicotinoyl chloride 
in 30 mL of CH2Cl2 though syringe. The acid chloride was prepared from isonicotinic 
acid (1.6 g, 13 mmol).
24
 The reaction mixture was stirred overnight. After completion, the 
reaction was diluted with CH2Cl2 (50 mL), washed by aqueous HCl (15 mL, 1N), 
NaHCO3 (saturated aqueous solution, 15 mL), brine (25 mL), and dried over MgSO4. The 
organic solvent was removed by evaporation. Purification by column chromatography in 
toluene/EtOAc (50/50) afforded 2.2 g of amide (89 %) as an off-white solid. Rf = 0.49 
(toluene/EtOAc 50/50), mp 126 – 128 oC (from diethyl ether). 1H NMR (400 MHz, 
CDCl3) δ 10.80 (s, 1H), 8.88 (dd, J = 6.1 Hz, 3.0 Hz, 1H), 8.86 – 8.82 (m, 3H), 8.18 (dd, 
J = 8.2 Hz, 1.7 Hz, 1H), 7.89 (dd, J = 4.5 Hz, 1.7 Hz, 2H), 7.60 – 7.55 (m, 2H), 7.48 (dd, 
J = 8.2 Hz, 4.5 Hz, 1H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 163.4, 151.0, 148.6, 142.1, 
138.7, 136.6, 133.9, 128.1, 127.5, 122.6, 122.0, 121.1, 117.0. HRMS (EIS+): Calculated 
for C15H11N3O [M+H]
+ 
 250.09749, Found  250.09737. 
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General procedure for copper-catalyzed monofluorination of quinoline amides in 
DMF 
A 1 dram vial equipped with a magnetic stir bar was charged with amide (0.25 mmol, 1 
equiv) and copper iodide (10 – 30 %). The vial was flushed with nitrogen, capped, and 
placed inside the glovebox. To this mixture was added NMO (3 – 4 equiv.), AgF (3 – 4 
equiv.), and anhydrous DMF (1.0 mL). The sealed vial was taken out the glovebox, 
strongly shaken, and stirred at room temperature for 5 minutes, covered with aluminum 
foil, and then transferred to preheated oil bath for indicated time. The reaction mixture 
was cooled to room temperature and diluted with ethyl acetate (2 mL). The suspension 
was filtered through a pad of Celite® and solid phase was washed with ethyl acetate (4 x 
20 mL). The filtrate was concentrated under reduced pressure. The residue was subjected 
to column chromatography on silica gel in hexane followed by appropriate solvent to 
elute the products. After concentrating the fractions containing the product, the residue 
was dried under reduced pressure. 
General procedure for copper-catalyzed monofluorination of quinoline amides in 
pyridine 
A 1 dram vial equipped with a magnetic stir bar was charged with amide (0.25 mmol, 1 
equiv), copper iodide (10 – 30 %), and pyridine (1 mL). The vial was stirred at room 
temperature for 3 minutes and then flushed with nitrogen, capped, and placed inside the 
glovebox. To this mixture was added NMO (3 – 4 equiv) and AgF (3 – 4 equiv). The 
sealed vial was taken out the glovebox, strongly shaken, stirred at room temperature for 5 
minutes, covered with aluminum foil, and then transferred to preheated oil bath for 
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indicated time. The reaction mixture was cooled to room temperature and diluted with 
ethyl acetate (2 mL). The suspension was filtered through a pad of Celite® and solid 
phase was washed with ethyl acetate (4 x 20 mL). The filtrate was concentrated under 
reduced pressure. The residue was subjected to column chromatography on silica gel in 
hexane followed by appropriate solvent to elute the products. After concentrating the 
fractions containing the product, the residue was dried under reduced pressure. 
Note: Premixing each and every substance before adding solvent, vigorous stirring 
(approximately 1500 rpm) at room temperature at least 5 minutes and during reaction 
time are crucial for reproducible yields. 
Optimization of monofluorination of quinoline amides: All reactions were carried out 
following the general procedure using N-(4-trifluoromethylbenzoyl)-8-aminoquinoline 
(80 mg, 0.25 mmol), fluorine source (3 equiv.), oxidant (4 equiv.), solvent (1 mL), 1 
hour. 1,3-Dichlorobenzene (5 μL) was added at the end of reaction as external standard. 
Conversion and GC yields were calculated by GC analysis and presented in Table 2.S1. 
Mixture with exact molar amounts of pure product and 1.3-dichlorobenzene was used as 
the standard to determine GC yields. Mixture with exact molar amounts of 1,3-
dichlorobenzene and starting material was used as the standard to determine percent of 
recovered starting material. 
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N
HN O
CF3
N
HN O
CF3
N
HN O
CF3
FF
F
S1 S2
Conditions
 
Catalysts (%) 
Fluoro 
source  
Oxidant Solvent 
T 
(
o
C) 
% 
unreacted 
SM 
S1 
(%) 
S2 
(%) 
Cu(OAc)2 (25%) CsF NMO DMSO 100 94   
Cu(OAc)2 (25%) AgF NMO DMSO 100 4 17 5 
Cu(OAc)2 (25%) AgF 
O2 
(balloon) 
DMSO 100 10 11 3 
Cu(OAc)2 (25%) AgF Ag2O DMSO 100 7 6 12 
Cu(OAc)2 (25%) AgF PhI(OPiv)2 DMSO 100 < 2 13 4 
Cu(OAc)2 (25%) AgF NMO Dioxane 100 55 32 < 2 
Cu(OAc)2 (25%) AgF NMO DMF 100 20 42 8 
Cu(OTf)(tBuCN) 
(25%) 
AgF NMO DMF 100 10 55 6 
CuI (25%) AgF NMO DMF 100 11 54 6 
CuI (25%) AgF NMO DMF 80 20 60 5 
CuI (25%) AgF NMO DMF 60 33 55 < 2 
CuI(15%) AgF NMO DMF 80 18 70 3 
CuI (15%) 
AgF 
(2 
equiv.) 
NMO DMF 80 35 44 < 2 
CuI (5 %) AgF NMO DMF 80 33 59 5 
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CuI (15%) 
AgF  
(4 
equiv.) 
NMO  
(5 equiv.) 
DMF 80 4 79 7 
CuI (15 %) AgF None DMF 80 15 4 < 2 
CuI(15%) 
AgF 
(4 
equiv.) 
NMO  
(5 equiv.) 
Pyridine
a 
80 16 80 3 
NiCl2 (20 %) AgF NMO DMF 80 >  98   
CoCl2 (20 %) AgF NMO DMF 80 > 98   
FeCl3 (20 %) AgF NMO DMF 80 > 98   
MnCl2 (20 %) AgF NMO DMF 80 > 98   
(a) reaction was run for 2 hours. 
 
 
 
 
 
2-Fluoro-N-(quinolin-8-yl)-4-(trifluoromethyl)benzamide (Table 2.2, Entry 1) 
N-(Quinolin-8-yl)-4-(trifluoromethyl)benzamide  (80 mg, 0.25 mmol), CuI (7.1 mg, 
0.0375 mmol), AgF (96 mg, 0.75 mmol), NMO (118 mg, 1.0 mmol), DMF (1.0 mL), 80 
o
C, 30 minutes. After column chromatography (hexanes, followed by gradient 
hexanes/EtOAc from 95/5 to 90/10), 50 mg (60 %) of a white solid was obtained. 
N-(Quinolin-8-yl)-4-(trifluoromethyl)benzamide  (80 mg, 0.25 mmol), CuI (7.1 mg, 
0.0375 mmol), AgF (127 mg, 1.0 mmol), NMO (150 mg, 1.25 mmol), DMF (1.0 mL), 80 
N
HN O
CF
3
F
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o
C, 30 minutes. After column chromatography (hexanes, followed by gradient 
hexanes/EtOAc from 95/5 to 90/10), 59 mg (71 %) of a white solid was obtained. 
Rf = 0.32 (hexanes/EtOAc 90/10), mp 82 – 84 
o
C (from diethyl ether). 
1
H NMR (400 
MHz, CDCl3) δ 11.15 (s, 1H), 8.93 (dd, J = 6.0 Hz, 3.2 Hz, 1H), 8.86 (dd, J = 4.5 Hz, 1.3 
Hz, 1H), 8.33 (t, J = 7.8 Hz, 1H), 8.17 (dd, J = 8.2 Hz, 1.3 Hz, 1H), 7.60 – 7.55 (m, 3H), 
7.52 – 7.45 (m, 2H). 13C NMR (100 MHz, CDCl3, ppm) δ 160.2 (d, J = 2.5 Hz), 160.0 (d, 
J = 252 Hz), 148.7, 138.8, 136.4, 135.3 (dq. J = 34 Hz, 8.7 Hz), 134.5, 133.2 (d, J = 2.5 
Hz), 128.0, 127.4, 125.4 (d, J = 11.3 Hz), 122.8 (dq, J = 274 Hz, 2.5 Hz), 122.6, 121.9, 
121.8 (septet, J = 3.6 Hz), 117.5, 114.2 (qq, J = 28 Hz, 3.6 Hz). 
19
F NMR (376 MHz, 
CDCl3, ppm) -63.0 – - 62.9 (m, 3F), -109.9 – -109.8 (m, 1F). HRMS (EIS+): Calculated 
for C17H10F4N2O [M+H]
+ 
335.08021, Found 335.08050. 
N
HN O
Me
F
 
2-Fluoro-N-(quinolin-8-yl)-4-methylbenzamide (Table 2.2, Entry 2) 
N-(Quinolin-8-yl)-4-methylbenzamide (66 mg, 0.25 mmol), CuI (12.0 mg, 0.0625 mmol), 
AgF (112 mg, 0.875 mmol), NMO (134 mg, 1.125 mmol), DMF (1.0 mL), 105 
o
C, 75 
minutes. After column chromatography (hexanes, followed by gradient hexanes/EtOAc 
from 95/5 to 90/10), 52 mg (75 %) of a white solid was obtained. Rf = 0.31 
(hexanes/EtOAc 90/10), mp 112 – 114 oC (from diethyl ether). 1H NMR (400 MHz, 
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CDCl3, ppm) δ10.15 (s, 1H), 8.97 (dd, J = 7.5 Hz, 1.3 Hz, 1H), 8.77 (dd, J = 4.3 Hz, 1.7 
Hz, 1H), 8.17 (dd, J = 8.1 Hz, 1.7 Hz, 1H), 7.61 – 7.55 (m, 2H), 7.45 (dd, J = 8.7 Hz, 4.3 
Hz, 1H), 7.34 – 7.30 (m, 1H), 7.08 (d, J = 8.1 Hz, 1H), 7.02 (t, J = 8.7 Hz, 1H), 2.51 (s, 
3H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 163.7, 159.6 (d, J = 248 Hz), 148.5, 138.8 (d, J 
= 3.1 Hz), 138.5, 136.5, 134.4, 130.9 (d, J = 9.5 Hz), 128.1, 127.5, 126.5 (d, J = 3.1 Hz), 
125.4 (d, J = 17 Hz), 122.2, 121.8, 116.9.113.4 (d, J = 22.4), 19.7. 
19
F NMR (376 MHz, 
CDCl3, ppm) -115.8 – -115.7 (s, 1F). HRMS (EIS+): Calculated for C17H13FN2O [M+H]
+ 
 
281.10847, Found 281.10851. 
N
HN O
COOMe
F
 
Methyl 3-fluoro-4-(quinolin-8-ylcarbamoyl)benzoate (Table 2.2, Entry 3) 
Methyl 4-(quinolin-8-ylcarbamoyl)benzoate (77 mg, 0.25 mmol), CuI (4.8 mg, 0.025 
mmol), AgF (127 mg, 1.0 mmol), NMO (150 mg, 1.25 mmol), DMF (1.0 mL), 90 
o
C, 1 
hour. After column chromatography (hexanes, followed by gradient hexanes/EtOAc from 
95/5 to 80/20), 45 mg (56 %) of a white solid was obtained. Rf = 0.36 (hexanes/EtOAc 
80/20), mp 124 – 125 oC (from diethyl ether). 1H NMR (400 MHz, CDCl3, ppm) δ 11.18 
(s, 1H), 8.95 (dd, J = 6.8 Hz, 2.3 Hz, 1H), 8.87 (dd, J = 4.5 Hz, 1.7 Hz, 1H), 8.27 (t, J = 
8.0 Hz, 1H), 8.18 (dd, J = 8.0 Hz, 1.7 Hz, 1H), 7.97 (dd, J = 8.2 Hz, 1.7 Hz, 1H), 7.89 
(dd, J = 11.5 Hz, 1.7 Hz, 1H), 7.60 – 7.55 (m, 2H), 7.47 (dd, J = 8.2 Hz, 4.5 Hz, 1H), 
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3.96 (s, 3H). 
13
C NMR (125 MHz, CDCl3, ppm) δ 165.3 (d, J = 2.4 Hz), 160.7 (d, J = 3.5 
Hz), 160.2 (d, J = 249 Hz), 148.7, 138.8, 136.4, 135.0 (d, J = 9.3 Hz), 134.6, 132.4, 
128.1, 127.5, 126.0 (d, J = 12.3 Hz), 125.8 (J = 3.5 Hz), 122.5, 121.9, 117.7 (d, J = 26.6 
Hz), 117.5, 52.8. 
19
F NMR (376 MHz, CDCl3, ppm) -111.4 – -111.3 (s, 1F). HRMS 
(EIS+): Calculated for C18H13FN2O3 [M+H]
+ 
 325.09830, Found 325.09837. 
N
HN O
CN
F
 
4-Cyano-2-fluoro-N-(quinolin-8-yl)benzamide (Table 2.2, Entry 4) 
4-Cyano-N-(quinolin-8-yl)benzamide (69 mg, 0.25 mmol), CuI (5.7 mg, 0.03 mmol), 
AgF (112 mg, 0.875 mmol), NMO (134 mg, 1.125 mmol), DMF (1.0 mL), 65 
o
C, 75 
minutes. After column chromatography (hexanes, followed by gradient hexanes/EtOAc 
from 95/5 to 80/20), 45 mg (62 %) of a white solid was obtained. Rf = 0.34 
(hexanes/EtOAc 80/20), mp 141 – 143 oC (from diethyl ether). 1H NMR (400 MHz, 
CDCl3) δ 11.16 (s, 1H), 8.92 (t, J = 4.5 Hz,, 1H), 8.86 (dd, J = 4.5 Hz, 1.7 Hz, 1H), 8.32 
(t, J = 7.8 Hz, 1H), 8.19 (dd, J = 8.2 Hz, 1.4 Hz, 1H), 7.64 – 7.58 (m, 3H), 7.55 (dd, J = 
10.4 Hz, 1.4 Hz, 1H), 7.49 (dd, J = 8.2 Hz, 4.5 Hz, 1H). 
13
C NMR (100 MHz, CDCl3, 
ppm) δ 159.8 (d, J = 252 Hz), 159.7 (d, J = 3.6 Hz), 148.8, 138.7, 136.5, 134.3, 133.4 (d, 
J = 2.4 Hz), 128.7 (d, J = 3.6 Hz), 128.1, 127.5, 126.6 (d, J = 12.4 Hz), 122.9, 122.0 , 
120.4 (d, J = 28.2 Hz), 117.6, 116.9 (d, J = 2.0 Hz), 116.7 (d, J = 10.6 Hz).
 19
F NMR 
 77 
(376 MHz, CDCl3, ppm) -109.4 – -109.3 (s, 1F). HRMS (EIS+): Calculated for C17H10F-
N3O [M+H]
+ 
 292.08807, Found 292.08780. 
 
N
HN O
FF3C
 
2-Fluoro-N-(quinolin-8-yl)-6-(trifluoromethyl)benzamide (Table 2.2, Entry 5) 
N-(Quinolin-8-yl)-2-(trifluoromethyl)benzamide (80 mg, 0.25 mmol), CuI (9.6 mg, 0.05 
mmol), AgF (127 mg, 1.0 mmol), NMO (150 mg, 1.25 mmol), DMF (1.0 mL), 120 
o
C, 
90 minutes. After column chromatography (hexanes, followed by gradient 
hexanes/EtOAc from 95/5 to 90/10), 66 mg (80 %) of a white solid was obtained. Rf = 
0.34 (hexanes/EtOAc 90/10), mp 74 – 76 oC (from diethyl ether). 1H NMR (400 MHz, 
CDCl3) δ 10.15 (s, 1H), 8.92 (dd, J =6.0 Hz, 2.8 Hz, 1H), 8.74 (dd, J = 4.3 Hz, 1.7 Hz, 
1H), 8.17 (dd, J = 8.3 Hz, 1.7 Hz, 1H), 7.61 – 7.57 (m, 4H), 7.45 – 7.38 (m, 2H). 13C 
NMR (100 MHz, CDCl3, ppm) δ 160.7, 159.5 (d, J = 252 Hz), 148.5, 138.4, 136.5, 134.1, 
131.5 (d, J = 8.7 Hz), 129.6 (dq, J = 33 Hz, 3.5 Hz), 128.0, 127.5, 124.4 (dd, J = 8.7 Hz, 
1.8 Hz), 123.2 (dq, J = 261 Hz, 1.8 Hz), 122.6, 122.3 (septet, J = 4. 2 Hz), 121.9, 120.1 
(d, J = 22.4), 117.2. 
19
F NMR (376 MHz, CDCl3, ppm) -59.0 – -58.7 (s, 3F), -113.0 – -
112.9 (m, 1F). HRMS (EIS+): Calculated for C17H10F4N2O [M+H]
+ 
 335.08021, Found 
335.08056. 
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2-Fluoro-N-(quinolin-8-yl)-6-methylbenzamide (Table 2.2, Entry 6) 
N-(Quinolin-8-yl)-2-methylbenzamide (66 mg, 0.25 mmol), CuI (12.0 mg, 0.0625 mmol), 
AgF (127 mg, 1.0 mmol), NMO (150 mg, 1.25 mmol), DMF (1.0 mL), 120 
o
C, 20 
minutes. After column chromatography (hexanes, followed by gradient hexanes/EtOAc 
from 95/5 to 88/12), 44 mg (63 %) of a white solid was obtained. Rf = 0.32 
(hexanes/EtOAc 90/10), mp 88 – 89 oC (from diethyl ether). 1H NMR (400 MHz, CDCl3) 
δ 10.15 (s, 1H), 8.97 (dd, J = 7.5 Hz, 1.4 Hz, 1H), 8.76 (dd, J = 4.2 Hz, 1.7 Hz, 1H), 8.17 
(dd, J = 8.1 Hz, 1.7 Hz, 1H), 7.61 – 7.55 (m, 2H), 7.45 (dd, J = 8.1 Hz, 4.2 Hz, 1H), 7.34 
– 7.29 (m, 1H), 7.08 (d, J = 7.5 Hz, 1H), 7.02 (t, J = 8.9 Hz,1H), 2.51 (s, 3H). 13C NMR 
(100 MHz, CDCl3, ppm) δ 163.7, 159.6 (d, J = 249 Hz), 148.5, 138.9 (d, J = 3.5 Hz), 
138.5, 136.5, 134.4, 130.9 (d, J = 9.5 Hz), 128.1, 127.5, 126.5 (d, J = 2.4 Hz), 125.4 (d, J 
= 17 Hz), 122.3, 121.8, 116.9, 113.4 (d, J = 22.1 Hz), 19.7. 
19
F NMR (376 MHz, CDCl3, 
ppm) -115.8 – -115.7 (s, 1F). HRMS (EIS+): Calculated for C17H13FN2O [M+H]
+ 
 
281.10847, Found 281.10866.  
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2-Fluoro-4-nitro-N-(quinolin-8-yl)benzamide (Table 2.2, Entry 7) 
4-Nitro-N-(quinolin-8-yl)benzamide (74 mg, 0.25 mmol), CuI (5.7 mg, 0.03 mmol), AgF 
(127 mg, 1.0 mmol), NMO (150 mg, 1.25 mmol), pyridine (1.0 mL), 60 
o
C, 2 hours. 
After column chromatography (hexanes, followed by gradient hexanes/EtOAc from 95/5 
to 80/20), 46 mg (60 %) of a light yellow solid was obtained. Rf = 0.28 (hexanes/EtOAc 
80/20), mp 151 – 152 oC (from diethyl ether). 1H NMR (400 MHz, CDCl3) δ 11.20 (d, J 
= 10.8 Hz, 1H), 8.94 – 8.92 (m, 1H), 8.88 (dd, J = 4.4 Hz, 1.4 Hz, 1H), 8.41 (t, J = 7.8 
Hz, 1H), 8.22 – 8.17 (m, 2H), 8.12 (dd, J = 10.8 Hz, 1.7 Hz, 1H), 7.62 – 7.60 (m, 2H), 
7.51 (dd, J = 8.2 Hz, 4.4 Hz, 1H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 159.9 (d, J = 254 
Hz), 159.4, 159.3, 148.8, 138.8, 136.4, 134.3, 133.4 (d, J = 2.4 Hz), 128.1, 128.0 (d, J = 
12.3 Hz), 127.4, 122.9, 122.0, 119.7 (d, J = 3.6 Hz), 117.7, 112.5 (d, J = 29.7 Hz). 
19
F 
NMR (376 MHz, CDCl3, ppm) -107.8 – -107.9 (s, 1F). HRMS (EIS+): Calculated for 
C16H10FN3O3 [M+H]
+ 
 312.07790, Found 312.07793. 
N
HN O
F
F3C  
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2-Fluoro-N-(quinolin-8-yl)-5-(trifluoromethyl)benzamide (Table 2.2, Entry 8) 
N-(Quinolin-8-yl)-5-(trifluoromethyl)benzamide (80 mg, 0.25 mmol), CuI (5.7 mg, 0.03 
mmol), AgF (127 mg, 1.0 mmol), NMO (150 mg, 1.25 mmol), DMF (1.0 mL), 100 
o
C, 
45 minutes. After column chromatography (hexanes, followed by gradient 
hexanes/EtOAc from 95/5 to 90/10), 59 mg (71 %) of a white solid was obtained. Rf = 
0.34 (hexanes/EtOAc 90/10), mp 83 – 85 oC (from diethyl ether). 1H NMR (400 MHz, 
CDCl3) δ 11.18 (d, J = 12.1 Hz, 1H), 8.93 (dd, J = 6.9 Hz, 2.3 Hz, 1H), 8.85 (dd, J = 4.1 
Hz, 1.7 Hz, 1H), 8.54 (dd, J = 6.9 Hz, 2.3 Hz, 1H), 8.18 (dd, J = 8.1 Hz, 1.7 Hz, 1H), 
7.80 – 7.77 (m, 1H), 7.60 – 7.55 (m, 2H), 7.47 (dd, J = 8.3 Hz, 4.1 Hz, 1H), 7.37 – 7.33 
(m, 1H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 162.1 (d, J = 254.6 Hz), 160.0 (d, J = 3.6 
Hz), 148.7, 138.8, 136.4, 134.5, 130.6 (td, J = 7.3 Hz, 3.6Hz), 130.1 (t, J = 3.6 Hz), 
128.0, 127.8 (dq, J = 33 Hz, 3.6 Hz), 127.5, 123.4 (q, J = 273 Hz), 122.8 (d, J = 13 Hz), 
122.6, 121.9, 117.5, 117.3.
 19
F NMR (376 MHz, CDCl3, ppm) -62.5 – -62.9 (s, 3F), -
106.9 – -107.0 (m, 1F). HRMS (EIS+): Calculated for C17H10F4N2O [M+H]
+ 
 335.08021, 
Found 335.08051. 
N
HN O
N
Me
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2-Fluoro-1-methyl-N-(quinolin-8-yl)-1H-indole-3-carboxamide (Table 2.2, Entry 9) 
1-Methyl-N-(quinolin-8-yl)-1H-indole-3-carboxamide (76 mg, 0.25 mmol), CuI (4.6 mg, 
0.025 mmol), AgF (127 mg, 1.0 mmol), NMO (150 mg, 1.25 mmol), DMF (1.0 mL), 50 
 81 
o
C, 1 hour. After column chromatography (hexanes, followed by gradient hexanes/EtOAc 
from 90/10 to 75/25), 43 mg (54 %) of a light tan solid was obtained. Rf = 0.29 
(hexanes/EtOAc 90/10), mp 182 – 184 oC (from acetonitrile). 1H NMR (400 MHz, 
DMSO-d6, ppm) δ 10.45 (d, J = 5.7 Hz, 1H), 8.94 (dd, J = 4.5 Hz, 1.7 Hz, 1H), 8.81 (dd, 
J = 7.8 Hz, 1.7 Hz, 1H), 8.43 (dd, J = 8.6 Hz, 1.7 Hz, 1H), 8.24 (dd, J = 5.7 Hz, 2.3 Hz, 
1H), 7.66 – 7.54 (m, 4H), 7.31 – 7.26 (m, 2H), 3.78 (s, 3H). 13C NMR (100 MHz, 
DMSO-d6, ppm) δ 160.7 (d, J = 4.1 Hz), 153.5, 151.3, 149.6, 138.1, 137.4, 135.2, 129.5 
(d, J = 283 Hz), 127.8, 123.8 (d, J = 3.6 Hz), 123.1, 123.0, 122.9 (d, J = 2.3 Hz), 121.7, 
121.1 (d, J = 5.0 Hz), 115.9, 111.0, 89.2 (d, J = 5.9 Hz), 28.9. 
19
F NMR (376 MHz, 
CDCl3, ppm) -122.0 (s, 1F). HRMS (EIS+): Calculated for C19H14F1N3O [M+H]
+ 
 
320.11937, Found 320.11941. 
N
HN O
N
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3-Fluoro-N-(quinolin-8-yl)isonicotinamide (Table 2.2, Entry 10) 
N-(Quinolin-8-yl)isonicotinamide (63 mg, 0.25 mmol), CuI (9.7 mg, 0.05 mmol), AgF 
(127 mg, 1.0 mmol), NMO (140 mg, 1.25 mmol), pyridine (1 mL), 65 
o
C, 2 hours. After 
column chromatography (hexanes, followed by gradient hexanes/EtOAc from 80/20 to 
60/40), and then HPLC (hexanes/EtOAc 65/35), 41.5 mg (62 %) of a white solid was 
obtained. Rf = 0.47 (hexanes/EtOAc 60/40), mp 122 – 124 
o
C (from diethyl ether). 
1
H 
NMR (400 MHz, CDCl3, ppm) δ 11.18 (d, J = 10.6 Hz, 1H), 8.95 – 8.90 (m, 1H), 8.87 
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(dd, J = 4.2 Hz, 1.8 Hz, 1H), 8.70 (d, J = 2.7 Hz, 1H), 8.64 (dd, J = 4.2 Hz, 1.4 Hz, 1H), 
8.19 (dd, J = 8.3 Hz, 1.4 Hz, 1H), 8.06 (dd, J = 6.8 Hz, 4.5 Hz, 1H), 7.61 – 7.56 (m, 2H), 
7.49 (dd, J = 8.3 Hz, 4.2 Hz, 1H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 159.5 (d, J = 1.9 
Hz), 156.2 (d, J = 259.3 Hz), 148.8, 146.9 (d, J = 4.9 Hz), 139.8 (d, J = 27.4 Hz), 138.7, 
136.5, 134.2, 128.7 (d, J = 10.6 Hz), 128.1, 127.4, 124.6, 122.9, 122.0, 117.6. 
19
F NMR 
(376 MHz, CDCl3, ppm), -127.3 – -127.2 (s, 1F). HRMS (EIS+): Calculated for C15H10-
FN3O [M+H]
+ 
 268.08807, Found 268.08824. 
General procedure for copper-catalyzed difluorination of quinoline amides 
A 1 dram vial equipped with a magnetic stir bar was charged with amide (0.25 mmol, 1 
equiv.), copper iodide (10 – 30 %), and additive (pyridine). The vial was flushed with 
nitrogen, capped, and placed inside the glovebox. To this mixture was added NMO (6 – 8 
equiv.), AgF (5 – 6 equiv.), and anhydrous DMF (1.0 mL). The sealed vial was taken out 
the glovebox, stirred at room temperature for 1 minute, covered with aluminum foil, and 
then transferred to preheated oil bath for indicated time. The reaction mixture was cooled 
to room temperature and diluted with ethyl acetate (2 mL). The suspension was filtered 
through a pad of Celite® and solid phase was washed with ethyl acetate (4 x 20 mL). The 
filtrate was concentrated under reduced pressure. The residue was subjected to column 
chromatography on silica gel in hexane followed by appropriate solvent to elute the 
products. After concentrating the fractions containing the product, the residue was dried 
under reduced pressure. 
Optimization of condition for difluorination of quinoline amides: All reactions were 
carried out following the general procedure using N-(4-trifluoromethylbenzoyl)-8-
 83 
aminoquinoline (80 mg, 0.25 mmol), AgF (x equiv.), NMO [(x + 2) equiv.], solvent (1 
mL), 90 minutes. 1,3-Dichlorobenzene (5 μL) was added at the end of reaction as 
external standard. Conversion and GC yields were calculated by GC analysis and 
presented in Table 2.S1. Mixture with exact molar amounts of pure product and 1.3-
dichlorobenzene was used as the standard to determine GC yields. Mixture with exact 
molar amounts of 1,3-dichlorobenzene and starting material was used as the standard to 
determine percent of unreacted starting material. 
N
HN O
CF3
CuI
AgF, NMO
Additive
DMF, t oC
N
HN O
CF3
N
HN O
CF3
FF
F
S1 S2  
Amount 
of CuI 
(%) 
Equiv. 
of AgF 
T (
o
C) Additive 
% 
unreacted 
SM 
S1 (%) S2 (%) 
10 5 80  6 42 16 
20 5 80  3 36 26 
40 5 80  < 2 25 23 
20 5 100  < 2 31 19 
20 6 80  < 2 17 38 
20 6 80 
K2CO3  
(1 equiv.) 
96 < 2 < 2 
20
a 
6 80  10 52 33 
20
 
6 80 Pyridine  < 2 4 70 
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(1 equiv.) 
20
 
6 80 
Pyridine  
(2 equiv.) 
< 2 5 78 
(a) Reaction was carried out in pyridine solvent. 
N
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2,6-Difluoro-N-(quinolin-8-yl)-4-(trifluoromethyl)benzamide (Table 2.3, Entry 1) 
N-(Quinolin-8-yl)-4-(trifluoromethyl)benzamide  (80 mg, 0.25 mmol), CuI (9.6 mg, 0.05 
mmol), AgF (191 mg, 1.5 mmol), NMO (240 mg, 2.0 mmol), DMF (1.0 mL), pyridine 
(40 mg, 0.5 mmol), 80 
o
C, 90 minutes. After column chromatography (hexanes, followed 
by gradient hexanes/EtOAc from 95/5 to 90/10), 56 mg (67 %) of a white solid was 
obtained. Rf = 0.38 (hexanes/EtOAc 90/10), mp 80 – 81 
o
C (from diethyl ether). 
1
H NMR 
(400 MHz, CDCl3) δ 10.38 (s, 1H), 1.89 (septet, J = 4.4 Hz, 1H), 8.78 (dd, J = 4.4 Hz, 
1.7 Hz, 1H), 8.18 (dd, J = 8.3 Hz, 1.7 Hz, 1H), 7.59 (d, J = 4.4 Hz, 2H), 7.47 (dd, J = 8.3 
Hz, 4.4 Hz, 1H), 7.30 (d, J = 6.8 Hz, 2H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 160.1 (dd, 
J = 256 Hz, 7.5 Hz), 157.1, 148.6, 138.4, 136.6, 134.3 (td, J = 34.5 Hz, 10.1 Hz), 133.8, 
128.0, 127.4, 122.9, 122.3 (tq, J = 273 Hz, 2.8 Hz), 122.0, 118.1 (t, J = 19.8 Hz), 117.3, 
110.0 (td, J = 27 Hz, 2.8 Hz). 
19
F NMR (376 MHz, CDCl3, ppm) δ -63.0 – -63.6 (m, 3F), 
-107.7 – -108.0 (s, 2F). HRMS (EIS+): Calculated for C17H9F5N2O [M+H]
+ 
 353.07078, 
Found 353.07101. 
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Methyl-3,5-difluoro-4-(quinolin-8-ylcarbamoyl)benzoate (Table 2.3, Entry 2) 
Methyl-4-(quinolin-8-ylcarbamoyl)benzoate (77 mg, 0.25 mmol), CuI (9.6 mg, 0.05 
mmol), AgF (191 mg, 1.5 mmol), NMO (240 mg, 2.0 mmol), DMF (1.0 mL), pyridine 
(40 mg, 2.0 mmol), 95 
o
C, 90 minutes. After column chromatography (hexanes, followed 
by gradient hexanes/EtOAc from 95/5 to 90/10), 53 mg (62 %) of a white solid was 
obtained. Rf = 0.38 (hexanes/EtOAc 80/20), mp 122 – 124 
o
C (from diethyl ether). 
1
H 
NMR (400 MHz, CDCl3) δ 10.36 (s, 1H), 8.90 (dd, J = 5.5 Hz, 3.5 Hz, 1H), 8.78 (dd, J = 
4.4 Hz, 1.7 Hz, 1H), 8.17 (dd, J = 8.1 Hz, 1.7 Hz, 1H), 7.68 – 7.64 (m, 2H), 7.60 – 7.56 
(m, 2H), 7.45 (dd, J = 8.1 Hz, 4.4 Hz, 1H), 3.96 (s, 3H). 
13
C NMR (100 MHz, CDCl3, 
ppm) δ 164.3 (t, J = 3.0 Hz), 159.9 (dd, J = 254.5 Hz, 7.1 Hz), 157.7, 148.6, 138.4, 136.5, 
134.0 (t, J = 9.5 Hz), 133.9, 128.0, 127.4, 122.8, 122.0, 118.6 (t, J = 20.6 Hz), 117.3, 
113.5 (d, J = 27.4 Hz), 53.1. 
19
F NMR (376 MHz, CDCl3, ppm) δ -109.9– -110.1 (s, 2F). 
HRMS (EIS+): Calculated for C18H12F2N2O3 [M+H]
+ 
 343.08888, Found 343.08917 
N
HN O
CN
FF
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4-Cyano-2,6-difluoro-N-(quinolin-8-yl)benzamide (Table 2.3, Entry 3) 
4-Cyano-N-(quinolin-8-yl)benzamide (69 mg, 0.25 mmol), CuI (8.6 mg, 0.045 mmol), 
AgF (165 mg, 1.25 mmol), NMO (210 mg, 1.75 mmol), DMF (1.0 mL), pyridine (40 mg, 
0.5 mmol), 75 
o
C, 2 hours. After column chromatography (hexanes, followed by gradient 
hexanes/EtOAc from 95/5 to 80/20), 54 mg (70 %) of a white solid was obtained. Rf = 
0.33 (hexanes/EtOAc 80/20), mp 143 – 145 oC (from diethyl ether). 1H NMR (400 MHz, 
CDCl3) δ 10.37 (s, 1H), 8.87 (dd, J = 5.7 Hz, 2.7 Hz, 1H), 8.78 (dd, J = 4.3 Hz, 1.7 Hz, 
1H), 8.20 (dd, J = 8.3 Hz, 1.4 Hz, 1H), 7.63 – 7.57 (m, 2H), 7.48 (dd, J = 8.3 Hz, 4.3 Hz, 
1H), 7.35 – 7.30 (m, 2H). 13C NMR (100 MHz, CDCl3, ppm) δ 160.0 (dd, J = 257 Hz, 7.3 
Hz), 156.5, 148.7, 138.3, 136.6, 133.7, 128.0, 127.4, 123.1, 122.1, 119.6, (t, J = 20.4 Hz), 
117.4, 116.5 (dd, J = 19.4 Hz, 7.6 Hz), 116.0 (t, J = 2.8 Hz), 115.4 (t, J = 11.5 Hz). 
19
F 
NMR (376 MHz, CDCl3, ppm) δ -107.4 – -117.5 (s, 2F). HRMS (EIS+): Calculated for 
C17H9F2N3O [M+H]
+ 
 310.07865, Found 310.07878. 
N
HN O
FF
 
1, 3-Difluoro-N-(quinolin-8-yl)-2-naphthamide (Table 2.3, Entry 4) 
N-(Quinolin-8-yl)-2-naphthamide (75 mg, 0.25 mmol), CuI (11.0 mg, 0.0575 mmol), 
AgF (191 mg, 1.5 mmol), NMO (240 mg, 2.0 mmol), DMF (1.0 mL), pyridine (40 mg, 
2.0 mmol), 100 
o
C, 90 minutes. After column chromatography (hexanes, followed by 
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gradient hexanes/EtOAc from 95/5 to 85/15), 58.5 mg (70 %) of a white solid was 
obtained. Rf = 0.55 (hexanes/EtOAc 80/20), mp 152 – 154 
o
C (from diethyl ether). 
1
H 
NMR (400 MHz, CDCl3) δ 10.46 (s, 1H), 8.99 (dd, J = 6.8 Hz, 1.4 Hz, 1H), 8.79 (dd, J = 
4.2 Hz, 1.4 Hz, 1H), 8.18 (t, J = 8.3 Hz, 2H), 7.83 (d, J = 8.3 Hz, 1H), 7.66 – 7.54 (m, 
4H), 7.48 – 7.40 (m, 2H). 13C NMR (100 MHz, CDCl3, ppm) δ 158.9, 156.8 (dd, J = 259 
Hz, 7.6 Hz), 156.6 (dd, J = 253 Hz, 7.2 Hz), 148.5, 138.6, 136.4, 134.5 (t, J = 6.6 Hz), 
134.4, 129.4, 128.1, 127.5, 127.1 (t, J = 4.3 Hz), 126.3, 122.4 , 121.8, 120.7 (d, J = 16.4 
Hz), 117.2, 112.3 (d, J = 18.5 Hz), 112.0 (J = 18.5 Hz), 108.1 (dd, J = 21.5 Hz, 4.3 Hz). 
19
F NMR (376 MHz, CDCl3, ppm) δ -116.2 – -116.3 (m, 1F), -118.8 (s, 1F). HRMS 
(EIS+): Calculated for C17H9F2N3O [M+H]
+ 
 335.09905, Found 335.09926. 
N
HN O
O
FF
Me  
2,6-Difluoro-4-methoxy-N-(quinolin-8-yl)benzamide (Table 2.3, Entry 5) 
4-Methoxy-N-(quinolin-8-yl)benzamide (70 mg, 0.25 mmol), CuI (14.3 mg, 0.075 
mmol), AgF (191 mg, 1.5 mmol), NMO (240 mg, 2.0 mmol), DMF (1.0 mL), pyridine 
(40 mg, 2.0 mmol), 100 
o
C, 90 minutes. After column chromatography (hexanes, 
followed by gradient hexanes/EtOAc from 95/5 to 85/15), 59 mg (75 %) of a white solid 
was obtained. Rf = 0.49 (hexanes/EtOAc 80/20), mp 111 – 113 
o
C (from diethyl ether). 
1
H NMR (400 MHz, CDCl3) δ 10.37 (s, 1H), 8.91 (d, J = 7.0 Hz, 1H), 8.77 (d, J = 3.0 
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Hz, 1H), 8.13 (d, J = 8.2 Hz, 1H), 7.57 – 7.50 (m, 2H), 7.41 (dd, J = 8.2 Hz, 4.4 Hz, 1H), 
6.52 (d, J = 10.1 Hz, 2H), 3.81 (s, 3H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 162.6 (d, J = 
15.5 Hz), 161.5 (dd, J = 252 Hz, 9.5 Hz), 158.8, 148.5, 138.5, 136.4, 134.5, 128.0, 127.4, 
122.2, 121.8, 116.9, 107.3 (t, J = 18.3 Hz), 98.7 (d, J = 28.7 Hz), 56.1. 
19
F NMR (376 
MHz, CDCl3, ppm) δ -109.7– -109.9 (s, 2F). HRMS (EIS+): Calculated for C17H12F2N2O2 
[M+H]
+ 
 315.09396, Found 315.09422. 
N
HN O
F
FF
 
2,4,6-Trifluoro-N-(quinolin-8-yl)benzamide (Table 2.3, Entry 6) 
4-Fluoro-N-(quinolin-8-yl)benzamide (67 mg, 0.25 mmol), CuI (9.6 mg, 0.05 mmol), 
AgF (191 mg, 1.5 mmol), NMO (240 mg, 2.0 mmol), DMF (1.0 mL), pyridine (40 mg, 
2.0 mmol), 85 
o
C, 90 minutes. After column chromatography (hexanes, followed by 
gradient hexanes/EtOAc from 95/5 to 90/10), 46 mg (61 %) of a white solid was 
obtained. Rf = 0.42 (hexanes/EtOAc 90/10), mp 72 – 74 
o
C (from diethyl ether). 
1
H NMR 
(400 MHz, CDCl3) δ 10.33 (s, 1H), 8.90 (dd, J = 6.3 Hz, 2.9 Hz, 1H), 8.79 (dd, J = 4.5 
Hz, 1.7 Hz, 1H), 8.18 (dd, J = 8.3 Hz, 1.7 Hz, 1H), 7.60 – 7.55 (m, 2H), 7.46 (dd, J = 8.3 
Hz, 4.5 Hz, 1H), 6.82 – 6.77 (m, 2H). 13C NMR (100 MHz, CDCl3, ppm) δ 163.7 (td, J = 
254.2 Hz, 15.3 Hz), 160.9 (ddd, J = 255.2 Hz, 15.3 Hz, 9.1 Hz), 157.8, 148.6, 138.4, 
136.5, 134.1, 128.0, 127.5, 122.6, 121.9, 117.2, 111.7 (dt, J = 19.1 Hz, 4.7 Hz), 101.3 (dt, 
J = 26.1 Hz, 3.3 Hz). 
19
F NMR (376 MHz, CDCl3, ppm) δ -103.0– -103.1 (m, 1F), -
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107.8– -108.1 (m, 2F). HRMS (EIS+): Calculated for C16H9F3N2O [M+H]
+ 
 303.07398, 
Found 303.07399. 
N
HN O
FF
Me  
2,6-Difluoro-3-methyl-N-(quinolin-8-yl)benzamide (Table 2.3, Entry 7) 
3-Methyl-N-(quinolin-8-yl)benzamide (66 mg, 0.25 mmol), CuI (9.6 mg, 0.05 mmol), 
AgF (191 mg, 1.5 mmol), NMO (240 mg, 2.0 mmol), DMF (1.0 mL), pyridine (40 mg, 
2.0 mmol), 105 
o
C, 90 minutes. After column chromatography (hexanes, followed by 
gradient hexanes/EtOAc from 95/5 to 90/10), 57 mg (77 %) of a white solid was 
obtained. Rf = 0.37 (hexanes/EtOAc 90/10), mp 102 – 103 
o
C (from diethyl ether). 
1
H 
NMR (400 MHz, CDCl3) δ 10.31 (s, 1H), 8.94 (dd, J = 6.8 Hz, 1.7 Hz, 1H), 8,79 (dd, J = 
4.3 Hz, 1.7 Hz, 1H), 8.17 (dd, J = 8.3 Hz, 1.7 Hz, 1H), 7.60 – 7.55 (m, 2H), 7.45 (dd, J = 
8.3 Hz, 4.3 Hz, 1H), 7.28 – 7.24 (m, 1H), 6.92 (dt, J = 8.5 Hz, 1.1 Hz, 1H). 13C NMR 
(100 MHz, CDCl3, ppm) δ 159.1, 158.3 (dd, J = 250 Hz, 6.6 Hz), 158.0 (dd, J = 251 Hz, 
7.1 Hz), 148.5, 136.5, 134.3, 133.2 (dd, J = 10.5 Hz, 7.1 Hz), 128.0, 127.5, 122.4, 121.8, 
121.7 (dd, J = 18.1 Hz, 3.6 Hz), 117.2, 114.5 (t, J = 20.5 Hz), 111.6 (dd, J = 21.7 Hz, 3.5 
Hz), 14.4 (d, J = 3.5 Hz). Signal for one carbon could not be located. 
19
F NMR (376 
MHz, CDCl3, ppm) δ -114.7– -114.8 (m, 1F), -115.7– -115.9 (m, 1F). HRMS (EIS+): 
Calculated for C17H12F2N2O [M+H]
+ 
 299.09905, Found 299.09936. 
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3,5-Difluoro-N-(quinolin-8-yl)isonicotinamide (Table 2.3, Entry 8) 
N-(Quinolin-8-yl)isonicotinamide (63 mg, 0.25 mmol), CuI (11.8 mg, 0.0625 mmol), 
AgF (191 mg, 1.5 mmol), NMO (240 mg, 2.0 mmol), pyridine (1 mL), 85 
o
C, 90 minutes. 
After column chromatography (hexanes, followed by gradient hexanes/EtOAc from 
80/20 to 60/40), and then HPLC (hexanes/EtOAc 65/35), 43.4 mg (61 %) of a white solid 
was obtained. Rf = 0.47 (hexanes/EtOAc 60/40), mp 118 – 120 
o
C (from diethyl ether). 
1
H NMR (400 MHz, CDCl3) δ 10.43 (s, 1H), 8.88 (dd, J = 6.7 Hz, 2.3 Hz, 1H), 8.80 (dd, 
J = 4.1 Hz, 1.7 Hz, 1H), 8.52 (s, 2H), 8.20 (dd, J = 8.1 Hz, 1.7 Hz, 1H), 7.62 – 7.57 (m, 
2H), 7.48 (dd, J = 8.1 Hz, 4.1 Hz, 1H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 156.2, 155.6 
(d, J = 265.3 Hz), 148.7, 138.4, 136.6, 135.5 (dd, J = 25.6 Hz, 3.9 Hz), 133.6, 128.0, 
127.4, 123.1, 122.1, 120.8 (t, J = 16.8 Hz), 117.5. 
19
F NMR (376 MHz, CDCl3, ppm) δ -
126.4 (s, 2F). HRMS (EIS+): Calculated for C15H9F2N3O [M+H]
+ 
 286.07865, Found 
286.07802. 
Note: Product contains less than 3 % of 3-fluoro-N-(quinolin-8-yl)isonicotinamide. 
Control experiments: all reactions were carried out following general procedure for 
monofluorination. 
Attempted fluorination of N-isopropylbenzamide under standard conditions afforded no 
fluorinated product. 
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Investigating contaminants: Reaction was carried out using new vial and new magnetic 
stirring bar. N-(Quinolin-8-yl)-4-(trifluoromethyl)benzamide  (80 mg, 0.25 mmol), CuI 
(> 99.99, trace metals basic) (7.1 mg, 0.0375 mmol), AgF (> 99.9 % trace metals basic) 
(127 mg, 1.0 mmol), NMO (from unopened bottle) (150 mg, 1.25 mmol), anhydrous 
DMF (from unopened bottle) (1.0 mL), 80 
o
C, 30 minutes. After column chromatography 
(hexanes, followed by gradient hexanes/EtOAc from 95/5 to 90/10), 61 mg (73 %) of a 
white solid was obtained. 
Reaction without copper: N-(Quinolin-8-yl)-4-(trifluoromethyl)benzamide  (80 mg, 0.25 
mmol), AgF (127 mg, 1.0 mmol), NMO (150 mg, 1.25 mmol), anhydrous DMF (1.0 mL), 
80 
o
C, 30 minutes. GC analysis showed less than 2 % of desired product. 
Large scale synthesis:  
A pressure vessel (50 mL) equipped with a magnetic stir bar (eggshape, 15mm in length 
x 6mm in diameter) was charged with 4-cyano-N-(quinolin-8-yl)benzamide (1.38 g, 5.0 
mmol) and CuI (114 mg, 0.6 mmol). The vessel was flushed with nitrogen, capped, and 
placed inside the glovebox. To this mixture was added AgF (2.24 g, 17.5 mmol), NMO 
(2.68 g, 22.5 mmol), and DMF (25 mL). The sealed vessel was taken out the glovebox, 
strongly shaken, stirred at room temperature for 20 minutes, covered with aluminum foil, 
and then transferred to preheated oil bath at 65 
o
C and stirred for 90 minutes. The 
reaction mixture was cooled to room temperature and diluted with ethyl acetate (20 mL). 
The suspension was filtered through a pad of Celite® and solid phase was washed with 
ethyl acetate (6 x 50 mL). The filtrate was concentrated under reduced pressure. The 
residue was subjected to column chromatography on silica gel in hexane followed by 
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gradient hexanes/EtOAc from 95/5 to 80/20. White solid (870 mg, 60 %) was obtained. 
1
H NMR (400 MHz, CDCl3) δ 11.16 (s, 1H), 8.92 (t, J = 4.5 Hz,, 1H), 8.86 (dd, J = 4.5 
Hz, 1.8 Hz, 1H), 8.32 (t, J = 7.8 Hz, 1H), 8.19 (dd, J = 8.2 Hz, 1.4 Hz, 1H), 7.64 – 7.58 
(m, 3H), 7.55 (dd, J = 10.4 Hz, 1.4 Hz, 1H), 7.49 (dd, J = 8.2 Hz, 4.5 Hz, 1H). 
Reactions without using glovebox:  
A 1 dram vial equipped with a magnetic stir bar was charged with methyl 4-(quinolin-8-
ylcarbamoyl)benzoate (77 mg, 0.25 mmol), CuI (4.8 mg, 0.025 mmol), AgF (127 mg, 1.0 
mmol), NMO (150 mg, 1.25 mmol), and DMF (1.0 mL). The sealed vial was flushed 
with nitrogen, capped, strongly shaken, covered with aluminum foil, and stirred at room 
temperature for 5 minutes. Vial was then transferred to preheated oil bath at 90 
o
C for 1 
hour. The reaction mixture was worked up following general procedure. After column 
chromatography (hexanes, followed by gradient hexanes/EtOAc from 95/5 to 80/20), 47 
mg (57 %) of a white solid was obtained. 
Removal of directing group  
N
HN O
F
FF
NaOH, EtOH
HO O
F
FF
 
A 2 dram vial equipped with a magnetic stir bar was charged 2,4,6-trifluoro-N-(quinolin-
8-yl)benzamide (151 mg, 0.5 mmol), NaOH (5 mmol), and EtOH (3 mL). The resulting 
mixture was stirred at room temperature for 1 minute before being heated to 90 
o
C for 24 
hours. After completion, reaction was cooled to room temperature and diluted with 
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dichloromethane (130 mL) followed by addition of aqueous 1N HCl (30 mL). Organic 
layer was washed with 1N HCl (5 x 20 mL), dried over MgSO4, filtered and the solvent 
was evaporated under reduced pressure to afford pure product as white solid (82 %, 72 
mg). This compound is known.
26
 
1
H NMR (400 MHz, CDCl3) δ 11.62 (broad singlet, 
1H), 7.68 – 7.73 (m, 2H). 
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Chapter 3 
Direct Arylation of C-H Bonds via Aryne Intermediates 
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Introduction 
The biaryl structural motif is often found in natural products as well as in many 
pharmaceutically relevant and biologically active compounds.
1
 As a consequence, for 
over a century new and progressively more efficient aryl-aryl bond-forming methods 
have been developed. In general, transition metal catalysis is commonly used for the 
construction of aryl-aryl bonds.
2
 Traditional methods for biaryl preparation involve a 
reaction of aryl halide or pseudohalide with an organometallic reagent. However, the 
preparation of starting materials adds extra steps to the synthetic sequences. Catalytic 
direct arylation provides more efficient routes by using simple arenes in the coupling 
reactions. Since organic molecules usually display many non-equivalent C-H bonds with 
comparable dissociation energies, modern direct arylation methods that allow reactions to 
proceed with excellent selectivity and high functional group tolerance are developed. 
 Recently, substantial progresses in transition-metal-catalyzed direct arylation 
reactions has been achieved. However, transition-metal impurities in the final products 
represent a major problem regarding purification and applications in pharmaceutical 
industry.
3
 Therefore, there is a need for more efficient routes whereby the same outcome 
is accomplished without transition-metal involvement. Within this chapter, transition-
metal-free direct arylation and alkynylation of sp
2
 C-H bonds via aryne intermediates will 
be discussed. Where appropriate, important previously disclosed reports and transition-
metal-free processes will be mentioned. 
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Chapter 3-1. Direct Arylation of Acidic sp2 C-H Bonds via Benzyne Intermediates 
3.1.1. Transition-metal-catalyzed Arylation of Acidic sp
2
 C-H Bonds 
 Aryl-aryl bond formation is one of the first reported transition metal-promoted 
reactions.
4
 Copper was the metal most widely employed for aryl-aryl bond formation 
during the first 70 years of the 20
th
 century. The first example of copper-promoted C-H 
bond direct arylation was reported in early 1940s.
5
 A mixture of dithienyl, trithienyl, and 
quaterthienyl was obtained when 2-iodothiophene was heated at 200
 o
C in the presence of 
copper bronze (Scheme 3.1.1). While dithienyl is the expected as Ullmann product, the 
formation of higher oligomers (n > 0) indicated the involvement of C-H bond 
functionalization. 
Scheme 3.1.1. Formation of higher oligomers of thiophene 
 
 A similar transformation was reported by Forrest in 1960.
6
 When m-
dinitrobenzene was employed as additive in the Ullmann coupling of iodobenzene, a 
small amount of 2,6-dinitrobiphenyl was observed (Scheme 3.1.2). Björklund and 
Nilsson subsequently disclosed a method for arylation of 1,3-dinitrobenzene by 
iodobenzene to afford 2,6-dinitrobiphenyl in good yield (67%) using stoichiometric 
copper(I) oxide in quinoline at 220 °C.
7 
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Scheme 3.1.2. Phenylation of 1,3-dinitrobenzene 
 
 In 1985, the palladium-catalyzed direct arylation of indoles was reported by Ohta 
group.
8
 The results indicated the positive effect of CuI additive. A similar influence was 
also observed later by Miura and co-workers in the arylation of azoles.
9
 They found that 
N-methylimidazole is preferentially arylated at 5-position if catalytic Pd is used. 
However, the arylation occurs at 2-position if stoichiometric amount of CuI is added. 
Furthermore, CuI itself can mediate the arylation in moderate yield (Scheme 3.1.3). 
Scheme 3.1.3. Palladium-catalyzed arylation of heterocycles 
 
This effect may arise from the involvement of organocopper intermediates in the 
reaction. If the presumed intermediate could be generated without a palladium cocatalyst, 
a cheap and efficient method for the heterocycle arylation would be achieved. By using 
this hypothesis, our group described a general method for the copper-catalyzed 
heterocycle arylation by aryl iodides.
10
 Strong bases were used to generate organocopper 
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species by deprotonation/transmetallation sequences. A variety heterocycles as well as 
electron-poor arenes possessing at least two electron-withdrawing groups on a benzene 
ring can be arylated in good yields. 
Scheme 3.1.4. Copper-catalyzed arylation of acidic arenes 
 
 
 
3.1.2. Arylation via Aryne Intermediates 
 Arynes are highly electrophilic species, and can react with various nucleophiles, 
forming aryl carbanions. The latter can react further with electrophiles intermolecularly 
or intramolecularly. A wide variety of anionic and uncharged nucleophiles are known to 
add readily to arynes. 
One of the first electrophilic carbon arylation reactions that proceeds via benzyne 
mechanism was reported in early 1945 by Bergstrom.
11
 In the presence of KNH2 in liquid 
ammonia, formation of 2-benzylquinoline was observed when chlorobenzene was treated 
with 2-methylquinoline. Similar results were obtained with pyridine, phenanthridine, and 
fluorene derivatives. 
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Scheme 3.1.5. C-Arylation of 2-methylquinoline and fluorene 
 
 
 Arylation of enamines via benzyne was also reported.
12
 Formation of benzyne 
from fluorobenzene and piperidyllithium in the presence of 1-pyrrolidiocyclohexene 
followed by hydrolysis led to the formation of 2-phenylcyclohexanone. 
Scheme 3.1.6. Carbon arylation of enamine 
 
 Indoles, like enamines, may be attacked at N-1 or C-3. Reactions of indoles with 
benzyne were described by Kuehne group.
13
 When benzyne generated from 
bromobenzene with sodium amide in liquid ammonia was reacted with indole, N-
phenylindole (5 %) and 3-phenylindole (15 %) were obtained. Under the same 
conditions, benzyne reaction with  N-methylindole did not lead to any N-methyl-3-
phenylindole (Scheme 3.1.7). 
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Scheme 3.1.7. Reaction of benzyne and indoles 
 
 
Formation of (2-hydroxyaryl)pyridine was observed when benzyne was treated 
with pyridine-N-oxide.
14
 Benzenediazonium-2-carboxylate was used as benzyne 
precursor and reactions were proposed to proceed via [2+2+4] rearrangement. Modified 
conditions were reported by Larock group in 2006.
14b
 Arynes were generated from 
silylaryl triflates and reactions proceed in good yields with high regioselectivity. 
Scheme 3.1.8. Reaction of aryne and pyridine-N-oxide 
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 A one-step synthesis of p-terphenyl via arynes has been developed.
15
 Reaction 
conditions involve the addition of 1,4-dibromo-2,5-diiodobenzene to excess aryl 
Grignard reagent. After aqueous quench, p-terphenyls were isolated in 30-50 % yields. 
Interestingly, yields can be improved by adding tBuOK or TMPLi to the reaction mixture 
prior to workup. 
Scheme 3.1.9. Formation of p-terphenyl derivatives via benzyne intermediates 
 
 
Another synthetic protocol to biaryl compounds via an aryne intermediate has 
been developed by Leroux and Schlosser.
16
 When 1-bromo-2-iodobenzene (1) was 
treated with 0.5 equiv of n - BuLi, 2-bromo-2′-iodobiphenyl was produced in 81% yield. 
The reaction presumably starts by an iodine–lithium exchange between 1 and n - BuLi, 
followed by the elimination of LiBr from the organolithium intermediate 2 to generate 
the transient benzyne species. Subsequent nucleophilic addition of 2 to benzyne generates 
 104 
the biphenyl scaffold. The resulting 2-biaryl lithium species 3 then undergoes lithium–
iodine exchange with the starting material 1 to afford 2-bromo-2′-iodobiphenyl, together 
with organolithium species 2. 
Scheme 3.1.10. 2-Bromo-2′-iodobiphenyl formation from 1-bromo-2-iodobenzene 
 
Arynes undergo nucleophilic addition with N-alkylimidazoles affording N-alkyl-
N-arylimidazolium salts.
17
 In contrast, if N-arylimidazoles are employed, desired product 
is not formed. In the reaction of 3-methoxybenzyne with N-methylimidazole, the addition 
occurs regioselectively at the position meta to the methoxy group. Similar regioselectivity 
has also been observed in other nucleophilic additions to 3-methoxybenzyne. 
Scheme 3.1.11. Reactions of arynes with N-alkylimidazoles 
 
3.1.3. Other Procedures for Transition-metal-free Biaryl Formation 
 A metal-free selective oxidative cross-coupling method for unfunctionalized 
electron-rich aromatic compounds has been developed by Kita group.
18
 The procedure 
employs a trivalent organoiodine oxidant. High yields and good regioselectivities were 
obtained. Initially, reaction of electron-rich aromatic compound with iodine oxidant 
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PhI(OH)OTs forms the stable iodonium(III) salts. The added TMSBr induces the reaction 
of iodonium(III) salts with another arene through the formal hydroarylation and 
successive elimination of iodobenzene. 
Scheme 3.1.12. Oxidative cross-coupling using PhI(OH)OTs oxidant 
 
 
 
 Biaryl coupling of electron-deficient heterocycles containing nitrogen with 
haloarenes promoted by tBuOK has been described by Itami group.
19
 Without addition of 
any exogenous transition metals, electron-deficient heterocycles such as pyridine, 
pyridazine, pyrimidine, pyrazine, and quinoxaline are arylated with aryl iodides in 
reasonable yields. However, large excess of heterocycles (40/1) is required and 
regioisomer mixtures were obtained in some cases. The control experiments indicated 
that radical processes are involved. 
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Scheme 3.1.13. tBuOK-promoted arylation of N-heterocycles 
 
 
The research groups of Shi, Shirakawa/Hayashi, and Kwong/Lei have recently 
independently reported in the construction of biaryl compounds from unactivated 
aromatic rings by direct C-H activation with the aid of organocatalysts.
20
 In particular, 
heating aryl iodides in benzene at 80 
o
C with one equivalent of potassium tert-butoxide 
and 20 mol% N,N’-dimethylethylenediamine (DMEDA) gave biaryls in 60–85% yields. 
Comparable yields were obtained if 1,10- phenanthroline or a substituted analogue was 
employed (Scheme 3.1.14). Large excess of arene coupling components is needed and 
H/D isotope effects are consistent with aryl radicals being involved. The addition of 
2,2,6,6-tetramethyl-1-piperidinoxyl (TEMPO) and other inhibitors blocked the reactions. 
Finally, ortho selectivities are observed in the additions of aryl radicals to substitued 
benzenes. 
Scheme 3.1.14. Biaryl formation via organocatalysis 
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 Arylation via SRN1 pathway has also been disclosed.
21
 Photo cleavage of 
benzenediazonium salts as well as aryl(pseudo) halides containing electron-donating 
groups leads to the corresponding phenyl cations in the triplet state. These intermediates 
react selectively with (hetero)arenes via SN1 pathway giving arylation products in good 
yields. 
Scheme 3.1.15. Photo-induced arylation 
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3.1.4. Direct Arylation of Acidic sp
2
 C-H Bonds via Benzyne Intermediates  
3.1.4.1. Introduction 
 Direct arylation of arene C-H bonds with aryl halides is one of the shortest and 
most efficient routes to biaryls. However, most of the aforementioned achievements are 
mediated or catalyzed by transition metals. From a practical point of view, transition-
metal-free processes are much preferred, especially in the pharmaceutical industry where 
the removal of undesired metal contamination can be expensive.
3
 Therefore, it is not 
surprising that numerous transition-metal-free approaches for direct arylation have been 
developed. Several recent reports describe arene and electron-deficient heterocycle 
arylation by aryl halides that presumably proceed by radical-type mechanisms without 
transition-metal involvement.
18-20
 However, arylation of simple arenes such as anisole 
afford isomer mixtures and the arene coupling component is often employed in large 
excess (up to 100 equivalents) as a solvent. Consequently, methods that are that highly 
regioselective with respect to arene coupling component and do not require large excess 
of any coupling components are needed. 
3.1.4.2. Results and Discussion 
 Recent examples of aryne arylations have been described by Hart, Schlosser, 
Meyers, Aubert, and Mamane.
14-16,22
 In all cases, prefunctionalized nucleophilic coupling 
partners, or transition-metal catalysts are required to obtained reasonable yields. Benzyne 
can be generated from silyl aryl triflates under mild conditions.
23
 However, these starting 
materials are quite expensive and only a few of them are commercially available. 
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Consequently, we decided to use readily accessible and cheap aryl chloride as an benzyne 
sources.  
 We have recently described a transition-metal-free, base-promoted intramolecular 
C-arylation of phenols with aryl halides.
24
 6H-Benzo[c]chromenes were obtained in high 
yields when 3-(2-halobenzyloxy)phenols were treated with t-BuOK in dioxane at 140 °C. 
The reaction proceeds by an initial formation of a benzyne intermediate followed by an 
aromatic sp
2
 C-H functionalization to form the carbon-carbon bond. To expand the 
synthetic utility of the reaction, we decided to investigate intermolecular carbon-carbon 
bond formation proceeding via benzyne intermediates. 
The involvement of benzyne intermediate in intermolecular arylation of acidic 
arenes by aryl halides was previously observed by our group.
10
 In the presence of tBuOK, 
mixture of regioisomeric coupling products were obtained in the reaction between 
bromotoluene and 4,5-dimethylthiazole. Reaction yield was low due to the nucleophilic 
attack of base on benzyne.  
Scheme 3.1.16. Involment of benzyne intermediates in copper-catalyzed arylation 
 
 We hypothesized that use of hindered 2,2,6,6-tetramethylpiperidide (TMP) should 
retard the reaction of benzyne with base.
25
 Relative reactivity of the base and aryl anion 
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with benzyne can be modulated by employing a solvent where amide base is sparingly 
soluble. A brief optimization of reaction conditions showed that best results are obtained 
by employing a mixed pentane/THF solvent system. In pentane, the arylations are slow 
due to low base solubility. Competitive addition of TMPLi to benzyne decreases 
arylation yields in THF. 
Table 3.1.1. Arylation scope with respect to aryl halides
a 
 
entry aryl halide product yield, % 
 
1   
 
78 
 
2   
 
61 
3 
  
 
77 
 
 
4 
  
 
81 
 
5 
  
 
62 
 
6 
  
 
75 
 
7 
  
 
73 
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8   
 
60 
50
b 
9 
  
85
c 
a
 Aryl halide (1.6-2.5 equiv), benzothiophene (1 equiv), 0.5 mmol scale. Yields are isolated 
yields. 
b
 tert-Butyl-3-bromobenzoate used. 
c
 Isomer mixture; m/p ratio 1/1.2 
 
 Arylation scope with respect to aryl halides is shown in Table 3.1.1. 
Benzothiophene is arylated by aryl halides at the most acidic position. meta-Substituted 
products were obtained in good yields when benzothiophene is arylated by 2-
chloroanisole and 2-chlorobenzotrifluoride (entries 1 and 2). Arylation by either 2- or 3-
chloro-N,N-dimethylaniline affords the m-substitution product (entries 3 and 4). This 
regioselectivity pattern may be advantageous if o-chloroarene is more available than the 
corresponding m-isomer. Substitutions by a benzyne mechanism often produce the same 
isomer if 2- and 3-haloarene starting materials are used.
26
 The regioselective nucleophile 
addition to benzyne is explained in terms of ground-state polarization of the aryne by 
electron-withdrawing substituents and the energy that is required to distort the aryne into 
two possible transition states.
26c 
3,5-Dimethoxychlorobenzene is reactive and arylation 
product is obtained in good yield (entry 5). Arylation by 2,3,4,5-tetrasubstituted 
chloroarenes is possible and benzothiophene is arylated by 9-chlorophenanthrene (entry 
6). If 3-chloro-4-methoxytoluene is used, the arylation occurs meta to the methoxy 
substituent (entry 7). Fluoroarene starting materials can be employed and the reaction 
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tolerates an ester group (entry 8). If 4-chloro-t-butylbenzene is used, a nearly 1/1 mixture 
of arylation product isomers is obtained (entry 9).
26
 
Table 3.1.2. Arylation scope with respect to heterocycles and arenes
a 
 
entry arene product yield, % 
 
1   
86 
72
b 
85
c 
2 
  
81 
75
d 
 
3   
80 
68
b 
 
4 
  
 
91 
81
b 
5 
  
72 
6 
  
80 
74
b 
7 
  
90 
8
e 
  
78 
9 
  
55 
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10 
 
 
71 
11 
  
95 
12 
  
81 
a
 Chlorobenzene (1.3-2 equiv), arene or heterocycle (1 equiv), 0.5 mmol scale. Yields are 
isolated yields. 
b 
Lithium dicyclohexylamide base. 
c
 PhF used instead of PhCl. 
d
 LiNiPr2 base. 
e
 
Phenylpyrrole (2 equiv), PhCl (1 equiv) 
 
The arylation scope with respect to heterocycles and arenes is presented in Table 
3.1.2. In most cases, TMPLi base affords slightly higher yields than either lithium 
dicyclohexylamide or diisopropylamide (entries 1, 2, 3, 4, 6). Fluorobenzene can be used 
instead of chlorobenzene and nearly identical yields were obtained in the reactions with 
benzothiophene (entry 1). Furan derivatives, such as benzofuran and 2-butylfuran, are 
reactive (entries 2 and 3). N-Methylbenzimidazole and benzothiazole are arylated in good 
yields (entries 4 and 5). Arylation of thiophene, indole, and pyrrole derivatives affords 
products in excellent yields (entries 6, 7, 8). The reaction is not limited to five-membered 
ring heterocycles. Arylation of pyridine and pyridazine derivatives is possible and 
arylated products are obtained in reasonable yields (entries 9 and 10). Arenes such as 1,3-
dimethoxybenzene and 3-methoxybenzotrifluoride are reactive (entries 11 and 12).  
A sequential, one-pot diarylation of N-methylimidazole was performed. The 
mixture of chlorobenzene with heterocycle was treated with LDA in THF at RT, followed 
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by quench with MeOH and evaporation. Following addition of 2-chloroanisole and 
TMPLi in THF, a single isomer of diarylation product was obtained in 50% yield. 
Scheme 3.1.17. Sequential diarylation of N-methylimidazole 
 
3.1.4.3. Conclusions 
A transition-metal-free method for base-promoted arylation of heterocycles and 
arenes by aryl chlorides and fluorides has been described. The reactions proceed via 
aryne intermediates at mild temperatures and allow for highly regioselective arylation of 
the arene and heterocycle C-H bonds. Functionalization occurs at the most acidic carbon-
hydrogen bond. 
 
 115 
3.1.4.4. Experimental Section 
General considerations: Reactions were performed in 2-dram vials using screw caps 
with 17 mm hole and white silicone septum with white teflon face (from SUPELCO). 
Column chromatography was performed on 60Å silica gel (Sorbent Technologies). 
Purification by preparative HPLC was performed on a Shimadzu Prominence LC (LC-
20AB) equipped with a SPD-20A UV-Vis detector and a Varian Dynamax (250 mm x 
21.4 mm) column. GC-MS analyses were performed on a Shimadzu GCMS-QP5000 
chromatograph equipped with a Restek column (Rtx-XLB, 30 m x 0.25 mm I.D.). The 
1
H, 
19
F and 
13
C NMR were recorded on JEOL EC-400 or JEOL EC-500 spectrometers 
using residual solvent peak as a reference. α,α,α-Trifluorotoluene (neat, δ = -62.3ppm) 
was employed as an external standard in 
19
F NMR spectra. Elemental analyses were 
performed by Atlantic Microlab Inc. of Norcross, GA. IR spectra were obtained on a 
ThermoNicolet Avatar 370 FT-IR instrument. Analytical thin layer chromatography was 
performed on silica gel IB-F (Baker-flex) by J. T. Baker. All procedures were performed 
under argon atmosphere unless otherwise noted. 
Materials. The following starting materials were obtained from commercial sources and 
were used without further purification: benzothiophene, benzothiazole, 1-methylindole, 
1-phenylpyrrole, 3-methoxypyrazine, 3-methoxypyridine, 2-chloroanisole, 2-
chlorobenzotrifluoride, 3-fluorobenzoic acid, N-methylbenzimidazole, 2-n-
butylthiophene, 2-n-butylfuran, 1,3-dimethoxybenzene, N-methylimidazole, 3-
trifluoromethylanisole, 3-chloro-N,N-dimethylaniline, 2-chloro-N,N-dimethylaniline, 
2,2,6,6-tetramethylpiperidine (TMPH), 9-chlorophenanthrene, 3,5-
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dimethoxychlorobenzene, 3-chloro-4-methoxytoluene, 4-tert-butylchlorobenzene, 2,3-
benzo[b]furan, and tert-butyl-3-bromo-benzoate. tert-Butyl-3-fluorobenzoate was 
synthesized from 3-fluorobenzoic acid.
27
 
TMPLi, Cy2NLi, LDA 1M in THF:  A 25 mL oven-fried flask equipped with a 
magnetic stirring bar and a septum was evacuated and backfilled with argon 5 times. 
TMPH (2,2,6,6-tetramethylpiperidine, 2.32 g, 16.5 mmol) or Cy2NH (dicyclohexylamine, 
2.98 g, 16.5 mmol) or diisopropylamine (1.67 g, 16.5 mmol) was added, followed by 
anhydrous THF to give 15 mL of solution. The mixture was cooled to -73 
o
C and stirred 
for 5 minutes. n-BuLi (2.5 M in hexanes, 6 mL, 15 mmol) was then added dropwise. The 
reaction mixture was stirred for 30 minutes at -73 
o
C followed by warming to 0
o
C and 
stirring for additional 30 minutes. After that, the reaction mixture was vacuumed to give 
15 mL of solution.  
TMPLi 1 M in pentane: A 50 mL oven-fried flask equipped with magnetic stirring bar 
and a septum was evacuated and backfilled with argon 5 times. TMPH (2,2,6,6-
tetramethylpiperidine, 4.64 g, 33.0 mmol) was added, followed by anhydrous pentane to 
give 30 mL of solution (marked the flask at the desired level). The mixture was cooled to 
-73 
o
C and stirred for 5 minutes. n-BuLi (2.5 M in hexanes, 12 mL, 30 mmol) was added 
dropwise and reaction mixture was stirred for 30 minutes at -73 
o
C, warmed up to room 
temperature and stirred overnight. The reaction mixture was vacuumed to give 30 mL (at 
the marked level) of TMPLi suspension.  
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The following cooling baths were used to attain the desired temperatures. Temperature 
control is very important to obtain reproducible yields. Temperature was monitored 
continuously and typically remained within 2 
o
C of the reported value.  
Diethylene glycol + CO2 : -13
 o
C 
Acetonitrile + CO2 : -46
 o
C  
Chloroform + CO2 : -63
 o
C 
Acetone + CO2 : -73
 o
C  
m-Toluidine + CO2 : -35
 o
C 
General procedure:  
A 2 dram vial equipped with a magnetic stir bar was charged with arene or heterocycle 
(0.5 mmol) and ArCl (1.3 – 2.5 equiv). The vial was flushed with argon and capped. To 
this mixture was added the appropriate base solution or suspension (2.5-4.5 equiv) at the 
specified reaction temperature by injecting through the septum via syringe. If TMPLi in 
pentane was used, the base suspension was stirred vigorously while being withdrawn by 
syringe. The vial was flushed with argon (20 seconds) and then stirred at specified 
temperature for indicated time. Unless otherwise stated, reaction mixture was quenched 
with anhydrous MeOH (1.0 mL), evacuated to 1.0 mL and subjected to column 
chromatography on silica gel in hexane followed by appropriate solvent to elute the 
products. After concentrating the fractions containing the product, the residue was dried 
under reduced pressure. 
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O
 
2-(3-Methoxyphenyl)benzothiophene (Entry 1, Table 3.1.1): 2-Chloroanisole (192 mg, 
1.35 mmol), benzothiophene (67 mg, 0.5 mmol), TMPLi in THF (1 M, 2.1 mL), rt, 1h. 
After column chromatography (hexanes/CH2Cl2 65/35), 94 mg (78 %) of white solid was 
obtained. Rf = 0.46 (hexanes/ CH2Cl2 60/40). This compound is known.
28
 
1
H NMR (400 
MHz, CDCl3) δ 7.85-7.84 (m, 1H), 7.80-7.78 (m, 1H), 7.60 (s, 1H), 7.39-7.31 (m, 4H), 
7.29-7.27 (m, 1H), 6.91 (td, J = 7.0 Hz, 2.3 Hz, 1H), 3.88 (s, 3H). 
13
C NMR (100 MHz, 
CDCl3, ppm)  160.1, 144.2, 140.7, 139.6, 135.7, 130.1, 124.7, 124.5, 123.7, 122.4, 
119.8, 119.2, 113.9, 112.2, 55.5. 
S
F3C
 
2-(3-Trifluoromethylphenyl)benzothiophene (Entry 2, Table 3.1.1): 2-
Chlorobenzotrifluoride (180 mg, 1 mmol), benzothiophene (67 mg, 0.5 mmol), TMPLi in 
THF (1.8 mL, 1.8 mmol), 0 
o
C, 4 hrs. After column chromatography (hexanes/CH2Cl2 
80/20), 84 mg (61 %) of light yellow solid was obtained. Rf = 0.57 (hexanes/CH2Cl2 
80/20), mp 108.5-109.5 
o
C (from hexanes). 
1
H NMR (400 MHz, CDCl3) δ 7.96 (s, 1H), 
7.87-7.83 (m, 2H), 7.80 (m, 1H), 7.61-7.51 (m, 3H), 7.37 (m, 2H). 
13
C NMR (100 MHz, 
CDCl3, ppm)  142.4, 140.5, 139.7, 135.2, 131.5 (q, JC-F = 32 Hz), 129.7, 129.6, 125.0, 
124.9, 124.8 (q, JC-F = 3.7 Hz), 124.1 (q, JC-F = 272 Hz), 124.0, 123.2 (q, JC-F = 3.7 Hz), 
122.5, 120.7. FT-IR (neat, cm
-1) υ 1326. 1297, 1179, 800, 754. Anal calcd for C15H9F3S 
(278.04g/mol): C, 64.74; H, 3.26; Found. C, 64.69; H, 3.23. 
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Note: Less than 5 % of isomeric 2-(2-trifluoromethylphenyl)benzothiophene was 
observed by GC. 
  
S
N
 
3-Benzothien-2-yl-N,N-dimethylbenzenamine (Entries 3 and 4, Table 3.1.1): 
2-Chloro-N,N-dimethylaniline (195 mg, 1.25 mmol), benzothiophene (67 mg, 0.5 mmol), 
TMPLi in THF (1 M, 2 mL), rt, 2 hrs. After column chromatography (hexanes/CH2Cl2 
20/80), 97 mg (77 %) of a light brown solid was obtained. 
3-Chloro-N,N-dimethylaniline (195 mg, 1.25 mmol), benzothiophene (67 mg, 0.5 mmol), 
TMPLi in THF (1 M, 2 mL), rt, 2 hrs. After column chromatography (hexanes/CH2Cl2 
20/80), 102 mg (81 %) of a light brown solid was obtained.  
Rf = 0.58 (hexanes/EtOAc 70/30), mp 77-77.5 
o
C (from hexanes).
 1
H NMR (400 MHz, 
CDCl3) δ 7.85 (d, J =8.0 Hz, 1H), 7.79 (d, J = 8.0 Hz, 1H), 7.57 (s, 1H), 7.39-7.31 (m, 
3H), 7.12 (d, J = 8.1 Hz, 1H), 7.08 (t, J = 2.2 Hz, 1H), 6.76 (dd, J = 8.1 Hz, 2.2 Hz, 1H), 
3.04 (s, 6H) . 
13
C NMR (100 MHz, CDCl3, ppm)  151.0, 145.5, 140.8, 139.6, 135.1, 
129.7, 124.5, 124.2, 123.6, 122.4, 119.4, 115.2, 112.7, 110.6, 40.7. FT-IR (neat, cm
-1) υ 
1698, 1500, 1439, 823, 760, 754, 725, 680. Anal calcd for C16H15NS (253.09g/mol): C, 
75.85; H, 5.97, N, 5.53; Found. C, 75.81; H, 5.90; N, 5.35. 
Note: Less than 3% of 2-benzothien-2-yl-N,N-dimethylbenzenamine was detected by 
GC. 
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2-(3,5-Dimethoxyphenyl)benzothiophene (Entry 5, Table 3.1.1): 3,5-Dimethoxy-1-
chlorobenzene (216 mg, 1.25 mmol), benzothiophene (67 mg, 0.5 mmol), TMPLi in THF 
(1 M, 2 mL), -73 
o
C, 12 hrs. After column chromatography (hexanes/CH2Cl2 40/60), 84 
mg (62 %) of a light yellow solid was obtained. Rf = 0.39 (hexanes/CH2Cl2 50/50). This 
compound is known.
27 1
H NMR (400 MHz, CDCl3) δ 7.83 (dd, J = 7.9 Hz, 1.0 Hz, 1H), 
7.78 (dd, J = 7.9 Hz, 1.0 Hz, 1H), 7.54 (s, 1H), 7.38-7.30 (m, 2H), 6.88 (d, J = 2.3 Hz, 
2H), 6.48 (t, J = 2.3 Hz, 1H), 3.86 (s, 6H). 
13
C NMR (100 MHz, CDCl3, ppm)  161.2, 
144.2, 140.6, 139.5, 136.2, 124.6, 124.5, 123.7, 122.4, 120.0, 104.9, 100.4, 55.6. 
S
 
2-(9-Phenanthrenyl)benzothiophene (Entry 6, Table 3.1.1): 9-Chlorophenanthrene 
(265 mg, 1.25 mmol), benzothiophene (67 mg, 0.5 mmol), TMPLi in THF (1 M, 2 mL), 0 
o
C, 3 hrs followed by 1 h at rt. After column chromatography (hexanes/CH2Cl2 90/10), 
116 mg (75 %) of a light yellow solid was obtained. Rf = 0.25 (hexanes/CH2Cl2 90/10), 
mp 146.5-148 
o
C (from hexanes). 
 1
H NMR (400 MHz, CDCl3) δ 8.8 (d, J = 8.3 Hz, 1H), 
8.72 (d, J = 8.3 Hz, 1H), 8.33 (dd, J = 8.2 Hz, 1.0 Hz, 1H), 7.95 (s, 1H), 7.94-7.87 (m, 
3H), 7.73-7.60 (m, 4H), 7.51 (s, 1H), 7.46-7.38 (m, 2H). 
13
C NMR (100 MHz, CDCl3, 
ppm)  142.2, 140.4, 140.3, 131.2, 131.1, 130.9, 130.7, 130.4, 129.6, 129.0, 127.4, 127.1, 
127.0, 126.9, 126.7, 124.6, 124.5, 124.4, 123.7, 123.1, 122.7, 122.3. FT-IR (neat, cm
-1) υ 
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1705, 1298, 1158. Anal calcd for C22H14S (310.08 g/mol): C, 85.12; H, 4.55; Found. C, 
84.98; H, 4.48. 
S
O
 
2-(5-Methoxy-2-methylphenyl)benzothiophene (Entry 7, Table 3.1.1): 3-Chloro-4-
methoxytoluene (195 mg, 1.25 mmol), benzothiophene (67 mg, 0.5 mmol), TMPLi in 
THF (1 M, 2 mL), rt, 4 hrs. After column chromatography (hexanes/CH2Cl2 70/30), 92 
mg (73 %) of a light yellow solid was obtained. Rf = 0.43 (hexanes/CH2Cl2 65/35), mp 
57.0-58 
o
C (from ether).
 1
H NMR (400 MHz, CDCl3) δ 7.85 (d, J = 7.8 Hz, 1H), 7.80 (d, 
J = 7.8 Hz, 1H),  7.40-7.32 (m, 2H), 7.27 (s, 1H), 7.23 (d, J = 8.5 Hz, 1H), 7.04 (d, J = 
2.8 Hz, 1H), 6.87 (dd, J = 8.5 Hz, 2.8 Hz, 1H), 3.83 (s, 3H), 2.41 (s, 3H). 
13
C NMR (100 
MHz, CDCl3, ppm)  157.6, 143.5, 140.2, 140.1, 135.1, 131.8, 128.5, 124.5, 124.2, 
123.6, 123.1, 122.1, 115.9, 114.2, 55.5, 20.3. FT-IR (neat, cm
-1) υ 1605, 1500, 1250, 
1032. Anal calcd for C16H14OS (254.08g/mol): C, 75.55; H, 5.55; Found. C, 75.04; H, 
5.48. 
S
O
O
  
tert-Butyl-(3-benzothien-2-yl)benzoate(Entry 8, Table 3.1.1):  
tert-Butyl-3-bromobenzoate (257 mg, 1 mmol), benzothiophene (67 mg, 0.5 mmol), 
TMPLi in THF (1 M, 2 mL), -73 
o
C while adding and then warm up to -46 
o
C by keeping 
vial inside the acetone-dry ice bath and not adding dry ice (2 hours); then move to 
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acetonitrile-dry ice bath, and hold at -46 
o
C for 8 hrs; then move to ice bath to warm up to 
0 
o
C and keep at that temperature for 30 minutes. After column chromatography 
(hexanes/Et2O 90/10), 77 mg (50 %) of a yellow solid was obtained.  
tert-Butyl-3-fluorobenzoate (192 mg, 1 mmol), benzothiophene (67 mg, 0.5 mmol), 
TMPLi in THF (1 M, 2 mL), -73 
o
C; then slowly warm up to -35 
o
C (2 hrs) and keep at 
that temperature for 8 hrs, then move to ice bath to warm the reaction mixture to 0 
o
C and 
keep at that temperature for 30 minutes. After column chromatography (hexanes/Et2O 
90/10), 93 mg (60 %) of yellow solid was obtained.  
Rf = 0.52 (hexanes/Et2O 90/10), mp 135.8-137.1 
o
C. 
1
H NMR (400 MHz, CDCl3) δ 8.35 
(t, J = 1.9 Hz, 1H), 7.96 (td, J = 7.8 Hz, 1.4 Hz, 1H), 7.86-7.82 (m, 2H), 7.79 (dd, J = 7.8 
Hz, 1.9 Hz, 1H), 7.61 (s, 1H), 7.47 (t, J = 7.8 Hz, 1H), 7.38-7.31 (m, 2H), 1.64 (s, 9H). 
13
C NMR (100 MHz, CDCl3, ppm)  165.5, 143.3, 140.7, 139.7, 134.5, 132.8, 130.3, 
129.1, 129.0, 127.4, 124.8, 124.7, 123.8, 122.4, 120.2, 81.5, 28.3. FT-IR (neat, cm
-1) υ 
1707, 1300, 1160. Anal calcd for C19H18O2S (310.10 g/mol): C, 73.52; H, 5.84; Found. C, 
73.23; H, 5.72. 
Note: The above two reactions were quenched with H2O (15 mL), followed by addition 
of Et2O (15 mL). The organic phase was then washed with brine (15 mL) and the 
aqueous layers were extracted with Et2O (2x10 mL).  The combined organic phase was 
then dried over MgSO4, and concentrated under vacuum. The residue was then dissolved 
in minimum amount of dichloromethane and subjected to the flash chromatography on 
silica gel. After concentrating the fraction containing the product, the residue was dried 
over reduced pressure to yield pure product.  
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2-(3-tert-Butylphenyl)benzothiophene  and 2-(4-tert-butylphenyl)benzothiophene 
(Entry 9, Table 3.1.1): 4-tert-butylchlorobenzene (135 mg, 0.8 mmol), benzothiophene 
(67 mg, 0.5 mmol), TMPLi in pentane (1 M, 1.5 mL) followed by anhydrous THF (0.38 
mL), rt, 1.5 hrs. After column chromatography (hexanes/CH2Cl2 90/10), 113 mg (85 %) 
of a white solid was obtained. The isomer ratio was determined to be 1/1.2 m/p by GC 
analysis. The isomers were separated by fractional crystallization from hexanes.  p-
Isomer was crystallized and collected by vacuum filtration at 0
 o
C. Rest of the liquid was 
cooled down to -20 
o
C. p-Isomer and some m-isomer were collected. Pure m-isomer was 
isolated from the liquid phase. The following amounts were obtained: p-isomer (white 
solid): 51 mg, m-isomer (colorless liquid): 41 mg; additionally, 17 mg of isomer mixture 
was recovered. 
p-Isomer is known.
28
 Rf = 0.27 (hexanes).
 1
H NMR (400 MHz, CDCl3) δ7.81 (d, J  = 8.1 
Hz, 1H), 7.75 (d, J  = 8.1 Hz, 1H), 7.65 (dt, J = 8.2 Hz, 2.0 Hz, 2H), 7.50 (s, 1H), 7.45 
(dt, J = 8.2 Hz, 2.0 Hz, 2H), 7.36-7.27 (m, 2H), 1.36 (s, 9H). 
13
C NMR (100 MHz, 
CDCl3, ppm)  151.6, 144.4, 140.9, 139.5, 131.6, 126.3, 126.0, 124.5, 124.2, 123.5, 
122.3, 119.0, 35.0, 31.3.  
m-Isomer: Rf = 0.39 (hexanes).
 1
H NMR (400 MHz, CDCl3) δ 7.84 (d, J = 7.8 Hz, 1H), 
7.79 (d, J = 7.8 Hz, 1H), 7.75-7.73 (m, 1H), 7.56-7.53 (m, 2H), 7.41-7.29 (m, 4H), 1.40 
(s, 9H). 
13
C NMR (100 MHz, CDCl3, ppm)  152.0, 145.0, 140.8, 139.6, 134.1, 128.8, 
125.6, 124.6, 124.3, 123.9, 123.7, 123.6, 122.4, 119.4, 34.9, 31.4. FT-IR (neat, cm
-1) υ 
S S
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1296. Anal calcd for C18H18S (266.11 g/mol): C, 81.15; H, 6.81; Found. C, 80.91; H, 
6.71. 
S
 
2- Phenylbenzothiophene (Entry 1, Table 3.1.2) :  
Benzothiophene (67 mg, 0.5 mmol), PhCl (84 mg, 0.75 mmol), TMPLi in pentane (1 M, 
1.4 mL) followed by anhydrous THF (0.35 mL), rt, 30 minutes. After column 
chromatography (90/10 hexanes/CH2Cl2), 90 mg (86 %) of a light yellow solid was 
obtained.  
Benzothiophene (67 mg, 0.5 mmol), PhCl (112.5 mg, 1 mmol), Cy2NLi in THF (1 M, 2.0 
mL), 0 
o
C, 3 hours. After column chromatography (hexanes), 75 mg (72 %) of a light 
yellow solid was obtained. 
Benzothiophene (67 mg, 0.5 mmol), PhF (120 mg, 1.25 mmol), TMPLi in THF (1 M, 2.0 
mL), rt, 10 minutes. After column chromatography (90/10 hexanes/DCM), 89 mg (85 %) 
of a light yellow solid was obtained.  
 Rf  = 0.35 (hexanes/CH2Cl2 95/5). This compound is known.
10
 
1
H NMR (400 MHz, 
CDCl3) δ 7.85 (d, J = 7.8 Hz, 1H), 7.77 (dd, J = 7.8 Hz, 1.3 Hz, 1H), 7.73 (dd, J = 7.8 
Hz, 1.3 Hz, 2H), 7.56 (s, 1H), 7.43 (dt, J = 7.8 Hz, 1.3 Hz, 2H), 7.38-7.30 (m, 3H). 
13
C 
NMR (100 MHz, CDCl3, ppm)  144.3, 140.8, 139.6, 134.4, 129.1, 128.4, 126.6, 124.6, 
124.4, 123.7, 122.4, 119.6. 
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O
     
2-Phenylbenzofuran (Entry 2, Table 3.1.2):  
Benzofuran (59 mg, 0.5 mmol), PhCl (84 mg, 0.75 mmol), TMPLi in pentane (1 M, 1.4 
mL) followed by anhydrous THF (0.07 mL), rt, 2.5 hours. After column chromatography 
(hexanes/CH2Cl2 85/15), 79 mg (81%) of a white solid was obtained.  
Benzofuran (59 mg, 0.5 mmol), PhCl (112.5 mg, 1 mmol), LDA in THF (1 M, 1.7 mL), 0 
o
C, 4 hours. After column chromatography (hexanes/ CH2Cl2 90/10), 72 mg (75 %) of a 
white solid was obtained.  
Rf = 0.40 (hexanes/CH2Cl2 95/5). This compound is known.
10
 
1
H NMR (400 MHz, 
CDCl3) δ 7.89 (dt, J = 7.3 Hz, 1.3 Hz, 2H), 7.60 (dd, J = 7.9 Hz, 1.3 Hz, 1H), 7.55 (dd, J 
= 7.9 Hz, 1.1 Hz, 1H), 7.47 (dt, J = 7.9 Hz, 1.8 Hz, 2H), 7.37 (tt, J = 7.9 Hz, 1.1 Hz, 1H), 
7.23-7.33 (m, 2H), 7.04(s, 1H). 
13
C NMR (100 MHz, CDCl3, ppm)  156.0, 155.0, 130.6, 
129.3, 128.9, 128.7, 125.0, 124.4, 123.0, 121.1, 111.3, 101.4. 
O
 
2-n-Butyl-5-phenylfuran (Entry 3, Table 3.1.2):  
2-n-Butylfuran (62 mg, 0.5 mmol), PhCl (84 mg, 0.75 mmol), TMPLi in pentane (1 M, 
1.4 mL) followed by anhydrous THF (0.35 mL), rt, 30 minutes. After column 
chromatography (hexanes/CH2Cl2 95/5), 80 mg (80 %) of a colorless oil was obtained.  
2-n-Butylfuran (62 mg, 0.5 mmol), PhCl (112 mg, 1 mmol), Cy2NLi in THF (1 M, 1.7 
mL), 0 
o
C, 4 hours. After column chromatography (hexanes), 68 mg (68 %) of a colorless 
oil was obtained.  
 126 
Rf = 0.53 (hexanes/CH2Cl2 95/5). This compound is known.
29
 
1
H NMR (400 MHz, 
CDCl3) δ 7.65-7.62 (m, 2H), 7.36 (t, J = 7.8 Hz, 2H), 7.21 (tt, J = 7.8 Hz, 1.6 Hz, 1H), 
6.55 (d, J = 3.3 Hz, 1H), 6.06 (d, J = 3.3 Hz, 1H), 2.69 (t, J = 7.7 Hz, 2H), 1.68 (pentet, J 
= 7.7 Hz, 2H), 1.42 (s, J = 7.7 Hz, 2H), 0.96 (t, J = 7.7 Hz, 3H). 
13
C NMR (100 MHz, 
CDCl3, ppm)  156.6, 152.1, 131.3, 128.7, 126.8, 123.4, 106.9, 105.7, 30.3, 28.0, 22.4, 
13.9.  
N
N
 
2-Phenyl-1-methylbenzimidazole (Entry 4, Table 3.1.2):  
1-Methylbenzimidazole (66 mg, 0.5 mmol), PhCl (84 mg, 0.75 mmol), TMPLi in pentane 
(1 M, 1.4 mmol) followed by anhydrous THF (0.15 mL), rt, 1 hour. After column 
chromatography (hexanes/EtOAc 55/45), 95 mg (91%) of a brown solid was obtained.  
1-Methylbenzimidazole (66 mg, 0.5 mmol), PhCl (112 mg, 1 mmol), Cy2NLi in THF (1 
M, 2.0 mmol), 0 
o
C, 3 hours. After column chromatography (hexanes/EtOAc 55/45), 84 
mg (81 %) of a brown solid was obtained.  
Rf  = 0.62 (hexanes/EtOAc 50/50). This compound is known.
10
 
1
H NMR (400 MHz, 
CDCl3) δ 7.84-7.81 (m, 1H), 7.77-7.74 (m, 2H), 7.54-7.49 (m, 3H), 7.40-7.37 (m, 1H), 
7.34-7.30 (m, 2H), 3.85 (s, 3H). 
13
C NMR (100 MHz, CDCl3, ppm)  153.9, 143.0, 
136.7, 130.3, 129.8, 129.6, 128.8, 122.9, 122.5, 119.9, 109.7, 31.8. 
 
 
 127 
N
S
  
2-Phenylbenzothiazole (Entry 5, Table 3.1.2): Benzothiazole (67 mg, 0.5 mmol), PhCl 
(112.5 mg, 1 mmol), TMPLi in THF (1 M, 1.8 mL), -46 
o
C, 12 hours. After column 
chromatography (hexanes/CH2Cl2 55/45), 76 mg (72 %) of a light yellow solid was 
obtained. Rf = 0.48 (hexanes/EtOAc : 80/20). This compound is known.
30
 
1
H NMR (400 
MHz, CDCl3) δ 8.11-8.07 (m, 3H), 7.90 (dt, J = 7.7 Hz, 0.9 Hz, 1H), 7.51-7.47 (m, 4H), 
7.38 (dt, J = 7.7 Hz, 0.9 Hz, 1H). 
13
C NMR (100 MHz, CDCl3, ppm)  168.2, 154.2, 
135.2, 133.7, 131.1, 129.1, 127.7, 126.4, 125.3, 123.3, 121.7. 
S
  
2-n-Butyl-5-phenylthiophene (Entry 6, Table 3.1.2):  
2-n-Butylthiophene (70 mg, 0.5 mmol), PhCl (73 mg, 0.65 mmol), TMPLi in pentane (1 
M, 1.4 mL) followed by anhydrous THF (0.15 mL), rt, 1 hour. After column 
chromatography (hexanes/CH2Cl2 95/5), 86 mg (80 %) of a colorless oil was obtained.  
2-n-Butylthiophene (70 mg, 0.5 mmol), PhCl (112 mg, 1 mmol), Cy2NLi in THF (1 M, 
1.7 mL), 0 
o
C, 4 hours. After column chromatography (hexanes), 80 mg (74 %) of a 
colorless oil was obtained.  
Rf  = 0.27 (hexanes). This compound is known.
31 1
H NMR (400 MHz, CDCl3) δ 7.58 (dt, 
J = 8.0 Hz, 1.3 Hz, 2H), 7.34-7.38 (m, 2H), 7.25 (tt, J = 8.0 Hz, 1.3 Hz, 1H), 7.14 (d, J = 
3.5 Hz, 1H), 6.76 (d, J = 3.5 Hz, 1H), 2.84 (t, J = 7.8 Hz, 2H), 1.71 (pt, J = 7.8 Hz, 2H), 
1.43 (sextet, J = 7.8 Hz, 2H), 0.97 (t, J = 7.8 Hz, 3H). 
13
C NMR (100 MHz, CDCl3, ppm) 
 145.8, 141.7, 134.9, 128.9, 127.0, 125.6, 125.1, 122.8, 33.9, 30.1, 22.3, 14.0. 
 128 
N
   
1-Methyl-2-phenylindole (Entry 7, Table 3.1.2):  
Procedure 1: A 2 dram vial equipped with a magnetic stir bar was charged with 1-
methylindole (66 mg, 0.5 mmol). The vial was flushed with argon and capped. To this 
mixture was added TMPLi as a suspension in pentane (1 M, 1.7 mL), followed by 
anhydrous THF (0.2 mL) via syringe. The solution was stirred at rt for 30 minutes. PhCl 
(112 mg, 1 mmol) was dissolved in 9/1 pentane/THF mixture (0.6 mL) and added to the 
vial via syringe and reaction mixture was stirred for 1.5 hours. After column 
chromatography (hexanes/CH2Cl2 90/10), 93 mg (90 %) of a light brown solid was 
obtained. 
Procedure 2 (following the general procedure): 1-Methylindole (66 mg, 0.5 mmol), PhCl 
(112 mg, 1 mmol), TMPLi in pentane (1 M, 1.8 mL), 40 
o
C, 24 hours. After column 
chromatography (hexanes/CH2Cl2 90/10), 92 mg (89 %) of a light brown solid was 
obtained. 
 Rf  = 0.48 (hexanes/CH2Cl2 85/15) . This compound is known.
32
 
1
H NMR (400 MHz, 
CDCl3) δ 7.68 (dt, J = 7.8 Hz, 0.9 Hz, 1H), 7.56-7.54 (m, 2H), 7.53-7.48 (m, 2H), 7.45-
7.39 (m, 2H), 7.29 (dt, J = 7.1 Hz, 1.3 Hz, 1H), 7.18 (dt, J =7.1 Hz, 1.3 Hz, 1H), 6.6(s, 
1H), 3.8 (s, 1H). 
13
C NMR (100 MHz, CDCl3, ppm)  141.7, 138.4, 133.0, 129.5, 128.6, 
128.0, 127.9, 121.8, 120.6, 120.0, 109.8, 101.8, 31.3. 
 129 
N
 
1,2-Diphenylpyrrole (Entry 8, Table 3.1.2): 1-Phenylpyrrole (143 mg, 1 mmol), PhCl 
(56 mg, 0.5 mmol), TMPLi in pentane (1 M, 1.4 mL), 40 
o
C, 24 hours. After column 
chromatography (hexanes/CH2Cl2 95/5), 85 mg (78%) of a white solid was obtained. Rf = 
0.56 (hexanes/CH2Cl2 90/10). This compound is known.
33
 
1
H NMR (400 MHz, CDCl3) 
δ7.35 (tq, J = 7.6 Hz, 1.4 Hz, 2H), 7.31-7.27 (m, 1H), 7.26-7.17 (m, 7H), 6.99 (dd, J = 
7.6 Hz, 4.5 Hz, 1H), 6.47 (dd, J = 7.6 Hz, 4.5 Hz, 1H), 6.41 (t, J = 7.6 Hz, 1H). 
13
C NMR 
(100 MHz, CDCl3, ppm)  140.6, 133.9, 133.1, 129.1, 128.4, 128.2, 126.7, 125.9, 124.5, 
110.8, 109.4. 
N
N O
 
2-Methoxy-3-phenylpyrazine (Entry 9, Table 3.1.2): 2-Methoxypyrazine (55 mg, 0.5 
mmol), PhCl (112 mg, 1 mmol), TMPLi in THF (1 M, 1.8 mL), -46 
o
C, 12 hours. After 
column chromatography (hexanes/EtOAc 40/60), 47 mg (55 %) of a yellow solid was 
obtained. Rf = 0.54 (hexanes/EtOAc 30/70). This compound is known.
34 1
H NMR (400 
MHz, CDCl3) δ 8.24 (d, J = 2.8 Hz, 1H), 8.05 (d, J = 2.8 Hz, 1H), 8.05-8.02 (m, 2H), 
7.49-7.42 (m, 3H), 4.03 (s, 3H). 
13
C NMR (100 MHz, CDCl3, ppm)  158.1, 143.5, 
139.2, 136.5, 135.9, 129.3, 129.2, 128.3, 53.8.  
 130 
N
O
 
3-Methoxy-4-phenylpyridine (Entry 10, Table 3.1.2):  
A 2 dram vial equipped with a magnetic stir bar was charged with 3-methoxypyridine (55 
mg, 0.5 mmol), PhCl (112.5 mg, 1 mmol). The vial was flushed with argon, capped and 
placed into the cooling bath (-13 
o
C). To this mixture was slowly added TMPLi in 
pentane (1 M, 1.7 mL) followed by anhydrous THF (0.13 mL) by injecting through the 
septum via syringe.. The vial was flushed with argon for 20 seconds and then stirred for 
12 hours at -13 °C. After column chromatography (hexanes/EtOAc 20/80), 66 mg (71 %) 
of a yellow solid was obtained. Rf = 0.32 (hexanes/EtOAc 20/80). This compound is 
known.
35 1
H NMR (400 MHz, CDCl3) δ 8.36-8.30 (m, 2H), 7.58-7.55 (m, 2H), 7.45 – 
7.37 (m, 3H), 7.24 (d, J = 5.3 Hz, 1H). 3.90 (s, 3H). 
13
C NMR (100 MHz, CDCl3, ppm)  
152.6, 143.0, 137.7, 135.8, 134.4, 129.3, 128.45, 128.4, 124.6, 56.4.   
O
O  
2,6-Dimethoxy-1,1
’
-biphenyl (Entry 11, Table 3.1.2): 1.3-Dimethoxybenzene (69 mg, 
0.5 mmol), PhCl (112 mg, 1 mmol), TMPLi in pentane (1 M, 1.7 mL), 40 
o
C, 24 hours. 
After column chromatography (hexanes/CH2Cl2 50/50), 101 mg (95%) of a white solid 
was obtained. Rf = 0.29 (hexanes/CH2Cl2 60/40). This compound is known.
35 1
H NMR 
(400 MHz, CDCl3) δ 7.49-7.37 (m, 5H), 7.34 (t, J = 8.4 Hz, 1H), 6.71 (d, J = 8.4 Hz, 
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2H), 3.78 (s, 6H). 
13
C NMR (100 MHz, CDCl3, ppm)  157.8, 134.3, 131.1, 128.8, 127.8, 
126.9, 119.6, 104.3, 56.1.1 
O
CF3  
2-Methoxy-6-trifluoromethyl-1,1
’
-biphenyl (Entry 12, Table 3.1.2): 3-
Trifluoromethylanisole (88 mg, 0.5 mmol), PhCl (84 mg, 0.75 mmol), TMPLi in pentane 
(1 M, 1.5 mL), followed by  anhydrous THF (0.1 mL), rt, 4h. After column 
chromatography (hexanes/CH2Cl2 80/20), 102 mg (81 %) of a white solid was obtained. 
Rf = 0.26 (hexanes/DCM 80/20). 
1
H NMR (400 MHz, CDCl3) δ 7.48-7.39 (m, 5H), 7.30-
7.27 (m, 2H), 7.16 (d, J = 8.3 Hz, 1H), 3.75 (s, 3H). 
13
C NMR (100 MHz, CDCl3, ppm)  
157.9, 134.9, 130.4, 130.3 (q, JC-F = 29.2 Hz), 130.1, 128.8, 127.7, 127.6, 124.05 (q, JC-F 
= 280 Hz), 117.85 (q, JC-F = 5.5 Hz), 114.3, 56.2. 
N
NO
 
2-(3-Methoxyphenyl)-1-methyl-5-phenylimidazole (Scheme 3.1.17) 
Two-step method with isolation of intermediate:  all reactions follow the general 
procedure. 
 Step 1: 1-Methylimidazole (41 mg, 0.5 mmol), PhCl (96 mg, 0.85 mmol), LDA (1 
M, 1.6 mL), rt, 3 hours. After column chromatography (hexanes/EtOAc 20/80), 63 mg 
(80 %) of 1-methyl-2-phenylimidazole (light yellow liquid) was obtained.  
 132 
 Step 2: 1-Methyl-2-phenylimidazole (79 mg, 0.5 mmol), 2-chloroanisole (142.5 
mg, 1.0 mmol), TMPLi in THF (1 M, 1.8 mL), rt, 2 hours. After column chromatography 
(MeOH/EtOAc 10/90), then HPLC (hexanes/EtOAc/MeOH 20/70/10), 94 mg (71 %) of 
yellowish liquid was obtained.  
Reactions without isolation of intermediate: A 2 dram vial equipped with a magnetic stir 
bar was charged 1-methylimidazole (41 mg, 0.5 mmol), PhCl (96 mg, 0.85 mmol). The 
vial was flushed with argon and capped. To this mixture was slowly added LDA in THF 
(1 M, 1.6 mL) by injecting through the septum via syringe. The vial was flushed with 
argon (20 seconds) and then stirred at room temperature for 3 hours. The reaction mixture 
was quenched with anhydrous MeOH (0.6 mL) and evacuated to remove all solvent and 
diisopropylamine. 2-Chloroanisole (142.5 mg, 1.0 mmol) was then added to the vial 
containing the residue. The vial was flushed with argon and capped. To this mixture was 
slowly added TMPLi in THF (1 M, 1.8 mL) by injecting through the septum via syringe. 
The vial was flushed with argon again (20 seconds) and stirred at room temperature for 
another 2 hours. After column chromatography (MeOH/EtOAc 10/90), and then HPLC 
(hexanes/EtOAc/MeOH 20/70/10), 66 mg (50 %) of a yellowish liquid was obtained. 
Rf = 0.18 (EtOAc). 
1
H NMR (400 MHz, CDCl3) δ 7.70-7.67 (m, 2H), 7.49-7.34 (m, 4H), 
7.20 (s, 1H), 7.03 (d, J = 7.8 Hz, 1H), 6.99 – 6.97 (m, 1H), 6.92 (dd, J = 7.8 Hz, 2.4 Hz, 
1H), 3.85 (s, 3H), 3.67 (s, 3H). 
13
C NMR (100 MHz, CDCl3, ppm)  159.9, 149.5, 135.4, 
131.6, 130.9, 129.9, 128.9, 128.8, 128.7, 127.7, 121.1, 114.5, 113.3, 55.4, 33.9. FT-IR 
(neat, cm
-1) υ 1605, 1580, 1480. 1467, 1248, 1031. Anal calcd for C17H16N2O (264.13 
g/mol): C, 77.25; H, 6.10; N, 10.60; Found. C, 77.08; H, 6.13; N, 10.88. 
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Chapter 3-2. Direct Arylation of Terminal Alkynes via Benzyne Intermediates 
3.2.1. Transition-metal-catalyzed Arylation of Terminal Alkynes 
 The Sonogashira cross-coupling reaction has been increasingly used because of its 
synthetic utility in the preparation of valuable compounds. Most of this work is still 
carried out following the procedure based on the combination of PdCl2(PPh3)2 and CuI 
catalysts. The development of more reactive palladium catalysts enables the reaction to 
proceed in the absence of copper(I) cocatalysis.
1 
Scheme 3.2.1. Sonogashira reactions 
 
 Recently, copper, iron, or nickel species have been reported to act as catalysts for 
Sonogashira reaction.
2
 In particular, the nickel-catalyzed Sonogashira coupling has been 
carried out for activated aryl iodides and aromatic terminal alkynes using NiCl2(PPh3)2 (5 
mol %) in the presence of copper(I) iodide (10 mol %). The copper(I) 
iodide/triphenylphosphine catalytic system allowed the cross-coupling reaction of aryl 
and vinyl iodides and terminal alkynes. Moreover, iron(III) acetylacetonate (10 mol%) 
combined with 2,2
’
-bipyridine (20 mol%) ligand has been found to catalyze cross-
coupling of terminal alkynes with aryl iodides. Transition-metal-free Sonogashira 
couplings have been reported.
3
 Different aryl or heteroaryl iodides and bromides were 
heated and irradiated in water at 170 °C in the presence of phenylacetylene. However, 
recent studies have shown that palladium contaminants down to 50 ppb found in 
commercially available sodium carbonate can efficiently catalyze Sonogashira coupling 
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reactions.
4
 Therefore, serious doubts have been raised about the identity of actual 
catalysts in non-palladium systems. 
3.2.2. Alkynylation via Arynes 
 One of the first transition-metal-free aryne alkynylation reactions was described 
by Roberts.
5
 The reactions of non-activated aryl halides with various nucleophiles such as 
anilide and phenyl acetylide induced by alkali amides in liquid ammonia were carried 
out. In all cases, isomeric products were obtained if halotoluenes was used indicating the 
formation of a benzyne intermediate. 
Scheme 3.2.2. Aryne alkynylation using aryl bromides in KNH2/NH3 
 
 
A reaction of polyhalobenzenes with alkenyl Grignards has been described.
6
 
Depending on particular polyhalobenzene used, from one to four new aryl-alkenyl bonds 
are formed. Three types of reactions are involved: formation of polyhaloaryl Grignards, 
followed by one or more sequences of aryne formation, and nucleophilic addition to the 
aryne. Similar reactions can be accomplished with alkynyl Grignards. 
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Scheme 3.2.3. Polyalkynylation and polyalkenylation via benzyne 
 
 Arynes generated from o-(trimethylsilyl)aryl triflates undergo cross coupling 
reactions with terminal alkynes in the presence of a copper catalyst.
7b
 Furthermore, other 
transition-metal-catalyzed reactions of alkynes with arynes have been described.
7  
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3.2.3. Direct Arylation of Terminal Alkynes via Benzyne Intermediates  
3.2.3.1. Introduction 
 Transition-metal-catalyzed reactions between aryl halides and terminal alkynes 
have been employed in a wide variety of areas.
8
 During the past decades, remarkable 
improvements in reaction efficiency have been achieved.
8b
 Several examples of 
transition-metal-free sp
2
-sp carbon-carbon bond formation reactions have been described 
in the literature.
9
 In most cases, however, either photochemical activation, preformed 
Grignard reagents, or activated aryl halides were employed. 
Several methods for direct arylation of terminal alkynes via benzyne 
intermediates have been described. Arynes generated from o-(trimethylsilyl)aryl triflates 
undergo cross coupling reaction with terminal alkynes in the presence of a copper 
catalyst.
7
 As previously mentioned, o-(trimethylsilyl)aryl triflates are expensive and their 
commercial availability is limited. Hart reported a procedure for reaction between 
polyhaloarenes and alkynyl Grignards proceeding via aryne intermediates.
6
 The 
requirement of preformed alkynylmetals limits the application of this method and only a 
few examples were disclosed. A general procedure for transition-metal-free direct 
arylation of alkynes using aryl halides has not been described. 
3.2.3.2. Results and Discussion 
In our previous report, a direct transition-metal-free, base-mediated 
intermolecular arylation of heterocycles and arenes by aryl halides has been disclosed.
10
 
The method employed hindered lithium amide bases in pentane/THF mixture. 
Mechanistically, the reaction proceeds via the simultaneous generation of arynes and aryl 
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anions from aryl halides and arenes, respectively. Since cross coupling reactions between 
arynes and alkynyl Grignards are known, we reasoned that direct aryl halide alkynylation 
under similar conditions is possible. 
Hindered LiTMP was used to suppress the reaction of benzyne with base. 
Relative reactivity of the base and alkynyl anion with benzyne is modulated by 
employing a solvent where amide base is sparingly soluble. The results indicated that 
reported conditions for arylation of sp
2
 C-H bonds are applicable to the aryl halide 
alkynylation. Interestingly, comparable yields were obtained when heating reaction 
mixture in dioxane in the presence of an alkoxide base. The latter set of conditions is 
based on previously published intramolecular arylation of phenol derivatives.
11
 
Table 3.2.1. Alkynylation Scope with Respect to Aryl Chlorides
a 
 
entry ArCl/conditions product yield, % 
1 
PhCl, A 
A 
B 
 
91 
61
b 
77
 
2 
2-ClC6H4OMe 
A   
 
75 
3
 
3-ClC6H4OMe 
B  
 
86 
4
 
3-ClC6H4NMe2 
A  
 
85 
5 
3-ClC6H4F 
B 
 
 
 
82 
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6 
3-ClC6H4CF3,  
A 
B 
 
 
70 
74 
7 
(a) 2-BrC6H4Ph 
A 
(b) 2-FC6H4Ph,  
A 
 
 
78 
 
70 
8
 
2-ClC6H4iPr 
A 
 
 
85 
9 
2-naphthyl chloride 
A  
 
 
81 
10 
1-naphthyl chloride 
A 
 
 
60 
11
 
3,5-(MeO)2C6H3Cl 
B 
 
81 
12 
2-MeO-4-MeC6H3Cl 
A 
 
75 
13 
9-chlorophen-anthrene 
A 
 
86 
14
c 
4-tBuC6H4Cl 
A  
90 
a
 Method A: aryl halide (1.5-2.5 equiv), phenylacetylene (1 equiv), TMPLi (3-4 equiv), 
pentane/THF, 25 °C. Method B: aryl halide (2.6-3 equiv), phenylacetylene (1 equiv), tBuONa or 
tBuOK (7 equiv), dioxane, 106-135 °C. Yields are isolated yields of a pure major isomer unless 
otherwise noted and reactions were run on 0.5 mmol scale. 
b
 1:1 Ratio of PhCl and alkyne. 
c
 
Isomer mixture; m/p ratio 1/1.2. 
 
 142 
 The reactions scope with respect to aryl chlorides is shown in Table 3.2.1. Higher 
yield was obtained when excess chlorobenzene was used (entry 1). 3-
Methoxydiphenylacetylene is obtained when phenylacetylene is arylated by either 2- or 
3-chloroanisole (entries 2 and 3).
12
 3-Chlorodimethylaniline and 3-chlorobenzotrifluoride 
are reactive, and products are obtained in good yields (entries 4 and 6).  For the latter 
substrate, both reaction conditions afford good yields. Interestingly, by employing 
tBuONa base, it is possible to selectively substitute chloride in 3-fluorochlorobenzene 
(entry 5). In several cases, isomer mixtures are obtained. For 2-chlorocumene (entry 8), a 
12/1 isomer mixture was obtained with 3-isomer as a major product. The alkynylation of 
1- and 2-chloronaphthalenes affords product as a 5.4/1 and 11.6/1 isomer mixtures, with 
2-naphthylphenylacetylene predominating (entries 9 and 10). The reported yields are 
those of a pure major isomer after purification by HPLC. Arylation by 3,5-
dimethoxychlorobenzene, 3-chloro-4-methoxy-toluene, and 9-chlorophenanthrene affords 
products in good yields (entries 11-13). When 4-chloro-t-butylbenzene is used, a nearly 
1/1 mixture of alkynylation product isomers is obtained (entry 14). 
Table 3.2.2. Alkynylation Scope with Respect to Alkynes
a 
 
entry alkyne/conditions product yield, % 
1 
Na acetylide (NaCCH) 
A
b 
B
c 
 
 
86 
78 
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2 
 
A 
B 
 
 
 
87 
75 
3 
 
A 
B 
 
 
 
90 
78 
4  
A
d 
 
50 
5
 
 
B 
 
 
73 
6 
 
A 
B 
 
 
93 
78 
7
e  
A  
67 
8
e 
 
A 
 
76 
9
  
A  
 
65 
 
10 
 
A 
 
62 
11 
 
A  
 
85 
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12
  
A  
 
93 
 
a
 Method A: PhCl (1.8-2 equiv), alkyne (1 equiv), TMPLi (3.2-4.4 equiv), pentane/THF, 
THF, or diethyl ether solvent, 25 °C. Method B: chlorobenzene (3.0 equiv), alkyne (1.0 equiv), 
tBuOK (7 equiv), dioxane, 106 °C. Yields are isolated yields and reactions were run on 0.5 mmol 
scale. See Supporting Information for details. 
b
 PhCl (4 equiv), TMPLi (5.6 equiv). 
c
 PhCl (5 
equiv), tBuOK (8 equiv). 
d
 Reaction at -55 °C. 
e
 Reaction at -63 °C.  
 
The reaction scope with respect to alkynes is presented in Table 3.2.2. Sodium 
acetylide can be diarylated in good yield (entry 1). Phenylacetylenes with electron-
donating or electron-withdrawing groups are reactive (entries 2-3). Cyano group is 
tolerated (entry 4). Arylation of 3-ethynylthiophene affords the product in good yield 
(entry 5). Many aliphatic alkynes can be used as coupling partners. Arylation of t-
butylacetylene, cyclohexylacetylene, and 3-methyl-1-hexyne is possible and couplings 
proceed in good yields (entries 6-8). However, for alkynes possessing propargylic 
hydrogens, careful temperature optimization is required to prevent base-mediated 
conversion to allene and method B is not applicable due to high reaction temperature. 
Isomerization to allenes was observed with primary alkylacetylenes and acceptable yields 
could not be obtained. Substrates containing tertiary and hindered secondary hydroxyl 
groups can be C-arylated selectively (entries 9 and 10). Silyl group-containing alkynes 
are arylated in good yields and cleavage of the silyl substituent is not observed if TMPLi 
base is employed (entries 11 and 12). 
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3.2.3.3. Mechanistic Studies 
Several experiments with deuterated reagents were conducted to investigate the 
reaction mechanism. Thus, 6.5 equiv tBuOD was added to mixture of 3-chloroanisole, 4-
methoxyphenylacetylene, and tBuOK in dioxane followed by heating to 110 ° (Scheme 
3.2.4). The H/D exchange conditions were chosen to mimic conditions B. After reaction, 
coupling product was obtained in 31% yield. Unreacted 3-chloroanisole was recovered in 
25% yield. Analysis by 
1
H-NMR showed extensive incorporation of deuterium label 
adjacent to methoxy and chloro substituents arising from metalation-deuteration sequence 
in recovered chloroarene and coupling product. Similar results were obtained in the 
reaction of 2-chloroanisole with 4-methoxyacetylene. Interestingly, t-BuOK is able to 
ortho-metalate nonactivated methoxyarenes as evidenced by deuteration of the p-
methoxyphenyl group.  
Scheme 3.2.4. Deuteration Experiments 
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Deuterium incorporation at 2- and 4-positions of recovered 3-chloroanisole is 
noteworthy. Deuterium incorporation in recovered 3-chloroanisole can be explained by 
the intermediacy of three isomers of the arylpotassium species – A, B, and C (Scheme 
3.2.5). ortho-Aryne can not be formed from C. Compound A can form only 3-
methoxybenzyne D that regioselectively reacts with alkyne anion to form the observed 
product F.
13
 On the other hand, arylpotassium B could form 4-methoxybenzyne E that 
would react to afford two product isomers F and G in nearly equal amounts. Since 
compound G is not observed, and deuteration experiment suggests that B is present in the 
reaction mixture, it must be concluded that aryne formation from A is more facile than 
aryne formation from B.
14 
Collum and coworkers have measured the rate constants for 
benzyne formation from substituted aryllithiums and concluded that haloanisoles are 
especially reactive toward LiX elimination. 
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Scheme 3.2.5. Metalation-Benzyne Formation Sequence 
 
3.2.3.4. Conclusions 
Two sets of conditions for base-mediated, transition-metal-free alkynylation of 
aryl chlorides have been developed. The first set of conditions involves the use of 
hindered TMPLi base in pentane/THF mixture at room temperature. The second set 
involves use of a metal alkoxide base in dioxane at elevated temperature. Functional 
groups such as fluoro, trifluoromethyl, silyl, tri-substituted amine, and cyano are 
tolerated. Tertiary and secondary alcohols are also compatible with the reaction 
conditions. 
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3.2.3.5. Experimental Section 
General considerations: When TMPLi (lithium 2,2,6,6-tetramethylpiperidide) was used, 
reactions were performed in 2-dram vials using screw caps with 17 mm hole and white 
silicone septum with white teflon face (from SUPELCO). If tert-butoxide bases were 
used, reactions were run in 1-dram vials using 13 mm screw caps with PTFE/Liner (from 
SUPELCO). Column chromatography was performed on 60Å silica gel (Sorbent 
Technologies). Purification by preparative HPLC was performed on a Shimadzu 
Prominence LC (LC-20AB) equipped with a SPD-20A UV-Vis detector and a Varian 
Dynamax (250 mm x 21.4 mm) column. GC-MS analyses were performed on a 
Shimadzu GCMS-QP5000 chromatograph equipped with a Restek column (Rtx-XLB, 30 
m x 0.25 mm I.D.). The 
1
H, 
19
F and 
13
C NMR were recorded on JEOL EC-400 or JEOL 
EC-500 spectrometers using residual solvent peak as a reference. α,α,α-Trifluorotoluene 
(neat, δ = -62.3ppm) was employed as an external standard in 
19
F NMR spectra. 
Elemental analyses were performed by Atlantic Microlab Inc. of Norcross, GA. IR 
spectra were obtained on a ThermoNicolet Avatar 370 FT-IR instrument. Analytical thin 
layer chromatography was performed on silica gel IB-F (Baker-flex) by J. T. Baker. All 
procedures were performed under argon atmosphere unless otherwise noted. 
Materials. The following starting materials were obtained from commercial sources and 
were used without further purification: sodium tert-butoxide, potassium tert-butoxide, 
phenylacetylene, 4-ethynyltoluene, 4-ethynylbenzotrifluoride, triisopropylsilylacetylene, 
trimethylsilylacetylene, 3-methyl-1-hexyne, cyclohexylacetylene, 3,3-dimethyl-1-butyne, 
1-ethynyl-1-cyclohexanol, 4-ethyl-1-octyn-3-ol, 3-ethynylthiophene, 3-chloro-N,N-
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dimethylaniline, 2-chloro-N,N-dimethylaniline, 2-chloroanisole, 3-chloroanisole, 
chlorobenzene, 3-chlorobenzotrifluoride, 2-chloroisopropylbenzene, 2-
chloronaphthalene, 2-bromobiphenyl, 2-fluorobiphenyl, 1-chloro-3-fluorobenzene, 4-tert-
butyl-1-chlorobenzene, 2,2,6,6-tetramethylpiperidine (TMPH), 9-chlorophenanthrene, 
3,5-dimethoxychlorobenzene, 3-chloro-4-methoxytoluene. Sodium acetylide was purified 
from mineral oil suspension by repeated washing with pentane followed by drying in 
vacuum.  1-Chloronaphthalene was synthesized according to literature.
 15
 
TMPLi 1M in THF:  A 25 mL oven-fried flask equipped with a magnetic stirring bar 
and a septum was evacuated and backfilled with argon 5 times. TMPH (2,2,6,6-
tetramethylpiperidine, 2.32 g, 16.5 mmol) was added via syringe, followed by anhydrous 
THF to give 15 mL of solution. The mixture was cooled to -73 
o
C and stirred for 5 
minutes. n-BuLi (2.5 M in hexanes, 6 mL, 15 mmol) was then added dropwise (in 15 
minutes). The reaction mixture was stirred for 45 minutes at -73 
o
C followed by warming 
to 0
o
C and stirring for additional 15 minutes. After that, the reaction mixture was 
vacuumed at room temperature to give 15 mL of solution.  
TMPLi 1M in Et2O:  A 25 mL oven-fried flask equipped with a magnetic stirring bar 
and a septum was evacuated and backfilled with argon 5 times. TMPH (2,2,6,6-
tetramethylpiperidine, 2.32 g, 16.5 mmol) was added via syringe, followed by anhydrous 
Et2O to give 15 mL of solution. The mixture was cooled to -73 
o
C and stirred for 5 
minutes. n-BuLi (2.5 M in hexanes, 6 mL, 15 mmol) was then added dropwise (in 15 
minutes). The reaction mixture was stirred for 45 minutes at -73 
o
C followed by warming 
to 0 
o
C and stirring for additional 5 minutes. After that, the reaction mixture was 
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vacuumed at 0 
o
C to remove all solvents. Anhydrous Et2O (15 mL) was added to the 
precipitate. 
TMPLi 1 M in pentane: A 50 mL oven-fried flask equipped with a magnetic stirring bar 
and a septum was evacuated and backfilled with argon 5 times. TMPH (4.64 g, 33.0 
mmol) was added, followed by anhydrous pentane to give 30 mL of solution (marked the 
flask at the level of solution). The mixture was cooled to -73 °C (dry ice-acetone) and 
stirred for 5 minutes. n-BuLi (2.5 M in hexanes, 12.0 mL, 30 mmol) was added dropwise 
and reaction mixture was stirred for 30 minutes at -73 °C, warmed up to room 
temperature and stirred overnight. The reaction mixture was vacuumed to give 30 mL (at 
the marked level) of TMPLi suspension.  
The following cooling baths were used to attain the desired temperatures. Temperature 
control is very important to obtain reproducible yields. Temperature was monitored 
continuously and typically remained within 2 °C of the reported value. 
Chloroform + CO2: -63
 
°C. 
Acetone + CO2: -73
 
°C. 
n-Octane + CO2: -55
 
°C. 
Room temperature: 25 °C. 
General procedures.  
Alkynylation using t-BuOK and t-BuONa bases: Outside the glovebox a 1-dram vial 
equipped with a magnetic stirring bar was charged with chloroarene (1.5 mmol) and 
alkyne (0.5 mmol). The vial was flushed with argon, capped and placed inside the 
glovebox. To this mixture was added dioxane (0.3 mL), t-BuONa or t-BuOK (3.5 mmol), 
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and dioxane (0.2 – 0.4 mL). The sealed vial was taken out the glovebox, stirred at room 
temperature for 5 minutes and then placed in preheated oil bath for indicated time. 
Reaction vials were occasionally shaken during first few hours to ensure complete 
mixing. The reaction mixture was cooled to room temperature and quenched with 0.5 mL 
anhydrous MeOH. The reaction mixture was evacuated to remove all solvent, dissolved 
in minimal amount of CH2Cl2, and subjected to flash chromatography on silica gel in 
hexanes or pentanes followed by appropriated solvent to elute the products. After 
concentrating the fractions containing the product, the residue was dried under reduced 
pressure to yield pure product. If necessary, purification by preparative HPLC was 
performed.  
TMPLi base: A 2 dram vial equipped with a magnetic stir bar was charged with alkyne 
(0.5 mmol) and ArCl (1.5 – 2.5 equiv). The vial was flushed with argon and capped. To 
this mixture was added the appropriate base solution or suspension (2.5-4.5 equiv) at the 
specified reaction temperature by injecting through the septum via 1mL syringe. If 
TMPLi in pentane was used, the base suspension was stirred vigorously during the time 
being withdrawn by syringe. The vial was flushed with argon (20 seconds) and then 
stirred at specified temperature for indicated time. Unless otherwise stated, reaction 
mixture was quenched with anhydrous MeOH (1.0 mL), evacuated to 1.0 mL and 
subjected to column chromatography on silica gel in hexane or pentane followed by 
appropriate solvent to elute the product. After concentrating the fractions containing the 
product, the residue was dried under reduced pressure. 
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Phenylethynylbenzene (Table 3.2.1, Entry 1; Table 3.2.2, Entry 1 ) 
Chlorobenzene (85 mg, 0.75 mmol), phenylacetylene (51 mg, 0.5 mmol), TMPLi in 
pentane (1 M, 1.5 mL), followed by anhydrous THF (0.1 mL), room temperature, 1.5 
hours. After column chromatography (hexanes/CH2Cl2 90/10), 81 mg (91 %) of a white 
solid was obtained.  
Chlorobenzene (169 mg, 1.5 mmol), phenylacetylene (51 mg, 0.5 mmol), t-BuOK (394 
mg, 3.5 mmol), dioxane (0.6 mL), 106 °C, 24 hrs. After column chromatography 
(gradient, hexanes/CH2Cl2: 100/0 - 90/10), 68 mg (77 %) of a white solid was obtained.  
Chlorobenzene (56.5 mg, 0.5 mmol), phenylacetylene (51 mg, 0.5 mmol), TMPLi in 
pentane (1 M, 1.1 mL), followed by anhydrous Et2O (0.1 mL), room temperature, 12 
hours. After column chromatography (hexanes/CH2Cl2 90/10), 54 mg (61 %) of a white 
solid was obtained.  
Chlorobenzene (284 mg, 2.5 mmol), sodium acetylide (24 mg, 0.5 mmol), t-BuOK (448 
mg, 4 mmol), dioxane (0.7 mL), 106 °C, 24 hrs. After column chromatography (gradient, 
hexanes/CH2Cl2:  100/0 - 90/10), 69 mg (78 %) of a white solid was obtained.  
Chlorobenzene (225 mg, 2.0 mmol), sodium acetylide (24 mg, 0.5 mmol), TMPLi in 
pentane (1 M, 2.8 mL), followed by anhydrous THF (0.25 mL), room temperature, 3 
hours. After column chromatography (hexanes/CH2Cl2 90/10), 78 mg (86 %) of a white 
solid was obtained.  
 153 
Rf = 0.15 (hexanes). This compound is known.
16
 
1
H NMR (400 MHz, CDCl3) δ 7.57 – 
7.54 (m, 4H), 7.38 – 7.34 (m, 6H). 13C NMR (100 MHz, CDCl3, ppm) δ 131.7, 128.5, 
128.4, 123.4, 89.5. 
O
 
1- Methoxy-3-(2-phenylethynyl)benzene (Table 3.2.1, Entries 2 and 3) 
2-Chloroanisole (178 mg, 1.25 mmol), phenylacetylene (51 mg, 0.5 mmol), TMPLi in 
THF (1M, 2 mL), room temperature, 3 hours. After column chromatography 
(hexanes/CH2Cl2 75/25), 78 mg (75 %) of a yellowish liquid was obtained.  
3-Chloroanisole (213.5 mg, 1.5 mmol), phenylacetylene (51 mg, 0.5 mmol), t-BuONa 
(336 mg, 3.5 mmol), dioxane (0.5 mL), 125 °C, 20 hours. After column chromatography 
(gradient, hexanes/CH2Cl2: 100/0 - 75/25), 89 mg (86 %) of a yellowish liquid was 
obtained.  
Rf = 0.18 (hexanes/CH2Cl2 80/20). This compound is known.
17
 
1
H NMR (400 MHz, 
CDCl3) δ 7.57 – 7.55 (m, 2H), 7.39 – 7.34 (m, 3H), 7.26 (d, J = 8.0 Hz, 1H), 7.15 (td, J = 
8.0 Hz, 1.3 Hz, 1H), 7.09 – 7.08 (m, 1H), 6.91 (ddd, J = 1.3 Hz, 2.8 Hz, 8.0 Hz, 1H), 3.84 
(s, 3H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 159.5, 131.7, 129.5, 128.5, 128.4, 124.4, 
124.3, 123.3, 116.4, 115.1, 89.4, 89.3, 55.4. 
N
 
N,N-Dimethyl-3-(2-phenylethynyl)benzenamine (Table 3.2.1, Entry 4) 
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3-Chloro-N,N-dimethylaniline (155.5 mg, 1.0 mmol), phenylacetylene (51 mg, 0.5 
mmol), TMPLi in THF (1M, 1.8 mL), room temperature, 3 hours. After column 
chromatography (hexanes/CH2Cl2 60/40), 95 mg (85 %) of a brownish liquid was 
obtained. Rf = 0.22 (hexanes/CH2Cl2 60/40). This compound is known.
18
 
1
H NMR (400 
MHz, CDCl3) δ 7.58 – 7.55 (m, 2H), 7.39 – 7.33 (m, 3H), 7.23 (t, J = 8.1 Hz, 1H), 6.94 – 
6.92 (m, 2H), 6.74 (dd, J = 8.1 Hz, 2.7 Hz, 1H), 2.98 (s, 6H). 
13
C NMR (100 MHz, 
CDCl3, ppm) δ 150.5, 131.7, 129.2, 128.4, 128.2, 123.7, 123.6, 120.0, 115.4, 113.0, 90.5, 
88.4, 40.6. 
F
 
1- Fluoro-3-(2-phenylethynyl)benzene (Table 3.2.1, Entry 5) 
3-Chloro-1-fluorobenzene (195.5 mg, 1.5 mmol), phenylacetylene (51 mg, 0.5 mmol), t-
BuONa (336 mg, 3.5 mmol), dioxane (0.5 mL), 125 °C, 36 hours. After column 
chromatography (gradient, hexanes/CH2Cl2: 100/0 - 90/10), 80 mg (82 %) of a colorless 
liquid was obtained. Rf = 0.21 (hexanes/CH2Cl2 90/10). This compound is known.
19
 
1
H 
NMR (400 MHz, CDCl3) δ 7.56 – 7.52 (m, 2H), 7.38 – 7.34 (m, 3H), 7.33 – 7.30 (m, 
2H), 7.26 – 7.23 (m, 1H), 7.08 – 7.02 (m, 1H). 13C NMR (100 MHz, CDCl3, ppm) δ 162.5 
(d, JC-F = 246.2 Hz), 131.8, 130.0 (d, JC-F = 8.7 Hz), 128.7, 128.5, 127.6 (d, JC-F = 3.0 
Hz), 125.2 (d, JC-F = 9.5 Hz), 122.8, 118.5 (d. JC-F = 23.1 Hz), 115.7 (d, JC-F = 21.6 Hz), 
90.4, 88.2 (d, JC-F = 3.8 Hz).  
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CF3
 
1-(2-Phenylethynyl)-3-(trifluoromethyl)benzene (Table 3.2.1, Entry 6) 
3-Chlorobenzotrifluoride (180 mg, 1.0 mmol), phenylacetylene (51 mg, 0.5 mmol), 
TMPLi in THF (1M, 1.8 mL), followed by anhydrous THF (0.2 mL), room temperature, 
2 hours. After column chromatography (hexanes/CH2Cl2 90/10), 86 mg (70 %) of a 
colorless liquid was obtained.  
3-Chlorobenzotrifluoride (270 mg, 1.3 mmol), phenylacetylene (51 mg, 0.5 mmol), t-
BuONa (336 mg, 3.5 mmol), dioxane (0.5 mL), 130 °C, 36 hours. After column 
chromatography (hexanes/CH2Cl2 90/10), 91 mg (74 %) of a colorless liquid was 
obtained.  
Rf = 0.24 (hexanes/CH2Cl2 90/10). This compound is known.
16
 
1
H NMR (400 MHz, 
CDCl3) δ 7.80 (s, 1H), 7.69 (d, J = 7.8 Hz, 1H), 7.60 – 7.53 (m, 3H), 7.47 (t, J = 7.8 Hz, 
1H), 7.40 – 7.35 (m, 3H). 13C NMR (100 MHz, CDCl3, ppm) δ 134.7, 131.8, 131.0 (q, JC-
F = 32 Hz), 129.0, 128.9, 128.6, 128.5 (q, JC-F = 4.1 Hz), 124.9 (q, JC-F = 4.1 Hz), 124.3, 
123.6 (q, JC-F = 272 Hz), 122.7, 91.0, 87.9. 
Ph
  
3-(Phenylethynyl)-1,1
’
-biphenyl (Table 3.2.1, Entry 7 ) 
2-Bromobiphenyl (209.7 mg, 0.9 mmol), phenylacetylene (51 mg, 0.5 mmol), TMPLi in 
pentane (1 M, 1.6 mL), followed by anhydrous THF (0.12 mL), room temperature, 5 
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hours. After column chromatography (hexanes/CH2Cl2 90/10), 99 mg (78 %) of a light 
yellow liquid was obtained. 
2-Fluorobiphenyl (172 mg, 1.0 mmol), phenylacetylene (51 mg, 0.5 mmol), TMPLi in 
pentane (1 M, 1.7 mL), followed by anhydrous THF (0.08 mL), room temperature, 3 
hours. After column chromatography (hexanes/CH2Cl2 90/10), 89 mg (70 %) of a light 
yellow liquid was obtained. 
Rf = 0.15 (hexanes/CH2Cl2 90/10). This compound is known.
20
 
1
H NMR (400 MHz, 
CDCl3) δ 7.81 (m, 1H), 7.65 – 7.62 (m, 2H), 7.60 – 7.57 (m, 4H), 7.51 – 7.44 (m, 3H), 
7.42 – 7.36 (m, 4H). 13C NMR (100 MHz, CDCl3, ppm) δ 141.5, 140.5, 131.8, 130.5, 
129.0, 128.5, 128.4, 128.3, 127.7, 127.3, 127.2, 123.8, 123.3, 89.6, 89.5. Signal for one 
carbon could not be located. 
 
1- Isopropyl-3-(2-phenylethynyl)benzene (Table 3.2.1, Entry 8) 
2-Chloroisopropylbenzene (139 mg, 0.9 mmol), phenylacetylene (51 mg, 0.5 mmol), 
TMPLi in pentane (1M, 1.6 mL), followed by anhydrous THF (0.15 mL), room 
temperature, 2 hours. GC Analysis showed that two isomers are formed in 12.2/1 ratio. 
After column chromatography (hexanes/CH2Cl2 95/5), 106 mg (96 %) of a colorless 
liquid containing 2 isomers in 12.1/1 ratio was obtained. The mixture was subjected to 
HPLC in hexanes to give 93.5 mg (85 %) of single major isomer as a colorless liquid. Rf 
= 0.18 (hexanes/CH2Cl2 95/5). This compound is known.
21
 
1
H NMR (400 MHz, CDCl3) 
δ 7.55 – 7.52 (m, 2H), 7.41 (t, J = 1.8 Hz, 1H), 7.36 – 7.31 (m, 4H), 7.27 (t, J = 7.8 Hz, 
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1H), 7.20 (td, J = 7.8 Hz, 1.8 Hz, 1H), 2.9 (septet, J = 7.0 Hz, 1H), 1.26 (d, J = 7.0 Hz, 
6H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 149.1, 131.7, 129.6, 129.2, 128.4, 128.3, 126.8, 
123.4, 123.1, 89.6, 89.0, 34.1, 24.0. Signal for one carbon could not be located.  
 
2-(2-Phenylethynyl)naphthalene (Table 3.2.1, Entries 9 and 10) 
2-Chloronaphthalene (162.5 mg, 1.0 mmol), phenylacetylene (51 mg, 0.5 mmol), TMPLi 
in pentane (1M, 1.8 mL), followed by anhydrous THF (0.2 mL), room temperature, 2 
hours. GC Analysis showed that two isomers are obtained in 11.5/1 ratio. After column 
chromatography (hexanes/CH2Cl2 90/10), 110 mg (94 %) of a white solid containing 2 
isomers in 11.6/1 ratio was obtained. The mixture was subjected to HPLC 
(hexanes/CH2Cl2 95/5), and 92 mg (81 %) of a single isomer as a white solid was 
isolated.  
1-Chloronaphthalene (162.5 mg, 1.0 mmol), phenylacetylene (51 mg, 0.5 mmol), TMPLi 
in pentane (1M, 1.8 mL), followed by anhydrous THF (0.2 mL), room temperature, 2 
hours. GC Analysis showed that two isomers are obtained in 5.4/1 ratio. After column 
chromatography (hexanes/CH2Cl2 90/10), 103 mg (90 %) of white solid containing 2 
isomers in 5.4/1 ratio was obtained. The mixture was then subjected to HPLC 
(hexanes/CH2Cl2 95/5) and 68 mg (60 %) of a single isomer as a white solid was isolated. 
Rf = 0.28 (hexanes/CH2Cl2 85/15). This compound is known.
16
 
1
H NMR (400 MHz, 
CDCl3) δ 8.07 (s, 1H), 7.84 – 7.81 (m, 3H), 7.60 – 7.58 (m, 3H), 7.52 – 7.48 (m, 2H), 
7.40 – 7.35 (m, 3H). 13C NMR (100 MHz, CDCl3, ppm) δ 133.1, 132.9, 131.8, 131.6, 
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128.6, 128.5, 128.4, 128.1, 127.9, 126.8, 126.7, 123.4, 120.7, 89.9, 89.8. Signal for one 
carbon could not be located. 
O
O  
1,3-Dimethoxy-5-(2-phenylethynyl)benzene (Table 3.2.1, Entry 11) 
5-Chloro-1,3-dimethoxybenzene (258.5 mg, 1.5 mmol), phenylacetylene (51 mg, 0.5 
mmol), t-BuONa (336 mg, 3.5 mmol), dioxane (0.5 mL), 125 °C, 18 hours. After column 
chromatography (gradient, hexanes/CH2Cl2: 100/0 - 30/70), 96 mg (81 %) of a yellowish 
liquid was obtained. Rf = 0.28 (hexanes/CH2Cl2 85/15). This compound is known.
22
 
1
H 
NMR (400 MHz, CDCl3) δ 7.55 – 7.52 (m, 2H), 7.37 – 7.33 (m, 3H), 6.70 (d, J = 2.3 Hz, 
2H), 6.47 (t, J = 2.3 Hz, 1H), 3.81 (s, 6H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 160.6, 
131.8, 131.7, 128.5, 124.6, 123.2, 109.4, 101.9, 89.5, 89.0, 55.5. 
O  
4-Methoxy-2-(2-phenylethynyl)toluene (Table 3.2.1, Entry 12) 
3-Chloro-4-methoxytoluene (195.5 mg, 1.25 mmol), phenylacetylene (51 mg, 0.5 mmol), 
TMPLi in THF (1M, 2 mL), room temperature, 4 hours. After column chromatography 
(hexanes/CH2Cl2 70/30), 84 mg (75 %) of a pale yellow liquid was obtained. Rf = 0.21 
(hexanes/CH2Cl2 70/30). 
1
H NMR (400 MHz, CDCl3) δ 7.55 – 7.52 (m, 2H), 7.38 – 7.31 
(m, 3H), 7.12 (d, J = 8.3 Hz, 1H), 7.04 (d, J = 2.8 Hz, 1H), 6.81 (dd, J = 8.3 Hz, 2.8 Hz, 
1H), 3.80 (s, 3H), 2.44 (s, 3H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 157.4, 132.5, 131.6, 
 159 
130.5, 128.5, 128.4, 123.7, 123.5, 116.2, 115.2, 93.2, 88.5, 55.5, 19.9. FT-IR (neat, cm
-1
) 
υ 1604, 1501, 1229, 1102, 1037. Anal calcd for C16H14O (222.28 g/mol): C, 86.45; H, 
6.35; Found. C, 86.44; H, 6.40. 
 
9-(2-Phenylethynyl)phenanthrene (Table 3.2.1, Entry 13 ) 
9-Chlorophenanthrene (212.5 mg, 1.0 mmol), phenylacetylene (51 mg, 0.5 mmol), 
TMPLi in pentane (1M, 1.8 mL), followed by anhydrous THF (0.2 mL), room 
temperature, 4 hours. After column chromatography (hexanes/CH2Cl2 80/20), 119 mg (86 
%) of a yellow solid was obtained. Rf = 0.30 (hexanes/CH2Cl2 80/20). This compound is 
known.
23
 
1
H NMR (400 MHz, CDCl3) δ 8.72 – 8.66 (m, 2H), 8.59 – 8.55 (m, 1H), 8.10 
(s, 1H), 7.88 (d, J = 7.8 Hz, 1H), 7.74 – 7.59 (m, 6H), 7.45 – 7.38 (m, 3H). 13C NMR 
(100 MHz, CDCl3, ppm) δ 131.9, 131.8, 131.4, 131.2, 130.4, 130.3, 130.2, 128.7, 128.6, 
127.6, 127.2, 127.1, 123.5, 122.9, 122.7, 119.8, 119.7, 94.0, 87.8. Signal for one carbon 
could not be located. 
 
A mixture of 1-(1,1-dimethylethyl)-4-(2-phenylethynyl)benzene [1] and 1-(1,1-
dimethylethyl)-3-(2-phenylethynyl)benzene [2] (Table 3.2.1, Entry 14) 
1-tert-Butyl-1-chlorobenzene (168.5 mg, 1.0 mmol), phenylacetylene (51 mg, 0.5 mmol), 
TMPLi in pentane (1M, 1.8 mL), followed by anhydrous THF (0.15 mL), room 
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temperature, 4 hours. Analysis by GC showed that two isomers are obtained in 1.2/1 
([1]/[2]) ratio. After column chromatography (hexanes/CH2Cl2 90/10), 105 mg (90 %) of 
a colorless liquid containing 2 isomers in the same ratio was obtained. These compounds 
are known.
24
 
1
H NMR of mixture of isolated two isomers (400 MHz, CDCl3) δ 7.60 – 
7.28 (m, 9H), 1.35 – 1.34 (overlapping singlets, 9H). 
 
4-(2-Phenylethynyl)toluene (Table 3.2.2, Entry 2) 
4-Ethynyltoluene (58 mg, 0.5 mmol), PhCl (102 mg, 0.9 mmol), TMPLi in pentane (1M, 
1.6 mL), followed by anhydrous THF (0.15 mL), room temperature, 2 hours. After 
column chromatography (hexanes/CH2Cl2 90/10), 84 mg (87 %) of a white solid was 
obtained.  
4-Ethynyltoluene (58 mg, 0.5 mmol), PhCl (169 mg, 1.5 mmol), t-BuOK (393 mg, 3.5 
mmol), dioxane (0.5 mL), 106 °C, 24 hours. After column chromatography (gradient, 
hexanes/CH2Cl2: 100/0 - 90/10), 72 mg (75 %) of a white solid was obtained. 
Rf = 0.19 (hexanes/CH2Cl2 90/10). This compound is known.
16
 
1
H NMR (400 MHz, 
CDCl3) δ 7.55 – 7.52 (m, 2H), 7.46 – 7.44 (m, 2H), 7.40 – 7.32 (m, 3H), 7.18 – 7.15 (m, 
2H), 2.38 (s, 3H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 138.5, 131.7, 131.6, 129.2, 128.4, 
128.2, 123.6, 120.3, 89.7, 88.8, 21.7. 
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F3C
 
1-(2-Phenylethynyl)-4-(trifluoromethyl)benzene (Table 3.2.2, Entry 3 ) 
4-Ethynylbenzotrifluoride (85 mg, 0.5 mmol), PhCl (102 mg, 0.9 mmol), TMPLi in 
pentane (1M, 1.6 mL), followed by anhydrous THF (0.15 mL), room temperature, 2 
hours. After column chromatography (hexanes/CH2Cl2 90/10), 110 mg (90 %) of a white 
solid was obtained. 
4-Ethynylbenzotrifluoride (85 mg, 0.5 mmol), PhCl (169 mg, 1.5 mmol), t-BuOK (393 
mg, 3.5 mmol), dioxane (0.5 mL), 106 °C, 24 hours. After column chromatography 
(gradient, hexanes/CH2Cl2: 100/0 - 90/10), 96 mg (78 %) of a white solid was obtained. 
Rf = 0.19 (hexanes/CH2Cl2 90/10). This compound is known.
16
 
1
H NMR (400 MHz, 
CDCl3) δ 7.65 – 7.59 (m, 4H), 7.58 – 7.54 (m, 2H), 7.39 – 7.34 (m, 3H). 
13
C NMR (100 
MHz, CDCl3, ppm) δ 131.9, 131.8, 130.0 (q, JC-F = 32 Hz), 128.9, 128.6, 127.2, 125.4 (q, 
JC-F = 3.7 Hz), 124.0 (q, JC-F = 262 Hz), 122.6, 91.8, 88.1. 
NC
 
4-(2-Phenylethynyl)benzonitrile (Table 3.2.2, Entry 4 ) 
4-Ethynylbenzonitrile (63.5 mg, 0.5 mmol), PhCl (112.5 mg, 1.0 mmol), TMPLi in Et2O 
(1M, 1.7 mL), -55 °C, 14 hours. After column chromatography (hexanes/Et2O 93/7), 51 
mg (50 %) of a white solid was obtained. Rf = 0.26 (hexanes/Et2O 90/10). This 
compound is known.
25
 
1
H NMR (400 MHz, CDCl3) δ7.62 – 7.51 (m, 6H), 7.39 – 7.34 (m, 
3H) .
13
C NMR (100 MHz, CDCl3, ppm) δ 132.2, 131.9, 129.3, 128.6, 128.3, 122.3, 118.7, 
111.5, 93.9, 87.9. 
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S  
3-(Phenylethynyl)thiophene (Table 3.2.2, Entry 5) 
3-Ethynylthiophene (54 mg, 0.5 mmol), PhCl (169 mg, 1.5 mmol), t-BuOK (393 mg, 3.5 
mmol), dioxane (0.5 mL), 106 °C, 24 hours. After column chromatography 
(hexanes/CH2Cl2 85/15), 67 mg (73 %) of a yellowish liquid was obtained. Rf = 0.23 
(hexanes/CH2Cl2 85/15). This compound is known.
24a
 
1
H NMR (400 MHz, CDCl3) δ 7.54 
– 7.50 (m, 3H), 7.36 – 7.32 (m, 3H), 7.31 – 7.29 (m, 1H), 7.20 (dd, J = 5.0 Hz, 1.2 Hz, 
1H) .
13
C NMR (100 MHz, CDCl3, ppm) δ 131.6, 130.0, 128.7, 128.5, 128.3, 125.5, 123.3, 
122.4, 89.0, 84.6. 
 
(3,3-Dimethyl-1-butynyl)benzene (Table 3.2.2, Entry 6) 
3,3-Dimethyl-1-butyne (41 mg, 0.5 mmol), PhCl (102 mg, 0.9 mmol), TMPLi in pentane 
(1M, 1.6 mL), followed by anhydrous THF (0.15 mL), room temperature, 2 hours. After 
column chromatography (pentane/CH2Cl2 95/5), 74 mg (93 %) of a colorless liquid was 
obtained. 
3,3-Dimethyl-1-butyne (41 mg, 0.5 mmol), PhCl (169 mg, 1.5 mmol), t-BuOK (393 mg, 
3.5 mmol), dioxane (0.5 mL), 106 °C, 24 hours. After column chromatography 
(pentane/CH2Cl2 95/5), 62 mg (78 %) of a colorless liquid was obtained. 
Rf = 0.35 (pentane/CH2Cl2 95/5). This compound is known.
26
 
1
H NMR (400 MHz, 
CDCl3) δ 7.39  - 7.36 (m, 2H), 7.29 – 7.23 (m, 3H), 1.31 (s, 9H) .
13
C NMR (100 MHz, 
CDCl3, ppm) δ 131.6, 128.2, 127.5, 124.1, 98.6, 79.1, 31.1, 28.0. 
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(2-Cyclohexylethynyl)benzene (Table 3.2.2, Entry 7 ) 
Cyclohexylacetylene (54 mg, 0.5 mmol), PhCl (112.5 mmol. 1.0 mmol), TMPLi in THF 
(1M, 1.8 mL), -63 °C, 16 hours. After column chromatography (pentanes), 62 mg (67 %) 
of a colorless liquid was obtained. Rf = 0.29 (hexanes/CH2Cl2 95/5). This compound is 
known.
16
 
1
H NMR (400 MHz, CDCl3) δ 7.41 – 7.38 (m, 2H), 7.30 – 7.25 (m, 3H), 2.6 
(septet, J = 4.0 Hz, 1H), 1.90 – 1.87 (m, 2H), 1.78 – 1.73 (m, 2H), 1.59 – 1.51 (m, 3H), 
1.41 – 1.31 (m, 3H) .13C NMR (100 MHz, CDCl3, ppm) δ 131.7, 128.2, 127.5, 124.2, 
94.6, 80.6, 32.8, 29.8, 26.0, 25.0. 
 
(3-Methyl-1-hexyn-1-yl)benzene (Table 3.2.2, Entry 8 ) 
3-Methyl-1-hexyne (48 mg, 0.5 mmol), PhCl (112.5 mg, 1.0 mmol), TMPLi in THF (1M, 
1.8 mL), -63 °C, 14 hours. After column chromatography (pentanes), 66 mg (76 %) of a 
colorless liquid was obtained. Rf = 0.35 (pentane/CH2Cl2 95/5). This compound is 
known.
27
 
1
H NMR (400 MHz, CDCl3) δ 7.44 – 7.40 (m, 2H), 7.31 – 7.25 (m, 3H), 2.67 
(sextet, J = 7.0 Hz, 1H), 1.61 – 1.45 (m, 4H), 1.27 (d, J = 7.0 Hz, 3H), 0.97 (t, J = 7.0 Hz, 
3H) .
13
C NMR (100 MHz, CDCl3, ppm) δ 131.7, 128.2, 127.5, 124.2, 94.9, 80.8, 39.3, 
26.4, 21.2, 20.7, 14.1. 
Note: Product contains 13% of another isomer derived from isomeric impurity present in 
starting material. 
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1-(2-Phenylethynyl)cyclohexanol (Table 3.2.2, Entry 9) 
1-Ethynyl-1-cyclohexanol (62 mg, 0.5 mmol), PhCl (112.5 mg, 1.0 mmol), TMPLi in 
THF (1M, 2.2 mL), room temperature, 3 hours. Reaction mixture was quenched with 
H2O (1 mL), followed by addition of Et2O (30 mL). The organic phase was then washed 
with brine (15 mL) and the aqueous layers were extracted with Et2O (3x15 mL).  The 
combined organic phase was then dried over MgSO4 and concentrated under vacuum. 
The residue was dissolved in minimal amount of dichloromethane and subjected to flash 
chromatography on silica gel in a slow hexanes/ Et2O gradient (100/0 - 75/25). After 
concentrating the fractions containing the product, the residue was dried under reduced 
pressure to yield 65 mg (65 %) of a white solid. Rf = 0.19 (hexanes/Et2O 80/20). This 
compound is known.
16
 
1
H NMR (400 MHz, CDCl3) δ  7.44 – 7.40 (m, 2H), 7.31 – 7.28 
(m, 3H), 2.11 (s, 1H), 2.02 – 1.96 (m, 2H), 1.76 – 1.56 (m, 7H), 1.31 – 1.20 (m, 1H).13C 
NMR (100 MHz, CDCl3, ppm) δ 131.8, 128.4, 128.3, 123.0, 92.8, 88.4, 69.2, 40.1, 25.3, 
23.5.  
HO
 
4-Ethyl-1-phenyl-1-octyn-3-ol (Table 3.2.2, Entry 10)  
A 2 dram vial equipped with a magnetic stir bar was charged with 3-ethyl-1-octyn-3-ol 
(78 mg, 0.5 mmol; mixture of two diastereomers) and PhCl (112.5 mg, 1.0 mmol). The 
vial was flushed with argon and capped. To this mixture was added TMPLi in pentane 
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(1M, 2.0 mL) at room temperature by injecting through the septum via syringe. The 
viscous reaction mixture was shaken vigorously followed by addition of anhydrous THF 
(0.13 mL). The vial was shaken again until all solids dissolved, then flushed with argon 
(20 seconds) and stirred at room temperature for 3 hours. Reaction mixture was quenched 
with H2O (1 mL), followed by addition of Et2O (30 mL). The organic phase was washed 
with brine (15 mL) and the aqueous layer was extracted with Et2O (3x15 mL).  The 
combined organic phase was dried over MgSO4 and concentrated under vacuum. The 
residue was dissolved in minimal amount of dichloromethane and subjected to flash 
chromatography on silica gel in hexanes/Et2O: 70/30. The fractions containing the 
product were concentrated and subjected to additional purification by HPLC 
(hexanes/Et2O: 80/20). Pure product (72 mg, 62 %) was obtained as a yellowish oil. Rf = 
0.30 (hexanes/Et2O 80/20). This compound is known.
28
 
1
H NMR (400 MHz, CDCl3) δ 
7.44 – 7.40 (m, 2H), 7.32 – 7.28 (m, 3H), 4.64 – 4.62 (m, 1H), 1.85 (s, 1H), 1.68 – 1.29 
(m, 9H), 1.00 – 0.87 (m, 6H). 
Note: Product is obtained as a mixture of diastereomers corresponding to two 
diastereomers in starting material.  
Si
 
Trimethyl(phenylethynyl)silane (Table 3.2.2, Entry 11) 
Trimethylsilylacetylene (49 mg, 0.5 mmol), PhCl (102 mg, 0.9 mmol), TMPLi in pentane 
(1M, 1.6 mL), followed by anhydrous THF (0.15 mL), room temperature, 2 hours. After 
column chromatography (pentanes), 74 mg (85 %) of a colorless liquid was obtained. Rf 
= 0.25 (pentane). This compound is known.
29
 
1
H NMR (400 MHz, CDCl3) δ 7.47 – 7.45 
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(m, 2H), 7.31 – 7.27 (m, 3H), 0.24 (s, 9H) .13C NMR (100 MHz, CDCl3, ppm) δ 132.1, 
128.6,  128.3, 123.2, 105.2, 94.2, 0.07. 
Si
 
[2-[Tris(1-methylethyl)silyl]ethynyl]benzene (Table 3.2.2, Entry 12) 
Triisopropylsilylacetylene (91 mg, 0.5 mmol), PhCl (102 mg, 0.9 mmol), TMPLi in 
pentane (1M, 1.6 mL), followed by anhydrous THF (0.15 mL), room temperature, 2 
hours. After column chromatography (pentane/CH2Cl2 95/5), 120 mg (93 %) of a 
colorless liquid was obtained. Rf = 0.35 (pentane). This compound is known.
16
 
1
H NMR 
(400 MHz, CDCl3) δ 7.50 – 7.48 (m, 2H), 7.32 – 7.29 (m, 3H), 1.15 (s, 21H) .
13
C NMR 
(100 MHz, CDCl3, ppm) δ 132.1, 128.4, 128.3, 123.7, 107.2, 90.5, 18.8, 11.4. 
Mechanistic studies 
Reaction between 3-chloroanisole and 4-ethynylanisole:  
O
O
Ha
Ha
Hb
Hb
HfHe
Hd
Hc  
3-Chloroanisole (214 mg, 1.5 mmol), 4-ethynylanisole (66 mg, 0.5 mmol), tBuONa (336 
mg, 3.5 mmol), dioxane (0.5 mL), 125 
o
C, 18 hours. After column chromatography 
(hexanes/CH2Cl2 72/25), 101 mg (85%) of a light yellow liquid was obtained. This 
compound is known.
30
 
1
H (400 MHz, C6D6) δ 7.42 – 7.45 (m, 2H, H
b
), 7.21 (dt, J = 7.8 
Hz, 1.1 Hz, 1H, H
f
), 7.16 – 7.18 (m, 1H, Hc), 6.92 (t, J = 7.8 Hz, 1H, He), 6.67 (ddd, J = 
7.8 Hz, 2.76 Hz, 1.1 Hz, 1H, H
d
), 6.60 – 6.63 (m, 2H, Ha), 3.14 (s, 3H), 3.10 (s, 3H) .  13C 
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NMR (125 MHz, C6D6, ppm)  159.7, 159.4, 133.2, 129.5, 124.7, 124.1, 116.2, 115.4, 
114.7, 114.1, 89.3. 88.1, 55.4.  
Alkynylation of 3-chloroanisole or 2-chloroanisole with added t-BuOD [Scheme 3.2.5]: 
A 4-dram vial equipped with a magnetic stirring bar was charged with 3-chloroanisole 
(427.5 mg, 3 mmol) or 2-chloroanisole (427.5 mg, 3 mmol), 4-ethynylanisole (264 mg, 
2.0 mmol), t-BuOD (1.0 g, 6.5 equiv.). The vial was flushed with argon and placed inside 
the glovebox. After addition of t-BuOK (1.24 g, 12 mmol) and dioxane (4 mL) the vial 
was sealed and taken out of the glovebox. The reaction mixture was stirred at room 
temperature for 5 minutes followed by heating at 110 °C (3-chloroanisole) or 120 °C (2-
chloroanisole) for 24 hours. The reaction was then cooled to room temperature and 
diluted with ethyl acetate (30 mL). The resulting solution was washed with brine (3 x 15 
mL), dried over MgSO4, and concentrated under vacuum. The residue was dissolved in 
minimal amount of dichloromethane and subjected to flash chromatography on silica gel 
(CH2Cl2/hexanes 25/75). The fractions containing product and unreacted starting material 
were collected and solvent was removed. In the alkynylation of 3-chloroanisole, 147 mg 
(31%) of product was obtained and 71 mg (25%) of 3-chloroanisole was recovered. In the 
alkynylation of 2-chloroanisole, 100 mg (21 %) of product was obtained and 108 mg 
(38%) of unreacted 2-chloroanisole was recovered. In both cases, 3,4’-
dimethoxydiphenylacetylene was the only product isolated. 
Hydrogen signals were assigned by using COSY spectrum. Deuterium incorporation was 
determined by integration of 
1
H signals and relaxation delay of 20 seconds was used. 
Methoxy group was used as standard in calculation. 
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Cl
O
O
tBuOK (6 equiv.)
tBuOD (6.5 quiv.)
Dioxane 4 mL
110 oC
24 hours
O
O
Cl
O
D
D
DD
D
D
D
D
26 %26 %
50 %32 %
28 %
25 %
49 %43 %
 
 
O
O
tBuOK (6 equiv.)
tBuOD (6.5 quiv.)
Dioxane 4 mL
120 oC
24 hours
O
O
D
D
DD
Cl
O
Cl
D
D
40 %40 %
45 %
38 %
37 %
41 %
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Chapter 3-3. Arylation of Acidic sp
2
 C-H Bonds Followed by Trapping of 
Aryllithium Intermediates  
3.3.1. Introduction 
 The biaryl structure is a central building block in a large number of natural 
products, organic materials, and biologically active compounds.
1
 Direct arylation through 
C-H cleavage represents an attractive and efficient alternative to classical methods for 
poly-aryl preparation.
2
 Second-row transition metals such as palladium, ruthenium, 
rhodium, and iridium have emerged as catalysts in many direct arylation reactions. 
Excellent regioselectivity with respect to arene C-H bonds has been achieved for 
arylation of heterocycles and directing-group containing arenes. In contrast, 
functionalization of electrically neutral arenes often suffers from unsatisfactory 
selectivity. More recently, efforts toward the use of inexpensive first-row-metal catalysts 
have attracted substantial interest. These non-noble transition metals, including copper, 
nickel, and iron, have demonstrated reactivity and selectivity in direct arylation of sp
2
 C-
H bonds.
2d
 However, purification of products contaminated with transition metals is often 
problematic.
3
 
 We have recently described direct base-promoted intermolecular arylation of 
heterocycle and arene C-H bonds. Reactions were carried at mild temperature, only 1.5 -
2.5 equiv of a C-H bond coupling partner was used, and functionalization occurs at the 
most acidic carbon-hydrogen bond.  Mechanistically, in the presence of hindered amide 
bases, the (hetero)arene is deprotonated while the aryl halide undergoes aryne formation. 
Addition of aryl anion to the aryne affords the o-anionic biaryl intermediate which is 
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protonated to form product (Scheme 3.3.1). It is well known that aryl lithium protonation 
by hindered amide bases such as TMPH at low temperature is slow.
4
 As a consequence, if 
benzyne can be generated at low temperature, intermediate aryl lithium could be trapped 
with different electrophiles. This would provide an efficient method to a wide range of 
substituted biaryl derivatives.  
Scheme 3.3.1. Mechanism of base-promoted arylation of heterocycle and arene C-H 
bonds 
 
 Reactions of arynes with nucleophiles followed by trapping of aryl Grignard 
intermediates with electrophiles have been shown.
5-8
 2-Iodobiaryls were obtained when 
iodine was used to quench reactions between o-bromoiodoarenes with arylmagnesium 
bromide (Scheme 3.3.2).
4
 
Scheme 3.3.2. Reactions of o-bromoiodoarenes with arylmagnesium bromide followed 
by iodine quenching 
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 Buchwald and co-workers have reported a useful synthetic route to functionalized 
(dialkylphosphino)biphenyl ligands by the addition of arylmagnesium halides to benzyne, 
followed by further reaction with dialkylchlorophosphines.
6
 This economical one-pot 
process has been subsequently applied to the synthesis of a number of structurally related 
biphenyl phosphine ligands. 
Scheme 3.3.3. (Dialkylphosphino)biphenyl ligand synthesis via benzynes 
 
 A method for trapping arynes by nucleophilic addition and iodination was 
recently described.
7a
 Barrett and co-workers employed this strategy to synthesize a key 
intermediate in the synthesis of clavilactone B.
7b 
Scheme 3.3.4. Aryne in total synthesis of clavilactone B 
 
 Arynes prepared from the aryl iodides via 2-magnesiated aryl sulfonates have 
been reported to undergo reaction with magnesium amides (Scheme 3.3.5).
8
 Intermediate 
ortho-aminoaryl magnesium species can be trapped in situ by various electrophiles. 
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Scheme 3.3.5. Addition of magnesium amide to aryne and trapping of intermediates  
 
 In most cases, however, disubstituted arenes and preformed nucleophiles are 
required and reaction scope is limited. A general procedure employing an accessible aryl 
halide aryne precursor, C-H bond nucleophiles and diverse trapping reagents has not been 
demonstrated. We report here a highly regioselective method for arylation of sp
2
 C-H 
bonds via benzyne intermediates. Electron-rich and electron-poor heterocycles as well as 
a variety of arenes can be used. Trapping of intermediate aryl anions with a variety of 
electrophiles is performed. 
3.3.2.Results and Discussion 
 We have previously used commercially available aryl halides as benzyne sources 
in direct arylation reactions.
10
 Formation of benzyne from halobenzene is achieved by 
deprotonation affording 2-haloarylanion followed by elimination of halide ion. Thus, 
better leaving group than halide would accelerate formation of benzyne allowing 
generation of benzyne at low temperatures, which is necessary for electrophilic trapping 
of intermediate aryl metals to avoid competitive protonation by TMPH. Aryl triflates 
react with LDA in THF at - 78 °C to form diisopropylanilines via benzyne intermediates 
(Table 3.3.1, entry 1).
9
 Treating chlorobenzene under the same conditions gave only a 
trace amount of corresponding product (entry 2). In diethyl ether, similar result was 
obtained when phenyl triflate was treated with LDA at- 78 °C (entry 3). Gratifyingly, in 
the presence of TMPLi, about 70 % of phenyl triflate was converted to benzyne (entry 4). 
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In addition, adding 2 % of THF to diethyl ether solvent shortened reaction time and 
higher conversion was obtained (entry 5). Consequently, the use of aryl triflates to 
generate benzyne at low temperature could allow us to arylate wide range of arenes and 
heterocycles and trap the aryl lithium intermediates with electrophiles. 
Table 3.3.1. Optimization of benzyne formation 
 
entry X base (B) solvent conversion (%) 
1 OTf LDA THF 95 
2 Cl LDA THF trace 
3 OTf LDA Et2O trace 
4 OTf TMPLi Et2O 70 
5 OTf TMPLi Et2O/THF (50/1) 89 
[a] Total volume of solvent 1.5 mL, 0.25 mmol scale, PhX/Base 1/2; 10 h; 6 h for entry 5. 
3.3.2.1. Expansion of Reaction Scope for Arylation of Arenes 
 We have reported a method for base-mediated arylation of (hetero)arenes by aryl 
halides.
10
 Best results in arene arylation were obtained by employing LiTMP and 
pentane/THF mixture. Tetrahydrofuran was added to accelerate benzyne formation. 
Under our previous reported conditions, some limitations were observed. Mono-
substituted methoxyarene arylation failed to give acceptable yields due to the 
nucleophilic attack of base on benzyne. In addition, arylation of arenes containing halides 
was not successful. Competition generation of arynes from these haloarenes was 
observed. As described by Mulvey and Stuart, o-metalation of simple benzene derivatives 
such as methoxyarenes by LiTMP is slow.
11
 We reasoned that using pentane as sole 
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solvent or conducting reactions at low temperature should allow for an efficient mono-
substituted arene arylation by slowing benzyne formation. Furthermore, as described in 
Table 3.3.1, an introduction of halide functionality is possible by the use of aryl triflate 
benzyne precursors. We were pleased to discover that modified conditions enable the 
arylation of arenes that were not reactive under our previous conditions (Table 3.3.2). 
Table 3.3.2. Arylation Scope with Respect to Arenes 
 
entry arene ArX product yield,% 
1 2-Methoxynaphthalene PhCl 
 
52 
2 Diphenyl ether PhCl 
 
71 
3 Dibenzofuran PhCl 
 
78 
4 Dibenzofuran 
2-Bromo 
cumene 
 
66 
5 Dibenzofuran 
2-Chloro 
naphthalene 
 
70 
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6 2,4-Dimethoxybenzonitrile PhCl 
 
51 
7 1,3-Dichlorobenzene PhOTf 
 
82 
8 1,3-Difluorobenzene PhOTf 
 
79 
9 1,2-Difluorobenzene PhOTf 
 
59 
10 2-chloro-1-fluorobenzene PhOTf 
 
62 
11 
2-Chloro-1,4-
bis(trifluoromethyl)benzene 
PhOTf 
 
65 
Conditions: ArX (1.7 – 3.0 equiv.), arene (1 equiv.), 0.25 mmol scale. Yields are isolated 
yields. See Experimental section for details. 
  
 Reaction of 2-methoxynapthalene with chlorobenzene affords o-phenylated 
product in reasonable yield (entry 1). Diphenyl ether is also reactive (entry 2). 
Dibenzofuran can be arylated by different aryl chlorides in good yields (entries 3-5). 
Polysubstituted arenes such as 2,4-dimethoxybenzonitrile can be used and  arylated 
product was obtained in reasonable yield (entry 6). For electron-deficient arenes 
possessing halide groups, aryl triflates are required for optimal results. 1,3-
Dichlorobenzene, 1,2-difluorobenzene, and 1,3-difluorobenzene are efficiently arylated 
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by phenyl triflate (entries 7-9). Reaction of 1,4-bis(trifluoromethyl)-2-chlorobenzene with 
phenyl triflate affords product in good yield (entry 11). Interestingly, arylation of 1-
chloro-2-fluorobenzene gave only biaryl product in which phenyl substituent is adjacent 
to fluoride group (entry 10). Functionalization of arenes occurs at most acidic carbon-
hydrogen bond. 
3.3.2.2. Arylation of Heteroarenes 
 Furans, imidazoles, indoles, pyrroles, pyrazine, and pyridines can be arylated by 
aryl halides using hindered amide bases. However, some heterocyles are not compatible 
with strong bases. Attempts to arylate several heterocyles such as triazole and 
halopyridines failed under our previous conditions.  To expand the synthetic utility of the 
transformation, broader reactions scope with respect to heterocycles was investigated by 
using low reaction temperatures and aryl triflate benzyne precursors.  
 The examples of heterocycle arylation are presented in Table 3.3.3. Arylation of 
1-methylindole by 2-chlorostyrene and 2-choro-N,N-dimethylaniline affords C2-arylation 
products in good yields (entries 1,2). 1-Phenylindole is reactive (entry 3). Noteworthy, 
under modified conditions, reactions of unprotected indoles afford C3-arylation products 
with only minor amounts of N-arylation (entries 4, 5).  Ester and hydroxy groups are 
tolerated (entries 6, 7). By using LDA base, 3-chlorothiophene can be monoarylated 
selectively at most acidic position (entry 8). Additionally, the use of aryl triflates allows 
for the arylation of heterocycles that was not possible when aryl halides were employed. 
In particular, reactions of 1-methyl-1,3,4-triazole and 1-phenylpyrazole with phenyl 
triflate afforded products in reasonable yields (entries 9, 10). Electron-poor six-member 
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ring heterocycles are reactive. 2,4,6-Trichloropyridine can be diarylated (entry 11). 
Interestingly, arylation by 2-trimethylsilyl phenyltriflate, common benzyne precursor, 
affords the ortho-substituted product in good yield with silyl group intact (entry 12). The 
regioselectivity can be explained by inductive electron donating effect of silicon.
12
 
Furthermore, substituents on pyridine derivatives can determine the arylation 
regioselectivity. Arylation of 2-phenylpyridine occurs at C6 position (entry 13) while 2-
methoxypyridine was arylated at C3 (entry 14). It is likely that methoxy group orients the 
deprotonation. As expected, when 4-methoxypyridine was used, functionalization occurs 
at C3 (entry 15). 
Table 3.3.3. Arylation Scope with Respect to Heterocycles
a 
 
entry heterocycle Ar-X product yield,% 
1 1-Methylindole Dimethylaniline 
 
70 
2 1-Methylindole 2-Bromostyrene 
 
68 
3 1-Phenylindole PhCl 
 
78 
4
b 
2-Methylindole PhCl 
 
 
80 
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5
b 
2,3-Dimethylindole PhCl 
 
77 
6 Benzofuran 
tert-Butyl 
-3-bromobenzoate 
 
50 
7 5-Hydroxybenzofuran PhCl 
 
53 
8
c 
3-Chlorothiophene 
2-Chloro 
benzotrifluoride 
 
62 
9
c 
1-Methyl-1,2,4-triazole PhOTf 
 
71 
10 1-Phenylpyrazole PhOTf 
 
58 
11 2,4,6-Trichloropyridine PhOTf 
 
60 
12 Benzothiophene o-TMS-PhOTf 
 
68 
13 2-Phenylpyridine PhCl 
 
70 
14 4-Methoxypyridine PhCl 
 
72 
15 2-Methoxypyridine PhCl 
 
63 
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Conditions: ArX (1.8 – 3.0 equiv.), heterocycle (1 equiv.), 0.25 mmol scale. Yields are isolated 
yields. 
b 
PhCl/Indole 1/3 was used. 
c 
LDA was used as base. See Experimental section for details 
 
3.3.2.3. (Hetero)Arene Arylation with Subsequent Aryl Lithium Intermediate 
Trapping 
Considerations 
 The synthesis of highly functionalized biaryls has been extensively investigated 
due to their widespread applications.
13
 Transition-metal-catalyzed multiple 
transformations or tandem reactions have been used to prepare these valuable 
compounds.
14
 The incorporation of benzyne into such multi-component coupling 
processes avoids the use of transition metals. In our reported conditions, arylated 
products were obtained by the protonation of o-anionic biaryl intermediates. Reaction of 
phenyllithium with TMPH at low temperature (- 78 °C) is slow.
4
 Thus, trapping aryl 
lithium intermediates with electrophiles other than proton should be feasible. 
Table 3.3.4. Trapping of intermediate reaction optimization 
 
entry PhX solvent T (
°
C) conversion A/(B+C) 
1 PhCl THF -65 78 1/2 
2 PhCl Et2O -65 5 15/1 
3 PhCl Et2O -20 74 1/22 
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4 PhCl Et2O -45 10 16/1 
5 PhCl Et2O/THF (9/1) -45 87 10/1 
6 PhOTf Et2O/THF (50/1) -78 91 12/1 
[a] PhX/benzothiophene 1.8/1; 24 hours, 0.25 mmol scale. 10 hours 
 Optimization of trapping conditions is shown in Table 3.3.4. Slow generation of 
benzyne from chlorobenzene was observed in THF at -63 °C when TMPLi was used.
11
 
Attempts to trap o-anionic biaryl intermediates with I2 at this temperature failed to give 
reasonable yields of A (entry 1). Changing solvent from THF to ether or hydrocarbon 
solvents gave 15/1 ratio of A/(B +C) but only 5 % conversion (entry 2). At - 20 °C, 75 % 
conversion was observed in diethyl ether and undesired B, C were formed predominantly 
(entry 3). Reactions at - 45 °C resulted in slow benzyne formation and 85 % of 2-
iodobenzothiophene was observed (entry 4). We reasoned that adding THF should 
facilitate benzyne formation. Gratifyingly, A was obtained in 80 % yield when reaction 
was run at - 45 °C in Et2O with 10 % THF as co-solvent (entry 5). Additionally, under 
modified condition using aryl triflates at -78 
o
C, shorter reaction time and higher 
conversion was obtained without significant change in A/B ratio (entry 6). Two sets of 
conditions, in summary, can be applied for arylation with subsequent trapping of aryl 
lithium intermediates. The first set of conditions involves the use of aryl chlorides in 
Et2O/THF (9/1) mixture at about -45 
o
C. The second set involve the use of aryl triflates  
in Et2O/THF (50/1) mixture at -78 
o
C. The later set of condition is beneficial for 
substrates that are thermally unstable or react with TMPLi.  
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Reaction Scope 
Table 3.3.5. Use of Various Electrophiles 
 
entry electrophile product Yield, % 
1 
I2 
CBr4 
CCl4  
X = I, 73 
X = Br, 81 
X = Cl, 86  
2 DMF 
 
78 
3 Pivaldehyde 
 
74 
4 
Methylchloroformate 
or CO2, MeI 
 
76 
62 
5 TMSCl 
 
68 
6 4-Chlorobenzoyl chloride 
 
62 
7 P(Ph)2Cl 
 
61 
8 PhSSPh 
 
80 
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Conditions: PhOTf/benzothiophene 1.8/1, 0.25 mmol scale. Yields are isolated yields. 
 The scope of arylation followed by aryllithium trapping is presented in Table 
3.3.5. Various electrophiles can be used in arylation of benzothiophene with phenyl 
triflate. Trapping by I2, CBr4, and CCl4 affords corresponding 2-(2-
halophenyl)benzothiophene products in good to excellent yields (entry 1). These products 
can be further functionalized by cross-coupling reactions. When DMF was used as 
electrophile, aldehyde was obtained in good yield (entry 2). As expected, biaryl lithium 
was quenched with pivaldehyde to form secondary alcohol (entry 3). Trapping of reaction 
mixture with methyl chloroformate or CO2 followed by MeI/NaH affords methyl 2-
(benzothiophen-2-yl)benzoate in good yield (entry 4). 4-Chlorobenzoyl chloride is 
reactive and diaryl ketone was obtained in a reasonable yield (entry 6). Other 
electrophiles such as PhSSPh and TMSCl can be used (entries 5, 8). Interestingly, 
treating reaction mixture with chlorodiphenylphosphine generates corresponding 
triarylphosphine in good yield. The reaction could be beneficial for efficient preparation 
of arylphosphine ligands. 
Table 3.3.6. Arylation of (Hetero)Arenes and Trapping of Aryllithium Intermediates 
 
entry (hetero)arene ArX/Electrophile Product Yield,% 
1 Benzothiophene 2-Bromocumene/I2 
 
70 
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2 Benzothiophene 
9-Bromophenanthrene 
/pivaldehyde 
 
65 
3 Benzothiophene o-TMS-PhOTf/CCl4 
 
71 
4 Benzothiophene o-TMS-PhOTf 
 
76 
5 Benzothiophene PhOTf/TMSCl 
 
70 
6 Benzothiophene o-TMS-PhOTf/CCl4 
 
79 
7 Benzofuran PhOTf/DMF 
 
71 
8 
3-Methoxy 
pyridine 
PhCl/I2 
 
64 
9 
3-Methoxy 
benzonitrile 
PhCl/none 
 
78 
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10 
3-Methoxy 
benzonitrile 
2-Chloroanisole/none 
 
72 
11 
1,3-Dimethoxy 
benzene 
PhCl/DMF 
 
74 
ArX(1.7 – 2.0 equiv.), Hetero(arene) (1 equiv.), 0.25 mmol. Yields are isolated yield. 
 Arylation of various (hetero)arenes by different aryl halides with subsequent 
trapping of aryl lithium intermediates is presented in Table 3.3.6. Arylation by 2-
bromocumene followed by quenching with I2 reagent afforded o-iodinated product in 
good yield (entry 1). When 9-bromophenanthrene was used and reaction mixture was 
quenched with pivaldehyde, 1-aryl-2,2-dimethylpropanol was obtained in reasonable 
yield (entry 2). Arylation by o-TMS-PhOTf followed by adding CCl4 afforded 
chlorobiaryl product in excellent yield (entry 3). Trapping reaction mixture with another 
benzyne molecule is also possible (entry 4). Interestingly, biaryl anion intermediate reacts 
with another equivalent of benzyne before being quenched with electrophile (entries 5, 
6). Arylation of benzofuran followed by trapping with DMF gives 2-(benzofuran-2-
yl)benzaldehyde in comparable yield to benzothiophene (entry 7). Six-memebered ring 
heterocycles are reactive. 3-Methoxypyridine was treated with chlorobenzene followed 
by trapping with iodine, and 4-(2-iodophenyl)-3-methoxypyridine was obtained in good 
yield (entry 8). Simple arenes can also be used and intramolecular trapping products are 
successfully obtained. When 3-methoxybenzonitrile was employed in reaction with 
chlorobenzene, aryllithium intermediate was trapped with cyano group forming 4-
methoxy-9-fluorenone (entry 9) after hydrolysis. This method could be beneficial for 
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making 9-fluorenone derivatives (entries 9, 10). Notably, when DMF quench was used 
for reaction of 1,3-dimethoxybenzene with chlorobenzene, 2',6'-dimethoxybiphenyl-2-
carbaldehyde was prepared in good yield (entry 11). By taking advantage of this reaction, 
we were able to synthesize Buchwald’s Sphos ligand in one-pot reaction with reasonable 
yield (Scheme 3.3.6).  
Scheme 3.3.6. Buchwald’s Sphos ligand synthesis via one-pot reaction 
 
 An important use of organolithium reagents is in the preparation of other 
organometallic compounds, usually by transmetallation. Among those, organocopper 
reagents are important in synthetic organic chemistry. Thus, transmetalation of biaryl 
lithium intermediates to aryl copper reagents was investigated (Table 3.3.7). 
Table 3.3.7. Intermediate trapping with copper salts and further transformations 
 
Entry (Hetero)arene Reagent Product Yield,% 
1 Benzothiophene MeI 
 
85 
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2 Benzothiophene Allyl bromide 
 
74 
3 Benzothiophene 
Ethyl-2-
(bromomethyl) 
acrylate 
 
68 
4 Benzothiophene 2-Ethyloxirane 
 
75 
5 1,3-Dichlorobenzene O2 
 
54 
6
b 
1,3-Dichlorobenzene O2 
 
48 
7
c 
n-Butylthiophene O2 
 
39 
Conditions: PhOTf/(hetero)arene = 1.8/1, 0.25 mmol scale. Yields are isolated yields. 
b
 1,3-
C6H4Cl2/PhOTf = 4. 
c
 n-Butylthiophene/PhOTf = 1/1. See Experimental section for details. 
 Biaryl lithium was generated by reaction of benzothiophene, phenyltriflate, and 
TMPLi. Transmetalation of reaction mixture with CuCN.LiCl followed by adding MeI 
afforded 2-o-tolylbenzothiophene in excellent yield (entry 1). Allyl bromide is reactive 
(entry 2). Alkylating reagent possessing ester group can be used and product was 
obtained in good yield (entry 3). Epoxide opening is possible and substitution takes place 
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at the less hindered position (entry 4). Reactions without added CuCN.LiCl gave 
substantially lower yields of products. 
 A method for first-row transition-metal-catalyzed deprotonative arene 
dimerization has been described.
15
 When oxygen was used as oxidant, a variety of arene 
and heterocycles can be efficiently dimerized. By employing this methodology, we were 
able to dimerize aryl copper reagents in good yield (entry 5). Interestingly, when 
heteroarenes are used in excess, cross-dimerization between biaryl copper and starting 
heteroaryl copper occurs predominately (entries 6, 7). These reactions produce diverse 
arenes in a one-pot fashion from readily available starting materials. 
3.3.2.4. Heterocyclic Arynes 
 Benzyne and its derivatives have been well-explored.
16
 In contrast, relatively few 
heterocyclic arynes have been investigated. Pyridynes and indolynes have been employed 
in the synthesis of complex natural products.
17
 To examine potential utility of 
heterocyclic arynes under our conditions, several attempts were made to investigate their 
formation, reactivity, and reaction regioselectivity. Treating benzothiophene with 2-
bromopyridine in the presence of TMPLi, 52 % of coupling product was obtained and 
nucleophilic attack occurred at C2 of pyridine (Scheme 3.3.7). The site of attack is in 
agreement with literature report.
18
 For challenging thiophyne generation, thiophenyl 
triflates are required. Interestingly, reaction of 2-butyl thiophenyl triflate with 
benzothiophene affords a single product in 35 % yield (Scheme 3.3.7). Analysis of 
product indicates that nucleophilic attack occurs at C3 position. These reactions show 
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potential in synthesis of structures which are challenging to access using traditional 
approaches. 
Scheme 3.3.7. Reactions of heterocyclic arynes 
 
 
3.3.3. Summary 
 A transition-metal-free method for base-promoted arylation of arenes and 
heterocycles by aryl halides and aryl triflates has been developed. The generation of 
arynes from corresponding aryl triflates at low temperature allows access to wide range 
of coupling products. A variety of functional groups are tolerated with alkene, ether, 
dimethylamino, trifluoromethyl, ester, cyano, halide, hydroxyl, and silyl functionalities 
compatible with reaction conditions. Moreover, NH-containing indole arylation at 3-
position by aryl chlorides was achieved. Additionally, a general method for trapping aryl 
lithium intermediates with various electrophiles is described. The method provides easy 
access to wide range of highly functionalized biaryls from readily available starting 
materials. Furthermore, synthesis of functionalized heterocyles using heterocylic aryne 
intermediates is also described. 
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3.3.4. Experimental Section 
General considerations:  
Reactions were performed in 2-dram vials using screw caps with 17 mm hole and white 
silicone septum with white teflon face (from SUPELCO). Column chromatography was 
performed on 60Å silica gel (Sorbent Technologies). Purification by preparative HPLC 
was performed on a Shimadzu Prominence LC (LC-20AB) equipped with a SPD-20A 
UV-Vis detector and a Varian Dynamax (250 mm x 21.4 mm) column. GC-MS analyses 
were performed on a Shimadzu GCMS-QP5000 chromatograph equipped with a Restek 
column (Rtx-XLB, 30 m x 0.25 mm I.D.). The 
1
H and 
13
C NMR were recorded on JEOL 
EC-400 or JEOL EC-500 spectrometers using residual solvent peak as a reference. 
Elemental analyses were performed by Atlantic Microlab Inc. of Norcross, GA. IR 
spectra were obtained on a ThermoNicolet Avatar 370 FT-IR instrument. Analytical thin 
layer chromatography was performed on silica gel IB-F (Baker-flex) by J. T. Baker. All 
procedures were performed under nitrogen atmosphere unless otherwise noted. 
Room temperature: 23 
o
C. 
Materials. The following starting materials were obtained from commercial sources and 
were used without further purification: dibenzofuran, 1,3-dichlorobenzene, 1,3-
difluorobenzene, 1,2-difluorobenzene, 3-methoxybenzonitrile, 2,4-
dimethoxybenzonitrile, 1,4-bis(trifluoromethyl)-2-chlorobenzene, 1-chloro-2-
fluorobenzene, 2-methoxynapthalene, 2-bromocumene, 2-chloronapthalene, 3-
chloroanisole, 2-chloroanisole, 2-chloro-N,N-dimethylaniline, 2-chlorostyrene, 2-
chlorobenzotrifluoride, 1-methylindole, 1-methyl-1,3,4-triazole, 1-phenylpyrazole, 2-
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phenylpyridine, 2-methoxypyridine, 3-methoxypyridine, 4-methoxypyridine, 2,4,6-
trichloropyridine, 3-chlorothiophene, tert-butyl-3-bromobenzoate, benzothiophene, 
benzoxazole, iodine, anhydrous dimethylformamide, pivaldehyde, chloro methylformate, 
chlorotrimethylsilane, benzoyl chloride, chlorodiphenylphosphine, diphenylsulfide, 9-
brormophenathrene, 1,3-dimethoxybenzene, chlorodicyclohexyl phosphine, methyl 
idodide, allyl bromide, ethyl-2-methylbromide arylate, copper cyanide lithium chloride in 
THF, 2-bromopyridine, 2-methoxypyridine, o-trimethylsilylphenyl triflate, 2-
butylthiophene.
 
TMPLi:  A 250 mL oven-dried flask equipped with a magnetic stirring bar and a septum 
was evacuated and backfilled with nitrogen 5 times. TMPH (15.5 g, 18.5 mL, 110 mmol) 
was added via syringe, followed by anhydrous pentane to give approximately 100 mL of 
solution. The mixture was cooled to -73 °C (dry ice-acetone bath) and stirred for 10 
minutes. n-BuLi (2.5 M in hexanes, 40.0 mL, 100 mmol) was added dropwise and 
reaction mixture was stirred for 30 minutes at -73 °C, then warmed up to room 
temperature (25 °C) and stirred overnight. The reaction mixture was vacuumed to remove 
all solvent and dried under vacuum for at least 5 hours. A light yellow powder of solid 
TMPLi was obtained. 
TMPLi 1 M in pentane/hexanes: A 50 mL oven-dried flask equipped with a magnetic 
stirring bar and a septum was evacuated and backfilled with argon 5 times. TMPH (4.64 
g, 33.0 mmol) was added, followed by anhydrous pentane to give 30 mL of solution 
(marked the flask at the level of solution). The mixture was cooled to -73 °C (dry ice-
acetone) and stirred for 5 minutes. n-BuLi (2.5 M in hexanes, 12.0 mL, 30 mmol) was 
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added dropwise and reaction mixture was stirred for 30 minutes at -73 °C, then warmed 
up to room temperature and stirred overnight. The reaction mixture was vacuumed to 
give 30 mL (at the marked level) of TMPLi suspension.  
General procedure for reactions without quenching intermediates: 
Outside the glovebox a 2-dram vial was equipped with a magnetic stirring bar. The vial 
was placed inside the glovebox. To the vial was added solid TMPLi (0.8 – 1.5 mmol). 
The sealed vial was taken out of the glovebox and placed into oil bath/ cooling bath at 
reaction temperature. Half of solvent or solvent mixture (0.8 - 1.0 mL) was added via 
syringe to reaction vial. Following that, heterocycle or arene (0.25 mmol) and 
chloroarene (0.5 – 1.0 mmol) or aryl triflate (0.5 – 1.0 mmol) were dissolved in another 
half of reaction solvents (0.8 – 1.0 mL) and added via syringe at reaction temperature. 
Reactions were run for indicated time. Reactions were quenched with methanol (0.5 mL, 
unless otherwise stated), diluted with ethyl acetate (30 mL) or dichloromethane (30 mL). 
Mixture were filtered through pad of short silicagel, washed with same solvent and 
evacuated. Residue was dissolved in eluent (1.5 mL) and subjected to flash 
chromatography in hexanes followed by appropriated solvent to elute the products. After 
concentrating the fractions containing the product, the residue was dried under reduced 
pressure to yield pure product. If necessary, purification by preparative HPLC was 
performed. Note: strong stirring (higher than 1000 rpm) is necessary to get reproducible 
yields. 
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General procedure for reactions with quenching intermediates with electrophiles: 
 Outside the glovebox a 2-dram vial was equipped with a magnetic stirring bar. 
The vial was placed inside the glovebox. To the vial was added solid TMPLi (0.8 – 1.5 
mmol). The sealed vial was taken out of the glovebox and placed into oil bath/ cooling 
bath at reaction temperature. Solvent mixture (1.0 mL) was added via syringe to reaction 
vial. Following that, heterocycle or arene (0.25 mmol) and chloroarene (0.5 – 1.0 mmol) 
or aryl triflate (0.5 – 1.0 mmol) were dissolved in reaction solvent (1.0 mL) and added 
via syringe at reaction temperature. Reactions were run for indicated time. Reactions 
were cooled to -75 
°
C. Electrophiles were added at -75 
°
C, followed by stirring at -75 
°
C 
for 1 hour. Subsequently, reactions were warmed up to room temperature (approximately 
3 hours). Reaction mixture was diluted with ethyl acetate (30 mL) or dichloromethane 
(30 mL) and filtered through pad of Celite. Celite pad was washed with diethyl ether and 
solvent was evaporated. Residue was dissolved in eluent (1.5 mL) and subjected to flash 
chromatography in hexanes followed by appropriate solvent to elute the products. After 
concentrating the fractions containing the product, the residue was dried under reduced 
pressure to yield pure product. If necessary, purification by preparative HPLC was 
performed. Note: strong stirring (higher than 1000 rpm) is necessary to get reproducible 
yields. 
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Arylation of Arenes 
 
1-Phenyl-2-methoxynaphthalene (Table 3.3.2, Entry 1) 
2-Methoxynapthalene (0.25 mmol), chlorobenzene (112.5 mg, 1.0 mmol), TMPLi (215 
mg, 1.5 mmol), pentane, 40 °C, 48 hours. After column chromatography (hexanes 
followed by hexanes/dichloromethane: 85/15), 30 mg (%) of a colorless oil was obtained. 
This compound is known.
19
 Rf = 0.43 (hexanes/dichloromethane 80/20). 
1
H NMR (400 
MHz, CDCl3) δ 7.81 – 7.76 (m, 3H), 7.61 (d, J = 8.2 Hz, 2H), 7.47 – 7.43 (m, 3H), 7.39 – 
7.34 (m, 2H), 7.23 (d, J = 8.2 Hz, 1H), 3.93 (s, 3H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 
155.3, 138.4, 134.1, 132.5, 130.1, 129.9, 128.9, 128.1, 127.8, 127.3, 126.4, 124.0, 105.7, 
55.7. Signal for one carbon could not be located. 
 
2-Phenoxy-1,1'-biphenyl (Table 3.3.2, Entry 2) 
Diphenyl ether (42.5 mg, 0.25 mmol), chlorobenzene (70 mg, 0.625 mmol), TMPLi (180 
mg, 1.25 mmol), diethyl ether (1.5 mL), tetrahydrofuran (THF) (0.2 mL), - 45 °C, 36 
hours. After column chromatography (hexanes followed by hexanes/dichloromethane: 
85/15), 43 mg (71 %) of a colorless oil was obtained. This compound is known.
20
 Rf = 
0.37 (hexanes/dichloromethane 85/15). 
1
H NMR (400 MHz, CDCl3) δ 7.63 – 7.59 (m, 
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2H), 7.54 – 7.49 (m, 1H), 7.45 – 7.24 (m, 7H), 7.10 – 7.04 (m, 2H), 7.02 – 6.95 (m, 2H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 157.9, 153.7, 137.9, 133.8, 131.5, 129.8, 129.4, 
128.8, 128.3, 127.4, 124.2, 122.8, 120.3, 118.3. 
 
4-Phenyldibenzofuran (Table 3.3.2, Entry 3) 
Dibenzofuran (42 mg, 0.25 mmol), chlorobenzene (113 mg, 0.5 mmol), TMPLi (150 mg, 
1.0 mmol), diether ether (1.5 mL), tetrahydrofuran (THF) (0.2 mL), -50 °C, 24 hours. 
After column chromatography (hexanes followed by hexanes/dichloromethane: 80/20), 
47 mg (78 %) of a white solid was obtained. This compound is known.
21
 Rf = 0.31 
(hexanes/dichloromethane 80/20). 
1
H NMR (400 MHz, CDCl3) δ 8.01 (d, J = 7.8 Hz, 
1H), 7.98 – 7.95 (m, 3H), 7.65 – 7.63 (m, 2H), 7.61 – 7.56 (m, 2H), 7.52 – 7.44 (m, 3H), 
7.39 (dt, J = 7.8 Hz, 0.8 Hz, 1H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 156.3, 153.3, 
136.6, 129.0, 128.8, 127.9, 127.4, 127.0, 126.0, 125.0, 124.4, 123.3, 122.9, 120.8, 119.8, 
112.0. 
 
4-[3-(1-Methylethyl)phenyl]dibenzofuran (Table 3.3.2, Entry 4) 
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Dibenzofuran (42 mg, 0.25 mmol), 2-bromocumene (100 mg, 0.5 mmol), TMPLi (150 
mg, 1.0 mmol), diether ether (1.5 mL), tetrahydrofuran (THF) (0.2 mL), -45 °C, 36 hours. 
After column chromatography (hexanes followed by hexanes/dichloromethane: 90/10), 
47 mg (66 %) of a colorless oil was obtained. Rf = 0.30 (hexanes/dichloromethane 
90/10). 
1
H NMR (400 MHz, CDCl3) δ 8.01 (d, J = 7.5 Hz, 1H), 7.96 (d, J = 7.5 Hz, 1H), 
7.81 – 7.78 (m, 2H), 7.64 (t, J = 7.2 Hz, 2H), 7.53 – 7.43 (m, 3H), 7.40 – 7.33 (m, 2H), 
3.08 (heptet, J = 6.8 Hz, 1H), 1.40 (d, J = 6.8 Hz, 6H). 
13
C NMR (100 MHz, CDCl3, ppm) 
δ 156.3, 153.5, 149.4, 136.5, 128.7, 127.3, 127.2, 127.1, 126.6, 126.4, 126.1, 125.0, 
124.4, 123.3, 122.9, 120.8, 119.7, 112.0, 34.4, 24.2. 
 
4-(2-Naphthyl)dibenzofuran (Table 3.3.2, Entry 5) 
Dibenzofuran (42 mg, 0.25 mmol), 2-chloronaphthalene (82 mg, 0.5 mmol), TMPLi (150 
mg, 1.0 mmol), diether ether (1.5 mL), tetrahydrofuran (THF) (0.2 mL), -45 °C, 24 hours. 
After column chromatography (hexanes followed by hexanes/dichloromethane: 85/15), 
51 mg (70 %) of a white solid was obtained. Rf = 0.32 (hexanes/dichloromethane 80/20). 
1
H NMR (400 MHz, CDCl3) δ 8.41 (s, 1H), 8.08 – 7.92 (m, 5H), 7.74 (d, J = 7.8 Hz, 1H), 
7.65 (d, J = 8.3 Hz, 1H), 7.57 – 7.46 (m, 4H), 7.39 (t, J = 7.8 Hz, 1H). 13C NMR (100 
MHz, CDCl3, ppm) δ 156.3, 153.7, 134.0, 133.7, 133.0, 128.5, 128.3, 128.0, 127.8, 127.4, 
127.3, 126.9, 126.4, 126.3, 126.0, 125.1, 124.3, 123.4, 122.9, 120.8, 119.9, 112.0. 
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2,6-Dimethoxy-3-carbonitrile-1,1
’
-biphenyl (Table 3.3.2, Entry 6) 
2,4-Dimethoxybenzonitrile (41 mg, 0.25 mmol), chlorobenzene ( 85 mg, 0.75 mmol), 
TMPLi (180 mg, 1.25 mmol), tetrahydrofuran (THF) (1.5 mL), - 65 °C, 30 hours. After 
column chromatography (hexanes followed by hexanes/EtOAc: 85/15), 31 mg (%) of a 
colorless oil was obtained. Rf = 0.38 (hexanes/EtOAc 80/20. 
1
H NMR (400 MHz, CDCl3) 
δ 7.56 (d, J = 8.7 Hz, 1H), 7.45 – 7.32 (m, 5H), 6.78 (d, J = 8.7 Hz, 1H), 3.79 (s, 3H), 
3.55 (s, 3H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 161.6, 161.1, 133.8, 132.1, 
130.4,128.2, 127.8, 125.0, 117.2, 107.1, 99.1, 61.7, 56.3. 
Note: Product contains less than 7 % of 2,4-dimethoxybenzonitrile starting material. 
 
2,6-Dichloro-1,1
’
-biphenyl (Table 3.3.2, Entry 7) 
1,3-Dichlorobenzene (0.25 mmol), phenyl triflate (113 mg, 0.5 mmol), TMPLi (150 mg, 
1.0 mmol), diether ether (1.5 mL), tetrahydrofuran (THF) (0.05 mL), -75 °C, 12 hours. 
After column chromatography (hexanes followed by hexanes/dichloromethane: 90/10), 
45 mg (82 %) of a colorless oil was obtained. This compound is known.
22
 Rf = 0.40 
(hexanes/dichloromethane 90/10). 
1
H NMR (400 MHz, CDCl3) δ 7.51 – 7.43 (m, 3H), 
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7.41 (d, J = 7.9 Hz, 2H), 7.29 – 7.26 (m, 2H), 7.24 (dd, J = 8.6 Hz, 1.0 Hz, 1H). 13C 
NMR (100 MHz, CDCl3, ppm) δ 139.6, 137.1, 135.1, 129.6, 129.1, 128.3, 128.2, 128.1. 
 
2,6-Difluoro-1,1
’
-biphenyl (Table 3.3.2, Entry 8) 
1,3-Difluorobenzene (29 mg, 0.25 mmol), phenyl triflate (113 mg, 0.5 mmol), TMPLi 
(150 mg, 1.0 mmol), diether ether (1.5 mL), tetrahydrofuran (THF) (0.05 mL), -75 °C, 12 
hours. After column chromatography (hexanes followed by hexanes/dichloromethane: 
90/10), 37 mg (79 %) of a colorless oil was obtained. This compound is known.
23
 Rf = 
0.42 (hexanes/dichloromethane 90/10). 
1
H NMR (400 MHz, CDCl3) δ 7.47 (d, J = 5.0 
Hz, 4H), 7.44 – 7.37 (m, 1H), 7.30 – 7.24 (m, 1H), 6.98 (dt, J = 7.4 Hz, 1.0 Hz, 2H). 13C 
NMR (100 MHz, CDCl3, ppm) δ 160.1 (dd, J = 248 Hz, 7.0 Hz), 130.4, 129.2, 128.9 (t, J 
= 10 Hz), 128.4, 128.3, 118.6 (t, J = 18.0 Hz), 111.8 (dd, J = 18.0 Hz, 7.0 Hz). 
 
2,3-Difluoro-1,1
’
-biphenyl (Table 3.3.2, Entry 9) 
1,2-Difluorobenzene (29 mg, 0.25 mmol), phenyl triflate (113 mg, 0.5 mmol), TMPLi 
(150 mg, 1.0 mmol), diether ether (1.5 mL), tetrahydrofuran (THF) (0.05 mL), -75 °C, 12 
hours. After column chromatography (hexanes followed by hexanes/dichloromethane: 
90/10), 28 mg (59 %) of a colorless oil was obtained. This compound is known.
24
 Rf = 
0.43 (hexanes/dichloromethane 90/10). 
1
H NMR (400 MHz, CDCl3) δ 7.55 – 7.52 (m, 
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2H), 7.45 (tt, J = 7.3 Hz, 1.4 Hz, 2H), 7.41 – 7.37 (m, 1H), 7.21 – 7.11 (m, 3H). 13C 
NMR (100 MHz, CDCl3, ppm) δ 151.3 (dd, J = 248.0 Hz, 13.6 Hz), 148.0 (dd, J = 248.0 
Hz, 13.6 Hz). 134.8 (d, J = 2.4 Hz), 131.4 (d, J = 10.5 Hz), 129.0 (d, J = 2.4 Hz), 128.7, 
128.3, 125.4 (t, J = 2.4 Hz), 124.2 (dd, J = 7.8 Hz, 4.9 Hz), 116.1 (d, J = 17.2 Hz). 
 
3-Chloro-2-fluoro-1,1
’
-biphenyl (Table 3.3.2, Entry 10) 
1-Chloro-2-fluorobenzene (0.25 mmol), phenyl triflate (113 mg, 0.5 mmol), TMPLi (150 
mg, 1.0 mmol), diether ether (1.5 mL), tetrahydrofuran (THF) (0.05 mL), -75 °C, 12 
hours. After column chromatography (hexanes followed by hexanes/dichloromethane: 
90/10), 32 mg (62 %) of a colorless oil was obtained. Rf = 0.37 
(hexanes/dichloromethane 90/10). 
1
H NMR (400 MHz, CDCl3) δ 7.53 – 7.51 (m, 2H), 
7.47 – 7.44 (m ,2H), 7.41 – 7.37 (m, 2H), 7.32 (dt, J = 7.5 Hz, 1.8 Hz, 1H), 7.14 (dt, J = 
8.1 Hz, 1.1 Hz, 1H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 155.3 (d, J = 250 Hz), 135.0, 
130.8 (d, J = 13.3 Hz), 129.6, 129.2 (d, J = 2.5 Hz), 129.1 (d, J = 2.5 Hz), 128.6, 128.2, 
124.7 (d, J = 5.0 Hz), 121.9 (d, J = 18.0 Hz). 
 
3,6-Bis(trifluoromethyl)-2-chloro-1,1
’
-biphenyl (Table 3.3.2, Entry 11) 
1,4-Bis(trifluoromethyl)-2-chlorobenzene (62 mg, 0.25 mmol), phenyl triflate (113 mg, 
0.5 mmol), TMPLi (150 mg, 1.0 mmol), diether ether (1.5 mL), tetrahydrofuran (THF) 
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(0.05 mL), - 75 °C, 12 hours. After column chromatography (hexanes followed by 
hexanes/dichloromethane: 85/15), 53 mg (65 %) of a colorless oil was obtained. This 
compound is known.
25
 Rf = 0.33 (hexanes/dichloromethane 85/15). 
1
H NMR (400 MHz, 
CDCl3) δ 7.95 (d, J = 1.7 Hz, 1H), 7.77 (d, J = 1.7 Hz, 1H), 7.49 – 7.46 (m, 3H), 7.40 – 
7.38 (m, 2H).  
 
N,N-Dimethyl-4-(1-methyl-2-indolyl)benzenamine (Table 3.3.3, Entry 1) 
1-Methylindole (33 mg, 0.25 mmol), 2-chloro-N,N-dimethylaniline (97 mg, 0.625 mmol), 
TMPLi (180 mg, 1.25 mmol), pentane (2.0 mL), THF (0.1 mL), rt, 36 hours. After 
column chromatography (hexanes followed by hexanes/dichloromethane: 80/20), 43 mg 
(70 %) of a colorless oil was obtained. This compound is known.
26
 Rf = 0.28 
(hexanes/dichloromethane 80/20). 
1
H NMR (400 MHz, CDCl3) δ 7.68 (d, J = 7.8 Hz, 
1H), 7.41 – 7.35 (m, 2H), 7.30 – 7.25 (m, 1H), 7.18 (t, J = 7.8 Hz, 1H), 6.90 – 6.88 (m, 
2H), 6.82 (dd, J = 8.2 Hz, 1.4 Hz, 1H), 6.61 (s, 1H), 3.79 (s, 3H), 3.02 (s, 6H). 
13
C NMR 
(100 MHz, CDCl3, ppm) δ 150.7, 142.7, 138.3, 133.7, 129.2, 128.1, 121.6, 120.5, 119.9, 
117.8, 113.8, 112.2, 109.7, 101.4, 40.7, 31.3. 
 
2-(3-Ethenyl-1-phenyl)-1-methylindole (Table 3.3.3, Entry 2) 
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1-Methylindole (33 mg, 0.25 mmol), 2-chlorostyrene (87 mg, 0.625 mmol), TMPLi (180 
mg, 1.5 mmol), pentane (2.0 mL), THF (0.05mL), rt, 36 hours. After column 
chromatography (hexanes followed by hexanes/dichloromethane: 90/10), 39 mg (68 %) 
of a colorless oil was obtained. Rf = 0.25 (hexanes/dichloromethane 90/10). 
1
H NMR 
(400 MHz, CDCl3) δ 7.67 (d, J = 7.8 Hz, 1H), 7.57 (s, 1H), 7.48 – 7.38 (m, 4H), 7.28 (t, J 
= 7.8 Hz, 1H), 7.17 (t, J = 7.8 Hz, 1H), 6.80 (dd, J = 17.6 Hz, 10.7 Hz, 1H), 6.60 (s, 1H), 
5.84 (d, J = 17.6 Hz, 1H), 5.34 (d, J = 10.7 Hz, 1H), 3.77 (s, 3H). 
13
C NMR (100 MHz, 
CDCl3, ppm) δ 141.5, 138.4, 138.0, 136.6, 133.2, 128.9, 128.8, 128.0, 127.4, 125.8, 
121.8, 120.6, 120.0, 114.8, 109.8, 101.8, 31.3. 
 
1,2-Diphenylindole (Table 3.3.3, Entry 3) 
1-Phenylindole (49 mg, 0.25 mmol), chlorobenzene (57 mg, 0.5 mmol), TMPLi (150 mg, 
1.0 mmol), pentane (2.0 mL), THF (0.1 mL), rt, 36 hours. After column chromatography 
(hexanes followed by hexanes/dichloromethane: 90/10), 52 mg (78 %) of a colorless oil 
was obtained. This compound is known.
27
 Rf = 0.30 (hexanes/dichloromethane 90/10) 
1
H 
NMR (400 MHz, CDCl3) δ 7.76 – 7.73 (m, 1H), 7.47 – 7.45 (m, 2H), 7.43 – 7.22 (m, 
11H), 6.87 (s, 1H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 140.9, 139.1, 138.6, 132.7, 
129.4, 129.1, 128.4, 128.3, 128.2, 127.5, 127.4, 122.5, 120.9, 120.7, 110.8, 103.9. 
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2-Methyl-3-phenyl-1H-indole (Table 3.3.3, Entry 4) 
2-Methylindole (131 mg, 1.0 mmol), chlorobenzene (57 mg, 0.5 mmol), TMPLi (270 mg, 
1.8 mmol), anhydrous cyclohexane (0.7 mL), anhydrous Et2O (0.7 mL), room 
temperature, 24 hours. After column chromatography (hexanes followed by 
hexanes/EtOAc 90/10), 83 mg (80 %) of a light yellowish oil was obtained. Less than 5 
% of N-arylation product was observed in crude reaction mixture by GC analysis. 
Rf = 0.33 (hexanes/EtOAc 90/10). This compound is known.
28
 
1
H NMR (400 MHz, 
CDCl3) δ 7.89 (s, 1H), 7.72 (d, J = 7.6 Hz, 1H), 7.56 – 7.54 (m, 2H), 7.52 – 7.48 (m, 2H), 
7.36 – 7.31 (m, 2H), 7.20 (dt, J = 7.2 Hz, 1.3 Hz, 1H), 7.15 (dt, J = 7.2 Hz, 1.3 Hz, 1H), 
2.5 (s, 3H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 135.6, 135.3, 131.6, 129.5, 128.6, 127.9, 
125.9, 121.6, 120.1, 118.9, 114.6, 110.5, 12.7. 
 
2,3-Dimethyl-3-phenyl-1H-indole (Table 3.3.3, Entry 5) 
2,3-Dimethylindole (145 mg, 1.0 mmol), chlorobenzene (57 mg, 0.5 mmol), TMPLi (270 
mg, 1.8 mmol), anhydrous cyclohexane (0.7 mL), anhydrous Et2O (0.7 mL), room 
temperature, 24 hours. After column chromatography (hexanes followed by 
 205 
hexanes/EtOAc 70/30), 85 mg (77 %) of a light yellowish oil was obtained. Less than 5 
% of N-arylation product was observed in crude reaction mixture by GC analysis. 
Rf = 0.22 (hexanes/EtOAc: 70/30). This compound is known.
29
 
1
H NMR (400 MHz, 
CDCl3) δ 7.59 (d, J = 7.9 Hz, 1H), 7.32 (dt, J = 7.5 Hz, 1.1 Hz, 1H), 7.28 – 7.21 (m, 3H), 
7.14 (dt, J = 7.5 Hz, 1.1 Hz, 1H), 7.08 (d, J = 7.2 Hz, 1H), 7.03 – 7.01 (m, 2H), 2.11 (s, 
3H), 1.68 (s, 3H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 187.3, 154.6, 147.2, 139.5, 128.9, 
127.9, 127.3, 126.2, 125.8, 122.5, 120.2, 61.9, 20.4, 16.0. 
 
3-(2-Benzofuranyl)-1,1-dimethylethylbenzoate (Table 3.3.3, Entry 6) 
tert-Butyl-3-fluorobenzoate (96 mg, 0.5 mmol), benzofuran (34 mg, 0.25 mmol), TMPLi 
(1.0 mmol), THF (2 mL), -73 °C; then slowly warm up to -35 °C (2 hrs) and keep at that 
temperature for 8 hrs, then move to ice bath to warm the reaction mixture to 0 °C and 
keep at that temperature for 30 minutes. After column chromatography (hexanes/Et2O 
90/10), 37 mg (50 %) of light yellow solid was obtained. Rf = 0.52 (hexanes/Et2O 90/10), 
mp 123-125 
o
C. 
1
H NMR (400 MHz, CDCl3) δ 8.32 (t, J = 1.8 Hz, 1H), 7.95 (td, J = 7.8 
Hz, 1.4 Hz, 1H), 7.85-7.82 (m, 2H), 7.78 (dd, J = 7.8 Hz, 1.8 Hz, 1H), 7.61 (s, 1H), 7.45 
(t, J = 7.8 Hz, 1H), 7.38-7.31 (m, 2H), 1.62 (s, 9H). 
13
C NMR (100 MHz, CDCl3, ppm)  
165.4, 143.3, 140.5, 139.7, 134.4, 132.8, 130.3, 129.0, 128.9, 127.4, 124.8, 124.7, 123.8, 
122.3, 120.2, 81.3, 28.2. 
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2-Phenyl-5-benzofuranol (Table 3.3.3, Entry 7) 
5-Hydroxybenzofuran (34 mg, 0.25 mmol), chlorobenzene (43 mg, 0.375 mmol), TMPLi 
(150 mg, 1.0 mmol), diethyl ether (1.6 mL). THF (0.4 mL), -50 °C, 14 hours. After 
column chromatography (hexanes followed by hexanes/EtOAc = 90/10), 27 mg (53 %) of 
a white solid was obtained. This compound is known.
30
 Rf = 0.34 (hexanes/Et2O 80/20), 
1
H NMR (400 MHz, CDCl3) δ 7.83 (d, J = 7.8 Hz, 2H), 7.47 – 7.41 (m, 2H), 7.38 – 7.32 
(m, 2H), 6.99 (d, J = 2.4 Hz, 1H), 6.93 (s, 1H), 6.79 (dd, J = 8.6 Hz, 2.4 Hz, 1H), 4.66 (s, 
1H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 157.0, 151.7, 150.1, 130.5, 130.2, 128.8, 128.7, 
125.0, 112.9, 111.7, 105.9, 101.3. 
Note: The above two reactions (Table 3.3.3, entries 6, 7) were quenched with H2O (15 
mL), followed by addition of Et2O (15 mL). The organic phase was then washed with 
brine (15 mL) and the aqueous layers were extracted with Et2O (2x10 mL).  The 
combined organic phase was then dried over MgSO4, and concentrated under vacuum. 
The residue was then dissolved in minimum amount of dichloromethane and subjected to 
the flash chromatography on silica gel. After concentrating the fraction containing the 
product, the residue was dried over reduced pressure to yield pure product. 
 
3-Chloro-2-[3-(trifluoromethyl)-1-phenyl]thiophene (Table 3.3.3, Entry 8) 
3-Chlorothiophene (30 mg, 0.25 mmol), 2-chlorobenzotrifluoride (135 mg, 0.75 mmol), 
LDA (1.25 mmol), THF, 0 °C, 4 hours. After column chromatography (hexanes followed 
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by hexanes/dichloromethane: 85/15), 40 mg (62 %) of a colorless oil was obtained. Rf = 
0.42 (hexanes/dichloromethane 80/20). 
1
H NMR (400 MHz, CDCl3) δ 7.91 (s, 1H), 7.84 
(d, J = 7.6 Hz, 1H), 7.62 – 7.53 (m, 2H), 7.32 (d, J = 5.5 Hz, 1H), 7.03 (d, J = 5.5 Hz, 
1H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 134.5, 133.1, 132.0, 131.2 (q, J = 33.5 Hz), 
129.6, 129.2, 125.5 (q, J = 3.8 Hz), 124.7, 124.8, 123.4 (q, J = 271 Hz), 122.4. 
 
1-Methyl-2-phenyl-1,3,4-triazole (Table 3.3.3, Entry 9) 
1-Methyl-1,3,4-triazole (21 mg, 0.25 mmol), phenyl triflate (170 mg, 0.75 mmol), LDA 
(1.25 mmol), THF, -75 °C, 10 hours. After column chromatography (hexanes followed 
by hexanes/EtOAc: 40/60), 28 mg (71 %) of a colorless oil was obtained. This compound 
is known
31
. Rf = 0.25 (hexanes/EtOAc 40/60). 
1
H NMR (400 MHz, CDCl3) δ 7.92 (s, 
1H), 7.66 – 7.64 (m, 2H), 7.50 – 7.46 (m, 3H), 3.97 (s, 3H). 13C NMR (100 MHz, CDCl3, 
ppm) δ 154.7, 150.8, 130.2, 128.9, 128.7, 127.9, 37.1. 
 
1,5-Diphenylpyrazole (Table 3.3.3, Entry 10) 
1-Phenylpyrazole (37 mg, 0.25 mmol), phenyl triflate (170 mg, 0.75 mmol), TMPLi (184 
mg, 1.25 mmol), diethyl ether (2.0 mL). THF (0.05 mL), -75 °C, 12 hours. After column 
chromatography (hexanes followed by hexanes/EtOAc: 60/40), 31 mg (58 %) of a 
colorless oil was obtained. This compound is known.
31
 Rf = 0.35 (hexanes/EtOAc 50/50). 
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1
H NMR (400 MHz, CDCl3) δ 7.73 (d, J = 1.8 Hz, 1H), 7.35 – 7.27 (m, 8H), 7.25 – 7.21 
(m, 2H), 6.51 (d, J = 1.8 Hz, 1H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 143.1, 140.4, 
140.2, 130.7, 129.0, 128.9, 128.6, 128.3, 127.5, 125.3, 107.9. 
 
2,4,6-Trichloro-3,5-diphenylpyridine (Table 3.3.3, Entry 11) 
 
2,4,6-Trichloropyridine (46 mg, 0.25 mmol), phenyl triflate (228 mg, 1.0 mmol), TMPLi 
(215 mg, 1.5 mmol), diethyl ether (2.0 mL). THF (0.05 mL), -75 °C, 12 hours. After 
column chromatography (hexanes followed by hexanes/dichloromethane: 60/40), 50 mg 
(60 %) of a white solid was obtained. Rf = 0.34 (hexanes/dichloromethane 50/50). 
1
H 
NMR (400 MHz, CDCl3) δ 7.53 – 7.45 (m, 6H), 7.32 – 7.28 (m, 4H). 
13
C NMR (100 
MHz, CDCl3, ppm) δ 149.1, 146.8, 135.3, 134.8, 129.4, 129.0, 128.8. 
 
2-[2-(Trimethylsilyl)-1-phenyl]benzothiophene (Table 3.3.3, Entry 12 and Table 
3.3.5, Entry 5) 
o-Trimethylsilylphenyl triflate (57 mg, 0.25 mmol), benzothiophene (67 mg, 0.5 mmol), 
TMPLi (150 mg, 1.0 mmol), diethyl ether (2.0 mL), THF (0.05 mL), -75 °C, 36 hours. 
After column chromatography (hexanes/dichloromethane 90/10), 48 mg (68 %) of 
colorless oil was obtained. TMPLi (150 mg, 1.0 mmol), pentane (2.0 mL), THF (0.15 
 209 
mL), -15 °C, 24 hours. After column chromatography (hexanes/Et2O 60/40), 29 mg (63 
%) of yellowish oil was obtained.  
Benzothiophene (34 mg, 0.25 mmol), phenyl triflate (112 mg, 0.5 mmol), TMPLi (150 
mg, 1.0 mmol), Et2O (1.5 mL), THF (0.05 mL), -75 °C, 12 hours. TMSCl (1.25 mmol) in 
Et2O was slowly added via syringe. After column chromatography (hexanes), 48 mg (68 
%) of colorless oil was obtained.  
Rf = 0.29 (hexanes). 
1
H NMR (400 MHz, CDCl3) δ 8.16 (d, J = 4.7 Hz, 1H), 7.61 (d, J = 
7.3 Hz, 1H), 7.57 – 7.53 (m, 2H), 7.44 – 7.40 (m, 2H), 7.37 – 7.32 (m, 1H), 6.99 – 6.95 
(dd, J = 7.3 Hz, 4.7 Hz, 1H), 3.97 (s, 3H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 161.0, 
145.8, 138.7, 136.9, 129.3, 128.3, 127.6, 124.8, 117.2, 53.6. 
 
2,6-Diphenylpyridine (Table 3.3.3, Entry 13) 
2-Phenylpyridine (39 mg, 0.25 mmol), chlorobenzene (57 mg, 0.5 mmol), TMPLi (150 
mg, 1.0 mmol), diethyl ether (1.5 mL), THF (0.15 mL), - 40 °C, 36 hours. After column 
chromatography (hexanes followed by hexanes/EtOAc: 90/10), 40 mg (70 %) of a 
colorless oil was obtained. This compound is known.
32
 Rf = 0.34 (hexanes/EtOAc 90/10). 
1
H NMR (400 MHz, CDCl3) δ 8.18 – 8.16 (m, 4H), 7.83 – 7.80 (m, 1H), 7.71 – 7.69 (m, 
2H), 7.53 – 7.49 (m, 4H), 7.46 – 7.42 (m, 2H). 13C NMR (100 MHz, CDCl3, ppm) δ 
156.9, 139.6, 137.6, 129.1, 128.8, 127.1, 118.7. 
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4-Methoxy-3-phenylpyridine (Table 3.3.3, Entry 14) 
4-Methoxypyridine (28 mg, 0.25 mmol), chlorobenzene (57 mg, 0.5 mmol), TMPLi (150 
mg, 1.0 mmol), pentane (2.0 mL), THF (0.15 mL), -15 °C, 24 hours. After column 
chromatography (hexanes/EtOAc 40/60), 33 mg (72 %) of yellowish oil was obtained. 
This compound is known.
33
 Rf = 0.28 (hexanes/EtOAc 40/60). 
1
H NMR (400 MHz, 
CDCl3) δ 8.47 (d, J = 5.7 Hz, 1H), 8.44 (s, 1H), 7.52 – 7.49 (m, 2H), 7.45 – 7.41 (m, 2H), 
7.37 (tt, J = 7.4 Hz, 2.3 Hz, 1H), 6.89 (d, J = 5.7 Hz, 1H), 3.86 (s, 3H). 
13
C NMR (100 
MHz, CDCl3, ppm) δ 162.6, 150.9, 150.6, 134.9, 129.6, 128.4, 127.8, 126.6, 106.5, 55.5. 
 
2-Methoxy-3-phenylpyridine (Table 3.3.3, Entry 15) 
2-Methoxypyridine (28 mg, 0.25 mmol), chlorobenzene (57 mg, 0.5 mmol), TMPLi (150 
mg, 1.0 mmol), pentane (2.0 mL), THF (0.15 mL), -15 °C, 24 hours. After column 
chromatography (hexanes/Et2O 60/40), 29 mg (63 %) of yellowish oil was obtained. This 
compound is known.
34
 Rf = 0.38 (hexanes/EtOAc 70/30). 
1
H NMR (400 MHz, CDCl3) δ 
8.16 (d, J = 4.7 Hz, 1H), 7.61 (d, J = 7.3 Hz, 1H), 7.57 – 7.53 (m, 2H), 7.44 – 7.40 (m, 
2H), 7.37 – 7.32 (m, 1H), 6.99 – 6.95 (dd, J = 7.3 Hz, 4.7 Hz, 1H), 3.97 (s, 3H). 13C 
NMR (100 MHz, CDCl3, ppm) δ 161.0, 145.8, 138.7, 136.9, 129.3, 128.3, 127.6, 124.8, 
117.2, 53.6. 
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(X : halogen) 
2-(2-Iodophenyl)benzothiophene (Table 3.3.5, Entry 1) 
 Benzothiophene (34 mg, 0.25 mmol), phenyl triflate (122 mg, 0.5 mmol), TMPLi (150 
mg, 1.0 mmol), Et2O (1.5 mL), THF (0.05 mL), - 75 °C, 12 hours. I2 (320 mg, 1.25 
mmol) in Et2O/THF (80/20; 0.8 mL) was slowly added via syringe at - 75 °C. Reaction 
was poured into aqueous saturated solution of NaI and Na2S2O3 (20 mL), diluted with 
Et2O (30 mL) and strongly stirred for 30 minutes. Aqueous layers were extracted with 
Et2O (2x20 mL).  The combined organic phase was then dried over MgSO4, and 
concentrated under vacuum. Residue was dissolved hexane/dichloromethane (90/10; 1.5 
mL) and subjected to flash chromatography in hexanes to elute the products. After 
concentrating the fractions containing the product, the residue was dried under reduced 
pressure to yield 61 mg of colorless oil. Rf = 0.26 (hexanes). 
1
H NMR (400 MHz, CDCl3) 
δ 8.0 (dd, J = 8.2 Hz, 1.1 Hz, 1H), 7.87 – 7.82 (m, 2H), 7.50 (dd, J = 7.6 Hz, 1.6 Hz, 1H), 
7.42 – 7.36 (m, 4H), 7.07 (dt, J = 7.6 Hz, 1.6 Hz, 1H). 13C NMR (100 MHz, CDCl3, ppm) 
δ 145.2, 140.3, 140.1, 139.7, 139.5, 131.6, 129.9, 128.2, 124.6, 124.4, 124.0, 122.3, 
99.2.Signal for one carbon could not be located. 
2-(2-Bromophenyl)benzothiophene (Table 3.3.5, Entry 1) 
Benzothiophene (34 mg, 0.25 mmol), phenyl triflate (112 mg, 0.5 mmol), TMPLi (150 
mg, 1.0 mmol), Et2O (1.5 mL), THF (0.05 mL), -75 °C, 12 hours. CBr4 (415 mg, 1.25 
mmol) in Et2O/THF (80/20; 0.8 mL) was slowly added via syringe at - 75 °C. After 
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column chromatography (hexanes), 58 mg (81 %) of white solid was obtained. This 
compound is known.
35
 Rf = 0.26 (hexanes). 
1
H NMR (400 MHz, CDCl3) δ 7.87 – 7.82 
(m, 2H), 7.71 (dd, J = 8.2 Hz, 1.1 Hz, 1H), 7.56 (dd, J = 7.8 Hz, 1.7 Hz, 1H), 7.51 (s, 
1H), 7.41 – 7.35 (m, 3H), 7.23 (dt, J = 7.8 Hz, 1.7 Hz, 1H). 13C NMR (100 MHz, CDCl3, 
ppm) δ 142.0, 140.3, 139.8, 135.4, 133.8, 132.4, 129.7, 127.6, 124.7, 124.6, 124.5, 124.0, 
123.1, 122.2. 
 
 
2-(2-Chlorophenyl)benzothiophene (Table 3.3.5, Entry 1) 
Benzothiophene (34 mg, 0.25 mmol), phenyl triflate (112 mg, 0.5 mmol), TMPLi (150 
mg, 1.0 mmol), Et2O (1.5 mL), THF (0.05 mL), -75 °C, 12 hours. CCl4 (193 mg, 1.25 
mmol) in Et2O/THF (80/20; 0.8 mL) was slowly added via syringe. After column 
chromatography (hexanes), 50 mg (82 %) of white solid was obtained. This compound is 
known.
35
 Rf = 0.25 (hexanes). 
1
H NMR (400 MHz, CDCl3) δ7.87 – 7.82 (m, 2H), 7.61 
(dd, J = 7.3 Hz, 2.2 Hz, 1H), 7.59 (s, 1H), 7.51 (dd, J = 7.3 Hz, 1.8 Hz, 1H), 7.41 – 7.28 
(m, 4H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 140.4, 140.3, 140.0, 133.3, 132.9, 132.0, 
130.7, 129.4, 127.1, 124.7, 124.6, 124.5, 124.0, 122.2. 
 
2-Benzothien-2-yl-benzaldehyde (Table 3.3.5, Entry 2) 
Benzothiophene (34 mg, 0.25 mmol), phenyl triflate (112 mg, 0.5 mmol), TMPLi (150 
mg, 1.0 mmol), Et2O (1.5 mL), THF (0.05 mL), -75 °C, 12 hours. DMF (1.5 mmol) in 
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Et2O (0.5 mL) was slowly added via syringe. After column chromatography 
(hexanes/Et2O 90/10), 46 mg (78 %) of white solid was obtained. This compound is 
known.
36
 Rf = 0.29 (hexanes/Et2O 90/10). 
1
H NMR (400 MHz, CDCl3) δ 10.25 (s, 1H), 
8.04 (d, J = 7.7 Hz, 1H), 7.87 (dd, J = 7.0 Hz, 1.7 Hz, 1H), 7.82 (dd, J = 7.0 Hz, 1.7 Hz, 
1H), 7.68 – 7.61 (m, 2H), 7.53 (dt, J = 7.0 Hz, 1.5 Hz, 1H), 7.45 – 7.37 (m, 2H), 7.28 (s, 
1H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 192.0, 140.7, 140.0, 138.9, 138.1, 134.6, 133.7, 
131.5, 128.9, 128.0, 126.5, 125.1, 125.0, 124.0, 122.2. 
 
1-[(2-Benzothien-2-yl)phenyl]-2,2-dimethylpropanol (Table 3.3.5, Entry 3) 
Benzothiophene (34 mg, 0.25 mmol), phenyl triflate (112 mg, 0.5 mmol), TMPLi (150 
mg, 1.0 mmol), Et2O (1.5 mL), THF (0.05 mL), -75 °C, 12 hours. Pivaldehyde (1.5 
mmol) in Et2O (0.5 mL) was slowly added via syringe. After column chromatography 
(hexanes/Et2O 95/5), 54 mg (74 %) of colorless oil was obtained. Rf = 0.42 
(hexanes/Et2O 90/10). 
1
H NMR (400 MHz, CDCl3) δ 7.84 (d, J = 7.7 Hz, 1H), 7.79 (dd, J 
= 7.7 Hz, 1.1 Hz, 1H), 7.69 (dd, J = 7.7 Hz, 1.1 Hz, 1H), 7.45 – 7.30 (m, 5H), 7.21 (s, 
1H), 5.15 (s, 1H), 1.92 (broad singlet, 1H), 0.83 (s, 9H). 
13
C NMR (100 MHz, CDCl3, 
ppm) δ 143.7, 141.1, 140.4, 140.1, 134.3, 131.3, 128.3, 128.2, 127.3, 124.5, 124.3, 123.8, 
123.6, 122.2, 77.0, 36.7, 26.2. 
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2-(Benzothien-2-yl)methylbenzoate (Table 3.3.5, Entry 4) 
Benzothiophene (34 mg, 0.25 mmol), phenyl triflate (112 mg, 0.5 mmol), TMPLi (150 
mg, 1.0 mmol), Et2O (1.5 mL), THF (0.05 mL), -75 °C, 12 hours. Methyl chloroformate 
(1.5 mmol) in Et2O (0.5 mL) was slowly added via syringe. After column 
chromatography (hexanes/Et2O 90/10), 50 mg (76 %) of colorless oil was obtained. 
Benzothiophene (34 mg, 0.25 mmol), phenyl triflate (112 mg, 0.5 mmol), TMPLi (150 
mg, 1.0 mmol), Et2O (1.5 mL), THF (0.05 mL), -75 °C, 12 hours. Gaseous CO2 was then 
then introduced into reaction mixture via syringe needle. Reaction was stirred at -75 °C 
for 6 hours before warming up to RT. Solution of MeI (1.25 mol) in THF (0.7 mL) was 
added, followed by addition of THF suspension of NaH (1.5 mmol, 1.0 mL). Reaction 
was stirred overnight. General work-up procedure was followed. After column 
chromatography (hexanes/Et2O 90/10), 41 mg (62 %) of colorless oil was obtained. 
This compound is known.
37 
Rf = 0.31 (hexanes/Et2O 90/10). 
1
H NMR (400 MHz, CDCl3) 
δ 7.84 (d, J = 7.7 Hz, 1H), 7.79 (td, J = 7.7 Hz, 2.0 Hz, 2H), 7.58 – 7.51 (m, 2H), 7.45 
(dt, J = 7.4 Hz, 1.3 Hz, 1H), 7.35 (doublet of quintet, J = 7.7 Hz, 1.3 Hz, 2H), 7.26 (s, 
1H), 3.73 (s, 3H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 169.0, 142.5, 140.5, 140.2, 134.4, 
131.9, 131.5, 131.3, 129.7, 128.4, 124.5, 124.4, 123.8, 122.9, 122.2, 52.2. 
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(2-Benzothien-2-ylphenyl)(4-chlorophenyl)methanone (Table 3.3.5, Entry 6) 
Benzothiophene (34 mg, 0.25 mmol), phenyl triflate (112 mg, 0.5 mmol), TMPLi (150 
mg, 1.0 mmol), Et2O (1.5 mL), THF (0.05 mL), -75 °C, 12 hours. 4-Chlorobenzoyl 
chloride (1.5 mmol) in Et2O (0.5 mL) was slowly added via syringe. After column 
chromatography (hexanes/Et2O 80/20), 54mg (62 %) of white solid was obtained. Rf = 
0.27 (hexanes/Et2O 80/20). 
1
H NMR (400 MHz, CDCl3) δ 7.71 – 7.69 (m, 1H), 7.67 – 
7.55 (m, 5H), 7.51 – 7.44 (m, 2H), 7.29 – 7.22 (m, 4H), 7.12 (s, 1H). 13C NMR (100 
MHz, CDCl3, ppm) δ 197.3, 141.3, 140.2, 140.1, 139.8, 139.0, 135.4, 133.0, 131.1, 130.5, 
128.8, 128.5, 128.4, 124.7, 124.6, 124.5, 123.9, 122.1. Signal for one carbon could not be 
located. 
 
(2-Benzothien-2-ylphenyl)diphenylphosphine (Table 3.3.5, Entry 7) 
Benzothiophene (34 mg, 0.25 mmol), phenyl triflate (112 mg, 0.5 mmol), TMPLi (150 
mg, 1.0 mmol), Et2O (1.5 mL), THF (0.05 mL), -75 °C, 12 hours. 
Chlorodiphenylphosphine (1.5 mmol) in Et2O (0.5 mL) was slowly added via syringe. 
After column chromatography (hexanes/dichloromethane 85/15), 60 mg (61 %) of light 
yellow solid was obtained. This compound is known.
38
 Rf = 0.33 
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(hexanes/dichloromethane 80/20). 
1
H NMR (400 MHz, CDCl3) δ7.80 – 7.78 (m, 1H), 
7.64 – 7.61 (m, 1H), 7.59 – 7.56 (m, 1H), 7.41 (dt, J = 7.8 Hz, 1.3 Hz, 1H), 7.35 – 7.25 
(m, 13H), 7.08 (ddd, J = 7.8 Hz, 3.7 Hz, 1.0 Hz, 1H), 7.00 (s, 1H). 
13
C NMR (100 MHz, 
CDCl3, ppm) δ 142.8 (d, J = 6.6 Hz), 140.5, 140.4 (d, J = 27 Hz), 139.9, 137.7 (d, J = 12 
Hz), 137.3 (d, J = 16 Hz), 134.6, 134.1, 133.9, 131.4 (d, J = 4.3 Hz), 128.8, 128.7, 128.6 
(d, J = 35 Hz), 128.5, 125.2 (d, J = 5.8 Hz), 124.3 (d, J = 4.8 Hz), 123.8, 122.1. 
 
2-[2-(Phenylthio)phenyl]benzothiophene (Table 3.3.5, Entry 8) 
Benzothiophene (34 mg, 0.25 mmol), phenyl triflate (112 mg, 0.5 mmol), TMPLi (150 
mg, 1.0 mmol), Et2O (1.5 mL), THF (0.05 mL), -75 °C, 12 hours. Diphenylsulfide (1.5 
mmol) in Et2O/THF (4/1; 0.7 mL) was slowly added via syringe. After column 
chromatography (hexanes/dichloromethane 90/10), 63 mg (80 %) of yellow solid was 
obtained. Rf = 0.36 (hexanes/dichloromethane 85/15). 
1
H NMR (400 MHz, CDCl3) δ 
7.87 – 7.85 (m, 1H), 7.83 – 7.81 (m, 1H), 7.59 (dd, J = 7.2 Hz, 1.8 Hz, 1H), 7.51 (s, 1H), 
7.41 – 7.25 (m, 10H). 13C NMR (100 MHz, CDCl3, ppm) δ 141.7, 140.5, 140.0, 136.4, 
135.1, 135.0, 132.4, 131.5, 131.4, 129.5, 129.0, 127.7, 126.8, 124.6, 124.5, 124.4, 123.9, 
122.2. 
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 2-[2-Iodo-3-(1-methylethyl)phenyl]benzothiophene (Table 3.3.6, Entry 1) 
Benzothiophene ( 34 mg, 0.25 mmol), 2-bromocumene (100 mg, 0.5 mmol), TMPLi (150 
mg, 1.0 mmol), Et2O (2.0 mL), THF (0.2 mL), - 45 °C, 36 hours. I2 (1.5 mmol) in 
Et2O/THF (4/1; 0.7 mL) was slowly added via syringe. After column chromatography 
(hexanes), 66 mg (70 %) of light brown oil was obtained. Rf = 0.30 (hexanes). 
1
H NMR 
(400 MHz, CDCl3) δ 7.87 – 7.80 (m, 2H), 7.41 – 7.25 (m, 6H), 3.42 (heptet, J = 6.9 Hz, 
1H), 1.29 (d, J = 6. 9 Hz, 6H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 151.9, 147.5, 140.8, 
140.3, 139.7, 129.2, 128.0, 126.0, 124.5, 124.4, 124.3, 123.9, 122.2, 107.2, 39.4, 23.4. 
 
1-[9-(10-Benzothio-2-yl)phenathrenyl]-2,2-dimethylpropanol (Table 3.3.6, Entry 2) 
Benzothiophene (0.25 mmol), 9-bromophenathrene (256 mg, 1.0 mmol), TMPLi (250 
mg, 1.75 mmol), Et2O (2.0 mL), THF (0.2 mL), - 35 °C, 24 hours. Pivaldehyde (1.5 
mmol) in Et2O (0.5 mL) was slowly added via syringe. After column chromatography 
(hexanes/dichloromethane 60/40), 64 mg (65 %) of yellow solid was obtained. Rf = 0.36 
(hexanes/dichloromethane 50/50). 
1
H NMR (400 MHz, CDCl3, 50 
o
C ) δ 9.20 (d, J = 6.8 
Hz, 1H), 8.73 (t, J = 7.8 Hz, 2H), 8.0 – 7.8 (m, 2H), 7.70 – 7.55 (m, 4H), 7.48 – 7.38 (m, 
4H), 5.4 (s, 1H), 2.3 (s, 1H), 0.99 (s, 9H). 
13
C NMR (100 MHz, CDCl3, ppm, 50 
oC) δ 
141.8, 140.6, 140.1, 136.8, 131.7, 131.5, 131.0, 130.9, 130.7, 130.3, 128.2, 127.9, 127.4, 
127.0, 126.9, 125.4, 124.7, 124.6, 123.7, 122.5, 122.4, 122.2, 81.9, 37.8, 29.0. 
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2-[2-Chloro-6-(trimethylsilyl)phenyl]benzothiophene (Table 3.3.6, Entry 3) 
o-Trimethylsilylphenyl triflate (89 mg, 0.3 mmol), benzothiophene (34 mg, 0.25 mmol), 
TMPLi (150 mg, 1.0 mmol), diethyl ether (2.0 mL), THF (0.05 mL), -75 °C, 24 hours. 
CCl4 (193 mg, 1.25 mmol) in Et2O/THF (4/1; 0.7 mL) was slowly added via syringe. 
After column chromatography (hexanes/dichloromethane 97/3), 56 mg (71 %) of 
colorless oil was obtained. Rf = 0.34 (hexanes/dichloromethane 95/5). 
1
H NMR (400 
MHz, CDCl3) δ 7.87 (d, J = 7.5 Hz, 1H), 7.82 (d, J = 7.5 Hz, 1H), 7.56 (dd, J = 8.0 Hz, 
1.8 Hz, 1H), 7.50 – 7.48 (m, 2H), 7.40 – 7.29 (m, 3H), 0.43 (s, 9H). 13C NMR (100 MHz, 
CDCl3, ppm) δ 141.2, 140.7, 140.4, 140.0, 139.6, 135.7, 133.6, 133.3, 126.3, 124.6, 
124.5, 124.4, 123.9, 122.2, -0.4. 
 
2-{2-(Trimethylsilyl)-6-[(2-(trimethylsilyl)phenyl]phenyl}benzothiophene (Table 
3.3.6, Entry 4) 
o-Trimethylsilylphenyl triflate (180 mg, 0.6 mmol), benzothiophene (34 mg, 0.25 mmol), 
TMPLi (150 mg, 1.0 mmol), diethyl ether (2.0 mL), THF (0.05 mL), -75 °C, 12 hours. 
After column chromatography (hexanes), 91 mg (85 %) of white solid was obtained. Rf = 
0.36 (hexanes). 
1
H NMR (400 MHz, CDCl3) δ 7.72 – 7.67 (m, 3H), 7.56 (d, J = Hz, 1H), 
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7.48 – 7.43 (m, 3H), 7.27 – 7.17 (m, 4H), 6.78 (s, 1H), 0.21 (s, 9H), 0.02 (s, 9H). 13C 
NMR (100 MHz, CDCl3, ppm) δ 147.8, 144.1, 140.9, 140.5, 140.4, 139.9, 139.4, 136.1, 
134.7, 134.0, 132.3, 131.3, 131.1, 127.1, 126.9, 124.0, 123.8, 123.7, 123.4, 121.9, 0.7, -
1.1. 
 
2-{2-[2-(Trimethylsilyl)phenyl]phenyl}benzothiophene (Table 3.3.6, Entry 5) 
Benzothiophene (34 mg, 0.25 mmol), phenyl triflate (172 mg, 0.75 mmol), TMPLi (185 
mg, 1.25 mmol), Et2O (1.5 mL), THF (0.05 mL), -75 °C, 12 hours. TMSCl (1.25 mmol) 
in Et2O (0.5 mL) was slowly added via syringe. After column chromatography (hexanes), 
62 mg (70 %) of colorless oil was obtained. Rf = 0.34 (hexanes). 
1
H NMR (400 MHz, 
CDCl3) δ 7.73 (d, J = 7.8 Hz, 1H), 7.68 – 7.63 (m, 2H), 7.58 – 7.55 (m, 1H), 7.44 (dt, J = 
7.5 Hz, 1.4 Hz, 1H), 7.36 (tt, J = 7.5 Hz, 1.4 Hz, 2H), 7.29 (dd, J = 7.5 Hz, 1.4 Hz, 2H), 
7.27 – 7.18 (m, 2H), 7.14 – 7.12 (m, 1H), 6.86 (s, 1H), 0.01 (s, 9H). 13C NMR (100 MHz, 
CDCl3, ppm) δ 147.3, 143.7, 142.4, 140.2, 139.9, 139.4, 135.0, 133.4, 131.7, 130.4, 
129.7, 128.6, 128.0, 127.3, 126.8, 124.1, 124.0, 123.6, 123.3, 121.9, 0.3. 
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2-{2-[2-(Trimethylsilyl)phenyl]-6-[2-chloro-6-(trimethylsilyl)phenyl]phenyl} 
benzothiophene (Table 3.3.6, Entry 6) 
o-Trimethylsilylphenyl triflate (180 mg, 0.6 mmol), benzothiophene (34 mg, 0.25 mmol), 
TMPLi (150 mg, 1.0 mmol), diethyl ether (2.0 mL), THF (0.05 mL), -75 °C, 12 hours. 
CCl4 (193 mg, 1.25 mmol) in Et2O/THF (4/1; 0.7 mL) was slowly added via syringe. 
After column chromatography (hexanes), 87 mg (76 %) of white solid was obtained. Rf = 
0.33 (hexanes). 
1
H NMR (400 MHz, CDCl3) δ 7.71 – 7.65 (m, 3H), 7.56 (dd, J = 7.0 Hz, 
1.4 Hz, 1H), 7.47 (t, J = 7.7 Hz, 1H), 7.41 (dd, J = 7.0 Hz, 2.0 Hz, 1H), 7.27 – 7.18 (m, 
4H), 6.89 (s, 1H), 0.31 (s, 9H), 0.01 (s, 9H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 144.7, 
143.3, 141.9, 140.3, 140.4, 140.2, 139.9, 139.2, 135.3, 134.8, 133.9, 133.5, 131.3, 127.3, 
125.6, 124.0, 123.8, 123.4, 123.1, 121.8, 0.3, -0.7. 
 
2-(2-Benzofuranyl)benzaldehyde (Table 3.3.6, Entry 7) 
Benzoxazole (30 mg, 0.25 mmol), phenyl triflate (112 mg, 0.5 mmol), TMPLi (150 mg, 
1.0 mmol), Et2O (1.5 mL), THF (0.05 mL), -75 °C, 12 hours. DMF (1.5 mmol) in Et2O 
(0.5 mL) was slowly added via syringe. After column chromatography (hexanes/Et2O 
90/10), 39 mg (71 %) of colorless oil was obtained. This compound is known.
39
 Rf = 0.38 
(hexanes/EtOAc 95/5). 
1
H NMR (400 MHz, CDCl3) δ 10.48 (s, 1H), 8.04 (d, J = 7.8 Hz, 
1H), 7.85 (d, J = 7.8 Hz, 1H), 7.70 – 7.64 (m, 2H), 7.57 – 7.51 (m, 2H), 7.36 (t, J = 7.8 
Hz, 1H), 7.29 (t, J = 7.3 Hz, 1H), 6.98 (s, 1H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 
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192.2, 155.6, 153.0, 134.0, 133.7, 133.2, 129.3, 129.1, 128.7, 128.3, 125.3, 123.5, 121.5, 
111.6, 108.0. 
 
3-Methoxy-4-(2-iodophenyl)pyridine (Table 3.3.6, Entry 8) 
3-Methoxypyridine (28 mg, 0.25 mmol), chlorobenzene (57 mg, 0.5 mmol), TMPLi (150 
mg, 1.0 mmol), Et2O (2.0 mL), THF (0.2 mL), - 45 °C, 24 hours. I2 (1.5 mmol) in 
Et2O/THF (4/1; 0.7 mL) was slowly added via syringe. After column chromatography 
(hexanes/Et2O 60/40), 49 mg (64 %) of light brown liquid was obtained. Rf = 0.36 
(hexanes/EtOAc 70/30). 
1
H NMR (400 MHz, CDCl3) δ 8.40 – 8.33 (m, 2H), 7.93 (dd, J = 
7.8 Hz, 1.0 Hz, 1H), 7.41 (dt, J = 7.8 Hz, 1.0 Hz, 1H), 7.20 (dd, J = 7.8 Hz, 1.8 Hz, 1H), 
7.10 – 7.05 (m, 2H), 3.88 (s, 3H). 13C NMR (100 MHz, CDCl3, ppm) δ 152.5, 142.7, 
141.5, 140.3, 139.2, 134.3, 130.0, 129.6, 128.2, 125.0, 98.6, 56.3. 
 
4-Methoxy-9-fluorenone (Table 3.3.6, Entry 9) 
3-Methoxybenzonitrile (34 mg, 0.25 mmol), chlorobenzene (57 mg, 0.5 mmol), TMPLi 
(150 mg, 1.0 mmol), Et2O (1.0 mL), THF (1.0 mL), - 50 °C, 36 hours. After column 
chromatography (hexanes/EtOAc 80/20), 40 mg (78 %) of white solid was obtained. This 
compound is known.
40
 Rf = 0.41 (hexanes/EtOAc 70/30). 
1
H NMR (400 MHz, CDCl3) δ 
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7.79 (d, J = 7.8 Hz, 1H), 7.61 (dd, J = 7.4 Hz, 1.0 Hz, 1H), 7.43 (dt, J = 7.8 Hz, 1.3 Hz, 
1H), 7.28 – 7.18 (m, 2H), 7.02 (dd, J = 7.8 Hz, 1.3 Hz, 1H), 3.96 (s, 3H). 13C NMR (100 
MHz, CDCl3, ppm) δ 194.4, 155.5, 143.9, 135.8, 134.9, 133.6, 131.3, 130.5, 128.1, 124.4, 
124.0, 117.9, 116.6, 55.7. 
 
1,5-Dimethoxy-9-fluorenone (Table 3.3.6, Entry 10) 
3-Methoxybenzonitrile (34 mg, 0.25 mmol), 2-chloroanisole (107 mg, 0.75 mmol), 
TMPLi (185 mg, 1.25 mmol), THF (1.8 mL), -50 °C, 24 hours. After column 
chromatography (hexanes/EtOAc 70/30), 43 mg (72 %) of white solid was obtained. This 
compound is known.
41
 Rf = 0.35 (hexanes/EtOAc 70/30). 
1
H NMR (400 MHz, CDCl3) δ 
7.46 – 7.38 (m, 2H), 7.28 – 7.21 (m, 2H), 7.00 (d, J = 7.7 Hz, 1H), 6.77 (d, J = 8.3 Hz, 
1H), 3.97 – 3.95 (two overlapped singlets, 6H). 13C NMR (100 MHz, CDCl3, ppm) δ 
192.3, 158.1, 155.4, 145.9, 137.0, 136.3, 130.6, 129.9, 119.4, 117.3, 117.1, 116.3, 112.3, 
55.9, 55.7. 
 
2',6'-Dimethoxy-1,1'-Biphenyl-2-carboxaldehyde (Table 3.3.6, Entry 11) 
1,3-Dimethoxybenzene (35 mg, 0.25 mmol), chlorobenzene (57 mg, 0.5 mmol), TMPLi 
(150 mg, 1.0 mmol), Et2O (1.5 mL), THF (0.2 mL), - 45 °C, 24 hours. DMF (1.5 mmol) 
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in Et2O (0.5 mL) was slowly added via syringe. After column chromatography 
(hexanes/Et2O 70/30), 44 mg (74 %) of colorless oil was obtained. This compound is 
known.
42
 Rf = 0.34 (hexanes/EtOAc 80/20). 
1
H NMR (400 MHz, CDCl3) δ 9.74 (s, 1H), 
8.01 (d, J = 7.8 Hz, 1H), 7.63 (dt, J = 7.5 Hz, 1.4 Hz, 1H), 7.46 (t, J = 7.5 Hz, 1H), 7.38 – 
7.34 (m, 2H), 6.67 (d, J = 8.3 Hz, 2H), 3.71 (s, 6H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 
193.1, 157.8, 138.2, 134.4, 133.5, 132.5, 130.1, 127.7, 126.6, 114.6, 104.0, 55.9. 
 
 
Dicyclohexyl[2',6'-dimethoxy(1,1'-biphenyl)-2-yl]phosphine (Scheme 3.3.6) 
A 50 mL oven-dried flask equipped with a magnetic stirring bar was placed inside the 
glovebox. To the flask was added solid TMPLi (2.7 g, 18 mmol). The sealed vial was 
taken out of the glovebox and placed into cooling bath at - 45 °C. Anhydrous Et2O (30 
mL) was added via syringe and mixture was stirred for 15 minutes. 1,3-
Dimethoxybenzene (690 mg, 5.0 mmol) was added via syringe followed by 
chlorobenzene (1.13 g, 10.0 mmol). To this mixture, THF (3.0 mL) was added and 
reaction was stirred for 24 hours at - 45 °C. Cooling bath was used to cool reaction 
mixture to - 75 °C. Chlorodicyclohexylphosphine (2.35 g, 10 mmol) from a feshly 
opened bottle was added dropwise via syringe in 10 minutes. Reaction was stirred for 
another 3 hours before slowly warming up to room temperature over a period of 3 hours 
and stirring for additional 1 hour at room temperature. The reaction mixture was filtered 
through the degassed plug of Celite
®
 under Ar, eluting with EtOAc (100 mL). The 
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resulting mixture was evaporated under reduced pressure. The residue was recrystallized 
under nitrogen from acetone to give 1.3 g of pure product (65 %) as white solid. This 
compound is known.
43
 
1
H NMR (400 MHz, C6D6) δ 7.57 (d, J = 7.3 Hz, 1H), 7.43 – 7.39 
(m, 1H), 7.24 – 7.13 (m, 3H), 6.41 (d, J = 8.5 Hz, 2H), 3.32 (s, 6H), 1.91 – 1.60 (m, 
12H), 1.38 – 1.00 (m, 10 H). 31P NMR (161 MHz, C6D6) δ: 8.7. 
 
 
Transmetallation and cross coupling reactions 
General procedure: Outside the glovebox a 2-dram vial was equipped with a magnetic 
stirring bar. The vial was placed inside the glovebox. To the vial was added solid TMPLi 
(0.8 – 1.5 mmol). The sealed vial was taken out of the glovebox and placed into oil bath/ 
cooling bath at reaction temperature. Reaction solvent (1.0 mL) was added via syringe to 
reaction vial. Following that, heterocycle or arene (0.25 mmol) and chloroarene (0.5 – 1.0 
mmol) or aryl triflate (0.5 – 1.0 mmol) were dissolved in reaction solvent (1.0 mL) and 
added via syringe at reaction temperature. Reactions were run for indicated time. 
CuCN.2LiCl solution in THF (0.95 – 1.10 M, 0.3 mL) was slowly added to vial. 
Reactions were stirred for additional 30 minutes at -75 
°
C followed by slow addition of 
electrophiles or injection of oxygen at -75 
°
C. THF (1 mL) was added in some cases. 
Subsequently, reaction was allowed to warm up to room temperature over the period of 3 
hours.  
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 2-(2-Methylphenyl)benzothiophene (Table 3.3.7, Entry 1) 
Benzothiophene (34 mg, 0.25 mmol), phenyl triflate (114 mg, 0.5 mmol), TMPLi (150 
mg, 1.0 mmol), Et2O (1.5 mL), THF (0.05 mL), -75 °C, 12 hours. CuCN.2LiCl (0.95 – 
1.10 M, 0.3 mL) was added. Reactions were stirred for additional 30 minutes at -75 
°
C. 
MeI (1.5 mmol) was dissolved in Et2O (0.5 mL) and added to reaction mixture via 
syringe. After column chromatography (hexanes), 47 mg (85 %) of white solid was 
obtained. This compound is known.
44
 Rf = 0.31 (hexanes). 
1
H NMR (400 MHz, CDCl3) δ 
7.88 (d, J = 8.0 Hz, 1H), 7.83 (d, J = 7.5 Hz, 1H), 7.52 (d, J = 7.0 Hz, 1H), 7.42 – 7.28 
(m, 6H), 2.51 (s, 3H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 143.6, 140.3, 140.2, 136.6, 
134.3, 130.9, 130.8, 128.5, 126.1, 124.5, 124.2, 123.6, 123.2, 122.2, 21.2. 
 
2-[(2-propen-1-yl)phenyl]benzothiophene (Table 3.3.7, Entry 2) 
Benzothiophene (34 mg, 0.25 mmol), phenyl triflate (114 mg, 0.5 mmol), TMPLi (150 
mg, 1.0 mmol), Et2O (1.5 mL), THF (0.05 mL), -75 °C, 12 hours. CuCN.2LiCl (0.95 – 
1.10 M, 0.3 mL) was added. Reactions were stirred for additional 30 minutes at -75 
°
C. 
Allyl bromide (1.25 mmol) was dissolved in Et2O (0.5 mL) and added to reaction mixture 
via syringe. After column chromatography (hexanes/dichloromethane 97/3), 46 mg (74 
%) of colorless oil was obtained. Rf = 0.20 (hexanes). 
1
H NMR (400 MHz, CDCl3) δ 7.86 
(d, J = 7.9 Hz, 1H), 7.80 (d, J = 7.9 Hz, 1H), 7.49 (dd, J = 7.7 Hz, 1.0 Hz, 1H), 7.41 – 
7.28 (m, 5H), 7.27 (s, 1H), 6.05 – 5.96 (m, 1H), 5.10 (qd, J = 9.7 Hz, 1.7 Hz, 1H), 5.00 
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(qd, J = 16.7 Hz, 1.7 Hz, 1H), 3.57 (td, J = 6.3 Hz, 1.7 Hz, 2H). 
13
C NMR (100 MHz, 
CDCl3, ppm) δ 143.0, 140.3, 140.2, 138.5, 137.7, 134.2, 131.2, 130.3, 128.7, 126.4, 
124.5, 124.2, 123.6, 123.3, 122.1, 116.3, 37.8. 
 
2-(2-Benzothionyl)-α-methylene ethylbenzenepropanoate (Table 3.3.7, Entry 3) 
Benzothiophene (34 mg, 0.25 mmol), phenyl triflate (114 mg, 0.5 mmol), TMPLi (150 
mg, 1.0 mmol), Et2O (1.5 mL), THF (0.05 mL), -75 °C, 12 hours. CuCN.2LiCl (0.95 – 
1.10 M, 0.3 mL) was added. Reactions were stirred for additional 30 minutes at -75 
°
C. 
Ethyl-2-(methylenbromide) acrylate (1.25 mmol) was dissolved in Et2O (0.5 mL) and 
added to reaction mixture via syringe. After column chromatography 
(hexanes/dichloromehane 70/30), 54 mg (68 %) of colorless oil was obtained. Rf = 0.25 
(hexanes/dichloromethane 70/30). 
1
H NMR (400 MHz, CDCl3) δ 7.84 (d, J = 7.5 Hz, 
1H), 7.78 (d, J = 7.0 Hz, 1H), 7.50 (dd, J = 7.5 Hz, 1.4 Hz, 1H), 7.39 – 7.27 (m, 5H), 
7.23 (s, 1H), 6.28 (d, J = 1.5 Hz, 1H), 6.26 (d, J = 1.5 Hz, 1H), 4.17 (q, J = 7.1 Hz, 2H), 
3.80 (s, 2H), 1.23 (t, J = 7.1 Hz, 3H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 167.0, 142.8, 
140.5, 140.3, 140.2, 137.2, 134.7, 131.4, 130.6, 128.7, 126.8, 126.7, 124.5, 124.2, 123.7, 
123.2, 122.1, 60.9, 35.7, 14.3. 
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2-(2-Benzothionyl)-α-ethyl benzeneethanol (Table 3.3.7, Entry 4) 
Benzothiophene (34 mg, 0.25 mmol), phenyl triflate (114 mg, 0.5 mmol), TMPLi (150 
mg, 1.0 mmol), Et2O (1.5 mL), THF (0.05 mL), -75 °C, 12 hours. CuCN.2LiCl (0.95 – 
1.10 M, 0.3 mL) was added. Reactions were stirred for additional 30 minutes at -75 
°
C. 2-
Ethyloxirane (1.25 mmol) was dissolved in Et2O (0.5 mL) and added to reaction mixture 
via syringe. After column chromatography (hexanes/EtOAc 90/10), 52 mg (75 %) of 
white solid was obtained. Rf = 0.32 (hexanes/EtOAc 90/10). 
1
H NMR (400 MHz, CDCl3) 
δ 7.85 (d, J = 8.0 Hz, 1H), 7.80 (d, J = 8.0 Hz, 1H), 7.47 (d, J = 7.4 Hz, 1H), 7.41 – 7.28 
(m, 5H), 7.27 (s, 1H), 3.72 (heptet, J = 4.3 Hz, 1H), 3.06 (dd, J = 14.2 Hz, 4.3 Hz, 1H), 
2.86 (dd, J = 14.2 Hz, 8.8 Hz, 1H), 1.60 – 1.41 (m, 3H), 0.87 (t, J = 7.4 Hz, 3H). 13C 
NMR (100 MHz, CDCl3, ppm) δ 143.1, 140.4, 140.1, 137.7, 134.8, 131.6, 130.7, 128.7, 
126.6, 124.5, 124.3, 123.7, 122.1, 73.8, 41.0, 29.9, 10.1. Signal for one carbon could not 
be located. 
 
2, 2''',6,6'''-Tetrachloro- 1,1':2',1'':2'',1'''-quaterphenyl (Table 3.3.7, Entry 5) 
1,3-Dichlorobenzene (0.25 mmol), phenyl triflate (0.5 mmol), TMPLi (150 mg, 1.0 
mmol), Et2O (1.5 mL), THF (0.05 mL), - 75 °C, 12 hours. CuCN.LiCl (0.95 – 1.10 M, 
0.3 mL) was added followed by addition of THF (0.75 mL) at -75 °C. Reaction was 
stirred at -75 °C for 2 hours before O2 was introduced via syringe and needle. Mixture 
was warmed up to room temperature over the period of 5 hours and stirred overnight. 
 228 
After column chromatography (hexanes/dichloromethane 90/10), 59 mg (54 %) of white 
solid was obtained. Rf = 0.33 (hexanes/dichloromethane 90/10). 
 1
H NMR (400 MHz, 
CDCl3) δ 7.51 (dd, J = 7.8 Hz, 1.4 Hz, 2H), 7.43 (dt, J = 7.8 Hz, 1.4 Hz, 2H), 7.34 (dd, J 
= 7.4 Hz, 1.4 Hz, 2H), 7.16 – 7.13 (m, 4H), 7.09 – 7.07 (m, 2H), 7.01 (dd, J = 7.8 Hz, 1.1 
Hz, 2H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 141.0, 138.5, 135.8, 135.3, 134.2, 131.1, 
129.4, 128.3, 127.8, 127.0. 
 
2,2'',6,6''-Tetrachloro- 1,1':2',1''-terphenyl (Table 3.3.7, Entry 6) 
1,3-Dichlorobenzene (147 mg, 1.0 mmol), phenyl triflate (0.25 mmol), TMPLi (215 mg, 
1.5 mmol), Et2O (1.5 mL), THF (0.05 mL), -75 °C, 24 hours. CuCN.LiCl (0.95 – 1.10 M, 
0.3 mL) was added followed by addition of THF (0.75 mL) at -75 °C. Reaction was 
stirred at -75 °C for 1 hour before O2 was introduced via syringe and needle. Mixture was 
warmed up to RT over the period of 5 hours and stirred overnight. After column 
chromatography (hexanes/dichloromethane 90/10), 43 mg (48 %) of white solid was 
obtained.
 
Rf = 0.27 (hexanes/dichloromethane 90/10). 
1
H NMR (400 MHz, CDCl3) δ 7.54 
– 7.51 (m, 2H), 7.44 – 7.41 (m, 2H), 7.26 – 7.21 (m, 4H), 7.10 (d, J = 7.3 Hz, 1H), 7.08 
(d, J = 7.3 Hz, 1H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 137.6, 136.1, 136.0, 132.2, 
129.0, 128.2, 128.1. 
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2,2'-(1,2-Phenylene) bis(5,5-butylthiophene) (Table 3.3.7, Entry 7) 
2-Butylthiophene (0.5 mmol), chlorobenzene (0.5 mmol), TMPLi (150 mg, 1.0 mmol), 
Et2O (1.5 mL), THF (0.2 mL), - 45 °C, 24 hours. Reaction was cooled down to -75 °C. 
CuCN.LiCl (0.95 – 1.10 M, 0.3 mL) was added followed by addition of THF (0.75 mL) 
at -75 °C. Reaction was stirred at -75 °C for 1 hour before O2 was introduced via syringe 
and needle. Mixture was warmed up to RT over the period of 5 hours and stirred 
overnight. After column chromatography (hexanes), 34 mg (39 %) of white solid was 
obtained.
 
Rf = 0.28 (hexanes). 
1
H NMR (400 MHz, CDCl3) δ 7.47 – 7.45 (m, 2H), 7.31 – 
7.29 (m, 2H), 6.71 (d, J = 3.5 Hz, 2H), 6.63 (d, J = Hz, 2H), 2.77 (t, J = 7.5 Hz, 4H), 1.63 
(quintet, J = 7.6 Hz, 4H), 1.38 (quintet, J = 7.6 Hz, 4H), 0.91 (t, J = 7.6 Hz, 6H). 
13
C 
NMR (100 MHz, CDCl3, ppm) δ 146.7, 140.3, 134.1, 130.9, 127.6, 126.7, 123.9, 33.9, 
29.9, 22.2, 13.9. 
 
2-Benzothien-2-ylpyridine (Scheme 3.3.7) 
Benzothiophene (34 mg, 0.25 mmol), 2-bromopyridine (158 mg, 1.0 mmol), TMPLi (215 
mg, 1.5 mmol), Et2O (1.5 mL), - 5 °C, 24 hours. After column chromatography 
(hexanes/Et2O 60/40), 27 mg (52 %) of light brown oil was obtained. This compound is 
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known.
45
 Rf = 0.24 (hexanes/EtOAc 80/20). 
1
H NMR (400 MHz, CDCl3) δ 8.64 – 8.62 
(m, 1H), 7.88 – 7.79 (m, 4H), 7.73 (dt, J = 7.8 Hz, 1.8 Hz, 1H), 7.38 – 7.32 (m, 2H), 7.23 
– 7.19 (m, 1H). 13C NMR (100 MHz, CDCl3, ppm) δ 152.6, 149.8, 144.9, 140.7, 140.5, 
136.7, 125.2, 124.6, 124.2, 122.7, 122.6, 121.2, 119.7. 
 
 2-(5-Butyl-3-thienyl)benzothiophene (Scheme 3.3.7) 
Benzothiophene (34 mg, 0.25 mmol), 2-butylthiophenyl triflate (288 mg, 1.0 mmol), 
TMPLi (215 mg, 1.5 mmol), Et2O (1.5 mL), - 65 °C, 24 hours. After column 
chromatography (hexanes), 23 mg (35 %) of colorless oil was obtained. Rf = 0.31 
(hexanes). 
1
H NMR (400 MHz, CDCl3) δ 7.79 (d, J = 8.0 Hz, 1H), 7.73 (d, J = 7.1 Hz, 
1H), 7.37 (s, 1H), 7.36 – 7.26 (m, 3H), 7.11 – 7.09 (m, 1H), 2.85 (t, J = 7.5 Hz, 2H), 1.70 
(quintet, J = 7.5 Hz, 2H), 1.44 (sextet, J = 7.5 Hz, 2H), 0.97 (t, J = 7.5 Hz, 3H). 
13
C NMR 
(100 MHz, CDCl3, ppm) δ 147.2, 140.6, 139.5, 139.0, 135.2, 124.6, 124.2, 123.4, 123.2, 
122.3, 119.1, 119.0, 33.8, 29.9, 22.3, 14.0. 
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Chapter 3-4. ortho-Arylation of Phenols and Anilines via Benzyne Intermediates 
3.4.1. Transition-metal-catalyzed C-Arylation of Phenols and Anilines 
 The first transition-metal-catalyzed ortho-arylation of phenol derivatives was 
reported by Miura.
1
 Under palladium catalysis, 2-phenylphenols and naphthols were 
mono- and diarylated regioselectively with aryl halides in good yields. In mechanistic 
studies, coordination of the phenolic oxygen to the palladium center was considered to be 
the key for the regioselective C-H bond activation. 
Scheme 3.4.1. Miura’s ortho-arylation of phenol derivatives 
 
A method for rhodium-catalyzed arylation of 2-substituted phenols has been 
described by Bedford group.
2
 The authors employed 5 % RhCl(PPh3)3, Cs2CO3 base, and 
15 % of a bulky phosphinite cocatalyst. The reduction in catalytic activity with 
decreasing steric bulk at phenol 2- position implies that the rate-determining step is likely 
the ortho-metalation of the phosphinite ligand. No activity was observed with 
unsubstituted phenol. 
Scheme 3.4.2. ortho-Arylation of 2-substituted phenols 
 
 236 
  
Recently, Dong has shown that phenols possessing ester and carbamate directing 
groups can be arylated under palladium catalysis by simple arenes.
3
 Reactions were run 
under acidic conditions with large excess of arenes and inexpensive sodium persulfate 
was used as an oxidant. Excellent reaction efficiencies and regioselectivities were 
observed with a range of electron-rich, electron-neutral, and electron-deficient arenes. 
Cyclopalladation, electrophilic metalation, and Pd(0/II) catalytic cycle were proposed to 
account for the reaction mechanism. A similar transformation using high valent 
arylidonium salts as arylating reagents was reported by Liu.
4 
Scheme 3.4.3. C-Arylation of phenol esters and carbamates 
 
 
Gevorgyan has shown that selective phenol and aniline derivative ortho-arylation 
is possible by employing a silicon-based tether that can be subsequently removed.
5
 In 
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particular, the TBDPS protecting group serves as a convenient aryl group donor for o-
bromophenols via an intramolecular arylation/deprotection sequence. Furthermore, 
employment of the newly designed Br-TBDPS protecting group in the same sequence 
allows for the facile introduction of a phenyl group at the ortho position of phenols and 
anilines. 
Scheme 3.4.4. Phenol and aniline ortho-arylation with silicon-base tether directing 
groups 
 
 
The Gaunt group has recently reported a direct arylation of phenol derivatives 
with exclusive para-selectivity.
6
 Blocking the para position results in ortho-arylation. 
Interestingly, phenol is a suitable substrate offering a direct access to arylated phenols. 
To increase the generality of this protocol, authors turned their attention to aniline 
derivatives. In the presence of 2,6-di-t-butylpyridine various mono- and dialkyl-protected 
anilines could be arylated in good yields. Although the mechanism is still not clearly 
elucidated, the authors suggested that Friedel-Crafts-type arylation could be operative in 
their arylation process. 
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Scheme 3.4.5. Copper-catalyzed para-arylation of phenols and anilines 
 
 
 
 Our group has developed a method for ortho-arylation of anilides.
7
 The procedure 
involves the combination of silver acetate, aryl iodides, and palladium catalyst under 
acidic conditions. Generally, the pivaloyl derivatives gave the cleanest reactions; 
however, acetamides are also compatible with the reaction conditions. The reaction is 
highly tolerant with respect to substituents on the anilide and aryl iodides. 
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Scheme 3.4.6. Palladium-catalyzed ortho-arylation of anilides 
 
 
Direct arylation of anilines possessing no protecting or directing groups has also 
been disclosed. The synthesis of aminobiaryls by radical chain reaction of 
arenediazonium salts with anilines was reported by Heinrich group.
8
 The method 
employed TiCl3 as promoter in aqueous HCl solution and electron-rich anilines were 
shown to be best suited precursors. However, isomer mixtures were obtained in many 
cases. 
Scheme 3.4.7. Ti-catalyzed C-arylation of unprotected anilines 
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3.4.2. Transition-metal-free ortho-Arylation of Anilines 
3.4.2.1. Introduction 
Functionalized aminoarenes are an important class of molecules because of their 
broad applications in new medicines, materials, and catalysis.
9
 The last few years have 
witnessed spectacular progress in developing aniline derivative C-H bond 
functionalization.
10
 Transition-metal-catalyzed arylation of aniline derivatives is of 
particular interest. The Buchwald-Hartwig amination is known to be applicable for N-
arylation of anilines.
11a
 Formation of N-arylated anilines has been described under copper 
catalysis.
11b
 An immediate obstacle to aniline C-H bond arylation is related to 
competition between N- and C-arylation. Thus, protected anilines have been frequently 
used in their C-H functionalization. Palladium-catalyzed ortho-arylation of anilides offers 
a short pathway to 2-aminobiphenyls or terphenyls.
7
 A method for intramolecular 
palladium-catalyzed arylation of anilines by employing a temporary silyl tether has been 
recently developed.
5
 However, several extra steps to install and remove directing groups 
are added into the synthetic sequences. In addition, selective transition-metal-free para- 
arylation of N-substituted anilines by employing diaryliodonium salt electrophiles has 
been recently reported.
6
 Moreover, a method for Ti-catalyzed arylation of free anilines 
affording aminobiphenyls by diazonium salts has been demonstrated.
8
 However, isomer 
mixtures were obtained in many cases. 
 Arynes are well known to react with anilines forming N-arylation products.
9
 By 
introducing a bulky trityl group substituent on the nitrogen atom, a direct ortho-arylation 
of anilines via benzyne has been described.
12
 An ene mechanism was suggested.
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However, acceptable yields could not be achieved for N- and o-substituted anilines. 
Therefore, a method for selective, direct o-arylation of unprotected anilines has not been 
yet disclosed. 
3.4.2.2. Results and Discussion 
 Haberfield observed that o-phenylaniline side product was formed when benzyne 
was generated in the presence of anilide.
13
 Interestingly, C/N arylation ratio increased 
when an excess of aniline was present in the reaction mixture and 2-aminobiphenyl could 
be obtained in up to 9 % yield. 
Scheme 3.4.8. Formation of o-phenylaniline 
 
 We have recently reported direct C-arylation of heterocycles, arenes, and alkynes 
proceeding via benzyne intermediates.
14
 The amount of C-arylation and the ratio of C- vs. 
N-arylation were observed to be dependent on the solvent. To expand the utility of this 
methodology, we decided to investigate aniline o-arylation. To increase the applicability 
of the arylation, readily accessible and cheap aryl chlorides were used as as aryne 
sources.  
 The optimization of reaction conditions was carried out for 2-naphthylamine 1 
arylation by chlorobenzene using lithium 2,2,6,6-tetramethylpiperidide (LiTMP) base 
(Table 3.4.1). Solvent, base, and 1/base ratio were found to have impact on the ratio of C-
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arylation vs. N-arylation. In THF, N-arylation product was formed predominantly and 
only minor amounts of C-arylation product was observed (entries 1-2). Arylation in Et2O 
afforded N-substitution (entry 3). If LDA was used instead of LiTMP, clean formation of 
N-phenyl-2-naphtylamine was observed (entry 4). Good C-arylation selectivity in diethyl 
ether was obtained when the reaction was run at -20 °C (entry 5). Reactions in pentane at 
40 °C gave substantial amount of C-arylation (entries 6-7). However, competitive 
formation of PhTMP was observed. Use of pentane/Et2O mixtures increased the C/N-
arylation ratio (entries 8-10). The optimal results were obtained in cyclohexane/diethyl 
ether mixed solvent at 25-50 °C (entries 11, 13, and 14) by using excess 1. Sensitive 
substrates can be arylated at low temperatures in diethyl ether. 
Table 3.4.1. Optimization of Reaction Conditions
a 
 
Entry 1/PhCl/base Temp, °C solvent 2/3 
1 1/2/3.6 25 °C THF 1/8 (10) 
2 2/1/3.6 25 °C THF 1/3 (12) 
3 1/2/3.6 25 °C Et2O 1/5 (16) 
4
b 
1/2/3.6 25 °C Et2O 1/50(<2) 
5 2/1/3.6 -20 °C Et2O 11/1(27) 
6 1/2/3.6 40 °C C5H12 1/2(29) 
7 2/1/3.6 40 °C C5H12 2/1(35) 
8 1/2/3.6 25 °C C5H12/Et2O 20:1 1.3/1(43) 
9 2/1/3.6 25 °C C5H12/Et2O 20:1 12/1(27) 
10 2/1/3.6 25 °C C5H12/Et2O 1:1 9/1(64) 
11 2/1/3.6 25 °C C6H12/Et2O 1:1 18/1(74) 
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12 1/2/3.6 25 °C C5H12/Et2O 1:1 1/2.2(25) 
13 3/1/4.8 50 °C C5H12/Et2O 14:1 50/1(78) 
14 3/1/4.8 50 °C C5H12/Et2O 1:1 5/1(50) 
a
 Total volume of solvent 0.9 mL, 0.25 mmol scale, 24 h; 12 h for entry 5. 
b
 LDA base. 
 The reaction scope with respect to aryl halides is presented in Table 3.4.2. Fluoro-
, chloro-, and bromobenzene can be used in the arylation of 2-naphthylamine (entries 1-
3). Interestingly, the arylation of 2-naphthylamine occurs selectively at 1-position. 
Arylation by 2-chlorostyrene affords the product in a good yield (entry 4). As expected, 
substitution occurs mainly at 3-position of the phenyl group, with less than 3% of 1-(2-
vinylphenyl)-2-naphthylamine formed. 2-Naphthylamine is ortho-arylated by 2-
chloroanisole, 2-chlorobenzotrifluoride, and 2-bromobiphenyl and the corresponding 
arylation products were obtained in good yields (entries 5, 6, and 7). Polycyclic aromatic 
chlorides are active (entries 8 and 9). Arylation product was obtained in moderate yield 
when 2-chlorodimethylaniline was employed (entry 10). At low temperature, arylation by 
3-chlorophenyl triflate is feasible and chloride group is tolerated (entry 11). Arylation by 
3-bromobenzoate ester results in substitution at 2-position of aryne, presumably by initial 
formation of 2-naphthylamide of 3-bromobenzoic acid (entry 12). As anticipated, 4-
chlorotoluene gave nearly equal mixture of isomeric products (entry 13). 
 The 2-naphthylamine arylation occurs selectively at the 1-position. In that 
context, observations by Pierini and Rossi may be informative.
15
 They have reported the 
photostimulated reaction of unactivated aryl bromides and iodides with 2-naphthylamide. 
Substitution occurred at N- and 1-positions of 2-naphthylamine. The authors explain the 
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arylation selectivity by the relative basicities of sites in an ambident naphthylamide 
anion.  
 Lower C-/N-arylation product ratios were obtained with substrates containing 
groups that can coordinate lithium. In order to obtain better yields and arylation 
selectivities, low temperatures are required. For example, presence of the dimethylamino 
substituent reduces C/N arylation selectivity from >50/1 (entry 2, Table 3.4.2) to about 
11/1 (entry 10, Table 3.4.2) even if temperature is lowered to -30 °C. 
Table 3.4.2. Arylation of 2-Naphthylamine
a 
 
Entry ArX Product Yield, % 
 
1
b 
 
PhF 
 
 
68 
2
b 
PhCl 2 72 
3
b 
PhBr 2 70 
 
4
c 
 
2-chlorostyrene 
 
 
70 
 
5
c 
 
2-chloroanisole 
 
 
67 
 
6
c 
 
2-chlorobenzo-trifluoride 
 
 
65 
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7
d 
 
2-bromobiphenyl 
 
 
70 
 
8
d 
 
9-chloro-phenanthrene 
 
 
71 
 
9
e 
 
2-chloro-naphthalene 
 
 
82 
 
10
f 
 
2-chloro-N,N-di-methylaniline 
 
 
61 
 
11
g 
 
3-chlorophenyl triflate 
 
 
50 
 
12
h 
 
t-butyl-3-bromo-benzoate 
 
 
70 
 
13
d 
 
4-chlorotoluene 
 
 
78 
 a
 2-Naphthylamine (1-2 mmol), ArX (0.5 mmol), LiTMP (1.8-3.4 mmol), solvent (1.4-3 
mL), -85 to 50 °C, 12-48 h. Yields are isolated yields. 
b
 Cyclohexane/Et2O (14/1), 25 °C, <5% N-
arylation product observed in crude reaction mixture. 
c
 Et2O, -25 °C, ca. 10% N-arylation. 
d
 
Cyclohexane/Et2O (14/1), 50 °C, <10 % N-arylation. 
e
 Cyclohexane/Et2O (1/1), 25 °C, <5% N-
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arylation. 
f 
Et2O, -30 °C, 8 % N-arylation. 
g
 THF,-85 °C, 7% N-arylation. 
h
 Cyclohexane/Et2O 
(1/1), -35 °C, LDA base. 
 The reaction scope with respect to anilines is presented in Table 3.4.3. Arylations 
of N-alkyl- and- arylanilines are possible (entries 1-5). Specifically, anilines possessing 
N-methyl-, phenyl, and benzyl substituents all give products in good to excellent yields 
(entries 1, 3, 5). Arylation of 1,2,3,4-tetrahydroisoquinoline occurs at 7-position and 
product was obtained in good yield (entry 2). Selective and efficient monoarylation of 
unsubstituted anilines (entries 6-14) can be achieved. Thus, aniline can be ortho-
phenylated in a moderate yield (entry 6). 3-Aminobenzotrifluoride is arylated giving 
about 3/1 mixture of isomers. 2-Phenyl-5-trifluoromethylaniline was isolated in 50% 
yield (entry 9). 3,5-Dimethylaniline is arylated in ortho-position in a good yield (entry 8). 
Anilides that possess 3- substituents are not efficiently ortho-arylated under palladium 
catalysis and thus product in entry 8 typically cannot be accessed by using transition-
metal catalysis. 4-Substituted anilines are arylated in good yields (entries 7, 10 and 11). 
Arylation of 1-naphthylamine occurs at 2-position (entry 12). 2-Aminobiphenyl can be 
arylated at 6-position affording 2,6-diphenylaniline (entry 13). 2,6-Diarylanilines are 
used in the synthesis of ligands for Brookhart-type transition-metal catalyzed olefin 
polymerization.
16
 The reaction tolerates chloro- and cyano substituents (entries 7 and 14). 
Arylation of enantiopure binaphthyldiamine afforded the monoarylation product in 47% 
yield and >99% ee (Scheme 3.4.9). 
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Table 3.4.3. Arylamine Phenylation
a
 
 
Entry Amine Product Yield, % 
1
b 
PhNHMe 
 
62 
2
b
 1,2,3,4-tetra-hydroquinoline 
 
70 
3
b
 diphenylamine 
 
78 
4
b
 N-phenyl-2-naphthylamine 
 
80 
5
c 
N-benzylamine 
 
70 
6
d 
aniline 
 
55 
7
e 
p-chloroaniline 
 
60 
8
d
 3,5-dimethylaniline 
 
70 
 248 
9
d,f
 3-aminobenzotri-fluoride 
 
50 
10
d
 4-t-butylaniline 
 
60 
11
d
 4-aminobiphenyl 
 
67 
12
b
 1-naphthylamine 
 
85 
13
d
 2-aminobiphenyl 
 
70 
14
g 
4-cyanoaniline 
 
65 
 a
 Amine (1-2 mmol), PhCl (0.5 mmol), LiTMP (1.8-3.4 mmol), solvent (1.4-3 mL), -60-
50 °C, 24-48 h. Yields are isolated yields. Please see Experimetal Section for C/N ratios. 
b
 
Cyclohexane/Et2O (1/1), 25 °C. 
c
 Pentane/THF (36/1), 25 °C. 
d
 Cyclohexane/Et2O (14/1), 50 °C. 
e
 
Pentane/Et2O (1/1), -50 °C, PhOTf. 
f
 Isomeric 2-phenyl-3-trifluoromethylaniline also isolated 
(17%). 
g
 THF/Et2O (1:1), -60 °C.  
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Scheme 3.4.9. o-Phenylation of enantiopure binaphthyldiamine 
 
 The reaction is selective (>50/1) for ortho-arylation as opposed to para-arylation. 
For entries 1, 6, and 13, Table 3.4.3, the crude reaction mixtures were analyzed by GC for 
the presence of p-phenyl derivatives (comparison with authentic commercial samples). 
No products arising from p-arylation were observed. 
 The amount of N- vs. C-arylation is dependent on solvent coordination ability, 
aniline/LiTMP base ratio, and reaction temperature. These features point to different 
reactivities of intermediate lithium anilide/LiTMP aggregates as the reason for switch in 
arylation regioselectivity. Due to complexity of lithium anilide solution state structures 
and insolubility of LiCl additive in reaction mixture further mechanistic speculations are 
premature at this point.
17 
3.4.2.3. Conclusions 
 A method for direct, transition-metal-free ortho-arylation of anilines by aryl 
chlorides, bromides, and fluorides has been developed. This methodology provides the 
most direct approach to 2-arylanilines since no protecting or directing groups on nitrogen 
are required. Easily available aryl chlorides can be used as the coupling partners. The 
arylation is functional-group tolerant, with alkene, ether, trifluoromethyl, dimethylamino, 
carbonyl, chloro, and cyano functionalities tolerated. 
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3.4.3. Reactions of Arynes with Phenols: Formation of 2-Arylphenols and Helicenes 
3.4.3.1. Introduction 
 2-Arylphenols are substructures of organocatalysts, phosphite ligands, and 
biologically active substances.
18
 The traditional methods for synthesis of these structures 
involve cross-coupling of an organometallic reagent with an aryl halide or 
pseudohalide.
19
 However, the requirement of protection of phenols adds extra steps to the 
synthetic sequences. Recent developments using C-H bond functionalization 
methodology provide shorter synthetic routes to 2-arylphenols.
1-6
 Miura reported a 
method for palladium-catalyzed ortho-arylations of 2-phenylphenol.
1 
However, in many 
cases, formation of a mixture of mono- and di-arylation products was obtained. 
Subsequently, a method for rhodium-catalyzed arylation of 2-substituted phenols was 
developed by Bedford group.
2
 Additionally, phenols possessing ester and carbamate 
directing groups can be arylated under palladium catalysis by aryl halides or simple 
arenes.
3,4 
A procedure for selective phenol derivative ortho-arylation has been recently 
demonstrated by employing a silicon-based tether.
5
 Direct arylation of phenol derivatives 
with exclusive para-selectivity is possible by using diaryliodonium salts.
6
 Direct ortho-
arylation of unprotected phenols by aryl chlorides has not yet been disclosed. 
3.4.3.2. Results and Disscussion 
 It is well known that O-arylation is preferentially observed in the reaction of 
benzynes with phenol.
20
 Minor amounts of C-arylation products may accompany diaryl 
ethers.
21
 We have recently reported direct C-arylation of heterocycles, arenes, and 
anilines proceeding via benzyne intermediates.
14
 The amount of C-arylation and the ratio 
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of C- vs. heteroatom arylation were observed to be dependent on the solvent and base. 
Thus, we decided to investigate phenol o-arylation. Arynes can be generated from silyl 
aryl triflates under nearly neutral conditions at room temperature.
22 
These starting 
materials are expensive and only a few of them are commercially available. 
Consequently, we used readily accessible and cheap aryl chlorides as aryne sources. Two 
different reaction conditions were examined for phenol arylation. The first set of 
conditions employs lithium 2,2,6,6-tetramethylpiperidide (LiTMP) base. The second set 
of conditions involves an alkalimetal alkoxide base in dioxane. These conditions are 
based on our earlier reports for heterocycle arylation and intramolecular phenol arylation, 
respectively.
23 
Table 3.4.4. Optimization of Reaction Conditions
a 
 
entry PhOH/PhCl/LiTMP solvent 1/2/conv. 
1 1/2/3.6 THF 4/1/32% 
2 1/2/3.6 Et2O 3/1/21% 
3
[b] 
1/2/3.6 C5H12 1/7/35% 
4 1/2/3.6 C5H12/THF 20:1 1/40/52% 
5 1/2/3.6 C5H12/THF 50:1 1/50/65% 
6 1/4/6 C5H12/THF 50:1 1/50/80% 
[a] Volume of solvent 1 mL, 0.25 mmol scale, 24 h, 25 °C. Conversion by GC analysis. [b] At 40 
°C. 
 Diphenyl ether together with a hydrocarbon in 4/1 ratio were obtained when 
phenol was reacted with chlorobenzene in presence of TMPLi solution in THF (Table 
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3.4.1, entry 1). The hydrocarbon product was shown to be benzo[c]phenanthrene 
(tetrahelicene). Helicenes have been used in asymmetric catalysis, as molecular machines 
for molecular recognition, and in materials science.
24 
Their syntheses require several 
steps.
25 
Therefore, formation of helicenes from simple, commercially available starting 
materials via one-step reaction would make these interesting structures more available. 
For example, 1,12-disubstituted helicene has been prepared in seven steps by employing 
Friedel-Crafts acylation.
24 
Consequently, we decided to optimize the helicene formation 
and investigate the reaction mechanism. As shown in Table 3.4.4, increase of 
phenol/chlorobenzene ratio to 1/4 and use of mixed pentane/THF solvent resulted in 80% 
conversion to tetrahelicene (entry 6). 
Table 3.4.5. Helicene Synthesis
[a] 
 
entry phenol helicene yield, % 
1 PhOH 
 
67 
2 2-tBu-phenol 
 
48 
3 2,3-di-Me-phenol 
 
58 
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4 2-Ph-phenol 
 
65 
5 2,6-di-iPr-phenol 
 
40 
6 3-CF3-phenol 
 
40 
7 3-tBu-phenol 
 
51 
8 3-TBSO-phenol 
 
52 
[a] Scale: 0.5 mmol. Yields are isolated yields 
  
 Examples of helicene synthesis are presented in Table 3.4.5. Reaction of phenol 
with chlorobenzene affords a 67% isolated yield of tetrahelicene (entry 1). 5-t-
Butyltetrahelicene is obtained in 48% yield from 2-t-butylphenol and chlorobenzene 
(entry 2). If 2,3-dimethylphenol is used as starting material, 5,6-dimethyltetrahelicene is 
produced in 58% yield (entry 3). Reaction of 2-phenylphenol affords 5-
phenyltetrahelicene in 65% yield (entry 4). Helicene synthesis from hindered 2,6-
diisopropylphenol is possible and 5,8-diisopropyltetrahelicene was formed in 40% yield 
(entry 5). 6-Trifluoromethyltetrahelicene can be obtained in 40% yield (entry 6). 3-t-
Butylphenol can be converted to 6-t-butyltetrahelicene in 51% yield (entry 7). A TBS-
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protected resorcinol afforded the product in a good yield (entry 8). Formation of two 
isomeric hydrocarbons in 2.1/1 ratio and 60% yield was obtained when 2,6-
dimethylphenol reacted with  1-chloronaphthalene. The major product was hexahelicene 
11 that could be isolated in 26% yield by fractional crystallization of the isomer mixture 
(Scheme 3.4.10). 
Scheme 3.4.10. Hexahelicene synthesis 
 
 Analysis of the reaction products shows that two molecules of aryl chloride with 
one molecule of phenol are required for helicene formation. Reaction of 3-t-butylphenol 
with chlorobenzene was carried out by changing reactant ratios (Scheme 3.4.11). 
Benzocyclooctadienone 12 was obtained in 61% yield if 1.6 equiv. of chlorobenzene was 
employed. Increasing amount chlorobenzene (3 equiv.) and LiTMP (4.2 equiv ) led to the 
formation of compound  13 in 64% yield. Interestingly, compound 12 could be converted 
to 13 by reacting with 2 equiv of PhCl in the presence of 3.2 equiv LiTMP. t-
Butyltetrahelicene 8 can be obtained from either 12 or 13 (Scheme 3.4.11). Direct 
reaction of 4 equiv chlorobenzene with 3-t-butylphenol in the presence of 6 equiv LiTMP 
affords 8 (entry 7, Table 3.4.5). In addition, the reaction of 4-hydroxybiphenyl with 
chlorobenzene afforded 14 which cannot easily aromatize by water elimination. These 
experiments show that 12 and 13 are competent intermediates en route to 8. X-Ray 
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crystallographic analysis of O-methyl derivative of 14 showed that hydroxyl and phenyl 
groups are in cis arrangement. 
Scheme 3.4.11. Reaction intermediates 
 
              
                                                                                        
 The following reaction mechanism is proposed (Scheme 3.4.12). Reaction of 
phenol with benzyne generated from chlorobenzene forms a benzocyclobutene 15. 
Product of ring-opening 16 undergoes another reaction with benzyne to form 17. Ten-
membered ring ketone 18 is formed via subsequent opening of the strained four-
membered ring in 17. Intramolecular nucleophilic attack followed by dehydration affords 
tetrahelicene 2. Intermediates related to 16 and 19 have been isolated and characterized 
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(12 and 14, Scheme 3.4.1). Benzene cycloaddition with benzyne producing a 
benzocyclobutane derivative that subsequently ring-opens to give benzocyclooctatetraene 
in low yield has been reported showing the viability of intermediates such as 15 and 
17.
26a 
Scheme 3.4.12. Reaction mechanism 
  
 As described above, C-arylated phenols could not be obtained if TMPLi was used. 
Minor amount of C-arylation product was obtained in dioxane by employing tBuONa 
base (Table 3.4.6). In enolate chemistry, the C- vs. O-functionalization ratios can be 
tuned by changing metal counterion.
26b 
Brookhart reported a procedure where C-
functionalization of hexafluoroacetylacetone can be achieved via its Ag salt.
26a 
Thus, 0.5-
1 equiv AgOAc was added to reaction mixture and good selectivity for C-arylation was 
observed. The optimized conditions include AgOAc additive, 155 °C, dioxane solvent, 
and NaOtBu base. 
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Table 3.4.6. Optimization of Phenol Arylation
[a] 
 
entry PhCl/PhOH/base solvent, T 1/20/conv 
1 2/1/3.9/LiTMP Et2O, 25 °C 50/<1/32% 
2 2/1/3.9/tBuOK dioxane, 110 °C 9/1/91% 
3 2/1/3.9/tBuONa dioxane, 155 °C 7/1/87% 
4
[b] 
2/1/3.9/tBuONa dioxane, 155 °C 1/30/87% 
5
[c] 
2/1/3.9/tBuONa dioxane, 155 °C 1/15/65% 
[a] Solvent (1 mL), 0.25 mmol scale, 24 h. Conversion by GC analysis.[b] Additive: 1 equiv 
AgOAc. [c] Additive: 0.1 equiv AgOAc. 
 
 The arylation scope is presented in Table 3.4.7. Mono- or diarylation can be 
selectively achieved by changing phenol/chlorobenzene ratio (entries 1 and 2). 
Introduction of 3-fluorophenyl substituent is possible (entry 3). 3-Methoxyphenylated 
derivative is generated in good yield by reaction of phenol with 2-chloroanisole (entry 4).
 
Arylations of substituted phenols, such as 3-methylphenol (entry 5), 4-
hydroxybenzophenone (entry 6), 1-naphthol (entry 7), and 2-naphthol (entry 8) afford 
products in good to excellent yields. The reaction is surprisingly functional group tolerant 
despite the use of strong t-butoxide base. Thus, fluoride (entry 3), ether (entry 4), ketone 
(entry 6), trifluoromethyl (entry 9), ester (entry 10), and cyano groups (entry 11) are 
tolerated. It is worth mentioning that arylation of 2-naphthol (entries 8-11) is possible in 
the absence of AgOAc. 
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Table 3.4.7. Phenol arylation
[a] 
 
entry phenol ArCl product yield, % 
1 phenol PhCl 
 
78 
2 phenol PhCl 
 
60 
3 phenol 1-Cl-3-FC6H4 
 
72 
4
[b] 
phenol 2-Cl-1-MeOC6H4 
 
64 
5 3-Me-phenol PhCl 
 
80 
6 4-hydroxy-
benzophenone 
PhCl 
 
58 
7 1-naphthol PhCl 
 
82 
8
[c] 
2-naphthol PhCl 
 
80 
9
[c]
 2-naphthol 3-Cl-1-CF3C6H4 
 
74 
10
[c]
 2-naphthol 3-Br-1-tBuO2CC6H4 
 
66 
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11
[c]
 2-naphthol 3-Cl-1-CNC6H4 
 
65 
[a] Scale: 0.5 mmol, 48-96 h, 0.5-2 equiv AgOAc, 1.6-5/1/3.6-8 ratio of ArCl/phenol/base. 
Yields are isolated yields. [b]
 
Crude: 9/1 isomer mixture. Yield of pure major isomer. 
c
 No 
AgOAc additive. 
 
 Arylated binol functionality is found in organocatalysts.18 The most common 
methods for synthesis of these structures require several steps from relatively expensive 
starting materials.
18
 Direct C-arylation of binol is the shortest possible route to such 
compounds. In addition, the introduction of two different aryl groups into binol moiety is 
also feasible, thus allowing access to structurally diverse organocatalysts. Diarylation of 
binol can be performed if excess chlorobenzene is used and product 21 was formed in 
51% yield (Scheme 3.4.13). A two-step synthesis of an unsymmetrical diarylbinol was 
also developed. Thus, binol was phenylated to afford 3-phenylbinol 22 in 67% yield. 
Subsequently, 22 was arylated by 1-chloro-3-fluorobenzene to afford 3,3’-diarylbinol 22 
in 60% yield. Additionally, enantiopure (R)- binol was arylated with 3-chloroanisole 
affording product 24 in 50% yield and 95 % ee. This reaction shows the applicability of 
the method to the synthesis of enantioenriched organocatalysts. 
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Scheme 3.4.13. Direct C-arylation of binols 
 
 
3.4.3.3. Conclusions 
 Two reactions of phenols with arynes were described. Helicene synthesis can be 
obtained by reaction of aryl chlorides with phenols in TMPLi base. If tBuONa base is 
used in dioxane at elevated temperature in the presence of AgOAc, selective o-arylation 
of phenols can be achieved. Direct C-arylation of binol, the shortest route to o,o’-
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diarylbinols, is demonstrated. Enantiopure binol arylation is also performed without 
significant loss in enantiomeric excess. 
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3.4.4. Experimental Section 
3.4.4.1. Transition-metal-free ortho-Arylation of Anilines 
General considerations: All reactions were performed in 2-dram vials using screw caps 
with 17 mm holes and white silicone septum with white teflon face (from SUPELCO). 
Column chromatography was performed on 60Å silica gel (Sorbent Technologies). 
Purification by preparative HPLC was performed on a Shimadzu Prominence LC (LC-
20AB) equipped with a SPD-20A UV-Vis detector and a Varian Dynamax (250 mm x 
21.4 mm) column. GC-MS analyses were performed on a Shimadzu GCMS-QP5000 
chromatograph equipped with a Restek column (Rtx-XLB, 30 m x 0.25 mm I.D.). The 
1
H 
and 
13
C NMR were recorded on JEOL EC-400 or JEOL EC-500 spectrometers using 
residual solvent peak as a reference. Elemental analyses were performed by Atlantic 
Microlab Inc. of Norcross, GA. IR spectra were obtained on a ThermoNicolet Avatar 370 
FT-IR instrument. Analytical thin layer chromatography was performed on silica gel IB-F 
(Baker-flex) by J. T. Baker. Low temperature reactions were performed using Immersion 
Cooler FC100 with Flexi Probe from SP Scientific. All procedures were performed under 
nitrogen atmosphere unless otherwise noted. 
Materials. The following starting materials were obtained from commercial sources and 
were used without further purification: 2-chloro-N,N-dimethylaniline, chlorobenzene, 
bromobenzene, fluorobenzene, 2-chlorobenzotrifluoride, 2-chloronaphthalene, 2-
bromonaphthalene, 2-bromobiphenyl, 2-fluorobiphenyl, 4-chlorotoluene, 2,2,6,6-
tetramethylpiperidine (TMPH), 9-chlorophenanthrene, 2-chlorostyrene, N-methylaniline, 
1,2,3,4-tetrahydroquinoline, diphenylamine, N-phenyl-2-naphthylamine, N-benzylaniline, 
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aniline, 3,5-dimethylaniline, 4-tert-butylaniline, 4-aminobiphenyl, 2-aminobiphenyl, 1-
naphthylamine, anhydrous cyclohexane, 2-chloroanisol, tert-butyl-3-bromobenzoate, 3-
aminobenzotrifluoride, 3-chlorophenol, 4-chloroaniline, 4-aminobenzonitrile, 1,1
’
-bis(2-
napthylamine) and 2-naphthylamine (CAUTION: environmental carcinogen; induces 
bladder cancer). All aryl triflates were synthesized according to literature.
27
   
Attempted arylation of 2,6-dimethylaniline resulted in N-arylation product and no C-
arylation product was observed by GC.
 
TMPLi:  A 250 mL oven-dried flask equipped with a magnetic stirring bar and a septum 
was evacuated and backfilled with nitrogen 5 times. TMPH (15.5 g, 18.5 mL, 110 mmol) 
was added via syringe, followed by anhydrous pentane to give approximately 100 mL of 
solution. The mixture was cooled to -73 °C (dry ice-acetone bath) and stirred for 10 
minutes. n-BuLi (2.5 M in hexanes, 40.0 mL, 100 mmol) was added dropwise and 
reaction mixture was stirred for 30 minutes at -73 °C, warmed up to room temperature 
(25 °C) and stirred overnight. The reaction mixture was vacuumed to remove all solvent 
and dried under vacuum for at least 5 hours. A light yellow powder of solid TMPLi was 
obtained. 
TMPLi 1 M in pentane/hexanes: A 50 mL oven-dried flask equipped with a magnetic 
stirring bar and a septum was evacuated and backfilled with argon 5 times. TMPH (4.64 
g, 33.0 mmol) was added, followed by anhydrous pentane to give 30 mL of solution 
(marked the flask at the level of solution). The mixture was cooled to -73 °C (dry ice-
acetone) and stirred for 5 minutes. n-BuLi (2.5 M in hexanes, 12.0 mL, 30 mmol) was 
added dropwise and reaction mixture was stirred for 30 minutes at -73 °C, then warmed 
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up to room temperature and stirred overnight. The reaction mixture was vacuumed to 
give 30 mL (at the marked level) of TMPLi suspension.  
General Procedures.  
Reactions at room temperature (25 °C): Outside the glovebox a 2-dram vial was 
equipped with a magnetic stirring bar. The vial was placed inside the glovebox. To the 
vial was added solid TMPLi (1.8 – 3.5 mmol). The sealed vial was taken out of the 
glovebox, cyclohexane and diethyl ether were added via syringe and the reaction mixture 
became homogeneous. Following that, amine (1.0 – 2.0 mmol) and chloroarene (0.5 
mmol) were added via syringe. Reactions were run at room temperature for 24 hours.  
Reactions at 50 °C: Outside the glovebox a 2-dram vial was equipped with a magnetic 
stirring bar. The vial was placed inside the glovebox. To the vial was added solid TMPLi 
(1.8 – 3.5 mmol). The sealed vial was taken out the glovebox, cyclohexane and diethyl 
ether were added via syringe and the reaction mixture became homogeneous. If 
hydrocarbon solvents were used (Table 3.4.S1, entries 6-8), the reaction mixture became 
viscous.  Following that, amine (1.0 – 2.0 mmol) and chloroarene (0.5 mmol) were added 
via syringe. Vial was then placed in preheated oil bath for indicated time.  
Work-up procedure for reactions at room temperature and 50 °C: 
The reaction mixture was cooled to room temperature (if necessary) and quenched by 
slow addition of anhydrous methanol (0.5 mL). The reaction mixture was evacuated to 
remove all solvent, residue was dissolved in minimal amount of ethyl acetate or 
dichloromethane and subjected to flash chromatography on silica gel in hexanes followed 
by appropriated solvent to elute the products. After concentrating the fractions containing 
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the product, the residue was dried under reduced pressure to yield pure product. If 
necessary, purification by preparative HPLC was performed.  
Reactions at low temperature (from – 85 to 0 oC): Outside the glovebox a 2-dram vial 
was equipped with a magnetic stirring bar. The vial was placed inside the glovebox. To 
the vial was added solid TMPLi (1.8 – 3.5 mmol). The sealed vial was taken out of the 
glovebox and placed into cooling bath. Mixed solvents were cooled to reaction 
temperature and added via syringe to reaction vial. Following that, amine (0.5 – 2.0 
mmol) and chloroarene (0.5 – 1.5 mmol) or aryl triflate (1.0 – 2.0 mmol) were added via 
syringe. Reactions were run at specified temperature for indicated time. Reactions were 
quenched with H2O (2 mL) at low temperature, diluted with EtOAc (20 mL), washed 
with brine (30 mL). Aqueous layer was washed again with EtOAc (2 x 15 mL). 
Combined organic layer was dried over MgSO4 and evacuated to 1 mL. Residue was 
subjected to flash chromatography in hexanes followed by appropriated solvent to elute 
the products. After concentrating the fractions containing the product, the residue was 
dried under reduced pressure to yield pure product. If necessary, purification by 
preparative HPLC was performed.  
Note:  
  In all procedures, the vial was charged with aniline and chloroarene outside the 
glovebox if these reagents are solid at room temperature unless otherwise stated. 
  Strong stirring  (higher than 1200 rpm) is necessary to get reproducible yields 
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Optimization of Conditions 
Procedure: All reactions were carried out following the general procedure, but on 0.25 
mmol scale. 2-Naphthylamine (x mmol), chlorobenzene (y mmol), TMPLi [1.2(x + y) 
mmol], solvents (0.9 mL total), 24 hours. Conversions and A/B ratio were calculated by 
GC analysis. Conversions are presented in Table 3.4.S1 and show the amount of product 
A and B formed (e.g. 70 % means that 70 % of starting limiting reagent is converted to A 
and B). Mixture with exact molar amounts of pure A and pure B was used as the standard 
to determine the ratio A/B. 
Table 3.4.S1. Optimization of Conditions 
NH2
PhCl
Conditions
24 hrs
NH2
H
N
A B  
Entry 
Amine/PhCl
/TMPLi 
Base/temperature Solvents 
Conversion 
(%) 
Ratio 
A/B 
1 1/2/3.6 TMPLi/ 25 
o
C THF 97 1/8 
2 2/1/3.6 TMPLi/ 25 
o
C THF 43 1/3 
3 1/2/3.6 TMPLi/ 25 
o
C Ether 94 1/5 
4 1/2/3.6 TMPLi/ - 46 
o
C Ether (12 hours) 29 8/1 
5 1/2/3.6 LDA/ 25 
o
C Ether 83 1/50 
6 1/2/3.6 TMPLi/ 40 
o
C Pentane 70 1/2 
7 1/4/6 TMPLi/ 40 
o
C Pentane 55 1/5 
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8 2/1/3.6 TMPLi/ 40 
o
C Pentane 62 2/1 
9 1/2/3.6 TMPLi/ 25 
o
C Pentane/THF (20/1) 95 1.5/1 
10 1/2/3.6 TMPLi/ 25 
o
C Pentane/ether (20/1) 92 1.3/1 
11 2/1/3.6 TMPLi/ 25 
o
C Pentane/ether (20/1) 35 12/1 
12 2/1/3.6 TMPLi/ 25 
o
C Pentane/ether (1/1) 85 9/1 
13 2/1/3.6 TMPLi/ 25 
o
C Cyclohexane/ether (1/1) 94 18/1 
14 1/2/3.6 TMPLi/ 25 
o
C Cyclohexane/ether (1/1) 96 1/2.2 
15 2/1/7.2 TMPLi/ 25 
o
C Cyclohexane/ether (1/1) 70 5/1 
16 2/4/3.6 TMPLi/ 25 
o
C Cyclohexane/ether (1/1) 50 20/1 
17
a 
2/1/3.6 TMPLi/ 25 
o
C Cyclohexane/ether (1/1)
 
97 
15.5/
1 
18 4/1/6 TMPLi/ 25 
o
C Cyclohexane/ether (1/1) 99 40/1 
19 3/1/4.8 TMPLi/ 50 
o
C 
Cyclohexane/ether 
(14/1) 
95 50/1 
20 3/1/4.8 TMPLi/ 50 
o
C Cyclohexane/ether (1/1) 72 5/1 
21 4/1/6 TMPLi/ 50 
o
C Cyclohexane/ether (14/1) 96 >50/1 
  
Reactions were run at 0.25 mmol scale. 
a 
Solvent 1.8 mL - compare to 0.9 mL in entry 
13. Changing the concentration of 2-napthylamine in reaction mixture does not make significant 
difference in reaction conversion and A/B ratio. Less than 7 % of C, N-diarylation product was 
observed by GC under all conditions in Table 3.4.4. 
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NH2
 
1-Phenyl-2-naphthylamine (Table 3.4.2, Entries 1, 2, and 3):  
2-Naphthylamine (143 mg, 1.0 mmol), chlorobenzene (57 mg, 0.5 mmol), TMPLi (265 
mg, 1.8 mmol), anhydrous cyclohexane (1.5 mL), anhydrous Et2O (0.1 mL), 50 °C, 48 
hours. After column chromatography (hexanes followed by hexanes/EtOAc: 90/10), 78 
mg (72%) of a tan solid was obtained. Less than 5% of N-arylation product was observed 
in crude reaction mixture by GC analysis. 
2-Naphthylamine (215 mg, 1.5 mmol), chlorobenzene (57 mg, 0.5 mmol), TMPLi (340 
mg, 2.3 mmol), anhydrous cyclohexane (0.7 mL), anhydrous Et2O (0.7 mL), room 
temperature, 24 hours. After column chromatography (hexanes followed by 
hexanes/EtOAc: 90/10), 91 mg (84 %) of a tan solid was obtained. Less than 5% of N-
arylation product was observed in crude reaction mixture by GC analysis.  
2-Naphthylamine (143 mg, 1.0 mmol), bromobenzene (79 mg, 0.5 mmol), TMPLi (265 
mg, 1.8 mmol), anhydrous cyclohexane (1.5 mL), anhydrous Et2O (0.1 mL), 50 °C, 48 
hours. After column chromatography (hexanes followed by hexanes/EtOAc: 90/10), 76 
mg (70%) of a tan solid was obtained. Less than 5% of N-arylation product was observed 
in crude reaction mixture by GC analysis. 
2-Naphthylamine (143 mg, 1.0 mmol), fluorobenzene (49 mg, 0.5 mmol), TMPLi (265 
mg, 1.8 mmol), anhydrous cyclohexane (1.5 mL), anhydrous Et2O (0.1 mL), 50 °C, 48 
hours. After column chromatography (hexanes followed by hexanes/EtOAc: 90/10), 74 
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mg (68%) of a tan solid was obtained. Less than 5% of N-arylation product was observed 
in crude reaction mixture by GC analysis. 
Rf = 0.27 (hexanes/EtOAc: 90/10). This compound is known.
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1
H NMR (400 MHz, 
CDCl3) δ 7.77 – 7.71 (m, 2H), 7.60 – 7.54 (m, 2H), 7.49 – 7.45 (m, 1H), 7.41 – 7.39 (m, 
2H), 7.34 – 7.22 (m, 3H), 7.05 (d, J = 8.7 Hz, 1H), 3.71 (s, 2H). 13C NMR (100 MHz, 
CDCl3, ppm) δ 141.2, 137.2, 133.9, 131.0, 129.4, 128.8, 128.1, 128.0, 127.7, 126.4, 
124.3, 122.3, 120.0, 118.2. 
NH2
H
C
CH2
 
1-(3-Vinylphenyl)-2-naphthylamine (Table 3.4.2, Entry 4):  
2-Naphthylamine (286 mg, 2.0 mmol), 2-chlorostyrene (70 mg, 0.5 mmol), TMPLi (500 
mg, 3.4 mmol), anhydrous cyclohexane (2.8 mL), anhydrous Et2O (0.2 mL), 50 
o
C, 48 
hours. After column chromatography (hexanes followed by hexanes/EtOAc: 90/10), 76 
mg (62 %) of a yellowish oil was obtained. About 20% of N-arylation product was 
observed in crude reaction mixture by GC analysis. 
2-Naphthylamine (77 mg, 0.5 mmol), 2-chlorostyrene (210 mg, 1.5 mmol), TMPLi (370 
mg, 2.5 mmol), anhydrous Et2O (1.5 mL), - 25 
o
C, 48 hours. After column 
chromatography (hexanes followed by hexanes/EtOAc: 90/10), 85 mg (70 %) of a 
yellowish oil was obtained. About 10 % of N-arylation product was observed in crude 
reaction mixture by GC analysis. 
 270 
Rf = 0.21 (hexanes/EtOAc: 90/10). 
1
H NMR (400 MHz, CDCl3) δ 7.76 – 7.70 (m, 2H), 
7.54 – 7.50 (m, 2H), 7.44 (s, 1H), 7.31 – 7.24 (m, 4H), 7.05 (d, J = 8.7 Hz, 1H), 6.79 (dd, 
J = 17.7 Hz, 11.0 Hz, 1H), 5.81 (d, J = 17.7 Hz, 1H), 5.30 (d, J = 11.0 Hz, 1H), 3.71 (s, 
2H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 141.2, 138.6, 137.5, 136.7, 133.8, 130.5, 129.6, 
128.9, 128.8, 128.0, 126.5, 125.5, 124.3, 122.3, 119.7, 118.2, 114.5. Signal for one 
carbon could not be located. FT-IR (neat, cm
-1) υ 2979, 1620, 1517. Anal calcd for 
C18H14N (245.12 g/mol): C, 88.13; H, 6.16; N, 5.71; Found. C, 88.55; H, 5.72; N, 5.38. 
Note: Product contains less than 4 % of another isomer, presumably 1-(2-vinylphenyl)-2-
naphthylamine. 
O
NH2
 
1-(3-Methoxy)-2-naphthylamine (Table 3.4.2, Entry 5): 
2-Naphthylamine (77 mg, 0.5 mmol), 2-chloroanisole (215 mg, 1.5 mmol), TMPLi (440 
mg, 3.0 mmol), anhydrous Et2O (1.5 mL), - 25 
o
C, 48 hours. After column 
chromatography (hexanes followed by hexanes/EtOAc: 80/20), 84 mg (67%) of light tan 
solid was obtained. About 10 % of N-arylation product was observed in crude reaction 
mixture by GC analysis. 
Rf = 0.28 (hexanes/EtOAc: 80/20). 
1
H NMR (400 MHz, CDCl3) δ 7.74 (dd, J = 8.2 Hz, 
1.1 Hz, 1H), 7.70 (d, J = 8.7 Hz, 1H), 7.46 (t, J = 8.2 Hz, 1H), 7.34 – 7.21 (m, 3H), 7.04 
(d, J = 8.7 Hz, 1H), 7.00 – 6.91 (m, 3H), 3.84 (s, 3H), 3.74 (s, 2H). 13C NMR (100 MHz, 
CDCl3, ppm) δ 160.4, 141.1, 138.6, 133.7, 130.4, 128.8, 128.0, 126.4, 124.4, 123.2, 
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122.3, 119.8, 118.2, 116.0, 113.5, 55.4.. FT-IR (neat, cm
-1) υ 3364, 2968, 1622, 1597. 
Anal calcd for C17H15O ( g/mol): C, 81.90 ; H, 6.06; N 5.62. Found. C, 81.45; H, 5.94; N, 
5.78. 
NH2
CF3
 
1-(3-Trifluoromethylphenyl)-2-naphthylamine (Table 3.4.2, Entry 6): 
2-Naphthylamine (215 mg, 2.0 mmol), 2-chlorobenzotrifluoride (91 mg, 0.5 mmol), 
TMPLi (500 mg, 3.4 mmol), anhydrous cyclohexane (0.7 mL), anhydrous Et2O (0.7 mL), 
room temperature, 24 hours. After column chromatography (hexanes followed by 
hexanes/EtOAc: 90/10), 86 mg (60%) of light tan oil was obtained. About 15% of N-
arylation product was observed in crude reaction mixture by GC analysis. 
2-Naphthylamine (77 mg, 0.5 mmol), 2-chlorobenzotrifluoride (270 mg, 1.5 mmol), 
TMPLi (370 mg, 2.5 mmol), anhydrous Et2O (1.5 mL), - 25 
o
C, 48 hours. After column 
chromatography (hexanes followed by hexanes/EtOAc: 90/10), 93 mg (65%) of light tan 
oil was obtained. About 8 % of N-arylation product was observed in crude reaction 
mixture by GC analysis. 
Rf = 0.30 (hexanes/EtOAc: 90/10). 
1
H NMR (400 MHz, CDCl3) δ 7.77 – 7.67 (m 5H), 
7.61 – 7.60 (m, 1H), 7.33 – 7.25 (m, 2H), 7.21 – 7. 19 (m, 1H), 7.05 (d, J = 8.7 Hz, 1H), 
3.68 (s, 2H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 141.3, 138.2, 134.7, 133.6, 131.8 (q, J 
= 32.1 Hz), 130.0, 129.5, 128.2, 128.0, 127.9 (q, J = 4.8 Hz), 126.8, 124.6 (q, J = 4.8 Hz), 
124.3 (q, J = 272.2 Hz), 123.7, 122.5, 118.2, 118.1. FT-IR (neat, cm
-1) υ 2921, 1626, 
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1326, 1120. Anal calcd for C17H12F3N (287.09 g/mol): C, 77.01; H, 4.21; N, 4.88. Found. 
C, 77.32; H, 4.32; N, 4.89. 
NH2
 
1-(1,1'-Biphenyl)-3-yl-2-naphthylamine (Table 3.4.2, Entry 7):  
2-Naphthylamine (286 mg, 2.0 mmol), 2-bromobiphenyl (117 mg, 0.5 mmol), TMPLi 
(500 mg, 3.4 mmol), anhydrous cyclohexane (2.8 mL), anhydrous Et2O (0.2 mL), 50 
o
C, 
48 hours. After column chromatography (hexanes followed by hexanes/EtOAc: 90/10), 
103 mg (70%) of a tan solid was obtained. Less than 10% of N-arylation product was 
observed in crude reaction mixture by GC analysis. 
2-Naphthylamine (286 mg, 2.0 mmol), 2-fluorobiphenyl (87 mg, 0.5 mmol), TMPLi (500 
mg, 3.4 mmol), anhydrous cyclohexane (2.8 mL), anhydrous Et2O (0.2 mL), 50 
o
C, 48 
hours. After column chromatography (hexanes followed by hexanes/EtOAc: 90/10),95 
mg (65%) of a tan solid was obtained. Less than 10% of N-arylation product was 
observed in crude reaction mixture by GC analysis. 
Rf = 0.24 (hexanes/EtOAc: 90/10), mp 114 – 115 
o
C (from hexanes). 
1
H NMR (400 
MHz, CDCl3) δ 7.82 – 7.65 (m, 7H), 7.51 – 7.40 (m, 5H), 7.39 – 7.27 (m, 2H), 7.08 (d, J 
= 8.7 Hz, 1H), 3.80 (s, 2H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 142.2, 141.2, 140.9, 
137.8, 130.0, 129.9, 129.8, 129.0, 128.2, 128.1, 127.7, 127.3, 126.6, 126.4, 124.4, 122.4, 
119.9, 118.3. Signals for two carbons could not be located. FT-IR (neat, cm
-1) υ 2998, 
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1626, 1510, 1392. Anal calcd for C22H17N (295.14 g/mol): C, 89.46; H, 5.80; N, 4.74; 
Found. C, 89.03; H, 5.69; N, 4.60. 
NH2
 
1-(9-Phenanthrenyl)-2-naphthylamine (Table 3.4.2, Entry 8): 
2-Naphthylamine (215 mg, 1.5 mmol), 9-chlorophenanthrene (107 mg, 0.5 mmol), 
TMPLi (380 mg, 2.6 mmol), anhydrous cyclohexane (2.8 mL), anhydrous Et2O (0.2 mL), 
50 
o
C, 48 hours. After column chromatography (hexanes followed by hexanes/EtOAc: 
85/15), 113 mg (71%) of a light yellow solid was obtained.  
Rf = 0.22 (hexanes/EtOAc: 85/15), mp 189 – 190 
o
C (from hexanes). 
1
H NMR (400 
MHz, CDCl3) δ 8.84 (t, J = 8.1 Hz, 2H),7.92 (dd, J = 7.8 Hz, 1.2 Hz, 1H), 7.86 – 7.82 (m, 
3H), 7.76 (dt, J = 7.8 Hz, 1.2 Hz, 1H), 7.71 – 7.65 (m, 2H), 7.54 – 7.52 (m, 1H), 7.46 – 
7.43 (m, 1H), 7.29 – 7.25 (m, 1H), 7.22 – 7.16 (m, 2H), 7.14 (d, J = 8.7 Hz, 1H), 3.66 (s, 
2H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 142.1, 134.6, 133.5, 132.2, 131.4, 131.2, 130.6, 
130.0, 129.3, 128.9, 128.2, 128.1, 127.2, 127.1, 127.0, 126.7, 126.6, 124.7, 123.1, 122.8, 
122.4, 118.3, 117.4. Signal for one carbon could not be located. FT-IR (neat, cm
-1) υ 
3005, 1623, 1513. Anal calcd for C24H17N (319.14 g/mol): C, 90.25; H, 5.36; N, 4.39; 
Found. C, 88.73; H, 5.30; N, 4.32. 
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NH2
 
1-(2-Naphthalenyl)-2-naphthylamine (Table 3.4.2, Entry 9):  
2-Naphthylamine (215 mg, 1.5 mmol), 2-chloronaphthalene (82 mg, 0.5 mmol), TMPLi 
(380 mg, 2.6 mmol), anhydrous cyclohexane (0.7 mL), anhydrous Et2O (0.7 mL), room 
temperature, 24 hours. After column chromatography (hexanes followed by 
hexanes/EtOAc: 90/10), 110 mg (82%) of light brown oil was obtained. Less than 5% of 
N-arylation product was observed in crude reaction mixture by GC analysis. 
2-Naphthylamine (215 mg, 1.5 mmol), 2-bromonaphthalene (107 mg, 0.5 mmol), TMPLi 
(380 mg, 2.6 mmol), anhydrous cyclohexane (0.7 mL), anhydrous Et2O (0.7 mL), room 
temperature, 24 hours. After column chromatography (hexanes followed by 
hexanes/EtOAc: 90/10), 107 mg (80%) of light brown oil was obtained. Less than 5% of 
N-arylation product was observed in crude reaction mixture by GC analysis. 
Rf = 0.31 (hexanes/EtOAc: 90/10). 
1
H NMR (400 MHz, CDCl3) δ 8.05 (d, J = 8.6 Hz, 
1H), 7.99 – 7.97 (m, 1H), 7.92 – 7.89 (m, 2H), 7.81 – 7.76 (m, 2H), 7.61 – 7.50 (m, 3H), 
7.39 – 7.36 (m, 1H), 7.31 – 7.25 (m, 2H), 7.08 (d, J = 8.6 Hz, 1H), 3.75 (s, 2H). 13C 
NMR (100 MHz, CDCl3, ppm) δ 141.5, 134.8, 134.1, 134.0, 132.9, 130.0, 129.2, 129.1, 
129.0, 128.1, 128.0, 126.6, 126.4, 126.3, 124.4, 122.4, 119.7, 118.3.  Signals for two 
carbons could not be located. FT-IR (neat, cm
-1) υ 3057, 1620, 1513. Anal calcd for 
C20H15N (269.12 g/mol): C, 89.19; H, 5.61; N, 5.20; Found. C, 89.14; H, 5.50; N, 5.03. 
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Note: Product contains less than 3 % of another isomer, presumably 1-(1-naphthalenyl)-
2-naphthylamine. 
NH2
N
Me
Me
H4
H1
H2
H3
H6
H7
H8 H9
H10
H5
 
1-[3-(Dimethylamino)phenyl]-2-naphthylamine (Table 3.4.2, Entry 10).  
2-Naphthylamine (77 mg, 0.5 mmol), 2-chloro-N,N-dimethylaniline (230 mg, 1.5 mmol), 
TMPLi (440 mg, 3.0 mmol), anhydrous Et2O (1.5 mL), - 30 
o
C, 48 hours. After column 
chromatography (hexanes followed by hexanes/EtOAc: 70/30), 79 mg (61 %) of a brown 
solid was obtained. About 8 % of N-arylation product was observed in crude reaction 
mixture by GC analysis. 
Rf = 0.23 (hexanes/EtOAc: 70/30), mp 108 – 110 °C (from hexanes). 
1
H NMR (400 
MHz, C6D6) δ 7.75 (d, J = 7.5 Hz, H
5
), 7.61 (d, J = 7.5 Hz, H
8
), 7.51 (d, J = 8.8 Hz, H
9
), 
7.27 (dd, J = 8.8 Hz,  7.5 Hz, H
2
), 7.15 (dt, J = 7.5 Hz, 1.4 Hz, H
6
), 7.08 (dt, J = 7.5 Hz, 
1.4 Hz, H
7
), 6.77 (d, J = 7.5 Hz, H
3
), 6.67 (s, H
4
), 6.62 (d, J = 8.8 Hz, H
10
), 6.58 (dd, J = 
8.8 Hz, 2.5 Hz, H
1
), 3.23 (s, 2H), 2.40 (s, 3H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 
151.4, 141.1, 138.0, 133.9 130.0, 128.5, 128.0, 127.9, 126.3, 124.7, 122.2, 121.0, 118.9, 
118.2, 114.8, 111.7, 40.7. FT-IR (neat, cm
-1) υ 2976, 1600, 1357. Anal calcd for 
C18H18N2 (262.15 g/mol): C, 82.41; H, 6.92; N, 10.68 Found. C, 82.73; H, 6.91; N, 10.54.  
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NH2
Cl
 
1-(3-Chlorophenyl)naphthalen-2-amine (Table 3.4.2, Entry 11) 
2-Naphthylamine (0.71 mg, 0.5 mmol), 3-chlorophenyl trifluoromethanesulfonate (400 
mg, 1.5 mmol), lithium diisopropylamide (LDA) (140 mg, 2.3 mmol), anhydrous THF 
(1.5 mL), - 85 
o
C, 12 hours. After column chromatography (hexanes followed by 
hexanes/EtOAc: 90/10), 64 mg (50%) of a tan solid was obtained. About 7 % of N-
arylation product was observed in crude reaction mixture by GC analysis. 
Rf = 0.30 (hexanes/EtOAc: 90/10). 
1
H NMR (400 MHz, CDCl3) δ 7.74 – 7.69 (m, 2H), 
7.50 – 7.41 (m, 2H), 7.39 (t, J = 1.8 Hz, 1H), 7.36 – 7.21 (m, 4H), 7.03 (d, J = 8.7 Hz, 
1H), 3.70 (s, 2H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 141.1, 139.2, 135.2, 133.6, 131.1, 
130.7, 129.4, 129.3, 128.1, 128.0, 127.9, 126.7, 123.9, 122.4, 118.3, 118.2. FT-IR (neat, 
cm
-1) υ 3376, 2232, 1513, 1273. Anal calcd for C16H12ClN (253.07 g/mol): C, 75.74; H, 
4.77; N, 5.52. Found. C, 76.02; H, 4.56; N, 5.12.  
NH
O
 
Benzo[a]phenanthridin-5(6H)-one (Table 3.4.2, Entry 12) 
2-Naphthylamine (71 mg, 0.5 mmol), tert-butyl-3-bromobenzoate (257 mg, 1.0 mmol), 
TMPLi (267 mg, 1.8 mmol), anhydrous Et2O (0.7 mL), anhydrous cyclohexane (0.7 mL), 
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- 35 
o
C, 12 hours and then 0 
o
C, 1 hour. After column chromatography (hexanes followed 
by hexanes/EtOAc: 50/50), 86 mg (70%) of light yellow solid was obtained. N-arylation 
product was not observed in crude reaction mixture by GC analysis. 
Rf = 0.20 (hexanes/EtOAc: 40/60). This compound is known.
29
 
1
H NMR (400 MHz, 
DMSO-d6) δ 10.53 (s, 1H), 8.42 (t, J = 2.5 Hz, 1H), 8.17 (t, J = 1.8 Hz, 1H), 7.98 – 7.96 
(m, 1H), 7.87 – 7.77 (m, 4H), 7.51 – 7.38 (m, 3H). 13C NMR (100 MHz, DMSO-d6, ppm) 
δ 164.7, 137.6, 137.0, 136.9, 134.9, 133.8, 131.3, 130.8, 130.6, 128.8, 128.0, 127.5, 
127.9, 125.4, 122.3, 121.4, 117.2. 
NH2
CH3
 
1-(4-Methylphenyl)-2-naphthylamine and 1-(3-Methylphenyl)-2-naphthylamine 
(Table 3.4.2, Entry 13).  2-Naphthylamine (215 mg, 1.5 mmol), 4-chlorotoluene (64 mg, 
0.5 mmol), TMPLi (385 mg, 2.6 mmol), anhydrous cyclohexane (2.8 mL), anhydrous 
Et2O (0.2 mL), 50 
o
C, 48 hours. After column chromatography (hexanes followed by 
hexanes/EtOAc: 90/10), 91 mg (78%) of a light tan solid was obtained. 
2-Naphthylamine (144 mg, 1.0 mmol), 4-chlorotoluene (64 mg, 0.5 mmol), TMPLi (270 
mg,1.8 mmol), anhydrous cyclohexane (0.7  mL), anhydrous Et2O (0.7 mL), room 
temperature, 24 hours. After column chromatography (hexanes followed by 
hexanes/EtOAc: 90/10), 85 mg (73%) of a light tan solid was obtained.  
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Ratio of p/m determined by integration of methyl 
1
H signals is 1.3/1. Analysis by GC 
showed that two isomers are obtained in 1.3/1 ratio. In both conditions, less than 5% of 
N-arylation product was observed in crude reaction mixture by GC analysis. 
 Rf = 0.31 (hexanes/EtOAc: 90/10). 
1
H NMR of mixture of isolated two isomers (400 
MHz, CDCl3) δ 7.83 – 7.68 (overlapping multiplets, 2H), 7.47 – 7.19 (overlapping 
multiplets of 2 isomers, 7H), 7.05 (overlapping doublets, J = 8.7 Hz, 1H), 3.71 
(overlapping singlets, 2H), 2.48 (singlet of m-isomer, 1.3H), 2.45 (singlet of p-isomer, 
1.7H). 
H
N
 
N-Methyl-(1,1'-biphenyl)-2-amine (Table 3.4.3, Entry 1).  
N-Methylaniline (162 mg, 1.5 mmol), chlorobenzene (57 mg, 0.5 mmol), TMPLi (340 
mg, 2.3 mmol), anhydrous cyclohexane (0.7 mL), anhydrous Et2O (0.7 mL), room 
temperature, 25 hours. After column chromatography (hexanes followed by 
hexanes/CH2Cl2 40/60), 56 mg (62%) of a light brown oil was obtained. About 20% of 
N-arylation product was observed in crude reaction mixture by GC analysis. 
Rf = 0.32 (hexanes/CH2Cl2: 40/60). This compound is known.
30
 
1
H NMR (400 MHz, 
CDCl3) δ 7.48 – 7.43 (m, 4H), 7.38 – 7.35 (m, 1H), 7.32 – 7.26 (m, 1H), 7.13 – 7.10 (m, 
1H), 6.80 (dt, J = 8.0 Hz, 1.1 Hz, 1H), 6.71 (d, J = 8.0 Hz, 1H), 3.98 (s, 1H), 2.81 (s, 3H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 146.3, 139.6, 130.1, 129.5, 129.0, 128.9, 127.7, 
127.3, 116.9, 109.9, 30.9. 
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N
H
 
1,2,3,4-Tetrahydro-8-phenylquinoline (Table 3.4.3, Entry 2).  
1,2,3,4-Terahydroquinoline (200 mg, 1.5 mmol), chlorobenzene (57 mg, 0.5 mmol), 
TMPLi (340 mg, 2.3 mmol), anhydrous cyclohexane (0.7 mL), anhydrous Et2O (0.7 mL), 
room temperature, 24 hours. After column chromatography (hexanes followed by 
hexanes/CH2Cl2 60/40), 73 mg (70%) of a colorless oil was obtained. About 15% of N-
arylation product was observed in crude reaction mixture by GC analysis. 
Rf = 0.25 (hexanes/CH2Cl2: 50/50).This compound is known.
31
 
1
H NMR (400 MHz, 
CDCl3) δ 7.48 – 7.43 (m, 4H), 7.38 – 7.33 (m, 1H), 6.99 (dd, J = 7.3 Hz, 1.3 Hz, 1H), 
6.94 (dd, J = 7.3 Hz, 1.3 Hz, 1H), 6.68 (t, J = 7.3 Hz, 1H), 4.10 (s, 1H), 3.26 (t, J = 5.4 
Hz, 2H), 2.86 (t, J = 6.4 Hz, 2H), 1.99 – 1.93 (m, 2H). 13C NMR (100 MHz, CDCl3, ppm) 
δ 141.8, 139.7, 129.5, 129.0, 128.9, 128.1, 127.1, 126.7, 121.4, 116.4, 42.1, 27.6, 22.1. 
H
N
 
N-Phenyl-(1,1'-biphenyl)-2-amine (Table 3.4.3, Entry 3).  
Biphenylamine (170 mg, 1.0 mmol), chlorobenzene (57 mg, 0.5 mmol), TMPLi (270 mg, 
1.8 mmol), anhydrous cyclohexane (0.7 mL), anhydrous Et2O (0.7 mL), room 
temperature, 24 hours. After column chromatography (hexanes followed by 
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hexanes/CH2Cl2 80/20), 95 mg (78%) of a white solid was obtained. Less than 5% of N-
arylation product was observed in crude reaction mixture by GC analysis. 
Biphenylamine (255 mg, 1.5 mmol), chlorobenzene (57 mg, 0.5 mmol), TMPLi (340 mg, 
2.3 mmol), anhydrous cyclohexane (0.7 mL), anhydrous Et2O (0.7 mL), room 
temperature, 24 hours. After column chromatography (hexanes followed by 
hexanes/CH2Cl2 80/20), 105 mg (87%) of a white solid was obtained. Less than 5% of N-
arylation product was observed in crude reaction mixture by GC analysis. 
Rf = 0.34 (hexanes/CH2Cl2: 80/20).This compound is known.
32
 
1
H NMR (400 MHz, 
CDCl3) δ 7.51 – 7.38 (m, 6H), 7.32 – 7.28 (m, 4H), 7.09 – 7.04 (m, 3H), 6.97 (tt, J = 7.6 
Hz, 1.1 Hz, 1H), 5.66 (s, 1H). 
13
C NMR (125 MHz, C6D6, ppm) δ 143.7, 140.3, 139.4, 
132.0, 131.0, 129.4, 129.3, 128.9, 128.4, 127.4, 121.5, 120.9, 118.4, 117.8. 
H
N
 
1,N-Diphenyl-2-naphthylamine (Table 3.4.3, Entry 4).  
N-Phenyl-2-naphthylamine (219 mg, 1.0 mmol), chlorobenzene (57 mg, 0.5 mmol), 
TMPLi (270 mg, 1.8 mmol), anhydrous cyclohexane (0.7 mL), anhydrous Et2O (0.7 mL), 
room temperature, 24 hours. After column chromatography (hexanes followed by 
hexanes/CH2Cl2 80/20), followed by HPLC (hexanes/CH2Cl2: 93/7), 118 mg (80%) of a 
light brown solid was obtained. Less than 5% of N-arylation product was observed in 
crude reaction mixture by GC analysis. 
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Rf = 0.32 (hexanes/CH2Cl2: 85/15), mp 100 – 101 
o
C (from hexanes).
1
H NMR (400 
MHz, CDCl3) δ 7.81 – 7.78 (m, 2H), 7.61 (d, J = 8.9 Hz, 1H), 7.57 – 7.53 (m, 2H), 7.49 – 
7.47 (m, 1H), 7.41 – 7.34 (m, 3H), 7.33 – 7.30 (m, 2H), 7.28 – 7.23 (m, 2H), 7.03 (d, J = 
7.8 Hz, 1H), 6.95 (t, J = 7.8 Hz, 1H), 5.55 (s, 1H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 
143.6, 138.1, 136.7, 133.9, 131.1, 129.4, 129.3, 128.4, 128.0, 127.9, 126.4, 125.3, 125.0, 
123.4, 121.5, 118.9, 118.7. Signal for one carbon could not be located. FT-IR (neat, cm
-1
) 
υ 1595, 1503, 1315. Anal calcd for C22H17N (295.14 g/mol): C, 89.46; H, 5.80; N, 4.74 
Found. C, 89.65; H, 5.52; N, 4.46. 
In order to confirm the arylation regioselectivity, 1,N-diphenyl-2-naphthylamine was 
prepared as follows: A 2 dram vial equipped with magnetic stirring bar was charged with 
1-phenyl-2-naphthylamine (110 mg, 0.5 mmol), PhI (204 mg, 1.0 mmol), CuI (20 mg, 0.1 
mmol), phenanthroline (36 mg, 0.2 mmol), K3PO4 (318 mg, 1.5 mmol), and DMF (1 
mL). Vial was then flushed with nitrogen and placed in the preheated oil bath (100 
o
C) 
for 24 hours. The reaction mixture was cooled to room temperature. The reaction mixture 
was subjected to flash chromatography on silica gel in hexanes followed by 
hexane/CH2Cl2 (85/15) to elute the product. After concentrating the fractions containing 
the product, the residue was dried under reduced pressure to yield 88 mg (60 %) of a light 
brown solid. 
1
H NMR (400 MHz, CDCl3) is identical with the product above (Table 
3.4.3, Entry 4). The experiment shows that the arylation for Table 3.4.3, entry 4 occurs on 
naphthyl and not phenyl group. 
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H
N
 
N-(Phenylmethyl)-(1,1'-biphenyl)-2-amine (Table 3.4.3, Entry 5):  
N-Benzylaniline (92 mg, 0.5 mmol), chlorobenzene (90mg, 0.8 mmol), TMPLi (265 mg, 
1.8 mmol), anhydrous pentane (1.8 mL), anhydrous THF (0.05 mL), room temperature, 
24 hours. After column chromatography (hexanes followed by hexanes/CH2Cl2 75/25), 
90 mg (70%) of a white solid was obtained. Less than 10% of N-arylation product was 
observed in crude reaction mixture by GC analysis. 
Rf = 0.33 (hexanes/CH2Cl2: 75/25). This compound is known.
33
 
1
H NMR (400 MHz, 
CDCl3) δ 7.52 – 7.45 (m, 4H), 7.40 – 7.32 (m, 5H), 7.30 – 7.19 (m, 2H), 7.15 (dd, J = 7.4 
Hz, 1.1 Hz, 1H), 6.81 (dt, J = 7.4 Hz, 1.1 Hz, 1H), 6.69 (d, J = 8.0 Hz, 1H), 4.44 (s, 1H), 
4.36 (d, J = 4.6 Hz, 2H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 145.0, 139.6, 130.4, 129.5, 
129.1, 128.8, 128.7, 127.7, 127.4, 127.2, 117.3, 110.8, 48.2. Signals for two carbons 
could not be located.  
NH2
 
2-Aminobiphenyl (Table 3.4.3, Entry 6).  
Aniline (186 mg, 2.0 mmol), chlorobenzene (57 mg, 0.5 mmol), TMPLi (500 mg, 3.4 
mmol), anhydrous cyclohexane (2.8 mL), anhydrous Et2O (0.2 mL), 50 
o
C, 48 hours. 
After column chromatography (hexanes followed by hexanes/EtOAc: 90/10), 46 mg (55 
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%) of a light brown solid was obtained. About 25% of N-arylation product was observed 
in crude reaction mixture by GC analysis. 
Using TMPLi solution: Vial equipped with magnetic stirring bar was charged with 
aniline (186 mg, 2.0 mmol) and chlorobenzene (57 mg, 0.5 mmol). Vial was flushed with 
nitrogen and capped. TMPLi 1M  suspension in pentane (3.2 mL, 3.2 mmol) was added, 
followed by anhydrous Et2O (0.2 mL) via syringe. Reaction was run at 50 
o
C for 48 
hours. General work up procedure was followed. After column chromatography (hexanes 
followed by hexanes/EtOAc: 90/10), 44 mg (53 %) of a light brown solid was obtained. 
About 25 % of N-arylation product was observed in crude reaction mixture by GC 
analysis. 
Rf = 0.26 (hexanes/EtOAc: 90/10). This compound is known.
34
 
1
H NMR (400 MHz, 
CDCl3) δ 7.47 – 7.43 (m, 4H), 7.37 – 7.33 (m, 1H), 7.18 – 7.13 (m, 2H), 6.84 (dt, J = 7.6 
Hz, 1.3 Hz, 1H), 6.75 (d, J = 7.6 Hz, 1H), 3.76 (s, 2H). 
13
C NMR (100 MHz, CDCl3, 
ppm) δ 143.6, 139.6, 130.5, 129.2, 128.9, 128.6, 127.7, 127.3, 118.7, 115.7. 
NH2
Cl  
5-Chlorobiphenyl-2-amine (Table 3.4.3, Entry 7) 
4-Chloroaniline (64 mg, 0.5 mmol), phenyltrifluoromethanesulfonate (340 mg, 1.5 
mmol), TMPLi (338 mg, 2.3 mmol), anhydrous Et2O (0.7 mL), anhydrous pentane (0.7 
mL), - 50 
o
C, 24 hours. After column chromatography (hexanes followed by 
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hexanes/EtOAc: 90/10), 61 mg (60%) of a tan solid was obtained. About 5 % of N-
arylation product was observed in crude reaction mixture by GC analysis. 
Rf = 0.30 (hexanes/EtOAc: 90/10). This compound is known.
12
 
1
H NMR (400 MHz, 
CDCl3) δ 7.46 – 7.40 (m, 4H), 7.36 (tt, J = 6.8 Hz, 1.7 Hz, 1H), 7.11- 7.08 (m, 2H), 6.68 
(d, J = 8.8 Hz, 1H), 3.75 (s, 2H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 142.0, 138.3, 
130.1, 129.2, 129.1, 129.0, 128.3, 127.8, 123.4, 116.9. 
NH2
 
4,6-Dimethyl-(1,1'-biphenyl)-2-amine (Table 3.4.3, Entry 8): 
3,5-Dimethylaniline (242 mg, 2.0 mmol), chlorobenzene (57 mg, 0.5 mmol), TMPLi (500 
mg, 3.4 mmol), anhydrous cyclohexane (2.8 mL), anhydrous Et2O (0.2 mL), 50 
o
C, 48 
hours. After column chromatography (hexanes followed by hexanes/EtOAc: 90/10), 68 
mg (70 %) of a light brown oil was obtained. About 10% of N-arylation product was 
observed in crude reaction mixture by GC analysis. 
Rf = 0.29 (hexanes/EtOAc: 90/10). This compound is known.
35
 
1
H NMR (400 MHz, 
CDCl3) δ 748 – 7.44 (m, 2H), 7.38 – 7.33 (m, 1H), 7.24 – 7.27 (m, 2H), 6.57 (s, 1H), 6.50 
(s, 1H), 3.42c (s, 2H), 2.29 (s, 3H), 2.00 (s, 3H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 
144.1, 138.4, 137.9, 136.9, 130.2, 129.1, 127.2, 125.3, 121.1, 113.5, 21.3, 20.6. 
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NH2
CF3     
NH2
CF3                               
6-(Trifluoromethyl)biphenyl-2-amine and 4-(trifluoromethyl)biphenyl-2-amine 
(Table 3.4.3, Entry 9) 
3-Aminobenzotrifluoride (322 mg, 2.0 mmol), chlorobenzene (57 mg, 0.5 mmol), TMPLi 
(485 mg, 3.2 mmol), anhydrous cyclohexane (2.8 mL), anhydrous Et2O (0.2 mL), 50 
o
C, 
48 hours. After column chromatography (hexanes followed by hexanes/EtOAc: 90/10), 
20 mg (17 %) of a light brown oil [4-(trifluoromethyl)biphenyl-2-amine] and 59 mg (50 
%) of a tan oil [6-(trifluoromethyl)biphenyl-2-amine] were obtained. About 15 % of N-
arylation product was observed in crude reaction mixture by GC analysis.These 
compounds are known.
36
 
4-(Trifluoromethyl)biphenyl-2-amine: Rf = 0.32 (hexane/EtOAc = 95/5). 
1
H NMR 
(400 MHz, CDCl3) δ 7.48 – 7.42 (m, 4H), 7.39 (tt, J = 7.5 Hz, 1.7 Hz, 1H), 7.20 (d, J = 
7.5 Hz, 1H), 7.04 (d, J = 7.5 Hz, 1H), 6.98 (s, 1H), 3.92 (s, 2H). 
13
C NMR (100 MHz, 
CDCl3, ppm) δ 143.7, 138.2, 131.0, 130.9, 130.8 (q, J = 24.2 Hz), 129.1, 128.9, 128.0, 
124.2 (q, J = 273 Hz), 115.2 (q, J = 3.2 Hz), 112.1 (q, J = 3.6 Hz). 
6-(Trifluoromethyl)biphenyl-2-amine: Rf = 0.27 (hexane/EtOAc = 90/10). 
1
H NMR 
(400 MHz, CDCl3) δ 7.47 – 7.44 (m, 2H), 7.40 (tt, J = 7.5 Hz, 1.2 Hz, 1H), 7.27 – 7.22 
(m, 3H), 7.14 (d, J = 7.5 Hz, 1H), 6.91 (d, J = 8.0 Hz, 1H), 3.56 (s, 2H). 
13
C NMR (100 
MHz, CDCl3, ppm) δ 145.6, 135.3, 130.1, 129.7 (q, J = 29.3 Hz), 128.8, 128.3, 128.1, 
125.6, 124.2 (q, J = 273 Hz), 118.3 (q, J = 2.4 Hz), 115.5 (q, J = 5.8 Hz). 
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NH2
 
5-(1,1-Dimethylethyl)-(1,1'-biphenyl)-2-amine (Table 3.4.3, Entry 10): 
4-tert-Butylaniline (298 mg, 2.0 mmol), chlorobenzene (57 mg, 0.5 mmol), TMPLi (500 
mg, 3.4 mmol), anhydrous cyclohexane (2.8 mL), anhydrous Et2O (0.2 mL), 50 
o
C, 48 
hours. After column chromatography (hexanes followed by hexanes/EtOAc 90/10), 67 
mg (60 %) of a brown solid was obtained. About 15 % of N-arylation product was 
observed in crude reaction mixture by GC analysis. 
Rf = 0.34 (hexanes/EtOAc: 90/10). This compound is known.
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1
H NMR (400 MHz, 
CDCl3) δ 7.51 – 7.45 (m, 4H), 7.38 – 7.34 (m, 1H), 7.22 (dd, J = 8.4 Hz, 2.3 Hz, 1H), 
7.17 (d, J = 2.3 Hz, 1H), 6.74 (d, J = 8.4 Hz, 1H), 3.68 (s, 2H), 1.32 (s, 9H). 
13
C NMR 
(100 MHz, CDCl3, ppm) δ 141.6, 141.1, 140.2, 129.3, 128.9, 127.5, 127.3, 127.2, 125.5, 
115.6, 34.1, 31.7. 
NH2
 
(1,1':3',1''-Terphenyl)-4'-amine (Table 3.4.3, Entry 11).  
4-Aminobiphenyl (338 mg, 2.0 mmol), chlorobenzene (57 mg, 0.5 mmol), TMPLi (500 
mg, 3.4 mmol), anhydrous cyclohexane (2.8 mL), anhydrous Et2O (0.2 mL), 50 
o
C, 48 
hours. After column chromatography (hexanes followed by hexanes/EtOAc 85/15), 81 
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mg (67 %) of a light brown solid was obtained. About 20% of N-arylation product was 
observed in crude reaction mixture by GC analysis. 
Rf = 0.27 (hexanes/EtOAc = 80/20). This compound is known.
38
 
1
H NMR (400 MHz, 
CDCl3) δ 7.61 – 7.59 (m, 2H), 7.55 – 7.53 (m, 2H), 7.52 – 7.46 (m, 3H), 7.45 – 7.38 (m, 
4H), 7.30 (t, J = 7.6 Hz, 1H), 6.86 (d, J = 8.0 Hz, 1H), 3.85 (s, 2H). 
13
C NMR (100 MHz, 
CDCl3, ppm) δ 143.1, 141.1, 139.5, 131.8, 129.3, 129.2, 129.0, 128.8, 128.0, 127.5, 
127.2, 126.6, 126.5, 116.1. 
NH2
 
2-Phenyl-1-naphthylamine (Table 3.4.3, Entry 12): 
1-Naphthylamine (143 mg, 1.0 mmol), chlorobenzene (57 mg, 0.5 mmol), TMPLi (340 
mg, 2.3 mmol), anhydrous cyclohexane (0.7 mL), anhydrous Et2O (0.7 mL), room 
temperature, 24 hours. After column chromatography (hexanes followed by 
hexanes/EtOAc: 90/10), 92 mg (85 %) of a tan solid was obtained. Less than 5% of N-
arylation product was observed in crude reaction mixture by GC analysis. 
Rf = 0.23 (hexanes/EtOAc 90/10). This compound is known.
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1
H NMR (400 MHz, 
CDCl3) δ 7.92 – 7.86 (m, 2H), 7.60 – 7.51 (m, 6H), 7.46 – 7.42 (m, 2H), 7.37 (d, J = 8.5 
Hz, 1H), 4.34 (s, 2H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 140.3, 138.7, 133.9, 129.8, 
129.1, 128.8, 128.7, 127.3, 126.0, 125.5, 123.8, 122.2, 121.3, 118.7.   
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NH2
 
(1,1':3',1''-Terphenyl)-2'-amine (Table 3.4.3, Entry 13): 
2-Aminobiphenyl (338 mg, 1.5 mmol), chlorobenzene (57 mg, 0.5 mmol), TMPLi (500 
mg, 3.4 mmol), anhydrous cyclohexane (2.8 mL), anhydrous Et2O (0.2 mL), 50 
o
C, 48 
hours. After column chromatography (hexanes followed by hexanes/EtOAc: 90/10), 85 
mg (70 %) of a light brown solid was obtained. About 15 % of N-arylation product was 
observed in crude reaction mixture by GC analysis. 
Rf = 0.22 (hexanes/EtOAc: 90/10). This compound is known.
40
 
1
H NMR (400 MHz, 
CDCl3) δ 7.57 – 7.55 (m, 4H), 7.51 – 7.48 (m, 4H), 7.42 – 7.38 (m, 2H), 7.18 (d, J = 7.6 
Hz, 2H), 6.93 (t, J = 7.6 Hz, 1H), 3.88 (s, 2H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 
140.9, 139.9, 129.9, 129.5, 129.0, 128.0, 127.4, 118.3. 
NH2
CN  
6-Aminobiphenyl-3-carbonitrile (Table 3.4.3, Entry 14) 
Outside the glovebox a 2-dram vial was equipped with a magnetic stirring bar. The vial 
was placed inside the glovebox. To the vial was added solid TMPLi (300 mg, 2.0 mmol). 
The sealed vial was taken out of the glovebox and placed into cooling bath at -60 
o
C. 
Anhydrous Et2O (0.7 mL) was added via syringe to reaction vial. 4-Aminobenzonitrile 
(60 mg, 0.5 mmol) solution in anhydrous THF (0.7 mL) was cooled to -60 
o
C and added 
slowly to reaction mixture. Following that, chlorobenzene (113 mg, 1.0 mmol) was added 
 289 
to vial. Reaction was run at -60 
o
C for 24 hours. Work-up procedure for reactions at low 
temperature was applied. After column chromatography (hexanes followed by 
hexanes/EtOAc: 75/25), 63 mg (65 %) of a brown oil was obtained. About 15 % of N-
arylation product was observed in crude reaction mixture by GC analysis. 
Rf = 0.23 (hexanes/EtOAc 70/30). This compound is known.
41
 
1
H NMR (400 MHz, 
CDCl3) δ 7.71 (dd, J = 7.6 Hz, 0.9 Hz, 1H), 7.58 (dt, J = 7.6 Hz, 1.4 Hz, 1H), 7.46 (d (J = 
8.0 Hz, 1H), 7.39 – 7.23 (m, 3H), 6.77 (d, J = 8.7 Hz, 2H), 3.82 (s, 2H). 13C NMR (100 
MHz, CDCl3, ppm) δ 147.2, 145.7, 133.9, 132.8, 130.0, 129.8, 128.2, 126.7, 119.4, 115.1, 
110.8. 
NH2
NH2
 
3-Phenyl-1,1'-binaphthyl-2,2'-diamine (Scheme 3.4.9) 
Outside the glovebox a 2-dram vial was equipped with a magnetic stirring bar. The vial 
was placed inside the glovebox. To the vial was added solid TMPLi (265 mg, 1.8  mmol). 
The sealed vial was taken out of the glovebox and placed into cooling bath at -30 
o
C. 
Anhydrous Et2O (1.4 mL) was added via syringe to reaction vial. (S)-(-)1,1’-Bis(2-
naphthylamine) (36 mg, 0.25 mmol) solution in anhydrous THF (0.7 mL) was added 
slowly to reaction mixture. Following that, chlorobenzene (113 mg, 1.0 mmol) was added 
to vial. Reaction was stirred at -30 
o
C for 48 hours. Work-up procedure for reactions at 
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low temperature was applied. Reaction residue was chromatographed with hexanes 
followed by hexanes/EtOAc (85/15) to obtain 26 mg (47 %) of a white solid. 
Determination of % ee by HPLC on chiral stationary phase: CHIRALCEL OD-H, 
hexanes/isopropanol 95:5, 0.75 mL/min, > 99 % ee. Retention time: major, (S) = 14.2 
min, (R) = 12.1 min.  
Rf = 0.28 (hexanes/EtOAc: 80/20). This compound is known.
42
 
1
H NMR (400 MHz, 
CDCl3) δ 7.82 – 7.78 (m, 3H), 7.76 (s, 1H), 7.62 (dd, J = 7.8 Hz, 1.4 Hz, 2H), 7.49 (t, J = 
7.8 Hz, 2H), 7.40 (tt, J = 7.4 Hz, 2.5 Hz, 1H), 7.23 – 7.23 (m, 4H), 7.16 (d, J = 8.2 Hz, 
2H), 7.06 (d, J = 8.2 Hz, 1H), 3.78 (broad overlapping singlet, 4H). 
13
C NMR (100 MHz, 
CDCl3, ppm) δ 142.8, 140.8, 139.3, 133.7, 133.2, 130.8, 129.9, 129.6, 129.5, 129.4, 
129.0, 128.9, 128.5, 128.3, 127.8, 127.0, 126.9, 124.1, 123.9, 122.7, 122.6, 118.5, 113.0, 
112.7. 
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3.4.4.2. Reactions Between Arynes and Phenols: 2-Arylphenols and Helicenes 
Synthesis 
General considerations:  
For helicene synthesis, reactions were performed in 2-dram vials using screw caps with 
17 mm hole and white silicone septum with white teflon face (from SUPELCO). For 
phenol arylation, reactions were run in 2-dram vials using 17 mm screw caps with 
PTFE/Liner (from SUPELCO). Column chromatography was performed on 60Å silica 
gel (Sorbent Technologies). Purification by preparative HPLC was performed on a 
Shimadzu Prominence LC (LC-20AB) equipped with a SPD-20A UV-Vis detector and a 
Varian Dynamax (250 mm x 21.4 mm) column. GC-MS analyses were performed on a 
Shimadzu GCMS-QP5000 chromatograph equipped with a Restek column (Rtx-XLB, 30 
m x 0.25 mm I.D.). The 
1
H and 
13
C NMR were recorded on JEOL EC-400 or JEOL EC-
500 spectrometers using residual solvent peak as a reference. Elemental analyses were 
performed by Atlantic Microlab Inc. of Norcross, GA. IR spectra were obtained on a 
ThermoNicolet Avatar 370 FT-IR instrument. Analytical thin layer chromatography was 
performed on silica gel IB-F (Baker-flex) by J. T. Baker. All procedures were performed 
under nitrogen atmosphere unless otherwise noted. 
Room temperature: 25 
o
C. 
Materials. The following starting materials were obtained from commercial sources and 
were used without further purification: phenol, 2-tert-butylphenol, 3-tert-butylphenol, 
2,3-dimethylphenol, 2,6-diisopropylphenol, 2-hydroxybenzotrifluoride, 4-
hydroxybiphenyl, 1-naphthol, 2-naphthol, 7-methoxy-2-naphthol, 4-
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hydroxybenzophenone, chlorobenzene, 2-chloroanisole, 3-chloro-1-fluorobenzene, 3-
chlorobenzonitrile 1-chloronaphthalene, 3-chlorobenzotrifluoride, 1,1'-binaphthyl-2,2'-
diol (racemic), silver acetate, tert-butyl-3-bromobenzoate, 2,2,6,6-tetramethylpiperidine 
(TMPH), iodomethane, m-cresol, (R)-(+)-1,1
’
-bi(2-naphthol). 3-(tert-
Butyldimethylsilyloxy) phenol was synthesized according to literature.
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TMPLi:  A 250 mL oven-dried flask equipped with a magnetic stirring bar and a septum 
was evacuated and backfilled with nitrogen 5 times. TMPH (15.5 g, 18.5 mL, 110 mmol) 
was added via syringe, followed by anhydrous pentane to give approximately 100 mL of 
solution. The mixture was cooled to -73 °C (dry ice-acetone bath) and stirred for 10 
minutes. n-BuLi (2.5 M in hexanes, 40.0 mL, 100 mmol) was added dropwise and 
reaction mixture was stirred for 30 minutes at -73 °C, then warmed up to room 
temperature (25 °C) and stirred overnight. The reaction mixture was vacuumed to remove 
all solvent and dried under vacuum for at least 5 hours. A light yellow powder of solid 
TMPLi was obtained. 
TMPLi 1 M in pentane/hexanes: A 50 mL oven-dried flask equipped with a magnetic 
stirring bar and a septum was evacuated and backfilled with argon 5 times. TMPH (4.64 
g, 33.0 mmol) was added, followed by anhydrous pentane to give 30 mL of solution 
(marked the flask at the level of solution). The mixture was cooled to -73 °C (dry ice-
acetone) and stirred for 5 minutes. n-BuLi (2.5 M in hexanes, 12.0 mL, 30 mmol) was 
added dropwise and reaction mixture was stirred for 30 minutes at -73 °C, then warmed 
up to room temperature and stirred overnight. The reaction mixture was vacuumed to 
give 30 mL (at the marked level) of TMPLi suspension.  
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General procedure for synthesis of helicenes: A 2 dram vial equipped with a magnetic 
stir bar was charged with appropriate phenol (0.5 mmol) and ArCl (3 – 4 equiv). The vial 
was flushed with nitrogen and capped. To this mixture was added the appropriate base 
solution or suspension (3.7 – 4.7 equiv) at the specified reaction temperature by injecting 
through the septum by 1 mL syringe. The base suspension was stirred vigorously during 
the time being withdrawn by syringe. Tetrahydrofuran (THF) or diethyl ether was then 
promptly added. The vial was flushed with nitrogen (20 seconds) and then stirred at 
specified temperature for indicated time. Unless otherwise stated, reaction mixture was 
quenched with anhydrous MeOH (0.5 mL), evacuated to volume of 1 mL and subjected 
to column chromatography on silica gel in hexanes or pentane followed by appropriate 
solvent to elute the product. After concentrating the fractions containing the product, the 
residue was dried under reduced pressure. 
Optimization of conditions of helicene synthesis: All reactions were carried out 
following the general procedure. Phenol (x mmol), chlorobenzene (y mmol), TMPLi [1M 
suspention in pentane/hexanes, 1.2*(x + y) mmol], 24 hours. Conversions and 1/2 ratio 
were calculated by GC analysis. Conversions are presented in Table 3.4.S1 and show the 
amount of product 1 and 2 formed (e.g. 70 % means that 70 % of starting limiting reagent 
is converted to 1 and 2). Mixture with exact molar amounts of pure 1 and pure 2 was used 
as the standard to determine the ratio 2/1. 
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Table 3.4.14. Reaction optimization in details 
Ph-Cl Ph-OH
Conditions
Ph-O-Ph
1 2  
Entry  PhOH
/PhCl 
Base/T (
o
C) Solvent Conversion 2/1 
1 1/2 TMPLi/ 25 
o
C THF 32 1/4 
2 1/2 TMPLi/ 25 
o
C Et2O 21 1/3 
3 1/2 LDA/ 25 
o
C Et2O 27 < 1/50 
3 1/2 TMPLi/ 40 
o
C Pentane 35 7/1 
4 2/1 TMPLi/ 40 
o
C Pentane 17 1/2 
5 1/2 TMPLi/ 25 
o
C Pentane/THF (10/1) 40 8/1 
6 1/2 TMPLi/ 25 
o
C Pentane/THF (8/1) 34 7/1 
7 1/2 TMPLi/ 25 
o
C Pentane/THF (20/1) 52 40/1 
8 1/2 TMPLi/ 25 
o
C Pentane/THF (36/1) 61 > 50/1 
9 1/2 TMPLi/ 25 
o
C Pentane/THF (50/1) 65 > 50/1 
10 1/4 TMPLi/ 25 
o
C Pentane/THF (50/1) 80  > 50/1 
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Benzophenanthrene (2) (Table 3.4.5, Entry 1) 
Chlorobenzene (225 mg, 2.0 mmol), phenol (48 mg, 0.5 mmol), TMPLi in 
pentane/hexanes (1M, 2.7 mL), followed by THF (0.05 mL), rt, 24 hours. After column 
chromatography (hexanes, followed by hexanes/CH2Cl2 90/10), 76 mg (67 %) of a light 
yellow solid was obtained.  
Chlorobenzene (112.5 mg, 1.0 mmol), benzocyclooctenone-5(6H) (85 mg, 0.5 mmol), 
TMPLi in pentane (1M, 1.8 mL), followed by THF (0.05 mL), rt, 24 hours. After column 
chromatography (hexanes, followed by hexanes/CH2Cl2 90/10), 102 mg (90 %) of a light 
yellow solid was obtained. Rf = 0.24 (hexanes/CH2Cl2 90/10). This compound is 
known.
44
 
1
H NMR (400 MHz, CDCl3) δ 9.15 (d, J = 8.4 Hz, 2H), 8.03 (dd, J = 8.0 Hz, 
1.3 Hz, 2H), 7.93 – 7.90 (m, 2H), 7.85 – 7.82 (m, 2H), 7.71 – 7.61 (m, 4H). 13C NMR 
(100 MHz, CDCl3, ppm) δ 133.6, 131.1, 130.4, 128.6, 128.0, 127.6, 127.4, 127.0, 126.2, 
126.0. 
 
5-tert-Butylbenzophenanthrene (3) (Table 3.4.5, Entry 2) 
Chlorobenzene (225 mg, 2.0 mmol), 2-tert-butylphenol (75 mg, 0.5 mmol), TMPLi in 
pentane/hexanes (1M, 2.7 mL), followed by THF (0.05 mL), rt, 24 hours. After column 
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chromatography (hexanes, followed by hexanes/CH2Cl2 90/10), 68 mg (48 %) of a 
colorless oil was obtained. Rf = 0.35 (hexanes/CH2Cl2 90/10). 
1
H NMR (400 MHz, 
CDCl3) δ 9.17 – 9.14 (m, 1H), 9.04 (d, J = 8.5 Hz, 1H), 8.69 – 8.66 (m, 1H), 8.01 (dd, J = 
7.8 Hz, 1.3 Hz, 1H), 7.91 – 7.80 (m, 3H), 7.69 – 7.59 (m, 5H), 1.76 (s, 9H). 13C NMR 
(100 MHz, CDCl3, ppm) δ 144.6, 133.6, 132.0, 131.9, 130.4, 129.9, 129.3, 128.6, 128.2, 
127.6, 127.1, 127.0, 126.7, 126.2, 125.6, 124.8, 124.7, 124.3, 36.0, 32.1. FT-IR (neat, cm
-
1
) 2965, 1599, 1368, 887. Anal calcd for C22H20 (284.16 g/mol): C, 92.91; H, 7.09; 
Found. C, 92.51; H, 7.15. 
 
5,6-Dimethylbenzophenanthrene (4) (Table 3.4.5, Entry 3) 
Chlorobenzene (225 mg, 2.0 mmol), 2,3-dimethylphenol (61 mg, 0.5 mmol), TMPLi in 
pentane/hexanes (1M, 2.7 mL), followed by THF (0.05 mL), rt, 24 hours. After column 
chromatography (hexanes, followed by hexanes/CH2Cl2 90/10), 74 mg (58 %) of a white 
solid was obtained. Rf = 0.27 (hexanes/CH2Cl2 90/10). This compound is known.
45
 
1
H 
NMR (400 MHz, CDCl3) δ 9.03 – 9.01 (m, 2H), 8.24 (dd, J = 8.2 Hz, 1.5 Hz, 1H), 8.12 
(d, J = 9.1 Hz, 1H), 8.02 (dd, J = 7.8 Hz, 1.5 Hz, 1H), 7.93 (d, J = 9.1 Hz, 1H), 7.68 – 
7.59 (m, 4H), 2.81 (s, 3H), 2.80 (s, 3H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 133.2, 
132.7, 130.7, 130.2, 130.0, 129.6, 129.1, 128.8, 128.7, 128.2, 127.2, 126.8, 126.0, 125.9, 
125.6, 124.7, 124.1, 122.8, 16.4, 16.2. 
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5-Phenylbenzophenanthrene (5) (Table 3.4.5, Entry 4) 
Chlorobenzene (225 mg, 2.0 mmol), 2-phenylphenol (85 mg, 0.5 mmol), TMPLi in 
pentane/hexanes (1M, 2.7 mL), followed by THF (0.05 mL), rt, 24 hours. After column 
chromatography (hexanes, followed by hexanes/CH2Cl2 90/10), 98 mg (65 %) of a light 
yellow solid was obtained. Rf = 0.19 (hexanes/CH2Cl2 90/10). This compound is 
known.
46
 
1
H NMR (400 MHz, CDCl3) δ 9.25 (d, J = 8.6 Hz, 1H), 9.21 (d, J = 8.6 Hz, 
1H), 8.14 (dd, J = 8.0 Hz, 1.1 Hz, 1H), 8.08 (dd, J = 8.0 Hz, 1.1 Hz, 1H), 7.95 (d, J = 8.6 
Hz, 1H), 7.86 (d, J = 8.6 Hz, 1H), 7.84 (s, 1H), 7.77 – 7.72 (m, 2H), 7.69 – 7.66 (m, 3H), 
7.61 – 7.57 (m, 3H), 7.55 – 7.52 (m, 1H). 13C NMR (100 MHz, CDCl3, ppm) δ 140.7, 
139.2, 133.7, 132.4, 130.9, 130.5, 130.3, 128.8, 128.6, 128.4, 128.1, 128.0, 127.6, 127.1, 
127.0, 126.9, 126.4, 126.2, 126.1, 126.0. Signals for two carbons could not be located. 
 
5,8-Diisopropylbenzophenanthrene (6) (Table 3.4.5, Entry 5) 
Chlorobenzene (225 mg, 2.0 mmol), 2.6-diisopropylphenol (89 mg, 0.5 mmol), TMPLi in 
pentane/hexanes (1M, 2.7 mL), followed by THF (0.05 mL), rt, 24 hours. After column 
chromatography (hexanes, followed by hexanes/CH2Cl2 90/10), 62 mg (40 %) of a white 
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solid was obtained. Rf = 0.34 (hexanes/CH2Cl2 90/10), mp 91 – 93 
o
C (from hexane). 
1
H 
NMR (400 MHz, CDCl3) δ 9.07 – 9.04 (m, 2H), 8.31 – 8.29 (m, 2H), 7.73 (s, 2H), 7.67 – 
7.62 (m, 4H), 3.84 (heptet, J = 6.5 Hz, 2H), 1.52 (d, J = 6.5 Hz, 12H). 
13
C NMR (100 
MHz, CDCl3, ppm) δ 143.2, 131.7, 130.6, 130.5, 128.9, 125.5, 125.4, 125.1, 123.7, 122.5, 
28.6, 23.5. FT-IR (neat, cm
-1
) 2963, 1603, 1521, 893. Anal calcd for C24H24 (312.19 
g/mol): C, 92.26; H, 7.74; Found. C, 92.55; H, 7.32. 
 
 
 
 
6-(Trifluoromethyl)benzophenanthrene (7) (Table 3.4.5, Entry 6) 
Chlorobenzene (225 mg, 2.0 mmol), 3-hydroxybenzotrifluoride (81 mg, 0.5 mmol), 
TMPLi in pentane/hexanes (1M, 2.7 mL), followed by THF (0.05 mL), rt, 24 hours. After 
column chromatography (hexanes, followed by hexanes/CH2Cl2 90/10), 59 mg (40 %) of 
a white solid was obtained. Rf = 0.31 (hexanes/CH2Cl2 90/10), mp 78 – 80 
o
C (from 
hexane). 
1
H NMR (400 MHz, CDCl3) δ 9.06 – 9.01 (m, 2H), 8.31 (s, 1H), 8.18 – 8.15 (m, 
1H), 8.08 – 8.02 (m, 2H), 7.98 (d, J = 9.1 Hz, 1H), 7.78 – 7.74 (m, 1H), 7.70 – 7.65 (m, 
3H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 133.2, 131.6, 131.0, 130.0, 129.6, 129.5, 129.1, 
128.4, 128.3, 128.2, 127.0 (q, J = 6.7 Hz), 126.9, 126.8, 126.5, 126.0, 124.9 (q, J = 273 
Hz), 124.5, (q, J = 30.8 Hz), 122.2 (q, J = 2.7 Hz). Signal for one carbon could not be 
located. FT-IR (neat, cm
-1
) 3680, 2967, 1328, 1110, 1054, 1032. Anal calcd for C19H11F3 
(296.08 g/mol): C, 77.02; H, 3.74; Found. C, 77.41; H, 3.72. 
CF3
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6-tert-Butylbenzophenanthrene (8) (Table 3.4.5, Entry 7) 
Chlorobenzene (225 mg, 2.0 mmol), 3-tert-butylphenol (75 mg, 0.5 mmol), TMPLi in 
pentane/hexanes (1M, 3.0 mL), followed by THF (0.05 mL), rt, 24 hours. After column 
chromatography (hexanes, followed by hexanes/CH2Cl2 90/10), 72 mg (51 %) of a light 
yellowish oil was obtained.  
6-tert-Butyl-6a,12b-dihydrobenzophenanthren-12b-ol (12) (151 mg, 0.5 mmol), TMPLi 
in pentane/hexanes (1M, 1.0 mL), followed by THF (0.03 mL), rt, 24 hours. After 
column chromatography (hexanes, followed by hexanes/CH2Cl2 90/10), 127 mg (90 %) 
of a light yellowish oil was obtained.  
Chlorobenzene (112.5 mg, 1.0 mmol), (7E,9Z)-7-tert-butylbenzo[8]annulen-5(6H)-one 
(11) (113 mg, 0.5 mmol), TMPLi in pentane/hexanes (1M, 2.5 mL), followed by THF 
(0.05 mL), rt, 24 hours. After column chromatography (hexanes, followed by 
hexanes/CH2Cl2 90/10), 82 mg (58 %) of a light yellow oil was obtained.  
Rf = 0.34 (hexanes/CH2Cl2 90/10). 
1
H NMR (400 MHz, CDCl3) δ 9.01 – 8.99 (m, 1H), 
8.94 – 8.92 (m, 1H), 8.51 (d, J = 9.1 Hz, 1H), 8.00 – 7.95 (m, 2H), 7.90 (s, 1H), 7.87 (d, J 
= 9.1 Hz, 1H), 7.62 – 7.56 (m, 4H), 1.72 (s, 9H). 13C NMR (100 MHz, CDCl3, ppm) δ 
143.9, 132.9, 132.3, 130.7, 129.8, 129.6, 129.2, 129.1, 128.4, 128.2, 127.7, 126.0, 125.6, 
125.5, 125.3, 125.2, 124.5, 36.1, 32.3. Signal for one carbon could not be located. FT-IR 
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(neat, cm
-1
) 2960, 1487, 1367, 889. Anal calcd for C22H20 (284.16 g/mol): C, 92.91; H, 
7.09; Found. C, 92.76; H, 6.88. 
 
 
 
(Benzo[c]phenanthren-6-yloxy)(tert-butyl)dimethylsilane (9) (Table 3.4.5, Entry 8) 
Chlorobenzene (225 mg, 2.0 mmol), 3-(tert-butyldimethylsilyloxy) phenol (112 mg, 0.5 
mmol), TMPLi in pentane/hexanes (1M, 3.0 mL), followed by THF (0.05 mL), rt, 24 
hours. After column chromatography (hexanes, followed by hexanes/CH2Cl2 90/10), 93 
mg (52 %) of a light yellow oil was obtained. Rf = 0.23 (hexanes/CH2Cl2 90/10). 
1
H 
NMR (400 MHz, CDCl3) δ 9.17 (d, J = 8.1 Hz, 1H), 9.08 (d, J = 8.1 Hz, 1H), 8.38 (d, J = 
8.7 Hz, 1H), 8.06 (dd, J = 7.9 Hz, 1.4 Hz, 1H), 7.97 (d, J = 8.7 Hz, 1H), 7.91 (dd, J = 7.9 
Hz, 1.4 Hz, 1H), 7.72 – 7.64 (m, 2H), 7.62 – 7.56 (m, 2H), 7.30 (s, 1H), 1.21 (s, 9H), 
0.42 (s, 6H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 149.8, 134.2, 133.7, 130.3, 129.3, 
128.6, 128.3, 128.1, 127.4, 127.3, 127.2, 126.7, 126.3, 126.2, 126.1, 124.0, 121.0, 112.0, 
26.1, 18.7, -4.0.  
 
 
O
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(Scheme 3.4.10) 
1-Chloronaphthalene (335 mg, 2.0 mmol), 2,6-dimethylphenol (62 mg, 0.5 mmol), 
TMPLi in pentane/hexanes (1M, 2.7 mL), followed by THF (0.05 mL), rt, 24 hours. After 
column chromatography (hexanes, followed by hexanes/CH2Cl2 90/10), 106 mg (60 %) 
of a light brown solid (mixture of isomers) was obtained. The isomer ratio was 
determined to be 2/1 10/9 by 
1
HNMR. The isomers were separated by fractional 
crystallization from hexanes. Compound 10 crystallized out and was collected by vacuum 
filtration at - 20
 o
C. Residue from crystallization contains a mixture of two isomers. 
White crystalline 10 was obtained (45 mg, 26% yield) and 61 mg of isomer mixture was 
recovered. Mixture: 
1
H NMR (400 MHz, CDCl3) δ 8.93 (d, J = 8.5 Hz), 8.16 – 8.11 (m), 
8.05 – 8.03 (m), 7.99 – 7.89 (m), 7.83 – 7.81 (m), 7.75 – 7.72 (m), 7.68 – 7.62 (m), 7.53 – 
7.47 (m), 7.43 (d, J = 8.8 Hz), 7.21 – 7.17 (m), 6.65 – 6.61 (m), 3.17 (s), 2.90 (s), 2.86 
(s). 
 3,6-Dimethylphenanthro[3,4-c]phenanthrene (11) (Scheme 3.4.10) 
Rf = 0.19 (hexanes/CH2Cl2 90/10), mp 240 – 242 
o
C (from hexanes). 
1
H NMR (400 MHz, 
CDCl3) δ 8.12 (d, J = 9.1 Hz, 2H), 7.93 (d, J = 9.1 Hz, 2H), 7.80 (dd, J = 8.3 Hz, 0.9 Hz, 
2H), 7.76 (s, 2H), 7.52 (d, J = 8.3 Hz, 2H), 7.19 = 7.15 (m, 2H), 7.65 – 7.60 (m, 2H), 
7,10-Dimethylnaphtho[2,1-c]chrysene (10) 
 
3,6-Dimethylphenanthro[3,4-c]phenanthrene (11) 
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2.90 (s, 6H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 133.2, 132.6, 131.4, 130.2, 130.1, 
128.6, 128.2, 127.3, 127.2, 126.8, 125.4, 124.5, 122.2, 122.1, 20.1. FT-IR (neat, cm
-1
) 
2380, 2343, 2334. Anal calcd for C28H20 (356.16 g/mol): C, 94.34; H, 5.66; Found. C, 
93.96; H, 5.64. 
 
 
5(6H)-Benzocyclooctenone (16) (Scheme 3.4.12) 
Chlorobenzene (90 mg, 0.8 mmol), phenol (48 mg, 0.5 mmol), TMPLi in 
pentane/hexanes (1M, 1.5 mL), followed by THF (0.04 mL), rt, 24 hours. After column 
chromatography (hexanes, followed by hexanes/EtOAc 70/30), 46 mg (55 %) of a 
colorless oil was obtained.  
Chlorobenzene (56 mg, 0.5 mmol), phenol (94 mg, 1.0 mmol), solid TMPLi (265 mg, 1.8 
mmol), benzene (1 mL), 45 
o
C, 24 hours. After column chromatography (hexanes, 
followed by hexanes/EtOAc 70/30), 53 mg (63 %) of a colorless oil was obtained.  
Rf = 0.32 (hexanes/EtOAc 70/30). This compound is known.
47
 
1
H NMR (400 MHz, 
CDCl3) δ 8.40 (dd, J = 8.0 Hz, 1.1 Hz, 1H), 7.54 (dt, J = 7.5 Hz, 1.6 Hz, 1H), 7.43 (d, J = 
7.5 Hz, 1H), 7.37 (dt, J = 7.5 Hz, 1.1 Hz, 1H), 6.87 (d, J = 12.9 Hz, 1H), 6.41 (dd, J = 
12.9 Hz, 4.5 Hz, 1H), 6.30 (dd, J = 10.1 Hz, 4.5 Hz, 1H), 5.86 (q, J = 10.1 Hz, 1H), 3.42 
(d, J = 8.1 Hz, 2H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 193.7, 137.3, 136.7, 134.4, 
132.4, 132.1, 131.0, 130.2, 128.8, 128.0, 127.1, 43.8. 
 
O
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(7E,9Z)-7-tert-Butylbenzo[8]annulen-5(6H)-one (12) (Scheme 3.4.11) 
Chlorobenzene (90 mg, 0.8 mmol), 3-tert-butylphenol (75 mg, 0.5 mmol), TMPLi in 
pentane/hexanes (1M, 1.4 mL), followed by THF (0.03 mL), rt, 24 hours. After column 
chromatography (hexanes, followed by hexanes/EtOAc 95/5), 69 mg (61 %) of a 
colorless oil was obtained.  
Chlorobenzene (56 mg, 0.5 mmol), 3-tert-butylphenol (225 mg, 1.5 mmol), TMPLi in 
pentane/hexanes (1M, 1.4 mL), followed by Et2O (0.03 mL), rt, 24 hours. After column 
chromatography (hexanes, followed by hexanes/EtOAc 95/5), 73 mg (65 %) of a 
colorless oil was obtained.  
Rf = 0.29 (hexanes/EtOAc 95/5). 
1
H NMR (400 MHz, CDCl3) δ 8.21 (dd, J = 8.1 Hz, 1.3 
Hz, 1H), 7.48 (dt, J = 7.4 Hz, 1.3 Hz, 1H), 7.33 – 7.27 (m, 1H), 6.78 (d, J = 12.3 Hz, 1H), 
6.41 (dd, J = 12.3 Hz, 4.5 Hz, 1H), 6.03 (d, J = 4.5 Hz, 1H), 3.55 (s, 2H), 1.12 (s, 9H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 199.9, 149.0, 137.5, 137.0, 132.1, 131.9, 131.1, 
130.7, 130.6, 127.0, 122.2, 45.9, 37.6, 29.3. . FT-IR (neat, cm
-1
) 2963, 1669, 1595, 1289. 
Anal calcd for C16H18O (226.14 g/mol): C, 84.91; H, 8.02; Found. C, 84.68; H, 7.85. 
HO
H
 
6-tert-Butyl-6a,12b-dihydrobenzophenanthren-12b-ol (13) (Scheme 3.4.11) 
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Chlorobenzene (168 mg, 1.5 mmol), 3-tert-butylphenol (75 mg, 0.5 mmol), TMPLi in 
pentane/hexanes (1M, 2.1 mL), followed by THF (0.04 mL), rt, 24 hours. After column 
chromatography (hexanes, followed by hexanes/EtOAc 95/15), 98 mg (65 %) of a 
yellowish oil was obtained.  
Chlorobenzene (112.5 mg, 1.0 mmol), (7E,9Z)-7-tert-butylbenzo[8]annulen-5(6H)-one 
(11) (113 mg, 0.5 mmol), TMPLi in pentane/hexanes (1M, 1.6 mL), followed by THF 
(0.03 mL), rt, 24 hours. After column chromatography (hexanes, followed by 
hexanes/EtOAc 95/15), 96 mg (64 %) of a light yellow oil was obtained.  
Rf = 0.34 (hexanes/EtOAc 95/5). 
1
H NMR (400 MHz, CDCl3) δ 7.92 (dd. J = 7.8 Hz, 0.8 
Hz, 1H), 7.42 (dt, J = 7.8 Hz, 1.3 Hz, 1H), 7.34 (dt, J = 7.8 Hz, 1.3 Hz, 1H), 7.21 (dt, J = 
7.5 Hz, 1.3 Hz, 1H), 7.14 – 7.08 (m, 2H), 6.98 (dt, J = 7.5 Hz, 1.3 Hz, 1H), 6.55 – 6.52 
(m, 2H), 6.42 (dd, J = 9.5 Hz, 3.2 Hz, 1H), 5.58 (dd, J = 9.5 Hz, 2.2 Hz, 1H), 3.73 (t, J = 
2.8 Hz, 1H), 2.45 (s, 1H), 1.26 (s, 9H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 147.5, 138.0, 
136.9, 133.9, 133.2, 129.5, 129.3, 128.6, 127.9, 127.8, 127.3, 126.9, 126.4, 126.2, 126.0, 
119.5, 74.9, 43.9, 36.2, 28.6. FT-IR (neat, cm
-1
) 2950, 1537, 1321. Anal calcd for 
C22H22O (302.17 g/mol): C, 87.38; H, 7.33; Found. C, 86.98; H, 7.45. 
 
 
 
6a-Phenyl-6a,12b-dihydrobenzophenanthren-12b-ol (14) (Scheme 3.4.11) 
Chlorobenzene (225 mg, 2.0 mmol), 4-hydroxybiphenyl (85 mg, 0.5 mmol), TMPLi in 
pentane/hexanes (1M, 2.7 mL), followed by THF (0.05 mL), rt, 24 hours. After column 
HO
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chromatography (hexanes, followed by hexanes/EtOAc 95/5), 122 mg (70 %) of a white 
solid was obtained.  
Rf = 0.31 (hexanes/EtOAc 90/10). 
1
H NMR (400 MHz, CDCl3) δ 7.43 – 7.40 (m, 3H), 
7.30 – 7.22 (m, 6H), 7.17 – 7.14 (m, 4H), 6.77 (d, J = 9.0 Hz, 2H), 5.97 (broad singlet, 
2H), 1.89 (s, 1H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 137.9, 136.9, 132.8 (broad), 131.7 
(broad), 129.4, 128.4, 128.3, 128.1, 127.7, 127.0, 126.5, 51.8. Signals for two carbons 
could not be located. FT-IR (neat, cm
-1
) 2955, 1544, 1334, 1235. Anal calcd for C24H18O 
(322.14 g/mol): C, 89.41; H, 5.63; Found. C, 88.97; H, 5.55. 
O
 
6a-Phenyl-6a-hydro-12b-methoxybenzophenanthrene (Scheme 3.4.11) 
A 2 dram vial equipped with magnetic stirring bar was charged with 6a-phenyl-6a,12b-
dihydrobenzophenanthren-12b-ol (13) (175 mg, 0.5 mmol), MeI (284 mg, 2.0 mmol). 
Vial was flushed with nitrogen and taken into glovebox. To this mixture, THF (1 mL) 
was added, followed by NaH (24 mg, 1.0 mmol). Vial was shaken to release all generated 
hydrogen. Vial was capped, taken out glovebox and placed in oil bath at 50 
o
C for 4 
hours. After completion, vial was allowed to cool down to room temperature and reaction 
mixture was quenched with H2O (10 mL). The reaction mixture was diluted with ethyl 
acetate (30 mL) and washed with brine (1 x 30 mL). The aqueous phase was extracted 
with ethyl acetate (3 x 15 mL). Combined organic phase was dried over anhydrous 
MgSO4 and concentrated under reduced pressure. The residue was dissolved EtOAc (1 
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mL) and subjected to column chromatography on silica gel (hexane followed 95/5 
hexane/EtOAc). After concentration of fractions containing product, 173 mg (91 %) of a 
light yellow solid was obtained. 
Recrystallization procedure: Vial equipped with magnetic stirring bar was charged with 
50 mg of product. Hexane (1.5 mL) was then added. Vial was placed into oil bath at 60 
o
C for an hour. CH2Cl2 was added to vial dropwise at 40 
o
C until all solid dissolved. Vial 
was capped and taken out oil bath and allowed to cool down to room temperature to 
obtain crystals suiTable 3.4.for X-ray analysis. 
Rf = 0.33 (hexanes/EtOAc 95/5). 
1
H NMR (400 MHz, CDCl3) δ 7.36 – 7.32 (m, 3H), 
7.28 – 7.24 (m, 3H), 7.22 – 7.17 (m, 4H), 7.17 – 7.10 (m, 4H), 6.66 (d, J = 9.6 Hz, 2H), 
5.98 (broad singlet, 2H), 3.08 (s, 3H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 138.63, 134.0 
(broad), 133.5 (broad), 129.3, 128.5, 128.2, 127.9, 127.7, 127.0, 126.0, 81.2, 53.6, 51.5. 
Signals for two carbons could not be located. 
General procedure for arylation of phenols: Outside the glovebox a 2-dram vial 
equipped with a magnetic stirring bar was charged with chloroarene (0.8 – 2.0 mmol), 
phenol (0.5 mmol), and AgOAc (0 – 1.0 mmol). The vial was flushed with nitrogen, 
capped and placed inside the glovebox. To this mixture was added dioxane (0.8 – 1.3 
mL), t-BuONa (1.5 – 3.0 mmol). The sealed vial was taken out the glovebox, stirred at 
room temperature for 5 minutes, placed in ultrasonic bath for 1 minute, covered with 
aluminum foil, and then transferred to preheated oil bath for indicated time. Reaction 
vials were occasionally shaken during first few hours to ensure complete mixing which is 
important to ensure reproducible yields. The reaction mixture was cooled to room 
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temperature and quenched with 10 % aqueous citric acid (10 mL). The reaction mixture 
was diluted with ethyl acetate (30 mL) and washed with brine (1 x 30 mL). The aqueous 
phase was extracted with ethyl acetate (3 x 15 mL). Combined organic phases were dried 
over anhydrous MgSO4 and concentrated under reduced pressure. The residue was 
dissolved in minimal amount of ethyl acetate and subjected to column chromatography 
on silica gel in hexane followed by appropriate solvent to elute the products. After 
concentrating the fractions containing the product, the residue was dried under reduced 
pressure. 
Optimization of conditions for phenol arylation: All reactions were carried out 
following the general procedure. Phenol (x mmol), chlorobenzene (y mmol), base [1.3*(x 
+ y) mmol], solvent (1 mL), 24 hours. Conversions and 3/1 ratio were calculated by GC 
analysis. Conversions are presented in Table 3.4.S1 and show the amount of product 1 
and 3 formed (e.g. 70 % means that 70 % of starting limiting reagent is converted to 1 
and 3). Mixture with exact molar amounts of pure 1 and pure 3 was used as the standard 
to determine the ratio 3/1. 
Table 3.4.15. Optimization of phenol o-arylation 
Ph-Cl Ph-OH
Conditions
Ph-O-Ph
1
OH
Ph
3  
Entry 
PhOH/
PhCl 
Base/T (
o
C) Solvent 
Additive 
/equiv. 
Conversion 3/1 
1 1/2 TMPLi/25 Etheral None 32 < 1/50 
 308 
2 1/2 TMPLi/25 Pentane/Ether None 15 < 1/50 
3 1/2 NaHMDS/50 THF None 95 < 1/50 
4 1/2 t-BuOK/110 Dioxane None 91 1/9 
5 1/2 t-BuONa/155 Dioxane None 87 1/7 
6 2/1 t-BuONa/155 Dioxane None 68 1/11 
7 1/2 t-BuONa/155 Toluene None 45 1/10 
8 1/2 t-BuONa/155 Dioxane AgOAc/1.0 87 30/1 
9 1/2 t-BuONa/155 Dioxane AgOAc/0.5 79 24/1 
10 1/2 t-BuONa/155 Dioxane AgOAc/0.1 65 15/1 
11 1/2 t-BuONa/155 Dioxane MnCl2/1.0 32 7/1 
12 1/2 t-BuONa/155 Dioxane NiCl2/1.0 < 5 ND 
14 1/2 t-BuONa/155 Dioxane FeCl3/1.0 13 3/1 
 
OH
Ph
 
2-Phenylphenol (Table 3.4.7, Entry 1) 
Chlorobenzene (101 mg, 0.9 mmol), phenol (47 mg, 0.5 mmol), AgOAc (42 mg, 0.25 
mmol), t-BuONa (192 mg, 2.0 mmol), dioxane (0.8 mL), 155 
o
C, 48 hours. After column 
chromatography (hexanes, followed by hexanes/EtOAc 90/10), 66 mg (78 %) of a light 
yellow solid was obtained. Rf = 0.32 (hexanes/EtOAc 90/10). This compound is known.
48
 
1
H NMR (400 MHz, CDCl3) δ 7.54 – 7.49 (m, 4H), 7.45 – 7.40 (m, 1H), 7.32 – 7.27 (m, 
2H), 7.06 – 7.00 (m, 2H), 5.30 (s, 1H). 13C NMR (100 MHz, CDCl3, ppm) δ 152.5, 137.2, 
130.4, 129.5, 129.3, 129.2, 128.3, 128.0, 121.0, 116.0. 
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2,6-Diphenylphenol (Table 3.4.7, Entry 2) 
Chlorobenzene (282 mg, 2.5 mmol), phenol (47 mg, 0.5 mmol), AgOAc (125 mg, 0.75 
mmol), t-BuONa (336 mg, 3.5 mmol), dioxane (1.2 mL), 155 
o
C, 96 hours. After column 
chromatography (hexanes, followed by hexanes/EtOAc 95/5), 73 mg (60 %) of a white 
solid was obtained. Rf = 0.27 (hexanes/EtOAc 95/5). This compound is known.
49
 
1
H 
NMR (400 MHz, CDCl3) δ 7.60 – 7.58 (m, 4H), 7.53 – 7.49 (m, 4H), 7.44 – 7.40 (m, 
2H), 7.31 (d, J = 7.5 Hz, 2H), 7.09 (t, J = 7.5 Hz, 1H), 5.44 (s, 1H). 
13
C NMR (100 MHz, 
CDCl3, ppm) δ 149.4, 137.7, 130.1, 129.5, 129.0, 128.9, 127.8, 120.8. 
 
 
3'-Fluorobiphenyl-2-ol (Table 3.4.7, Entry 3) 
1-Fluoro-3-chlorobenzene (105 mg, 0.8 mmol), phenol (47 mg, 0.5 mmol), AgOAc (58 
mg, 0.35 mmol), t-BuONa (173 mg, 1.8 mmol), dioxane (1.0 mL), 135 
o
C, 48 hours. 
After column chromatography (hexanes, followed by hexanes/EtOAc 90/10), 67 mg (72 
%) of a light yellowish oil was obtained. Rf = 0.29 (hexanes/EtOAc 90/10). This 
compound is known.
50
 
1
H NMR (400 MHz, CDCl3) δ 7.47 – 7.41 (m, 1H), 7.30 – 7.19 
(m, 4H), 7.11 – 7.06 (m, 1H), 7.02 – 6.96 (m, 2H), 5.17 (s, 1H). 13C NMR (100 MHz, 
CDCl3, ppm) δ 163.3 (d, JC-F = 247.7 Hz), 152.4, 139.5 (d, JC-F = 7.8 Hz), 130.7 (d, JC-F = 
8.7 Hz), 130.3, 129.7, 127.0, 124.8 (d, JC-F = 2.5 Hz), 121.2, 116.3 (d, JC-F = 21.9 Hz), 
116.2, 114.8 (d, JC-F = 21.9 Hz). 
OH
PhPh
OH
F
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3'-Methoxybiphenyl-2-ol (Table 3.4.7, Entry 4) 
2-Chloroanisole (215 mg, 1.5 mmol), phenol (47 mg, 0.5 mmol), t-BuONa (240 mg, 2.5 
mmol), AgOAc (67 mg, 0.4 mmol), dioxane (1.0 mL), 155 
o
C, 48 hours. After column 
chromatography (hexanes, followed by hexanes/EtOAc 85/15), 64 mg (64 %) of a white 
solid was obtained. Rf = 0.25 (hexanes/EtOAc 85/15). This compound is known.
51
 
1
H 
NMR (400 MHz, CDCl3) δ 7.41 (t, J = 7.8 Hz, 1H), 7.30 – 7.25 (m, 2H), 7.07 – 7.04 (m, 
1H), 7.02 – 6.99 (m, 3H), 6.95 (dd, J = 8,2 Hz, 2.7 Hz, 1H), 5.39 (s, 1H), 3.85 (s, 3H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 160.4, 152.5, 138.5, 130.5, 130.2, 129.4, 128.0, 
121.3, 120.9, 115.9, 114.6, 113.7, 55.4. 
 
OH
 
4-Methylbiphenyl-2-ol (Table 3.4.7, Entry 5) 
Chlorobenzene (170 mg, 1.5 mmol), m-cresol (54 mg, 0.5 mmol), AgOAc (144 mg, 0.85 
mmol), sodium tert-pentoxide (336 mg, 3.0 mmol), dioxane (1.0 mL), 155 
o
C, 48 hours. 
After column chromatography (hexanes, followed by hexanes/EtOAc 93/7), 73 mg (80 
%) of a colorless oil was obtained. Isomer ratio in crude product was determined to be 
9/1 (4-methylbiphenyl-2-ol)/(6-methylbiphenyl-2-ol) by GC analysis. 
Rf = 0.28 (hexanes/EtOAc 93/7). This compound is known.
52
 
1
H NMR (400 MHz, 
CDCl3) δ 7.49 – 7.44 (m, 4H), 7.39 – 7.36 (m, 1H), 7.13 (d, J = Hz, 1H), 6.82 – 6.81 (m, 
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2H), 5.15 (s, 1H), 2.36 (s, 3H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 152.3, 139.5, 137.2, 
130.1, 129.4, 129.2, 127.8, 125.3, 121.8, 116.5, 21.3. 
O
OH  
(6-Hydroxybiphenyl-3-yl)(phenyl)methanone (Table 3.4.7, Entry 6) 
Chlorobenzene (225 mg, 2.0 mmol), 4-hydroxybenzophenone (99 mg, 0.5 mmol), t-
BuONa (338 mg, 3.5 mmol), AgOAc (167 mg, 1.0 mmol), dioxane (1.0 mL), 155 
o
C, 96 
hours. After column chromatography (hexanes, followed by hexanes/EtOAc 50/50), 79 
mg (58 %) of a white solid was obtained. Rf = 0.31 (hexanes/EtOAc 40/60). This 
compound is known.
53
 
1
H NMR (400 MHz, DMSO-d6) δ 10.64 (s, 1H), 7.69 – 7.67 (m, 
2H), 7.63 – 7.58 (m, 3H), 7.52 – 7.49 (m, 4H), 7.38 (t, J = 7.6 Hz, 2H), 7.29 (tt, J = 7.6 
Hz, 2.2 Hz, 1H), 7.06 (d, J = 8.7 Hz, 1H).
13
C NMR (100 MHz, DMSO-d6, ppm) δ 194.8, 
159.5, 138.5, 138.0, 133.5, 132.5, 131.9, 129.8, 129.6, 129.0, 128.8, 128.7, 128.3, 127.6, 
116.5. 
OH
Ph
 
1-Phenyl-1-naphthol (Table 3.4.7, Entry 7) 
Chlorobenzene (225 mg, 2.0 mmol), 1-naphthol (72 mg, 0.5 mmol), AgOAc (167 mg, 1.0 
mmol), t-BuONa (384 mg, 4.0 mmol), dioxane (1.0 mL), 155 
o
C, 48 hours. After column 
chromatography (hexanes, followed by hexanes/EtOAc 93/7), 90 mg (82 %) of a white 
solid was obtained. Rf = 0.28 (hexanes/EtOAc 90/10). This compound is known.
54
 
1
H 
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NMR (400 MHz, CDCl3) δ 8.31 – 8.29 (m, 1H), 7.84 – 7.81 (m, 1H), 7.58 – 7.54 (m, 
4H), 7.53 – 7.48 (m, 3H), 7.47 – 7.42 (m, 1H), 7.37 (d, J = 8.5 Hz, 1H), 5.84 (s, 1H). 13C 
NMR (100 MHz, CDCl3, ppm) δ 147.8, 137.5, 134.3, 129.7, 129.5, 128.0, 127.7, 127.6, 
126.6, 125.7, 124.4, 122.5, 121.3, 120.3. 
Ph
OH
 
1-Phenyl-2-naphthol (Table 3.4.7, Entry 8) 
Chlorobenzene (225 mg, 2.0 mmol), 2-naphthol (72 mg, 0.5 mmol), t-BuONa (384 mg, 
4.0 mmol), dioxane (1.0 mL), 155 
o
C, 72 hours. After column chromatography (hexanes, 
followed by hexanes/EtOAc 93/7), 87 mg (80 %) of a light brown solid was obtained.  
Large scale synthesis: A 50 mL pressure vessel equipped with a stir bar was charged with 
2-naphthol (1.44 g, 10.0 mmol) and chlorobenzene (4.5 g, 40.0 mmol). The vessel was 
flushed with nitrogen, capped and placed inside the glovebox. To this mixture was added 
dioxane (20 mL) and t-BuONa (7.6 g, 80 mmol). The sealed vessel was taken out the 
glovebox, reaction mixture was stirred at room temperature for 5 minutes, then placed in 
preheated oil bath at 155 
o
C for 72 hours. The reaction mixture was cooled to room 
temperature and quenched with 10 % aqueous citric acid (50 mL). The reaction mixture 
was diluted with ethyl acetate (100 mL) and washed with brine (1 x 50 mL). The aqueous 
phase was extracted with ethyl acetate (3 x 30 mL). Combined organic phases were dried 
over anhydrous MgSO4 and concentrated under reduced pressure. The residue was 
dissolved in minimal amount of ethyl acetate and subjected to column chromatography 
on silica gel in hexane followed by hexanes/EtOAc 93/7 to elute the product. After 
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concentrating the fractions containing the product, 1.69 g (77 %) of a light brown solid 
was obtained. 
Rf = 0.27 (hexanes/EtOAc 90/10). This compound is known.
55
 
1
H NMR (400 MHz, 
CDCl3) δ7.85 – 7.81 (m, 2H), 7.61 – 7.58 (m, 2H), 7.54 – 7.50 (m, 1H), 7.45 – 7.41 (m, 
3H), 7.37 – 7.33 (m, 2H), 7.28 (d, J = 8.6 Hz, 1H), 5.18 (s, 1H). 13C NMR (100 MHz, 
CDCl3, ppm) δ 150.3, 134.3, 133.3, 131.3, 129.8, 129.6, 129.0, 128.6, 128.2, 126.6, 
124.7, 123.4, 121.1, 117.5. 
OH
CF3
 
1-(3-(Trifluoromethyl)phenyl)-2-naphthol (Table 3.4.7, Entry 9) 
3-Chlorobenzotrifluoride (360 mg, 2.0 mmol), 2-naphthol (72 mg, 0.5 mmol), t-BuONa 
(384 mg, 4.0 mmol), dioxane (1.0 mL), 135 
o
C, 48 hours. After column chromatography 
(hexanes, followed by hexanes/EtOAc 90/10), 106 mg (74 %) of a light brown oil was 
obtained. Rf = 0.29 (hexanes/EtOAc 90/10). 
1
H NMR (400 MHz, CDCl3) δ 7.86 – 7.82 
(m, 2H), 7.80 – 7.78 (m, 1H), 7.75 – 7.70 (m, 2H), 7.65 – 7.63 (m, 1H), 7.41 – 7.31 (m, 
3H), 7.27 (d, J = 8.8 Hz, 1H), 5.1 (s, 1H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 150.3, 
135.6, 134.8, 133.2, 132.0 (q, JC-F = 32 Hz), 130.3, 130.1, 129.1, 128.3, 128.2 (q, JC-F = 
3.7 Hz), 127.0, 125.3 (q, JC-F = 3.7 Hz), 124.3, 124.0 (q, JC-F = 272 Hz), 123.7, 119.7, 
117.7. FT-IR (neat, cm
-1
) 1331, 1166, 1123. Anal calcd for C17H11F3O (288.08 g/mol): C, 
70.83; H, 3.85; Found. C, 71.12; H, 3.52. 
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OH
CO2tBu
 
tert-Butyl 3-(2-hydroxynaphthalen-1-yl)benzoate (Table 3.4.7, Entry 10) 
tert-Butyl-3-bromobenzoate (385 mg, 1.5 mmol), 2-naphthol (72 mg, 0.5 mmol), t-
BuONa (384 mg, 4.0 mmol), dioxane (1.0 mL), 150 
o
C, 24 hours. After column 
chromatography (hexanes, followed by hexanes/EtOAc 90/10), 112 mg of a light 
yellowish oil containing a mixture of product and 2-naphthol was obtained. NMR 
analysis showed that the mixture contains 104 mg (66 %) of product. Attempts to 
completely separate product from starting material by preparative TLC and HPLC failed. 
Rf = 0.27 (hexanes/EtOAc 90/10). 
1
H NMR (400 MHz, CDCl3) δ 8.15 (td, J = 7.8 Hz, 1.4 
Hz, 1H), 8.04 (t, J = 1.4 Hz, 1H), 7.84 – 7.81 (m, 2H), 7.65 (t, J = 7.8 Hz, 1H), 7.58 (td, J 
= 7.8 Hz, 1.4 Hz, 1H), 7.36 – 7.30 (m, 3H), 7.25 (s, 1H), 5.00 (s, 1H), 1.59 (s, 9H) . 13C 
NMR (100 MHz, CDCl3, ppm) δ 165.4, 150.3, 135.4, 134.5, 133.5, 133.3, 132.1, 129.9, 
129.7, 129.6, 129.0, 128.2, 126.8, 124.5, 123.6, 120.3, 117.5, 81.6, 28.3. FT-IR (neat, cm
-
1
) 2965, 1662, 1597, 1289. Anal calcd for C21H20O3 (320.14 g/mol): C, 78.73; H, 6.29; 
Found. C, 78.24; H, 6.03. 
OH
CN
 
3-(2-Hydroxynaphthalen-1-yl)benzonitrile (Table 3.4.7, Entry 11) 
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3-Chlorobenzonitrile (205.5 mg, 1.5 mmol), 2-naphthol (72 mg, 0.5 mmol), t-BuONa 
(288 mg, 3.0 mmol), dioxane (1.0 mL), 140 
o
C, 72 hours. After column chromatography 
(hexanes, followed by hexanes/EtOAc 75/25), 79 mg (65 %) of a brown oil was obtained. 
Rf = 0.22 (hexanes/EtOAc 75/25). 
1
H NMR (400 MHz, CDCl3) δ 7.84 – 7.81 (m, 2H), 
7.79 – 7.74 (m, 2H), 7.69 – 7.67 (m, 2H), 7.39 – 7.35 (m, 2H), 7.30 – 7.26 (m, 1H), 7.25 
(d, J = 8.7 Hz, 1H), 5.48 (s, 1H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 150.3, 136.6, 
136.1, 135.0, 133.1, 131.9, 130.5, 130.3, 129.0, 128.4, 127.2, 124.0, 123.8, 119.1, 118.6, 
117.8, 113.5. FT-IR (neat, cm
-1
) 3394, 2232, 1513, 1273. Anal calcd for C17H11NO 
(245.08 g/mol): C, 83.25; H, 4.52; Found. C, 83.41; H, 4.04. 
Note: product contains less than 3 % of another isomer. 
OH
Ph
OH
Ph  
3,3
’
-Diphenyl-1,1'-binaphthyl-2,2'-diol (21) (Scheme 3.4.13) 
Chlorobenzene (337 mg, 3.0 mmol), 1,1'-binaphthyl-2,2'-diol (143 mg, 0.5 mmol), t-
BuONa (432 mg, 4.5 mmol), AgOAc (168 mg, 1.0 mmol), dioxane (1.3 mL), 155 
o
C, 96 
hours. After column chromatography (hexanes, followed by hexanes/EtOAc 90/10), 111 
mg (51 %) of a light yellow solid was obtained. Rf = 0.36 (hexanes/EtOAc 90/10). This 
compound is known.
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1
H NMR (400 MHz, CDCl3) δ 8.02 (s, 2H), 7.92 (d, J = 8.3 Hz, 
2H), 7.75 – 7.71 (m, 4H), 7.51 – 7.47 (m, 4H), 7.42 – 7.37 (m, 4H), 7.34 – 7.30 (m, 2H), 
7.24 (t, J = 8.7 Hz, 2H), 5.35 (s, 2H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 150.2, 137.5, 
133.0, 131.5, 130.7, 129.7, 129.5, 128.6, 128.5, 127.9, 127.5, 124.4, 124.3, 112.4. 
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OH
Ph
OH
 
3-Phenyl-1,1'-binaphthyl-2,2'-diol (22) (Scheme 3.4.13) 
Chlorobenzene (192 mg, 1.7 mmol), 1,1'-binaphthyl-2,2'-diol (143 mg, 0.5 mmol), t-
BuONa (288 mg, 3.0 mmol), AgOAc (144 mg, 0.85 mmol), dioxane (1.0 mL), 155 
o
C, 48 
hours. After column chromatography (hexanes, followed by hexanes/EtOAc 87/13), 120 
mg (67 %) of a light yellow solid was obtained. Rf = 0.26 (hexanes/EtOAc 85/15). This 
compound is known.
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1
H NMR (400 MHz, CDCl3) δ 8.04 (s, 1H), 7.97 (d, J = 9.1 Hz, 
1H), 7.94 – 7.89 (m, 2H), 7.76 – 7.73 (m, 2H), 7.53 – 7.49 (m, 2H), 7.45 – 7.31 (m, 6H), 
7.27 – 7.25 (m, 1H), 7.17 (d, J = 8.5 Hz, 1H), 5.33 (s, 1H), 5.13 (s, 1H). 13C NMR (100 
MHz, CDCl3, ppm) δ 152.8, 150.4, 137.5, 133.5, 133.1, 131.6, 131.5, 130.8, 129.7, 129.6, 
128.7, 128.6, 128.5, 127.9, 127.6, 124.5, 124.4, 124.3, 124.1, 117.9, 111.9, 111.6. Signals 
for two carbons could not be located. 
OH
Ph
OH
F
 
3-(3-Fluorophenyl)-3'-phenyl-1,1'-binaphthyl-2,2'-diol (23) (Scheme 3.4.13) 
1-Chloro-3-fluorobenzene (260 mg, 2.0 mmol), 3-phenyl-1,1'-binaphthyl-2,2'-diol (180 
mg, 0.5 mmol), t-BuONa (338 mg, 3.5 mmol), AgOAc (168 mg, 1.0 mmol), dioxane (1.0 
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mL), 135 
o
C, 96 hours. After column chromatography (hexanes, followed by 
hexanes/EtOAc 93/7), 136 mg (60 %) of a light yellow solid was obtained. Rf = 0.31 
(hexanes/EtOAc 90/10), mp  118 – 120 oC (from hexanes). 1H NMR (400 MHz, CDCl3) 
δ 8.06 (d, J = 2.7 Hz, 2H), 7.95 (d, J = 7.8 Hz, 2H), 7.77 – 7.74 (m, 2H), 7.55 – 7.50 (m, 
4H), 7.46 – 7.40 (m, 4H), 7.37 – 7.33 (m, 2H), 7.27 – 7.24 (m, 2H), 7.12 (ddt, J = 8.4 Hz, 
2.7 Hz, 0.9 Hz, 1H), 5.39 (s, 2H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 162.8 (d, JC-F = 
244.6 Hz), 150.4, 150.0, 139.8 (d, JC-F = 7.9 Hz), 137.4, 133.2, 133.0, 131.7 (d, JC-F = 
10.4 Hz), 130.8, 129.9, 129.8, 129.7, 129.6, 129.5, 128.8, 128.7, 128.6, 128.0, 127.8, 
127.6, 125.4 (d, JC-F = 2.8 Hz), 124.6, 124.4, 124.3, 116.8 (d, JC-F = 22.2 Hz), 114.6 (d, 
JC-F = 22.2 Hz).112.8, 112.0. Signals for two carbons could not be located. FT-IR (neat, 
cm
-1
) 2956, 1434, 1263, 1121. Anal calcd for C32H21FO2 (456.15 g/mol): C, 84.19; H, 
4.64; Found. C, 84.01; H, 4.65. 
Note: product contains less than 4 % of another isomer. 
 
 
 
 
3-(3-Methoxyphenyl)-(R)-(+)-1,1'-binaphthyl-2,2'-diol (24) (Scheme 3.4.13) 
3-Chloroanisole (285 mg, 2.0 mmol), (R)-(+)-1,1
’
-bi(2-naphthol) (143 mg, 0.5 mmol), t-
BuONa (336 mg, 3.5 mmol), AgOAc (153 mg, 0.9 mmol), dioxane (1.0 mL), 130 
o
C, 36 
hours. After column chromatography (hexanes, followed by hexanes/EtOAc 85/15), and 
then HPLC (hexanes/EtOAc 87/13), 97 mg (50 %) of a light yellow solid was obtained.  
OH
OH
O
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Determination of % ee by HPLC on chiral stationary phase: CHIRALPAK ID, 
hexanes/isopropanol 95:5, 0.75 mL/min, 95 % ee. Retention time: major, (R) = 31.3 min, 
(S) = 34.6 min.  
Rf = 0.22 (hexanes/EtOAc 85/15). 
1
H NMR (400 MHz, CDCl3) δ 8.02 (s, 1H), 7.97 (d, J 
= 8.9 Hz, 1H), 7.90 (t, J = 8.5 Hz, 2H), 7.42 – 7.35 (m, 4H), 7.33 – 7.21 (m, 5H), 7.15 (d, 
J = 8.5 Hz, 1H), 6.96 (ddd, J = 8.2 Hz, 2.7 Hz, 0.9 Hz, 1H), 5.16 (broad singlet, 2H), 3.86 
(s, 3H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 159.8, 152.8, 152.7, 150.3, 138.8, 133.5, 
131.6, 131.5, 131.4, 129.7, 129.6, 128.6, 128.5, 127.6, 127.5, 124.5, 124.4, 124.3, 124.1, 
122.0, 117.8, 115.3, 113.6, 111.9, 111.7, 110.9, 55.5. FT-IR (neat, cm
-1
) 2946, 1344, 
1363. Anal calcd for C27H20O3 (492.14 g/mol): C, 82.63; H, 5.14; Found. C, 82.11; H, 
4.85. 
Note: Product contains less than 3 % of 1,1
’
-bi(2-naphthol). 
Control experiment: Diphenyl ether (78 mg, 0.5 mmol), PhCl (113 mg, 1.0 mmol), 
AgOAc (170 mg, 1.0 mmol), dioxane (1 mL), 155 
o
C, 48 hours. No detectable amount of 
2-phenylphenol was observed by GC and diphenyl ether was recovered. 
Additional examples 
 
 
 
2,4-Diphenylphenol 
Chlorobenzene (136 mg, 1.2 mmol), 4-phenylphenol (85 mg, 0.5 mmol), AgOAc (42 mg, 
0.25 mmol), t-BuONa (192 mg, 2.0 mmol), dioxane (1.0 mL), 155 
o
C, 72 hours. After 
OH
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column chromatography (hexanes, followed by hexanes/EtOAc 90/10), 94 mg (77 %) of 
a white solid was obtained. Rf = 0.25 (hexanes/EtOAc 90/10). This compound is 
known.
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1
H NMR (400 MHz, CDCl3) δ 7.6 – 7.56 (m ,2H), 7.54 – 7.49 (m, 6H), 7.44 – 
7.40 (m, 3H), 7.33 – 7.29 (m, 1H), 7.07 (d, J = 7.6 Hz, 1H), 5.29 (s, 1H). 13C NMR (100 
MHz, CDCl3, ppm) δ 152.1, 140.7, 137.1, 134.1, 129.5, 129.3, 129.1, 128.9, 128.5, 128.1, 
127.9, 127.0, 126.9, 116.4. 
Ph
OHO
 
7-Methoxy-1-phenyl-2-naphthol 
Chlorobenzene (225 mg, 2.0 mmol), 7-methoxy-2-naphthol (87 mg, 0.5 mmol), t-BuONa 
(384 mg, 4.0 mmol), dioxane (1.0 mL), 155 
o
C, 48 hours. After column chromatography 
(hexanes, followed by hexanes/EtOAc 85/15), 108 mg (87 %) of a white solid was 
obtained. Rf = 0.21 (hexanes/EtOAc 85/15). This compound is known.
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1
H NMR (400 
MHz, CDCl3) δ 7.74 – 7.71 (m, 2H), 7.61 – 7.57 (m, 2H), 7.52 – 7.48 (m, 1H), 7.46 – 
7.43 (m, 2H), 7.13 (d, J = 8.7 Hz, 1H), 7.01 (dd, J = 8.7 Hz, 2.4 Hz, 1H), 6.72 (d, J = 2.4 
Hz, 1H), 5.18 (s, 1H), 3.70 (s, 3H). 
13
C NMR (100 MHz, CDCl3, ppm) δ 158.4, 150.9, 
134.7, 134.5, 131.3, 129.8, 129.7, 129.4, 128.6, 124.4, 120.4, 115.4, 115.0, 103.9, 55.2. 
OH
Ph
 
4-tert-Butylbiphenyl-2-ol 
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Chlorobenzene (136 mg, 1.2 mmol), 3-tert-butylphenol (75 mg, 0.5 mmol), AgOAc (42 
mg, 0.25 mmol), t-BuONa (192 mg, 2.0 mmol), dioxane (1.0 mL), 155 
o
C, 48 hours. 
After column chromatography (hexanes, followed by hexanes/EtOAc 95/5), 81 mg (72 
%) of a white solid was obtained. Rf = 0.33 (hexanes/EtOAc 95/5). This compound is 
known.
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1
H NMR (400 MHz, CDCl3) δ 7.50 – 7.45 (m, 4H), 7.40 – 7.36 (m, 1H), 7.20 – 
7.17 (m, 1H), 7.05 – 7.01 (m, 2H), 5.18 (s, 1H), 1.35 (s, 9H). 13C NMR (100 MHz, 
CDCl3, ppm) δ 153.0, 152.1, 137.2, 129.8, 129.4, 129.1, 127.7, 125.2, 118.1, 113.1, 34.7, 
31.4. 
X-RAY DATA 
All measurements were made with a Siemens SMART platform diffractometer equipped 
with a 4K CCD APEX II detector. A hemisphere of data (1271 frames at 6 cm detector 
distance) was collected using a narrow-frame algorithm with scan widths of 0.30\% in 
omega and an exposure time of 45s/frame. The data were integrated using the Bruker-
Nonius SAINT program, with the intensities corrected for Lorentz factor, polarization, air 
absorption, and absorption due to variation in the path length through the detector 
faceplate. A psi scan absorption correction was applied based on the entire data set. 
Redundant reflections were averaged. Final cell constants were refined using 3030 
reflections having I>10\s(I), and these, along with other information pertinent to data 
collection and refinement, are listed in Table 3.4.S1. The Laue symmetry was determined 
to be 2/m, and from the systematic absences noted the space group was shown 
unambiguously to be P2(1)/c. 
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Crystal Data and Structure Refinement for O-methylated 14 
Empirical formular   C25H20O 
Formular weight   336.41 
Temperature    223 (2) K 
Wavelength    0.71073 Å 
Crystal system, space group  Monoclinic, P-2 
Unit cell dimensions   a = 11.7510 (9) Å alpha = 90.00 
     b = 7.5332 (6) Å beta = 95.651 (1) 
     c = 19.9382 (15) Å gamma = 90.00 
Volume    1756.4 (2) Å
^ 
3 
Z, calculated density   4, 1.272 Mg/m
^
3 
Absorption coefficient  0.076 mm
^
-1 
F(000)     712 
Crystal color and shape  colorless plate 
Crystal size    0.35 x 0.30 x 0.06 mm 
Theta range for data collection 1.74 to 25.02 deg. 
Limiting indices   -13<=h<=13, 0<=k<=8, 0<=l<=23 
Reflections collected/unique  8948/3346 [R(int) = 0.0277] 
Completeness to theta 25.02  96.2 % 
Absorption correction   Empirical 
Max. and min. transmission  0.9877  and 0.8927 
Refinement method   Full-matrix least squares on F
^
2 
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Data/restrains/parameter  3090/0/237 
Goodness-of-fit on F
^
2  0.973 
Final R indices [I>4sigma(I)]  R1 = 0.0299 and wR2 = 0.0772 
R indices (all data)   R1 = 0.0525 and wR2 = 0.0916 
 
Figure 3.4.1. ORTEP view of 6a-phenyl-6a-hydro-12b-methoxybenzophenanthrene 
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